<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Inicet Mock Test-3 - 22-09-2025 - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / GT
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">200</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 93340,
    "choices": [
      {
        "id": 371624,
        "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-c, 3-b, 4-a</span></p>"
      },
      {
        "id": 371625,
        "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-a, 3-d, 4-b</span></p>"
      },
      {
        "id": 371626,
        "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-b, 3-a, 4-c</span></p>"
      },
      {
        "id": 371627,
        "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-b, 3-c, 4-a</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following procedures with their correct clinical indication or description:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-16%20173923_5dYxYzv.jpg\" width=\"928\" height=\"288\"></strong></span></p>",
    "unique_key": "Q9832208",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1-d, 2-c, 3-b, 4-a</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Paul Miculicz procedure (1-d) Resection of sigmoid with double-barrel stoma:</strong> Resection of sigmoid with double-barrel stoma, commonly performed in strangulated sigmoid volvulus with contamination risk.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bishop-Koop procedure (2-c)</strong> <strong>Procedure for meconium ileus:</strong> Used in <strong>meconium ileus</strong>, creating a proximal stoma with distal chimney to decompress bowel.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hartmann procedure (3-b)</strong> <strong>End colostomy with rectal stump left inside:</strong> Performed for complicated sigmoid disease, involving resection and <strong>end colostomy</strong> while leaving rectal stump inside.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anterior resection (4-a) Performed for rectal cancers:</strong> Standard operation for rectal cancers where the anal sphincter is preserved.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Paul Miculicz = double-barrel stoma, Bishop-Koop = meconium ileus, Hartmann = rectal stump with colostomy, and anterior resection = rectal cancers.</span></p>",
    "correct_choice_id": 371624,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93340/NEET_PG_22_Sep_2025_Surgery_Question_8.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93340/NEET_PG_22_Sep_2025_Surgery_Question_8.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93640,
    "choices": [
      {
        "id": 372796,
        "text": "<p><span style=\"font-size:14.0pt;\">Zidovudine</span></p>"
      },
      {
        "id": 372797,
        "text": "<p><span style=\"font-size:14.0pt;\">Efavirenz</span></p>"
      },
      {
        "id": 372798,
        "text": "<p><span style=\"font-size:14.0pt;\">Tenofovir</span></p>"
      },
      {
        "id": 372799,
        "text": "<p><span style=\"font-size:14.0pt;\">Atazanavir</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 39-year-old man with advanced HIV infection has recently been started on combination antiretroviral therapy. Two weeks later, he returns with complaints of vivid dreams, dizziness, impaired concentration, and episodes of confusion. His partner also reports noticeable changes in his mental status and mood swings. Which antiretroviral medication is most likely responsible for these neurological toxicities?</span></p>",
    "unique_key": "Q7767169",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Efavirenz</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Efavirenz</strong> is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in highly active antiretroviral therapy (HAART).</span></li><li><span style=\"font-size:14.0pt;\">It is well known to cause <strong>neurological toxicity</strong>, including <strong>altered mental status, insomnia, impaired concentration, vivid dreams, dizziness, and depression</strong>.</span></li><li><span style=\"font-size:14.0pt;\">These neuropsychiatric side effects are particularly problematic early in therapy but may persist in some patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Zidovudine:</strong> A nucleoside reverse transcriptase inhibitor (NRTI); major side effects include <strong>bone marrow suppression (anemia, neutropenia)</strong> and <strong>myopathy</strong>, not neurotoxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tenofovir:</strong> Another NRTI; associated with <strong>renal toxicity (Fanconi syndrome, tubular dysfunction)</strong> and <strong>bone mineral loss</strong>, not altered mental status.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Atazanavir:</strong> A protease inhibitor; adverse effects include <strong>indirect hyperbilirubinemia</strong> and <strong>nephrolithiasis</strong>, not neurological symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is associated with neurological toxicity, including vivid dreams, confusion, dizziness, and altered mental status.</span></p>",
    "correct_choice_id": 372797,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93640/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_17.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93640/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_17.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92879,
    "choices": [
      {
        "id": 369812,
        "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-a, 3-b, 4-d</span></p>"
      },
      {
        "id": 369813,
        "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-b, 3-a, 4-d</span></p>"
      },
      {
        "id": 369814,
        "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-d, 3-b, 4-a</span></p>"
      },
      {
        "id": 369815,
        "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-a, 3-d, 4-b</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following antimicrobial resistance mechanisms (Column A) with their respective bacterial examples (Column B):</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20120850.jpg\" width=\"1242\" height=\"414\"></span></p>",
    "unique_key": "Q1796310",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) 1-c, 2-d, 3-b, 4-a</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Efflux pumps \u2192 Escherichia coli (1\u2013c):&nbsp;</strong>E. coli commonly resists tetracycline via <strong>efflux pumps</strong> (e.g., tetA and tetB genes), which actively transport the drug out of the cell, reducing intracellular antibiotic concentration.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Enzymatic inactivation \u2192 Pseudomonas aeruginosa (2\u2013d):&nbsp;</strong>Pseudomonas is notorious for producing <strong>metallo</strong> <strong>beta-lactamases</strong>, <strong>aminoglycoside-modifying enzymes</strong>, and other <strong>drug-degrading enzymes</strong> that inactivate antibiotics before they reach their targets.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Target site modification \u2192 Staphylococcus aureus (MRSA) (3\u2013b):&nbsp;</strong>MRSA develops resistance by altering the target <strong>penicillin-binding protein (PBP2a)</strong> encoded by the <strong>mecA gene</strong>, making beta-lactams ineffective.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Reduced cell wall permeability \u2192 Mycobacterium tuberculosis (4\u2013a):&nbsp;</strong>M. tuberculosis has a <strong>waxy, lipid-rich cell wall</strong>, reducing drug penetration. This intrinsic barrier contributes to resistance against many antibiotics.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Each bacterium often employs a <strong>specific resistance strategy</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">E. coli \u2192 <strong>Efflux pump</strong> for tetracycline resistance</span></li><li><span style=\"font-size:14.0pt;\">Pseudomonas \u2192 <strong>Enzyme-mediated inactivation</strong></span></li><li><span style=\"font-size:14.0pt;\">MRSA \u2192 <strong>Target site modification (PBP2a)</strong></span></li><li><span style=\"font-size:14.0pt;\">M. tuberculosis \u2192 <strong>Reduced permeability</strong> due to its unique cell wall</span></li></ul>",
    "correct_choice_id": 369814,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92879/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_6.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92879/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_6.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93641,
    "choices": [
      {
        "id": 372800,
        "text": "<p><span style=\"font-size:14.0pt;\">Pretomanid is metabolized in part by CYP3A4, and hence contraindicated in patients receiving strong or moderate enzyme inducers.</span></p>"
      },
      {
        "id": 372801,
        "text": "<p><span style=\"font-size:14.0pt;\">Pretomanid belongs to the bicyclic nitroimidazole class and acts by inhibiting mycolic acid synthesis in mycobacteria.</span></p>"
      },
      {
        "id": 372802,
        "text": "<p><span style=\"font-size:14.0pt;\">Pretomanid is combined with Bedaquiline and Linezolid and is FDA approved for treatment of pre-XDR-TB.</span></p>"
      },
      {
        "id": 372803,
        "text": "<p><span style=\"font-size:14.0pt;\">Pretomanid is ineffective in cases of MDR-TB that are resistant to rifampicin or fluoroquinolones.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Pretomanid is incorrect?</span></p>",
    "unique_key": "Q9001070",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Pretomanid is ineffective in cases of MDR-TB that are resistant to rifampicin or fluoroquinolones</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pretomanid <strong>is effective</strong> in MDR-TB, particularly in cases resistant to <strong>rifampicin and fluoroquinolones</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Pretomanid is metabolized in part by CYP3A4, and hence contraindicated in patients receiving strong or moderate enzyme inducers:&nbsp;</strong>Pretomanid is metabolized by <strong>CYP3A4</strong>, and co-administration with enzyme inducers (e.g., rifampicin) reduces its efficacy. Thus, it is <strong>contraindicated with enzyme-inducer drugs</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Pretomanid belongs to the bicyclic nitroimidazole class and acts by inhibiting mycolic acid synthesis in mycobacteria:</strong> Pretomanid is a <strong>bicyclic nitroimidazole</strong> that targets <strong>mycolic acid synthesis</strong>, a critical component of mycobacterial cell wall formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pretomanid is combined with Bedaquiline and Linezolid and is FDA approved for treatment of pre-XDR-TB:&nbsp;</strong>Pretomanid, in combination with <strong>Bedaquiline and Linezolid</strong>, was FDA-approved in <strong>2019</strong> for <strong>XDR-TB</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pretomanid is a bicyclic nitroimidazole, metabolized by CYP3A4, contraindicated with enzyme-inducer drugs, and FDA-approved with bedaquiline + linezolid for Pre-XDR/XDR-TB.</span></p>",
    "correct_choice_id": 372803,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93641/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_18.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93641/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_18.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93329,
    "choices": [
      {
        "id": 371580,
        "text": "<p><span style=\"font-size:14.0pt;\">Contact dermatitis</span></p>"
      },
      {
        "id": 371581,
        "text": "<p><span style=\"font-size:14.0pt;\">Dyshidrotic eczema</span></p>"
      },
      {
        "id": 371582,
        "text": "<p><span style=\"font-size:14.0pt;\">Epidermolysis bullosa simplex</span></p>"
      },
      {
        "id": 371583,
        "text": "<p><span style=\"font-size:14.0pt;\">Herpes simplex</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old man presents with a 3-day history of severe burning itch on both hands. Examination reveals multiple clear vesicles as shown in the figure. He also has erythema, fissuring, and maceration between the 4th and 5th toes of the left foot, along with bilateral but asymmetrical vesiculopustular lesions on the insteps. He has a history of atopy. There is no history of contact with irritant chemicals in the recent past. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KvGfqCQ.png\" width=\"407\" height=\"301\"></span></p>",
    "unique_key": "Q6164314",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Dyshidrotic eczema</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Dyshidrotic eczema (pompholyx) is characterized by symmetric, pruritic vesicles on the palms and soles that may coalesce into bullae.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A history of atopy is often present, and triggers include stress.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The clinical picture of diffuse vesicles with severe itching strongly supports this diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Contact dermatitis:&nbsp;</strong>Allergic or irritant contact dermatitis usually produces localized erythema, scaling, and vesiculation at the site of allergen exposure. This patient denies exposure to irritants, and the symmetrical involvement of both palms is atypical.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Epidermolysis bullosa simplex:&nbsp;</strong>This is a genetic blistering disorder where blisters develop at sites of friction, often in childhood. In contrast, the current case shows acute onset vesicles with atopic history, favoring dyshidrotic eczema rather than a hereditary blistering condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Herpes simplex:&nbsp;</strong>Herpetic whitlow presents with painful grouped vesicles, usually on one finger or hand, not with diffuse bilateral palm involvement. The absence of a prodromal viral history also makes herpes simplex unlikely here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Dyshidrotic eczema (pompholyx) presents with recurrent, symmetric pruritic vesicles on the palms and soles, often linked to atopy and triggered by stress or fungal infections, distinguishing it from contact dermatitis, genetic blistering disorders, and viral infections.</span></p>",
    "correct_choice_id": 371581,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93329/NEET_PG_22_Sep_2025_Derma_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      18
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93329/NEET_PG_22_Sep_2025_Derma_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93330,
    "choices": [
      {
        "id": 371584,
        "text": "<p><span style=\"font-size:14.0pt;\">HPV 1, 2, and 3</span></p>"
      },
      {
        "id": 371585,
        "text": "<p><span style=\"font-size:14.0pt;\">HPV 3 and 5</span></p>"
      },
      {
        "id": 371586,
        "text": "<p><span style=\"font-size:14.0pt;\">HPV 6 and 11</span></p>"
      },
      {
        "id": 371587,
        "text": "<p><span style=\"font-size:14.0pt;\">HPV 16 and 18</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old sexually active man presents with growths over the shaft and glans of his penis. On examination, the lesions are as shown below. Which strains of human papillomavirus (HPV) are most commonly responsible for these lesions?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_OwYs7FX.png\" width=\"326\" height=\"357\"></span></p>",
    "unique_key": "Q3556196",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) HPV 6 and 11</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Genital warts, also known as condyloma acuminata, are most commonly caused by HPV types 6 and 11.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These strains have <strong>low oncogenic potential</strong> but are highly contagious and spread through sexual contact.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The lesions are soft, fleshy, and verrucous, and histology often shows koilocytosis (cells with perinuclear halo).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. HPV 1, 2, and 3:&nbsp;</strong>These HPV strains are associated with cutaneous warts (verruca vulgaris and plantar warts) rather than genital warts. They typically appear on hands and feet, not in the genital region.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. HPV 3 and 5:&nbsp;</strong>These are linked with epidermodysplasia verruciformis, a rare inherited condition with widespread flat warts and a predisposition to skin cancers, not genital lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. HPV 16 and 18:&nbsp;</strong>These are <strong>high-risk oncogenic strains</strong> associated with cervical, anal, and penile intraepithelial neoplasia and cancers. While they can cause flat lesions, they are not the most common cause of exophytic genital warts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Genital warts (condyloma acuminata) are most commonly caused by <strong>HPV 6 and 11</strong>, which have low malignant potential, whereas high-risk HPV strains (16, 18, 31, 33) are linked to cervical and anogenital cancers.</span></p>",
    "correct_choice_id": 371586,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93330/NEET_PG_22_Sep_2025_Derma_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      18
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93330/NEET_PG_22_Sep_2025_Derma_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93559,
    "choices": [
      {
        "id": 372488,
        "text": "<p><span style=\"font-size:14.0pt;\">Creatinine 1.24 mg/dl</span></p>"
      },
      {
        "id": 372489,
        "text": "<p><span style=\"font-size:14.0pt;\">Platelet counts 164,000/microL</span></p>"
      },
      {
        "id": 372490,
        "text": "<p><span style=\"font-size:14.0pt;\">Alkaline phosphatase 142 IU/L</span></p>"
      },
      {
        "id": 372491,
        "text": "<p><span style=\"font-size:14.0pt;\">Total protein of 252 mg in a 24-hour urine collection</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A multiparous patient who did not attend any antenatal visit and came to the emergency room with a complaint of bleeding. On examination, uterine tone was increased with BP &gt;150/90 mmHg. Which of the following tests supports the diagnosis of preeclampsia?</span></p>",
    "unique_key": "Q3365625",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\">&nbsp;<strong>Ans. A) Creatinine 1.24 mg/dl</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Preeclampsia</strong> is diagnosed by the presence of <strong>elevated blood pressure</strong> after 20 weeks of gestation (\u2265140/90 mmHg) and either <strong>proteinuria</strong> or <strong>end-organ dysfunction</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">One of the markers of <strong>end-organ dysfunction</strong> in preeclampsia is renal impairment, which can be indicated by an elevated serum creatinine level.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>serum creatinine level of &gt;0.9 mg/dL</strong> is considered abnormal in pregnancy and supports the diagnosis of <strong>preeclampsia</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The value of <strong>1.24 mg/dL</strong> in this patient is above the normal threshold, indicating renal involvement and supporting the diagnosis of preeclampsia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Platelet counts 164,000/microL:&nbsp;</strong>Normal count. Thrombocytopenia in preeclampsia is defined as &lt;100,000/microL.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Alkaline phosphatase 142 IU/L:&nbsp;</strong>Alkaline phosphatase levels typically rise during pregnancy due to placental production, so this is not a specific indicator of preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Total protein of 252 mg in a 24-hour urine collection:&nbsp;</strong>While proteinuria is a key feature of preeclampsia, the threshold for diagnosis is <strong>\u2265300 mg/24 hours</strong>. A level of 252 mg is below this threshold and does not meet the diagnostic criteria for preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Serum creatinine &gt;1.1 mg/dL</strong> is an indicator of renal involvement in preeclampsia and supports the diagnosis in patients with elevated blood pressure after 20 weeks of gestation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Other indicators, such as thrombocytopenia or proteinuria, may indicate severity but are not always present early in the disease course.</span></li></ul>",
    "correct_choice_id": 372488,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93559/NEET_PG_22_Sep_2025_OBG_Question_20.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93559/NEET_PG_22_Sep_2025_OBG_Question_20.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93541,
    "choices": [
      {
        "id": 372416,
        "text": "<p><span style=\"font-size:14.0pt;\">Oxytocin 10 units intramuscularly after delivery</span></p>"
      },
      {
        "id": 372417,
        "text": "<p><span style=\"font-size:14.0pt;\">Prophylactic methylergometrine administration with delivery of the anterior shoulder</span></p>"
      },
      {
        "id": 372418,
        "text": "<p><span style=\"font-size:14.0pt;\">Restriction of intravenous fluids</span></p>"
      },
      {
        "id": 372419,
        "text": "<p><span style=\"font-size:14.0pt;\">Shortening of the second stage of labor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following measures is not recommended in the intrapartum management of a woman with preeclampsia?</span></p>",
    "unique_key": "Q3805076",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Prophylactic methylergometrine administration with delivery of the anterior shoulder</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In women with <strong>preeclampsia</strong>, intrapartum management focuses on controlling blood pressure, preventing seizures, and avoiding complications such as pulmonary edema and intracranial hemorrhage.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Methylergometrine</strong> is contraindicated because it causes potent vasoconstriction and can lead to <strong>sudden severe hypertension</strong>, stroke, or myocardial ischemia in preeclamptic women.</span></li><li><span style=\"font-size:14.0pt;\">Instead, <strong>oxytocin</strong> is the uterotonic of choice for prevention of postpartum hemorrhage in these patients.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fluid restriction</strong> helps avoid pulmonary edema, as preeclamptic patients have increased vascular permeability and reduced oncotic pressure.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Shortening the second stage of labor</strong> (e.g., with assisted delivery) reduces maternal stress, helps prevent BP surges, and minimizes the risk of complications.</span></li><li><span style=\"font-size:14.0pt;\">Thus, the incorrect and unsafe measure is <strong>prophylactic methylergometrine at delivery of the anterior shoulder</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Oxytocin 10 units intramuscularly after delivery</strong>: Correct practice. Safe in preeclampsia for postpartum hemorrhage prevention without the hypertensive risks associated with ergot derivatives.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Restriction of intravenous fluids:</strong>&nbsp; Correct practice. Reduces the risk of pulmonary edema in preeclamptic patients, who are prone to fluid overload due to increased capillary permeability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Shortening of the second stage of labor</strong>: Correct practice. Minimizes prolonged maternal effort, reduces risk of BP spikes, and lowers the chance of cerebrovascular complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>preeclampsia</strong>, <strong>methylergometrine</strong> is avoided during labor and delivery because of its potent vasoconstrictive effect, which can precipitate severe hypertension and life-threatening complications.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Oxytocin</strong> is preferred for uterine contraction after delivery.</span></li></ul>",
    "correct_choice_id": 372417,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93541/NEET_PG_22_Sep_2025_OBG_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93541/NEET_PG_22_Sep_2025_OBG_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92894,
    "choices": [
      {
        "id": 369872,
        "text": "<p><span style=\"font-size:14.0pt;\">Mapleson A</span></p>"
      },
      {
        "id": 369873,
        "text": "<p><span style=\"font-size:14.0pt;\">Mapleson B</span></p>"
      },
      {
        "id": 369874,
        "text": "<p><span style=\"font-size:14.0pt;\">Mapleson C</span></p>"
      },
      {
        "id": 369875,
        "text": "<p><span style=\"font-size:14.0pt;\">Mapleson D</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old man is taken to the operating room for incision and drainage of a perianal abscess under general anesthesia. He is breathing spontaneously throughout the procedure. The anesthesiologist must choose the most efficient breathing circuit for spontaneous ventilation with minimal fresh gas flow requirements. Which of the following is the most appropriate choice?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q8767369",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Mapleson A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Mapleson A (Magill circuit) is the <strong>circuit of choice for spontaneous ventilation</strong> because it requires the lowest fresh gas flow\u2014approximately equal to the patient\u2019s minute ventilation (around 5 L/min).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its efficiency in minimizing rebreathing under spontaneous breathing makes it ideal for such cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mapleson B:&nbsp;</strong>This circuit is rarely used in clinical practice. It is inefficient for both spontaneous and controlled ventilation, as it requires high fresh gas flows to prevent rebreathing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Mapleson C:&nbsp;</strong>The Mapleson C <strong>(Waters circuit)</strong> is a compact version of the Mapleson B and is commonly used in postoperative recovery rooms because of its portability. However, it is not the best for spontaneous breathing intraoperatively since it requires higher flows compared to Mapleson A.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mapleson D:&nbsp;</strong>The Mapleson D <strong>(Bain circuit)&nbsp;</strong>system, particularly in its coaxial Bain modification, is highly efficient for <strong>controlled ventilation</strong>, not for spontaneous breathing. It requires higher gas flows for spontaneous ventilation and is therefore not the first choice in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Mapleson A (Magill) circuit</strong> is the most efficient breathing system for <strong>spontaneous ventilation</strong>, while <strong>Mapleson D (Bain circuit)</strong> is the preferred choice for <strong>controlled ventilation</strong>.</span></p>",
    "correct_choice_id": 369872,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92894/NEET_PG_22_Sep_2025_Anesthesia_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      19
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92894/NEET_PG_22_Sep_2025_Anesthesia_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93652,
    "choices": [
      {
        "id": 372844,
        "text": "<p><span style=\"font-size:14.0pt;\">Excess TSH secretion due to pituitary adenoma</span></p>"
      },
      {
        "id": 372845,
        "text": "<p><span style=\"font-size:14.0pt;\">Autoimmune destruction of thyroid follicular cells</span></p>"
      },
      {
        "id": 372846,
        "text": "<p><span style=\"font-size:14.0pt;\">Defective synthesis of thyroglobulin</span></p>"
      },
      {
        "id": 372847,
        "text": "<p><span style=\"font-size:14.0pt;\">Excess production of thyroglobulin by thyroid follicular cells</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 39-year-old woman presents with fatigue, weight gain, cold intolerance, and constipation. On examination, she has dry skin, coarse hair, and a diffusely enlarged, non-tender thyroid gland. Laboratory studies reveal elevated thyroid-stimulating hormone (TSH) and decreased free thyroxine (T4). Fine-needle aspiration biopsy demonstrates lymphocytic infiltration with Hurthle cell changes. Which of the following mechanisms is most likely responsible for this presentation?&nbsp;</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4PvNbOV.png\" width=\"489\" height=\"325\"></span></p>",
    "unique_key": "Q5145078",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Autoimmune destruction of thyroid follicular cells</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 39-year-old woman has classical features of hypothyroidism: fatigue, weight gain, constipation, cold intolerance, dry skin, coarse hair, and a diffuse non-tender goiter.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Laboratory data show increased TSH and low T4, confirming primary hypothyroidism.</span></li><li><span style=\"font-size:14.0pt;\">The key histological findings \u2014 lymphocytic infiltration and Hurthle cell changes \u2014 are characteristic of Hashimoto thyroiditis, the most common cause of hypothyroidism in iodine-sufficient regions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The pathogenesis involves autoimmune destruction of thyroid follicular cells, mediated by cytotoxic T lymphocytes and associated with anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the correct answer is autoimmune destruction of thyroid follicular cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Excess TSH secretion due to pituitary adenoma:</strong> This would cause secondary hyperthyroidism with high TSH and high T4, leading to symptoms such as weight loss, heat intolerance, and palpitations. This is the opposite of the patient\u2019s presentation, which is hypothyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Defective synthesis of thyroglobulin:</strong> Rare congenital defects in thyroglobulin synthesis can lead to hypothyroidism, but they present in infancy with congenital hypothyroidism features, not in a 45-year-old woman with autoimmune histology (lymphocytic infiltration and Hurthle cells).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Excess production of thyroglobulin by thyroid follicular cells:</strong> Increased thyroglobulin alone does not lead to hypothyroidism. It may occur in certain thyroid neoplasms, but it is not associated with Hashimoto thyroiditis or lymphocytic infiltration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hashimoto thyroiditis, the most common cause of hypothyroidism in iodine-sufficient areas, is due to autoimmune destruction of thyroid follicular cells and is characterized by lymphocytic infiltration and Hurthle cell changes.</span></p>",
    "correct_choice_id": 372845,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93652/NEET_PG_22_Sep_2025_Pathology_Question_6.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93652/NEET_PG_22_Sep_2025_Pathology_Question_6.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93565,
    "choices": [
      {
        "id": 372508,
        "text": "<p><span style=\"font-size:14.0pt;\">Intravenous methylprednisolone</span></p>"
      },
      {
        "id": 372509,
        "text": "<p><span style=\"font-size:14.0pt;\">Teprotumumab infusions</span></p>"
      },
      {
        "id": 372510,
        "text": "<p><span style=\"font-size:14.0pt;\">Selenium supplementation</span></p>"
      },
      {
        "id": 372511,
        "text": "<p><span style=\"font-size:14.0pt;\">External beam radiation therapy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man with Graves\u2019 hyperthyroidism presents with gritty eyes, double vision, and eyelid swelling for 3 months. He has uncontrolled hyperthyroidism on carbimazole and is a smoker. Examination reveals proptosis, conjunctival injection, and restricted extraocular movements, with preserved vision. Orbital CT shows thickened extraocular muscles, confirming severe thyroid eye disease (TED). All of the following can be used in his treatment except:</span></p>",
    "unique_key": "Q2525525",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Selenium supplementation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s symptoms (gritty eyes, double vision, eyelid swelling), signs (proptosis, conjunctival injection, restricted extraocular movements), and CT findings (thickened extraocular muscles) indicate <strong>moderate-to-severe thyroid eye disease (TED)</strong> associated with Graves\u2019 hyperthyroidism. Smoking and uncontrolled hyperthyroidism exacerbate TED; preserved vision excludes optic neuropathy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Selenium supplementation</strong> is primarily used for <strong>mild TED</strong> to reduce inflammation, especially in selenium-deficient areas.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In moderate-to-severe TED with significant proptosis and diplopia, as in this patient, selenium lacks efficacy as a primary treatment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">First-line options include IV glucocorticoids or teprotumumab, with radiation as a second-line choice.</span></li><li><span style=\"font-size:14.0pt;\">Treatment involves achieving euthyroidism (e.g., optimizing carbimazole), smoking cessation, local measures (lubricating drops, dark glasses), and specific therapies like glucocorticoids or teprotumumab, with external beam radiation for refractory cases, based on clinical severity.&nbsp;</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Severity.jpg\" width=\"1473\" height=\"1846\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Intravenous methylprednisolone</strong>: Can be used. IV glucocorticoids (e.g., methylprednisolone, 0.5\u20131 g/week) are a first-line treatment for moderate-to-severe TED, effectively reducing inflammation, proptosis, and diplopia, suitable for this patient\u2019s active disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Teprotumumab infusions</strong>: Can be used. Teprotumumab is a first-line therapy for moderate-to-severe TED, targeting IGF-1 receptors to improve proptosis and diplopia, ideal for this patient, though access in India may be limited.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. External beam radiation therapy</strong>: Can be used. As a second-line option, external beam radiation is appropriate for moderate-to-severe TED with persistent inflammation or failure of first-line therapies, reducing orbital inflammation when combined with glucocorticoids, despite potential access constraints in India.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Intravenous methylprednisolone controls inflammation in moderate-to-severe TED with conjunctival injection and diplopia.</span></li><li><span style=\"font-size:14.0pt;\">Teprotumumab infusions improve proptosis and extraocular movement restriction in moderate-to-severe TED.</span></li><li><span style=\"font-size:14.0pt;\">External beam radiation is a second-line option for persistent moderate-to-severe TED.</span></li></ul>",
    "correct_choice_id": 372510,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93565/Neet_Pg_22_Sep_2025_Medicine_Question_22.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93565/Neet_Pg_22_Sep_2025_Medicine_Question_22.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93622,
    "choices": [
      {
        "id": 372728,
        "text": "<p><span style=\"font-size:14.0pt;\">Hydralazine</span></p>"
      },
      {
        "id": 372729,
        "text": "<p><span style=\"font-size:14.0pt;\">Tolazoline</span></p>"
      },
      {
        "id": 372730,
        "text": "<p><span style=\"font-size:14.0pt;\">Nitroglycerin</span></p>"
      },
      {
        "id": 372731,
        "text": "<p><span style=\"font-size:14.0pt;\">Propranolol</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 46-year-old man is brought to the emergency department with a sudden severe headache, palpitations, sweating, and markedly elevated blood pressure (220/120 mmHg). His wife reports that earlier in the evening he had attended a party where he consumed aged cheese, red wine, and smoked meats. The patient has a history of major depressive disorder that has been poorly controlled with multiple medications, and he is currently taking phenelzine. Which of the following medications is the drug of choice for managing this patient\u2019s current hypertensive crisis?</span></p>",
    "unique_key": "Q6567875",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Tolazoline</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has a <strong>hypertensive crisis</strong> triggered by ingestion of <strong>tyramine-containing foods</strong> (aged cheese, wine, smoked meats) while on a <strong>monoamine oxidase inhibitor (MAOI)</strong> such as phenelzine or tranylcypromine.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tyramine</strong> displaces norepinephrine from presynaptic vesicles, causing a <strong>massive adrenergic surge</strong> and severe hypertension (\u201ccheese reaction\u201d).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tolazoline</strong>, a <strong>non-selective alpha-adrenergic antagonist</strong>, is the <strong>drug of choice (DOC)</strong> for such hypertensive crises. By blocking alpha-adrenergic receptors, it counteracts the excessive catecholamine effect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hydralazine:</strong> Direct arteriolar vasodilator, but not the specific DOC for catecholamine-driven crises.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Nitroglycerin:</strong> Primarily a venodilator used for angina, not effective for this mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Propranolol:</strong> Non-selective beta-blocker; contraindicated in catecholamine crisis due to risk of <strong>unopposed alpha stimulation</strong>, which can worsen hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Tolazoline is the drug of choice for hypertensive crisis precipitated by tyramine ingestion (\u201ccheese reaction\u201d) in patients taking monoamine oxidase inhibitors.</span></p>",
    "correct_choice_id": 372729,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93622/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93622/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93625,
    "choices": [
      {
        "id": 372740,
        "text": "<p><span style=\"font-size:14.0pt;\">Doxorubicin</span></p>"
      },
      {
        "id": 372741,
        "text": "<p><span style=\"font-size:14.0pt;\">5-Fluorouracil</span></p>"
      },
      {
        "id": 372742,
        "text": "<p><span style=\"font-size:14.0pt;\">Methotrexate</span></p>"
      },
      {
        "id": 372743,
        "text": "<p><span style=\"font-size:14.0pt;\">Paclitaxel</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old woman with metastatic breast cancer has been receiving chemotherapy for the past 2 months. She now reports progressive burning pain and tingling in her palms and soles. On examination, there is erythema, swelling, and peeling of the skin on both hands, along with tender, thickened patches and ulceration on the soles. The symptoms worsen when she grips objects or walks long distances. Which of the following chemotherapeutic agents is most strongly associated with this adverse effect?</span></p>",
    "unique_key": "Q5444097",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 5-Fluorouracil</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with <strong>painful erythema, swelling, and desquamation of the palms and soles</strong>, consistent with <strong>hand-foot syndrome (palmar-plantar erythrodysesthesia)</strong>, a dose-limiting toxicity of some chemotherapeutic drugs.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Capecitabine</strong> and <strong>5-fluorouracil</strong> have the <strong>highest incidence</strong> of causing this syndrome.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The prolonged exposure leads to accumulation of toxic metabolites in the capillaries of palms and soles, producing characteristic changes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Doxorubicin:</strong> Anthracycline associated with <strong>cardiotoxicity (dilated cardiomyopathy)</strong>, myelosuppression, and alopecia, but not hand-foot syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Methotrexate:</strong> It is associated with hepatotoxicity, megaloblastic anemia, bone marrow suppression and pulmonary fibrosis but not hand and foot syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Paclitaxel:</strong> Microtubule inhibitor; dose-limiting toxicities include <strong>peripheral neuropathy, myelosuppression, and alopecia</strong>, not hand-foot syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Capecitabine, an oral prodrug of 5-fluorouracil, carries the maximum risk of hand-foot syndrome, characterized by painful erythema, swelling, and desquamation of the palms and soles.</span></p>",
    "correct_choice_id": 372741,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93625/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_7.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93625/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_7.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92946,
    "choices": [
      {
        "id": 370076,
        "text": "<p><span style=\"font-size:14.0pt;\">3\u2032 to 5\u2032 polymerase activity of DNA polymerase \u03b4</span></p>"
      },
      {
        "id": 370077,
        "text": "<p><span style=\"font-size:14.0pt;\">3\u2032 to 5\u2032 exonuclease activity of DNA polymerase \u03b3</span></p>"
      },
      {
        "id": 370078,
        "text": "<p><span style=\"font-size:14.0pt;\">5\u2032 to 3\u2032 polymerase activity of DNA polymerase III</span></p>"
      },
      {
        "id": 370079,
        "text": "<p><span style=\"font-size:14.0pt;\">3\u2032 to 5\u2032 exonuclease activity of DNA polymerase \u03b4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following proofreading activities is critical for ensuring the<strong>&nbsp;</strong>accuracy of nuclear DNA replication in eukaryotic cells?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q8728062",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 3\u2032 to 5\u2032 exonuclease activity of DNA polymerase \u03b4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>eukaryotic nuclear DNA replication</strong>, DNA polymerase \u03b4 (lagging strand) and DNA polymerase \u03b5 (leading strand) are responsible for the bulk of synthesis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Both possess <strong>3\u2032 to 5\u2032 exonuclease activity</strong>, which serves as the <strong>proofreading function</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During synthesis, if an incorrect nucleotide is incorporated, the polymerase pauses.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>3\u2032 to 5\u2032 exonuclease</strong> removes the mispaired nucleotide from the 3\u2032 end.</span></li><li><span style=\"font-size:14.0pt;\">DNA synthesis then resumes in the correct sequence, maintaining high fidelity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key point:</strong> Accuracy in <strong>nuclear</strong> DNA replication depends on proofreading by nuclear DNA polymerases (\u03b4 &amp; \u03b5), not mitochondrial enzymes or prokaryotic polymerases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 3\u2032 to 5\u2032 polymerase activity of DNA polymerase \u03b4:</strong> Incorrect. No DNA polymerase synthesizes in the 3\u2032 to 5\u2032 direction; polymerases work 5\u2032 to 3\u2032 only.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. 3\u2032 to 5\u2032 exonuclease activity of DNA polymerase \u03b3:</strong> Incorrect. While this activity exists, DNA polymerase \u03b3 functions in <strong>mitochondrial</strong> DNA replication, not <strong>nuclear</strong> DNA replication.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. 5\u2032 to 3\u2032 polymerase activity of DNA polymerase III:</strong> Incorrect. DNA polymerase III is a <strong>prokaryotic</strong> enzyme and not involved in eukaryotic nuclear DNA synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>3\u2032 to 5\u2032 exonuclease activity of DNA polymerase \u03b4</strong> is the primary proofreading mechanism ensuring the accuracy of <strong>nuclear DNA replication</strong> in eukaryotes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Prokaryotic DNA Polymerase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20171855.jpg\" width=\"969\" height=\"362\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note: DNA Polymerase I, II, III have proofreading ability.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Eukaryotic DNA Polymerase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20171959.jpg\" width=\"630\" height=\"429\"></strong></span></p>",
    "correct_choice_id": 370079,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92946/NEET_PG_22_Sep_2025_Biochemistry_Question_6.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      1
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92946/NEET_PG_22_Sep_2025_Biochemistry_Question_6.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92917,
    "choices": [
      {
        "id": 369964,
        "text": "<p><span style=\"font-size:14.0pt;\">A</span></p>"
      },
      {
        "id": 369965,
        "text": "<p><span style=\"font-size:14.0pt;\">B</span></p>"
      },
      {
        "id": 369966,
        "text": "<p><span style=\"font-size:14.0pt;\">C</span></p>"
      },
      {
        "id": 369967,
        "text": "<p><span style=\"font-size:14.0pt;\">D</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">During a surgical procedure for endolymphatic sac decompression, it is crucial to identify a specific anatomical landmark to guide the surgery. Which structure, based on the provided diagram, is the appropriate surgical landmark?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20174030.jpg\" width=\"480\" height=\"417\"></span></p>",
    "unique_key": "Q3706417",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) C</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The correct surgical landmark for endolymphatic sac decompression is <strong>C</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is due to <strong>Donaldson's line</strong>, which passes through the horizontal semicircular canal and bisects the posterior semicircular canal.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The endolymphatic sac lies <strong>anterior</strong> and <strong>inferior</strong> to this line, making it an essential reference point during surgery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20174044.jpg\" width=\"716\" height=\"541\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In endolymphatic sac decompression, <strong>Donaldson\u2019s line</strong> is used as a landmark to locate the <strong>endolymphatic sac</strong>, as it passes through the horizontal and posterior semicircular canals</span></p>",
    "correct_choice_id": 369966,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92917/Neet_Pg_22_Sep_2025_Ent_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      9
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92917/Neet_Pg_22_Sep_2025_Ent_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93336,
    "choices": [
      {
        "id": 371608,
        "text": "<p><span style=\"font-size:14.0pt;\">Extracorporeal shock wave lithotripsy (ESWL)</span></p>"
      },
      {
        "id": 371609,
        "text": "<p><span style=\"font-size:14.0pt;\">Uretero-renoscopic removal (URS)</span></p>"
      },
      {
        "id": 371610,
        "text": "<p><span style=\"font-size:14.0pt;\">Wait and watch</span></p>"
      },
      {
        "id": 371611,
        "text": "<p><span style=\"font-size:14.0pt;\">Plain CT KUB</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old man presents with acute left flank pain radiating to the groin. After giving him NSAIDs for the pain, an X-ray KUB is shown below. What is the most appropriate next step in this patient\u2019s evaluation?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ftuzC9l.png\" width=\"336\" height=\"345\"></strong></span></p>",
    "unique_key": "Q7959880",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Plain CT KUB</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Non-contrast CT KUB (kidneys, ureters, bladder) is the <strong>gold standard for diagnosing urolithiasis</strong>, as it provides precise information on stone size, location, density, and associated obstruction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It guides the choice of definitive management (ESWL, URS, PCNL, or conservative).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hence, it is the most appropriate next step before intervention.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Extracorporeal shock wave lithotripsy (ESWL):</strong> Extracorporeal shock wave lithotripsy is a treatment modality for stones less than 2 cm in the kidney or upper ureter. However, it is not the immediate next step before confirming stone size and location on CT KUB.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Uretero-renoscopic removal (URS):&nbsp;</strong>Ureteroscopy is a treatment option for ureteric stones, particularly in the mid and lower ureter. As with ESWL, the choice of URS requires prior imaging confirmation with CT KUB for stone location and suitability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Wait and watch:&nbsp;</strong>Observation is appropriate for <strong>small stones (&lt;5 mm)</strong> that have a high chance of spontaneous passage. However, in this case, further imaging with CT KUB is required first to confirm stone size and position before adopting a conservative approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Non-contrast CT KUB is the investigation of choice in suspected renal/ureteric calculi, as it defines stone size, location, and density, thereby guiding the decision between conservative management and intervention.</span></p>",
    "correct_choice_id": 371611,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93336/NEET_PG_22_Sep_2025_Surgery_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93336/NEET_PG_22_Sep_2025_Surgery_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93548,
    "choices": [
      {
        "id": 372444,
        "text": "<p><span style=\"font-size:14.0pt;\">Nonsteroidal anti-inflammatory drugs (NSAIDs)</span></p>"
      },
      {
        "id": 372445,
        "text": "<p><span style=\"font-size:14.0pt;\">Levonorgestrel-releasing intrauterine system (LNG-IUS)</span></p>"
      },
      {
        "id": 372446,
        "text": "<p><span style=\"font-size:14.0pt;\">Copper intrauterine device</span></p>"
      },
      {
        "id": 372447,
        "text": "<p><span style=\"font-size:14.0pt;\">Combination oral contraceptives (COCs)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old multiparous woman presents with progressive dysmenorrhea and heavy menstrual bleeding. Pelvic exam reveals a uniformly enlarged, tender, boggy uterus consistent with adenomyosis. She does not desire future fertility and requests medical therapy to control symptoms. Which of the following is not an appropriate medical treatment for this condition?</span></p>",
    "unique_key": "Q2529980",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Copper intrauterine device</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>copper intrauterine device</strong> lacks progestin; it commonly <strong>increases menstrual bleeding and cramping</strong>, which can <strong>worsen adenomyosis</strong> symptoms rather than treat them.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the <strong>copper intrauterine device</strong> is <strong>not</strong> an appropriate <strong>medical</strong> therapy for <strong>adenomyosis</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Nonsteroidal anti-inflammatory drugs (NSAIDs)</strong>: Appropriate. NSAIDs reduce prostaglandin synthesis, thereby improving <strong>dysmenorrhea</strong> and contributing to decreased menstrual blood loss. They are a standard <strong>medical</strong> first-line option for <strong>adenomyosis</strong> symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Levonorgestrel-releasing intrauterine system (LNG-IUS)</strong>: Appropriate. The <strong>LNG-IUS</strong> delivers local progestin, causing endometrial decidualization/atrophy, significantly reducing <strong>heavy menstrual bleeding</strong> and <strong>dysmenorrhea</strong> in <strong>adenomyosis</strong>; it is among the most effective <strong>medical</strong> therapies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Combination oral contraceptives (COCs)</strong>: Appropriate. <strong>COCs</strong> regulate cycles, reduce <strong>menorrhagia</strong>, and alleviate <strong>dysmenorrhea</strong> through endometrial suppression\u2014well-accepted <strong>medical</strong> therapy for <strong>adenomyosis</strong> when fertility is not desired.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For <strong>adenomyosis</strong>, evidence-based <strong>medical</strong> treatments include <strong>NSAIDs</strong>, <strong>COCs</strong>, and especially <strong>LNG-IUS</strong>; the <strong>copper intrauterine device</strong> (non-hormonal) is <strong>not</strong> appropriate because it can <strong>increase bleeding and cramping</strong>, potentially worsening symptoms.</span></p>",
    "correct_choice_id": 372446,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93548/NEET_PG_22_Sep_2025_OBG_Question_9.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93548/NEET_PG_22_Sep_2025_OBG_Question_9.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93317,
    "choices": [
      {
        "id": 371536,
        "text": "<p><span style=\"font-size:14.0pt;\">Cardiac arrest</span></p>"
      },
      {
        "id": 371537,
        "text": "<p><span style=\"font-size:14.0pt;\">Foreign body aspiration</span></p>"
      },
      {
        "id": 371538,
        "text": "<p><span style=\"font-size:14.0pt;\">Ventricular tachycardia</span></p>"
      },
      {
        "id": 371539,
        "text": "<p><span style=\"font-size:14.0pt;\">Hypothermia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">What is the indication for the following maneuvers being done in this infant?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_uMwebjc.png\" width=\"480\" height=\"440\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ltt3yLd.png\" width=\"453\" height=\"442\"></span></p>",
    "unique_key": "Q4942868",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Foreign body aspiration</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The maneuvers illustrated are <strong>back blows and chest thrusts</strong>, which are specifically recommended for infants &lt;1 year old with <strong>complete airway obstruction due to foreign body aspiration</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Abdominal thrusts (Heimlich maneuver) are avoided in infants because of the risk of visceral injury, so chest thrusts are the safer alternative.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These steps aim to generate high intrathoracic pressure to expel the obstructing object.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cardiac arrest:&nbsp;</strong>Cardiac arrest management in infants requires <strong>high-quality CPR</strong> with chest compressions and ventilation, not back blows or chest thrusts. These maneuvers are ineffective in restoring circulation during arrest and are not part of resuscitation algorithms for cardiac arrest.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ventricular tachycardia:&nbsp;</strong>Infant ventricular tachycardia is managed depending on stability: unstable VT requires synchronized cardioversion, while stable VT may be treated with antiarrhythmics. Mechanical maneuvers like chest thrusts or back blows have no therapeutic role in arrhythmia management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hypothermia:&nbsp;</strong>Hypothermia in infants requires <strong>warming measures</strong> such as warm blankets, radiant warmers, and heated oxygen delivery. Physical thrust maneuvers do not address hypothermia and could worsen the infant\u2019s instability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Back blows and chest thrusts are the first-line interventions for relieving complete airway obstruction due to foreign body aspiration in infants under one year of age.</span></p>",
    "correct_choice_id": 371537,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93317/NEET_PG_22_Sep_2025_PEDIATRICS_Question_1_4iOi1As.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      13
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93317/NEET_PG_22_Sep_2025_PEDIATRICS_Question_1_4iOi1As.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93341,
    "choices": [
      {
        "id": 371628,
        "text": "<p><span style=\"font-size:14.0pt;\">Duodenal switch</span></p>"
      },
      {
        "id": 371629,
        "text": "<p><span style=\"font-size:14.0pt;\">Roux-en-Y gastric bypass</span></p>"
      },
      {
        "id": 371630,
        "text": "<p><span style=\"font-size:14.0pt;\">Sleeve gastrectomy</span></p>"
      },
      {
        "id": 371631,
        "text": "<p><span style=\"font-size:14.0pt;\">Minigastric bypass</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old woman with morbid obesity undergoes bariatric surgery. Which of the following best describes the procedure performed?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8sZUVEW.png\" width=\"478\" height=\"329\"></strong></span></p>",
    "unique_key": "Q9265617",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Roux-en-Y gastric bypass</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This surgery involves creating a small gastric pouch and connecting it to a Roux limb of the jejunum, bypassing the majority of the stomach and duodenum.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is one of the most effective bariatric procedures, leading to significant weight loss by restricting intake and inducing malabsorption.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Duodenal switch:&nbsp;</strong>This procedure combines sleeve gastrectomy with a long intestinal bypass, preserving the pylorus and duodenum. It's more complex and has a higher risk of nutritional deficiencies than Roux-en-Y.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_RuIEpIM.png\" width=\"410\" height=\"354\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sleeve gastrectomy: </strong>This procedure reduces the stomach volume by removing its greater curvature, leaving behind a narrow tubular gastric conduit. It is restrictive but does not involve intestinal bypass, unlike the Roux-en-Y.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_pIasiLI.png\" width=\"484\" height=\"308\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Minigastric bypass:&nbsp; </strong>Mini-gastric bypass (MGB) is a bariatric surgery in which a long, narrow gastric pouch is created and connected to the small intestine about 150\u2013200 cm distal to the ligament of Treitz. It combines restrictive and malabsorptive mechanisms, leading to significant weight loss and improvement in obesity-related&nbsp;comorbidities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Roux-en-Y gastric bypass is a bariatric surgery that creates a small gastric pouch and diverts food into the jejunum, bypassing the duodenum and part of the small bowel, combining restriction with malabsorption for weight reduction.</span></p>",
    "correct_choice_id": 371629,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93341/NEET_PG_22_Sep_2025_Surgery_Question_9.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93341/NEET_PG_22_Sep_2025_Surgery_Question_9.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93555,
    "choices": [
      {
        "id": 372472,
        "text": "<p><span style=\"font-size:14.0pt;\">Expectant management</span></p>"
      },
      {
        "id": 372473,
        "text": "<p><span style=\"font-size:14.0pt;\">Single-dose inj Methotrexate</span></p>"
      },
      {
        "id": 372474,
        "text": "<p><span style=\"font-size:14.0pt;\">Laparoscopic salpingostomy</span></p>"
      },
      {
        "id": 372475,
        "text": "<p><span style=\"font-size:14.0pt;\">Laparoscopic salpingotomy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old woman presents to the gynecology OPD with an ultrasound report confirming an unruptured tubal ectopic pregnancy. She has no symptoms and is hemodynamically stable. Her \u03b2-hCG level is 600 IU/L. The scan shows a gestational sac measuring 20 mm in the right adnexa with no yolk sac or embryo seen. What is the most appropriate management?</span></p>",
    "unique_key": "Q9986993",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Expectant management</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In this scenario, <strong>expectant management</strong> is the most appropriate option. Expectant management involves close observation without active intervention.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is indicated in cases where the following criteria are met:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The <strong>\u03b2-hCG</strong> level is <strong>low</strong> (typically &lt;1,000 IU/L, and in this case, it is 600 IU/L).</span></li><li><span style=\"font-size:14.0pt;\">The patient is <strong>hemodynamically stable</strong> with <strong>no symptoms</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>gestational sac size</strong> is less than 3.5 cm.</span></li><li><span style=\"font-size:14.0pt;\">There is <strong>no yolk sac or cardiac activity</strong> seen on the scan.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Since this patient has all the criteria for expectant management, close follow-up with serial <strong>weekly \u03b2-hCG measurements</strong> would be appropriate.</span></li><li><span style=\"font-size:14.0pt;\">The \u03b2-hCG levels should steadily decrease over time, and if they fall as expected, no further treatment is necessary.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Single-dose inj Methotrexate:&nbsp;</strong>Methotrexate is typically used for medical management in cases where the <strong>\u03b2-hCG level is between 1,000 and 5,000 IU/L</strong>. In this case, with a very low \u03b2-hCG level of 600 IU/L, expectant management is more appropriate. Methotrexate may be considered if the \u03b2-hCG levels were higher (e.g., &gt;1,000 but &lt;5,000 IU/L).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Laparoscopic salpingostomy:&nbsp;</strong>Surgical management, such as salpingostomy, is reserved for cases where the <strong>\u03b2-hCG level is &gt;5,000 IU/L</strong>, the patient is symptomatic, or the ectopic pregnancy is larger than 3.5 cm. In this stable, asymptomatic patient, surgery is unnecessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Laparoscopic salpingotomy:&nbsp;</strong>Similar to salpingostomy, salpingotomy is indicated in cases where the pregnancy is more advanced, the <strong>patient is unstable</strong>, or medical management is contraindicated or has failed. This is not required in this case due to the stable condition and low \u03b2-hCG level.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In patients with an unruptured, asymptomatic ectopic pregnancy and low <strong>\u03b2-hCG levels (&lt;1,000 IU/L)</strong>, <strong>expectant management</strong> is an appropriate option.</span></li><li><span style=\"font-size:14.0pt;\">Regular follow-up with serial <strong>\u03b2-hCG</strong> measurements is necessary to confirm that the pregnancy is resolving spontaneously.</span></li></ul>",
    "correct_choice_id": 372472,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93555/NEET_PG_22_Sep_2025_OBG_Question_16.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93555/NEET_PG_22_Sep_2025_OBG_Question_16.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93539,
    "choices": [
      {
        "id": 372408,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only&nbsp;</span></p>"
      },
      {
        "id": 372409,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4 and 5 only</span></p>"
      },
      {
        "id": 372410,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4 and 5 only</span></p>"
      },
      {
        "id": 372411,
        "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is/ are correct regarding the highlighted structure (in red) shown below?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-18%20143413.jpg\" width=\"357\" height=\"449\"></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Its superior border is the inguinal ligament.</span></li><li><span style=\"font-size:14.0pt;\">Its lateral border is formed by the sartorius muscle.</span></li><li><span style=\"font-size:14.0pt;\">Its medial border is formed by the adductor magnus muscle.</span></li><li><span style=\"font-size:14.0pt;\">The femoral artery and vein pass through this structure.</span></li><li><span style=\"font-size:14.0pt;\">The saphenous nerve passes through this structure.</span></li></ol>",
    "unique_key": "Q8124793",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) 1, 2, 4, and 5 only</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>femoral triangle</strong> is an important anatomical region located in the upper anterior thigh.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;<strong>Its boundaries are:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Statement 1. Its superior border is the inguinal ligament:&nbsp;</strong>This ligament stretches from the anterior superior iliac spine (ASIS) to the pubic tubercle, forming the upper border of the triangle.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 2. Its lateral border is formed by the sartorius muscle:</strong> This long, thin muscle runs diagonally across the thigh and serves as the lateral boundary.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>4. The femoral artery and vein pass through this structure:&nbsp;</strong>The <strong>contents</strong> of the femoral triangle, arranged from lateral to medial, are:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Femoral nerve</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Femoral artery</strong> (<strong>Statement 4 \u2013 Correct</strong>)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Femoral vein</strong> (<strong>Statement 4 \u2013 Correct</strong>)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lymphatics</strong></span></li></ol></li><li><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>5. The saphenous nerve passes through this structure:</strong> Additionally, the <strong>saphenous nerve</strong> (a sensory branch of the femoral nerve) passes through the femoral triangle before entering the adductor canal.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Its medial border is formed by the adductor magnus muscle:</strong> <strong>Adductor longus muscle</strong>, not adductor magnus. The adductor magnus lies deeper and more posterior, so it does not form the medial border of the femoral triangle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_fjk5dp3.png\" alt=\"Femoral Triangle - Gross Anatomy Flashcards | ditki medical and biological  sciences\" width=\"543\" height=\"453\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>femoral triangle</strong> is bounded superiorly by the inguinal ligament, laterally by the sartorius muscle, and medially by the adductor longus muscle.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its contents include the femoral nerve, artery, vein, lymphatics, and the saphenous nerve.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>adductor magnus</strong> is not part of its borders.</span></li></ul>",
    "correct_choice_id": 372410,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93539/NEET_PG_22_Sep_2025_Anatomy_Question_10.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      3
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93539/NEET_PG_22_Sep_2025_Anatomy_Question_10.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93615,
    "choices": [
      {
        "id": 372700,
        "text": "<p><span style=\"font-size:14.0pt;\">4, 2, 1, 5, 3</span></p>"
      },
      {
        "id": 372701,
        "text": "<p><span style=\"font-size:14.0pt;\">4, 2, 5, 3, 1</span></p>"
      },
      {
        "id": 372702,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4, 5, 1, 3</span></p>"
      },
      {
        "id": 372703,
        "text": "<p><span style=\"font-size:14.0pt;\">4, 2, 5, 1, 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old woman presents with acute onset of eye pain, blurred vision, headache, and halos around lights. Examination reveals a mid-dilated pupil, corneal edema, and markedly raised intraocular pressure. She is diagnosed with primary angle closure glaucoma. Arrange the following events in the order in which they occur in the pathogenesis of primary angle closure glaucoma:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Peripheral anterior synechiae</span></li><li><span style=\"font-size:14.0pt;\">Iris bombe</span></li><li><span style=\"font-size:14.0pt;\">Optic nerve and visual field changes</span></li><li><span style=\"font-size:14.0pt;\">Relative pupillary block</span></li><li><span style=\"font-size:14.0pt;\">Irido-trabeculo-corneal contact</span></li></ol>",
    "unique_key": "Q7512218",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 4, 2, 5, 1, 3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Primary angle closure glaucoma occurs due to a mechanical obstruction of aqueous humor flow, leading to a sequence of events:</span></li><li><span style=\"font-size:14.0pt;\"><strong>Relative pupillary block (4)</strong>: Resistance to aqueous flow from posterior to anterior chamber occurs at the mid-dilated pupil, leading to pressure buildup behind the iris.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Iris bombe (2)</strong>: The posterior chamber pressure bows the peripheral iris forward.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Irido-trabeculo-corneal contact (5)</strong>: The bowed iris blocks the trabecular meshwork, impeding aqueous outflow and raising IOP.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Peripheral anterior synechiae (1)</strong>: Prolonged iridocorneal contact results in adhesions (synechiae), permanently closing the angle.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Optic nerve and visual field changes (3)</strong>: Sustained elevated IOP damages the optic nerve, resulting in visual field loss and glaucomatous optic neuropathy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20120524.jpg\" width=\"1287\" height=\"464\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Primary angle closure glaucoma</strong> begins with a <strong>relative pupillary block</strong>, leading to <strong>iris bombe</strong>, <strong>angle closure</strong>, formation of <strong>peripheral anterior synechiae</strong>, and finally <strong>optic nerve damage</strong> with <strong>visual field defects</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>PACG sequence</strong>:</span><ul><li><span style=\"font-size:14.0pt;\">Relative pupillary block \u2192 Iris bombe \u2192 Angle contact \u2192 Peripheral anterior synechiae \u2192 Optic nerve damage</span></li><li><span style=\"font-size:14.0pt;\">Early recognition of this sequence is critical to prevent irreversible vision loss.</span></li></ul></li></ul>",
    "correct_choice_id": 372703,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93615/NEET_PG_22_Sep_2025_Opthalmology_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      8
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93615/NEET_PG_22_Sep_2025_Opthalmology_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93659,
    "choices": [
      {
        "id": 372872,
        "text": "<p><span style=\"font-size:14.0pt;\">HLA-DR3/DR4</span></p>"
      },
      {
        "id": 372873,
        "text": "<p><span style=\"font-size:14.0pt;\">Inheritance of the \u03b54 allele at the ApoE gene</span></p>"
      },
      {
        "id": 372874,
        "text": "<p><span style=\"font-size:14.0pt;\">Inheritance of a mutant prion gene</span></p>"
      },
      {
        "id": 372875,
        "text": "<p><span style=\"font-size:14.0pt;\">Expansion of CAG repeats on chromosome 4p16</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old woman with an 8-year history of progressive cognitive decline and dementia dies of bronchopneumonia. At autopsy, the brain is shown below. Microscopic evaluation reveals numerous neuritic plaques in the hippocampus, amygdala, and neocortex, and Congo red staining demonstrates amyloid deposition within cerebral arteries. Which of the following genetic factors is most likely associated with this disease?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8kdCf3b.png\" width=\"655\" height=\"429\"></span></p>",
    "unique_key": "Q6517974",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Inheritance of the \u03b54 allele at the ApoE gene</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 70-year-old woman had a long course of progressive dementia and died of a common terminal complication (bronchopneumonia).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Autopsy revealed cerebral atrophy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The cerebral atrophy seen here mainly in the frontal and parietal regions is characterized by&nbsp;narrowed gyri&nbsp;along with&nbsp;widened sulci, and histology showed numerous neuritic plaques in the hippocampus, amygdala, and neocortex.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Congo red staining demonstrated amyloid deposition in cerebral arteries.</span></li><li><span style=\"font-size:14.0pt;\">These findings are diagnostic of Alzheimer disease, the most common cause of dementia in elderly individuals.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A major genetic risk factor for late-onset Alzheimer disease is inheritance of the \u03b54 allele of the ApoE gene, which increases deposition of \u03b2-amyloid derived from amyloid precursor protein (APP).</span></li><li><span style=\"font-size:14.0pt;\">Thus, the most likely genetic factor involved is ApoE \u03b54.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>HLA-DR3/DR4:&nbsp;</strong>These HLA types are associated with Rheumatoid arthritis, type 1 diabetes mellitus, not Alzheimer disease. They are unrelated to amyloid deposition or neuritic plaques.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Inheritance of a mutant prion gene:</strong> Mutations in the prion protein gene cause Creutzfeldt-Jakob disease, a rapidly progressive dementia characterized by spongiform encephalopathy and death within months. This patient\u2019s 8-year dementia history with neuritic plaques and amyloid angiopathy is not consistent with prion disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Expansion of CAG repeats on chromosome 4p16:&nbsp;</strong>This trinucleotide repeat expansion is the cause of Huntington disease, which presents with chorea, psychiatric symptoms, and progressive dementia beginning in mid-adulthood. It is not associated with amyloid plaques or Congo red\u2013positive vascular deposits.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Alzheimer disease is characterized by progressive dementia, neuritic plaques, cerebral amyloid angiopathy, and cerebral atrophy. Inheritance of the \u03b54 allele of the ApoE gene is a major genetic risk factor for late-onset Alzheimer disease.</span></p>",
    "correct_choice_id": 372873,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93659/NEET_PG_22_Sep_2025_Pathology_Question_13.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93659/NEET_PG_22_Sep_2025_Pathology_Question_13.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93313,
    "choices": [
      {
        "id": 371520,
        "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
      },
      {
        "id": 371521,
        "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
      },
      {
        "id": 371522,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
      },
      {
        "id": 371523,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following statements are true regarding national anemia and deworming programs, except:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Pregnant women receive 60 mg elemental iron and 500 mcg folic acid weekly.</span></li><li><span style=\"font-size:14.0pt;\">Adolescents are given blue tablets weekly under IFA prophylaxis.</span></li><li><span style=\"font-size:14.0pt;\">Albendazole is given only to children aged 12\u201359 months.</span></li><li><span style=\"font-size:14.0pt;\">Deworming in women of reproductive age is carried out biannually.</span></li></ol>",
    "unique_key": "Q9043490",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Pregnant women receive 60 mg elemental iron and 500 mcg folic acid weekly:</strong> False. Pregnant and lactating women are given <strong>daily</strong> supplementation, not weekly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Albendazole is given only to children aged 12\u201359 months:&nbsp;</strong>False. Deworming is provided to <strong>children (1\u201319 years)</strong>, <strong>WRA</strong>, and <strong>pregnant women</strong>. So Albendazole is not limited to 12\u201359 months.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>True Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Adolescents are given blue tablets weekly under IFA prophylaxis:</strong> True. Adolescents (10\u201319 years) are provided <strong>60 mg elemental iron + 500 mcg folic acid</strong> weekly in the <strong>blue tablet form</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Deworming in women of reproductive age is carried out biannually:</strong> True. WRA (20\u201349 years) receive <strong>400 mg Albendazole</strong> <strong>twice a year</strong>, under the National Deworming Day program.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">National IFA and Deworming Supplementation</span></li><li><span style=\"font-size:14.0pt;\">Iron-Folic Acid Supplementation</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_H6QWVlp.png\" width=\"1156\" height=\"370\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">NPNL = Non-pregnant, Non-lactating</span></li><li><span style=\"font-size:14.0pt;\">Pregnancy: From 4th month POG onwards for 180 days</span></li><li><span style=\"font-size:14.0pt;\"><strong>Albendazole Deworming (400 mg Tablet)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6Qzz5Xp.png\" width=\"1033\" height=\"338\"></strong></span></p>",
    "correct_choice_id": 371520,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93313/Neet_Pg_22_Sept_2025_Psm_Q_20.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93313/Neet_Pg_22_Sept_2025_Psm_Q_20.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93557,
    "choices": [
      {
        "id": 372480,
        "text": "<p><span style=\"font-size:14.0pt;\">Amniocentesis for amniotic fluid spectrophotometry</span></p>"
      },
      {
        "id": 372481,
        "text": "<p><span style=\"font-size:14.0pt;\">Arrange for cordocentesis and consider intrauterine transfusion if PCV &lt; 30%</span></p>"
      },
      {
        "id": 372482,
        "text": "<p><span style=\"font-size:14.0pt;\">Give Betamethasone for fetal lung maturity and deliver</span></p>"
      },
      {
        "id": 372483,
        "text": "<p><span style=\"font-size:14.0pt;\">Repeat MCA PSV after 1 week</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old G3P2 presented to the OPD at 29 weeks. Her blood group is B negative and her husband's blood group is B positive. An ICT (indirect Coombs test) revealed high titers of 1 in 32, and an MCA (Middle Cerebral Artery) Doppler shows an increased peak systolic velocity (&gt;1.5 MoM). Which of the following is correct?</span></p>",
    "unique_key": "Q5536308",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Arrange for cordocentesis and consider intrauterine transfusion if PCV &lt; 30%</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient has <strong>Rh alloimmunization</strong> with an increased risk of <strong>fetal anemia</strong>, as evidenced by high titers of antibodies (1:32) and elevated <strong>MCA peak systolic velocity</strong> (&gt;1.5 MoM), which indicates fetal anemia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The next appropriate step in management is to arrange for <strong>cordocentesis</strong> (also known as <strong>percutaneous umbilical blood sampling (PUBS)</strong>) to confirm the diagnosis and assess the fetal hemoglobin level.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If the fetal <strong>PCV is &lt;30%</strong>, the fetus may require an <strong>intrauterine transfusion</strong> to treat anemia.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>MCA peak systolic velocity</strong> is used as a non-invasive way to detect fetal anemia. An MCA PSV &gt;1.5 MoM is a reliable indicator of moderate to severe fetal anemia.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cordocentesis</strong> allows direct measurement of fetal hemoglobin and blood gases, guiding the decision on whether to perform an intrauterine transfusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Amniocentesis for amniotic fluid spectrophotometry:&nbsp;</strong>This method was traditionally used to assess fetal anemia (based on amniotic fluid bilirubin levels) but has largely been replaced by the more reliable and non-invasive <strong>MCA Doppler</strong> for assessing fetal anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Give Betamethasone for fetal lung maturity and deliver:&nbsp;</strong>While <strong>Betamethasone</strong> may be given to promote fetal lung maturity if early delivery is necessary, it is too early to consider delivery at 29 weeks based solely on anemia. First, the fetal anemia should be confirmed and managed with intrauterine transfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Repeat MCA PSV after 1 week:&nbsp;</strong>With a significantly elevated MCA PSV (&gt;1.5 MoM), the situation likely indicates moderate to severe fetal anemia. Immediate action, such as cordocentesis and intrauterine transfusion, is needed rather than waiting to repeat the MCA Doppler after a week.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In cases of <strong>Rh alloimmunization</strong> with elevated <strong>MCA peak systolic velocity</strong> (&gt;1.5 MoM), the next step is <strong>cordocentesis</strong> to confirm fetal anemia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If fetal hemoglobin levels are low (PCV &lt;30%), <strong>intrauterine transfusion</strong> is indicated to treat the anemia and improve fetal outcomes.</span></li></ul>",
    "correct_choice_id": 372481,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93557/NEET_PG_22_Sep_2025_OBG_Question_18.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93557/NEET_PG_22_Sep_2025_OBG_Question_18.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93540,
    "choices": [
      {
        "id": 372412,
        "text": "<p><span style=\"font-size:14.0pt;\">Oral antihypertensive therapy</span></p>"
      },
      {
        "id": 372413,
        "text": "<p><span style=\"font-size:14.0pt;\">Immediate corticosteroid therapy for fetal lung maturity</span></p>"
      },
      {
        "id": 372414,
        "text": "<p><span style=\"font-size:14.0pt;\">Magnesium sulphate therapy and induction of labor</span></p>"
      },
      {
        "id": 372415,
        "text": "<p><span style=\"font-size:14.0pt;\">Expectant management with close monitoring</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old primigravida woman presents at 29 weeks gestation with headache and a blood pressure of 160/110 mmHg. Investigations reveal 2+ proteinuria on dipstick, elevated SGOT and SGPT, and a platelet count of 80,000/mm\u00b3. What is the best management?</span></p>",
    "unique_key": "Q9535846",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Magnesium sulphate therapy and induction of labor</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 30-year-old primigravida at <strong>29 weeks gestation</strong> presents with <strong>severe hypertension</strong> (BP 160/110 mmHg), <strong>proteinuria (2+ on dipstick)</strong>, <strong>elevated liver enzymes (SGOT, SGPT)</strong>, and <strong>thrombocytopenia (platelet count 80,000/mm\u00b3)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">These findings indicate <strong>severe preeclampsia with HELLP syndrome</strong> (Hemolysis, Elevated Liver enzymes, Low Platelets).</span></li><li><span style=\"font-size:14.0pt;\">The definitive management for severe preeclampsia or HELLP <strong>after viability is delivery</strong>, regardless of gestational age, to prevent maternal and fetal complications (such as eclampsia, placental abruption, DIC, fetal demise).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Magnesium sulphate therapy</strong> is initiated to prevent seizures (eclampsia prophylaxis).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Induction of labor</strong> is preferred over expectant management in severe disease with end-organ involvement.</span></li><li><span style=\"font-size:14.0pt;\">Thus, <strong>Magnesium sulphate therapy and induction of labor</strong> is the correct, guideline-supported approach for this patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Oral antihypertensive therapy:</strong> Incorrect. While antihypertensives are important for blood pressure control, they do not address the underlying severe preeclampsia or HELLP. Definitive management requires <strong>delivery</strong>, and delaying for sole BP control risks maternal and fetal morbidity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Immediate corticosteroid therapy for fetal lung maturity</strong>: Incorrect. Antenatal corticosteroids (e.g., betamethasone) can be considered if delivery is anticipated before 34 weeks, but in this patient with <strong>severe features and thrombocytopenia</strong>, immediate delivery is indicated after maternal stabilization, not delay for 48 hours solely to complete steroid dosing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Expectant management with close monitoring</strong>: Incorrect. Expectant management may be considered in mild preeclampsia without severe features before 37 weeks, but is <strong>contraindicated</strong> in HELLP or severe disease due to high maternal and fetal risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>severe preeclampsia or HELLP syndrome</strong>, <strong>Magnesium sulphate</strong> is given for seizure prophylaxis, and <strong>delivery is the definitive treatment</strong>, regardless of gestational age, after maternal stabilization.</span></p>",
    "correct_choice_id": 372414,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93540/NEET_PG_22_Sep_2025_OBG_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93540/NEET_PG_22_Sep_2025_OBG_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93532,
    "choices": [
      {
        "id": 372380,
        "text": "<p><span style=\"font-size:14.0pt;\">Pubic symphysis</span></p>"
      },
      {
        "id": 372381,
        "text": "<p><span style=\"font-size:14.0pt;\">Intervertebral disc</span></p>"
      },
      {
        "id": 372382,
        "text": "<p><span style=\"font-size:14.0pt;\">Epiglottis</span></p>"
      },
      {
        "id": 372383,
        "text": "<p><span style=\"font-size:14.0pt;\">Articular cartilage</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following anatomical locations normally contains this type of tissue, as shown in the image?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Wq5R1JM.png\" width=\"675\" height=\"438\"></span></p>",
    "unique_key": "Q6017328",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Intervertebral disc</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fibrocartilage is a specialized connective tissue composed of <strong>type I collagen</strong> fibers arranged in thick bundles, providing high tensile strength.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It contains chondrocytes in lacunae but lacks a perichondrium. This tissue is ideally suited for areas under both compressive and tensile forces.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intervertebral discs</strong>, particularly in the annulus fibrosus, are composed of fibrocartilage.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The tissue shown in the histology image demonstrates elongated collagen fibers with interspersed chondrocytes\u2014characteristic of fibrocartilage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pubic symphysis:</strong> Also made of fibrocartilage, but in this context, the correct answer is the <strong>intervertebral disc</strong> because of the direct clinical and histological correlation described.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Epiglottis:</strong> Contains <strong>elastic cartilage</strong>, rich in type II collagen and elastic fibers, giving flexibility. Found in the epiglottis, external ear, and Eustachian tube.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Articular cartilage:</strong> Composed of hyaline cartilage, which has type II collagen and a smooth, glassy appearance, specialized for reducing friction in synovial joints.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Fibrocartilage, composed primarily of <strong>type I collagen</strong> and lacking a perichondrium, is found in the <strong>intervertebral discs, pubic symphysis, and tendon-bone junctions</strong>, providing resistance to both compressive and tensile forces.</span></p>",
    "correct_choice_id": 372381,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93532/NEET_PG_22_Sep_2025_Anatomy_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      3
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93532/NEET_PG_22_Sep_2025_Anatomy_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93257,
    "choices": [
      {
        "id": 371300,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 4</span></p>"
      },
      {
        "id": 371301,
        "text": "<p><span style=\"font-size:14.0pt;\">2 and 3</span></p>"
      },
      {
        "id": 371302,
        "text": "<p><span style=\"font-size:14.0pt;\">3 only</span></p>"
      },
      {
        "id": 371303,
        "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A public health program adopts a service-based approach, aiming to deliver health services directly to the community. However, this strategy is later evaluated for long-term effectiveness and community engagement. All of the following statements are limitations of the service approach, except?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">It often ignores the felt needs of the community.</span></li><li><span style=\"font-size:14.0pt;\">Long-term sustainability is a concern due to lack of ownership.</span></li><li><span style=\"font-size:14.0pt;\">It enhances local leadership involvement and participatory decision-making.</span></li><li><span style=\"font-size:14.0pt;\">It may lead to passive dependence on external healthcare providers.</span></li></ol>",
    "unique_key": "Q5800008",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) 3 only</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Statement 3. It enhances local leadership involvement and participatory decision-making:&nbsp;</strong>Is not a limitation \u2013 Rather, encouragement of local leadership and participation is a strength of approaches like <strong>primary healthcare</strong> or <strong>health education</strong>, not the service approach.</span></li><li><span style=\"font-size:14.0pt;\">Service approach is typically <strong>top-down</strong>, with services provided irrespective of community participation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>It often ignores the felt needs of the community:</strong> True. Service approach often provides what is deemed important by health authorities, not necessarily what the community needs or asks for.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Long-term sustainability is a concern due to lack of ownership:</strong> True. Without community involvement, such programs tend to <strong>fade</strong> over time due to lack of ownership.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>It may lead to passive dependence on external healthcare providers:</strong> True. This model may result in <strong>passive dependency</strong>, rather than empowering people to take control of their own health.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>service approach</strong> delivers care <strong>without empowering</strong> the community, often leading to <strong>unsustainable health gains</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Participatory strategies remain key for <strong>long-term behavior change and self-reliance</strong> in public health.</span></li></ul>",
    "correct_choice_id": 371302,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93257/Neet_Pg_22_Sept_2025_Psm_Q_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93257/Neet_Pg_22_Sept_2025_Psm_Q_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93503,
    "choices": [
      {
        "id": 372268,
        "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-C, 4-A</span></p>"
      },
      {
        "id": 372269,
        "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-A, 3-D, 4-B</span></p>"
      },
      {
        "id": 372270,
        "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-C, 3-D, 4-A</span></p>"
      },
      {
        "id": 372271,
        "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-A, 4-B</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">The following patients are victims of a mass casualty. Assign appropriate triage codes to them:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_iuGKCyq.png\" width=\"577\" height=\"196\"></span></p>",
    "unique_key": "Q1712148",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1-C, 2-A, 3-D, 4-B</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In mass casualty incidents, triage is used to prioritize patients based on the severity of their injuries and their potential for survival with immediate treatment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A four-tier system is commonly used:</span></li><li><span style=\"font-size:14.0pt;\"><strong>Red</strong>: Immediate care needed; life-threatening injuries with a good chance of survival if treated promptly.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hemothorax</strong> requires immediate drainage to prevent death = <strong>Red (1\u2013C)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Yellow</strong>: Delayed care; serious injuries but not immediately life-threatening and the patient can wait for a short period without loss of life or limb.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Compound tibial fracture</strong> is serious but stable = <strong>Yellow (2\u2013A)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Green</strong>: Minor injuries; the patient can wait for longer periods for care without significant risk.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Arm laceration</strong> without significant bleeding = <strong>Green (3\u2013D)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Black</strong>: Expectant; injuries are so severe that survival is unlikely even with treatment.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>90% fourth-degree burns</strong> have extremely poor prognosis even with care = <strong>Black (4\u2013B)</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-17%20125648.jpg\" width=\"727\" height=\"646\"></span></p>",
    "correct_choice_id": 372269,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93503/NEET_PG_22_Sep_2025_Surgery_Question_14.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93503/NEET_PG_22_Sep_2025_Surgery_Question_14.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92914,
    "choices": [
      {
        "id": 369952,
        "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
      },
      {
        "id": 369953,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
      },
      {
        "id": 369954,
        "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
      },
      {
        "id": 369955,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3 and 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about epistaxis are correct?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Kiesselbach\u2019s plexus is the source of bleeding in 90% of cases</span></li><li><span style=\"font-size:14.0pt;\">Antibiotic prophylaxis should be given if anterior nasal packing is left for more than 48 hours</span></li><li><span style=\"font-size:14.0pt;\">Anterior nasal packing is easier to insert and less traumatic than balloon tamponade</span></li><li><span style=\"font-size:14.0pt;\">Trotter\u2019s method is used as a first aid measure in epistaxis</span></li></ol>",
    "unique_key": "Q4360334",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 3 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Kiesselbach\u2019s plexus is the source of bleeding in 90% of cases: </strong>Correct<strong>.&nbsp;</strong>Kiesselbach\u2019s plexus (Little\u2019s area) is indeed the most common source (90%) of anterior epistaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Anterior nasal packing is easier to insert and less traumatic than balloon tamponade: </strong>Correct<strong>.</strong> Anterior nasal packing is simpler and less traumatic compared to balloon tamponade, which is reserved for special situations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Trotter\u2019s method is used as a first aid measure in epistaxis: </strong>Correct<strong>.</strong> Trotter\u2019s method (sitting upright, leaning forward, mouth open) is the standard first-aid for epistaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Antibiotic prophylaxis should be given if anterior nasal packing is left for more than 48 hours:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Antibiotics are needed if packing is left for <strong>more than 24 hours</strong>, not 48 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Epistaxis is most often from Kiesselbach\u2019s plexus, managed initially with Trotter\u2019s method and anterior nasal packing; prophylactic antibiotics are required if packing exceeds 24 hours.</span></p>",
    "correct_choice_id": 369953,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92914/Neet_Pg_22_Sep_2025_Ent_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      9
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92914/Neet_Pg_22_Sep_2025_Ent_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93332,
    "choices": [
      {
        "id": 371592,
        "text": "<p><span style=\"font-size:14.0pt;\">Squamous cell carcinoma</span></p>"
      },
      {
        "id": 371593,
        "text": "<p><span style=\"font-size:14.0pt;\">Squamous papilloma with central crater</span></p>"
      },
      {
        "id": 371594,
        "text": "<p><span style=\"font-size:14.0pt;\">Molluscum contagiosum</span></p>"
      },
      {
        "id": 371595,
        "text": "<p><span style=\"font-size:14.0pt;\">Herpes zoster</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old girl has had a persistent lesion on her face for the past 3 months. A skin biopsy was performed, and the histology is shown below. What is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_wpalmsz.png\" width=\"471\" height=\"293\"></span></p>",
    "unique_key": "Q1717825",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Molluscum contagiosum</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Molluscum contagiosum is caused by a poxvirus (MCV, most commonly type 1) and is frequent in children.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Histopathology shows a characteristic <strong>cup-shaped epidermal hyperplasia with intracytoplasmic inclusion bodies (Henderson\u2013Paterson bodies)</strong> in keratinocytes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clinically, lesions are dome-shaped, pearly white, umbilicated papules, often on the face in children.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Squamous cell carcinoma:&nbsp;</strong>SCC is a malignant neoplasm of keratinocytes, usually presenting as a hyperkeratotic nodule or ulcer. Histology shows atypical keratinocytes with keratin pearls and dysplasia\u2014not the cup-shaped crater with inclusion bodies seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Squamous papilloma with central crater: </strong>Squamous papilloma typically shows papillomatous projections with fibrovascular cores and hyperkeratosis. The absence of viral inclusion bodies differentiates it from molluscum contagiosum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Herpes zoster:&nbsp;</strong>Herpes zoster (shingles) presents with grouped vesicular lesions along a dermatomal distribution. Histology shows multinucleated giant cells and ballooning degeneration, not large intracytoplasmic inclusions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Molluscum contagiosum is a viral skin infection caused by molluscum contagiosum virus, showing <strong>umbilicated papules clinically</strong> and <strong>cup-shaped epidermal invagination with Henderson\u2013Paterson bodies histologically</strong>, distinguishing it from SCC, papillomas, and herpesvirus infections.</span></p>",
    "correct_choice_id": 371594,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93332/NEET_PG_22_Sep_2025_Derma_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      18
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93332/NEET_PG_22_Sep_2025_Derma_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93516,
    "choices": [
      {
        "id": 372316,
        "text": "<p><span style=\"font-size:14.0pt;\">Decreased sensitivity of the peripheral chemoreceptors to hypoxia</span></p>"
      },
      {
        "id": 372317,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased respiratory drive due to metabolic acidosis</span></p>"
      },
      {
        "id": 372318,
        "text": "<p><span style=\"font-size:14.0pt;\">Delayed detection of changes in blood CO\u2082 by central chemoreceptors</span></p>"
      },
      {
        "id": 372319,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased lung stiffness leading to decreased tidal volume</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old woman with a history of advanced dilated cardiomyopathy is brought by her daughter because of episodes of abnormal breathing during the night. She is noted to have alternating cycles of deep, rapid breathing followed by complete pauses in respiration. On examination, she has bilateral basal lung crackles and elevated jugular venous pressure. Which of the following best explains the mechanism underlying this patient\u2019s breathing pattern?</span></p>",
    "unique_key": "Q9604340",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Delayed detection of changes in blood CO\u2082 by central chemoreceptors</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient demonstrates <strong>Cheyne\u2013Stokes respiration</strong>, characterized by cyclical hyperventilation followed by apnea.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In chronic heart failure, reduced cardiac output delays blood flow from the lungs to the brain.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This leads to a lag in CO\u2082 detection by the central chemoreceptors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The delayed feedback results in overcorrection: hyperventilation when CO\u2082 rises, followed by apnea when CO\u2082 falls too low, producing the waxing and waning breathing pattern.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Decreased sensitivity of the peripheral chemoreceptors to hypoxia:&nbsp;</strong>Incorrect. Peripheral chemoreceptors do respond to hypoxia, but they are not the primary cause of the cyclical breathing in Cheyne\u2013Stokes respiration. The key defect lies in delayed CO\u2082 feedback, not hypoxic sensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Increased respiratory drive due to metabolic acidosis:&nbsp;</strong>Incorrect. Metabolic acidosis produces rapid and deep breathing (Kussmaul respiration), not the cyclic waxing and waning seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased lung stiffness leading to decreased tidal volume:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Lung fibrosis or stiffness causes shallow, rapid breathing. It does not produce the alternating hyperventilation and apnea characteristic of Cheyne\u2013Stokes respiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cheyne\u2013Stokes breathing is defined by alternating cycles of hyperventilation and apnea, most often seen in heart failure, and is caused by delayed detection of CO\u2082 changes by central chemoreceptors.</span></p>",
    "correct_choice_id": 372318,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93516/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      2
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93516/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93321,
    "choices": [
      {
        "id": 371552,
        "text": "<p><span style=\"font-size:14.0pt;\">X-ray</span></p>"
      },
      {
        "id": 371553,
        "text": "<p><span style=\"font-size:14.0pt;\">CT Head</span></p>"
      },
      {
        "id": 371554,
        "text": "<p><span style=\"font-size:14.0pt;\">MRI Brain</span></p>"
      },
      {
        "id": 371555,
        "text": "<p><span style=\"font-size:14.0pt;\">Transcranial ultrasound</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 2-day-old preterm infant develops generalized tonic\u2013clonic seizures in the NICU. The neonate is unstable, and the treating team decides to perform an imaging study that can be done to identify the underlying pathology. Which of the following is the most appropriate initial investigation?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q3947452",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Transcranial ultrasound</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cranial ultrasonography is the <strong>investigation of choice in premature neonates</strong> with seizures.</span></li><li><span style=\"font-size:14.0pt;\">It can be performed at the bedside, is non-invasive, and allows visualization of intraventricular hemorrhage, ischemia, hydrocephalus, and evolving lesions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This makes it ideal for unstable neonates.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. X-ray:&nbsp;</strong>Plain radiographs have <strong>no diagnostic value in neonatal seizures</strong>, as they cannot assess brain parenchyma, hemorrhage, or infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. CT Head:</strong> CT is useful in detecting hemorrhage or infarction but requires shifting the neonate to a scanner, which can be risky. Radiation exposure is another drawback, so it is considered adjunctive, not first-line.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. MRI Brain:&nbsp;</strong>MRI provides superior structural detail and is excellent for diagnosing cortical malformations and subtle ischemic changes. However, it is impractical as an <strong>initial bedside tool</strong> in unstable neonates.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cranial ultrasonography is the preferred initial investigation for neonatal seizures, particularly in preterm infants, due to its bedside availability, safety, and effectiveness in detecting hemorrhagic and ischemic lesions.</span></p>",
    "correct_choice_id": 371555,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93321/NEET_PG_22_Sep_2025_PEDIATRICS_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      13
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93321/NEET_PG_22_Sep_2025_PEDIATRICS_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93339,
    "choices": [
      {
        "id": 371620,
        "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">N2a</span></p>"
      },
      {
        "id": 371621,
        "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">N2b</span></p>"
      },
      {
        "id": 371622,
        "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">N2c</span></p>"
      },
      {
        "id": 371623,
        "text": "<p><span style=\"font-size:14.0pt;\">N3a</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman with breast cancer undergoes imaging that demonstrates metastasis to the internal mammary lymph nodes, without axillary spread. No distant metastasis is noted on staging workup. According to the TNM classification system, what is the N stage of her breast carcinoma?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q9925361",
    "difficulty_level": "intermediate",
    "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Ans. B) N2b</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">N2b is spread to internal mammary LN alone.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;N2a:&nbsp;</strong>Is ipsilateral fixed axillary LN spread.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>N2c:</strong> Is not a part of the N stage in breast cancer.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>N3a:</strong> Is spread to ipsilateral infra-clavicular LN.</span></p><p>&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Involvement of the internal mammary lymph nodes in breast cancer is classified as N2b and corresponds to stage IIIA/B of the TNM classification.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>N staging of breast cancer</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20132504.jpg\" width=\"802\" height=\"286\"></strong></span></p>",
    "correct_choice_id": 371621,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93339/NEET_PG_22_Sep_2025_Surgery_Question_7.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93339/NEET_PG_22_Sep_2025_Surgery_Question_7.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93613,
    "choices": [
      {
        "id": 372692,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
      },
      {
        "id": 372693,
        "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
      },
      {
        "id": 372694,
        "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
      },
      {
        "id": 372695,
        "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following are recognized early clinical features of central retinal artery occlusion (CRAO)?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Sudden, painless vision loss</span></li><li><span style=\"font-size:14.0pt;\">Relative afferent pupillary defect (RAPD)</span></li><li><span style=\"font-size:14.0pt;\">Photophobia and eye pain</span></li><li><span style=\"font-size:14.0pt;\">History of amaurosis fugax</span></li></ol>",
    "unique_key": "Q3713077",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Central retinal artery occlusion (CRAO)</strong> is an ophthalmic emergency characterized by sudden, profound, <strong>painless monocular vision loss</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20165712.jpg\" width=\"340\" height=\"283\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The key early clinical features include:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Sudden, painless vision loss:</strong> The hallmark presentation due to retinal ischemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Relative afferent pupillary defect (RAPD):</strong> Common in CRAO due to profound loss of retinal function.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. History of amaurosis fugax:</strong> Transient vision loss episodes caused by retinal emboli often precede a full-blown CRAO.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Photophobia and eye pain:</strong> Are <strong>not typical</strong> of CRAO; these are more indicative of <strong>anterior segment pathology</strong> like uveitis or acute angle-closure glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">CRAO presents with sudden, painless monocular vision loss, RAPD, and may be preceded by transient ischemic episodes (amaurosis fugax).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Photophobia and pain are not features of retinal artery occlusion.</span></li></ul>",
    "correct_choice_id": 372692,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93613/NEET_PG_22_Sep_2025_Opthalmology_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      8
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93613/NEET_PG_22_Sep_2025_Opthalmology_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92891,
    "choices": [
      {
        "id": 369860,
        "text": "<p><span style=\"font-size:14.0pt;\">Statements 1 and 2 are correct.</span></p>"
      },
      {
        "id": 369861,
        "text": "<p><span style=\"font-size:14.0pt;\">Statements 2, 3 and 4 are correct.</span></p>"
      },
      {
        "id": 369862,
        "text": "<p><span style=\"font-size:14.0pt;\">Statements 1, 3 and 4 are correct.</span></p>"
      },
      {
        "id": 369863,
        "text": "<p><span style=\"font-size:14.0pt;\">All are correct.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Consider the following statements:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statement 1: Lithium is excreted primarily by the kidneys and requires dose adjustment in renal impairment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statement 2: Thiazide diuretics increase serum lithium levels and may precipitate toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statement 3: Lithium should be avoided during pregnancy, preferably, due to the risk of Ebstein\u2019s anomaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statement 4: Lithium reduces suicidality in patients with mood disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is correct?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q2874077",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) All are correct</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Statement 1. Lithium is excreted primarily by the kidneys and requires dose adjustment in renal impairment:&nbsp;</strong>Correct. Lithium is <strong>renally excreted</strong> and must be used cautiously in patients with <strong>renal dysfunction</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 2. Thiazide diuretics increase serum lithium levels and may precipitate toxicity:&nbsp;</strong>Correct. Thiazides causes hypo natremia. Thiazides reduce sodium reabsorption in the distal tubule, leading to <strong>increased lithium reabsorption</strong> in the proximal tubule, raising the <strong>risk of toxicity</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 3. Lithium should be avoided during pregnancy, preferably, due to the risk of Ebstein\u2019s anomaly:&nbsp;</strong>Correct. Lithium is <strong>teratogenic</strong>, especially in the <strong>first trimester</strong>, with a known association with <strong>Ebstein\u2019s anomaly</strong> (tricuspid valve malformation).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 4. Lithium reduces suicidality in patients with mood disorders:&nbsp;</strong>Correct. Lithium is <strong>the only mood stabilizer with anti-suicidal properties</strong>, especially in <strong>bipolar disorder</strong> and <strong>major depressive disorder</strong> with suicidality.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lithium is a first-line <strong>mood stabilizer</strong> used in <strong>bipolar disorder</strong> and <strong>treatment-resistant depression</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Renally excreted</strong> \u2013 avoid in renal failure; monitor serum levels regularly (target: 0.6\u20131.2 mEq/L).</span></li><li><span style=\"font-size:14.0pt;\">Common adverse effects: <strong>Tremor</strong>, <strong>hypothyroidism</strong>, <strong>nephrogenic diabetes insipidus</strong>, and <strong>weight gain</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Narrow therapeutic index</strong>; toxicity &gt;1.5 mEq/L (features: ataxia, confusion, seizures).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Teratogenic</strong>: causes <strong>Ebstein\u2019s anomaly</strong> \u2013 avoid in 1st trimester of pregnancy.</span></li><li><span style=\"font-size:14.0pt;\">Interacts with <strong>thiazides, NSAIDs, and ACE inhibitors</strong> \u2013 can raise lithium levels dangerously.</span></li><li><span style=\"font-size:14.0pt;\">Unique property: <strong>Anti-suicidal effect</strong> among mood stabilizers.</span></li></ul>",
    "correct_choice_id": 369863,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92891/NEET_PG_22_Sep_2025_PSYCHIATRY_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      16
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92891/NEET_PG_22_Sep_2025_PSYCHIATRY_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93621,
    "choices": [
      {
        "id": 372724,
        "text": "<p><span style=\"font-size:14.0pt;\">Trastuzumab</span></p>"
      },
      {
        "id": 372725,
        "text": "<p><span style=\"font-size:14.0pt;\">Bevacizumab</span></p>"
      },
      {
        "id": 372726,
        "text": "<p><span style=\"font-size:14.0pt;\">Alemtuzumab</span></p>"
      },
      {
        "id": 372727,
        "text": "<p><span style=\"font-size:14.0pt;\">Daratumumab</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 63-year-old man with a history of hypertension and smoking is diagnosed with metastatic colorectal cancer. Despite surgical resection of the primary tumor and multiple cycles of standard chemotherapy, repeat imaging shows progressive hepatic and pulmonary metastases. His oncologist recommends adding a monoclonal antibody therapy that works by binding vascular endothelial growth factor A (VEGF-A), thereby preventing new blood vessel formation and restricting tumor growth through inhibition of angiogenesis. Which of the following monoclonal antibodies best fits this mechanism of action?</span></p>",
    "unique_key": "Q2695426",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Bevacizumab</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient with <strong>metastatic colorectal cancer</strong> is being considered for therapy targeting <strong>angiogenesis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bevacizumab</strong> is a monoclonal antibody against <strong>VEGF-A</strong>, a growth factor that stimulates angiogenesis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">By neutralizing VEGF-A, bevacizumab reduces <strong>tumor vascular supply</strong>, slows metastatic progression, and enhances chemotherapy efficacy.</span></li><li><span style=\"font-size:14.0pt;\">It is used in several <strong>metastatic cancers</strong>, including <strong>colorectal carcinoma, renal cell carcinoma, and non-small cell lung cancer</strong>, as well as in <strong>wet age-related macular degeneration</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Trastuzumab:</strong> Targets the <strong>HER2/neu receptor</strong> (a tyrosine kinase). Used in <strong>HER2-positive breast cancer</strong> and <strong>HER2-positive gastric adenocarcinoma</strong>. It does not target VEGF-A.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Alemtuzumab:</strong> Targets <strong>CD52</strong>, leading to destruction of mature lymphocytes. Used in <strong>chronic lymphocytic leukemia (CLL)</strong> and <strong>multiple sclerosis</strong>. Not an anti-angiogenic agent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Daratumumab:</strong> Targets <strong>CD38</strong> on plasma cells, inducing apoptosis. Used in <strong>multiple myeloma</strong>, not metastatic solid tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bevacizumab is a monoclonal antibody that binds VEGF-A, inhibiting angiogenesis and reducing tumor vascularization in metastatic cancers such as colorectal carcinoma.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Other monoclonal antibodies target different molecules (HER2, CD52, CD38) and are used in other malignancies.</span></li></ul>",
    "correct_choice_id": 372725,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93621/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93621/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93261,
    "choices": [
      {
        "id": 371316,
        "text": "<p><span style=\"font-size:14.0pt;\">a\u20132, b\u20134, c\u20133, d\u20131</span></p>"
      },
      {
        "id": 371317,
        "text": "<p><span style=\"font-size:14.0pt;\">a\u20131, b\u20133, c\u20134, d\u20132</span></p>"
      },
      {
        "id": 371318,
        "text": "<p><span style=\"font-size:14.0pt;\">a\u20134, b\u20132, c\u20131, d\u20133</span></p>"
      },
      {
        "id": 371319,
        "text": "<p><span style=\"font-size:14.0pt;\">a\u20132, b\u20133, c\u20134, d\u20131&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following growth ratings with their Population Doubling Times:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20130037.jpg\" width=\"790\" height=\"370\"></p>",
    "unique_key": "Q2822773",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) a\u20132, b\u20133, c\u20134, d\u20131</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>a\u20132. Rapid growth</strong> corresponds to an <strong>Annual Growth Rate (AGR) of 1.0\u20131.5%</strong>, which leads to a <strong>population doubling time of 70\u201347 years</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>b\u20133. Explosive growth (AGR 3.5\u20134%)</strong> is the fastest and results in the <strong>shortest doubling time of 20\u201318 years</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>c\u20134. Stationary population</strong> indicates <strong>no growth</strong>, and thus, there is <strong>no doubling time</strong> \u2014 population size remains constant.</span></li><li><span style=\"font-size:14.0pt;\"><strong>d\u20131. Slow growth</strong> (AGR &lt;0.5%) has a <strong>population doubling time greater than 139 years</strong>, indicating minimal increase over time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Annual Growth Rate directly influences the population doubling time.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Higher AGR \u2192 shorter doubling time.</span></li><li><span style=\"font-size:14.0pt;\">Stationary populations have no doubling time.</span></li><li><span style=\"font-size:14.0pt;\">Explosive growth (AGR &gt;3.5%) can double population in less than 20 years.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Relation between Annual Growth Rate (AGR) and Population Doubling Time</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8CG6dOO.png\" width=\"832\" height=\"508\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">*India&nbsp;</span></p>",
    "correct_choice_id": 371319,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93261/Neet_Pg_22_Sept_2025_Psm_Q_9.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93261/Neet_Pg_22_Sept_2025_Psm_Q_9.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93323,
    "choices": [
      {
        "id": 371560,
        "text": "<p><span style=\"font-size:14.0pt;\">1\u2013c, 2\u2013b, 3\u2013a, 4\u2013d, 5\u2013e</span></p>"
      },
      {
        "id": 371561,
        "text": "<p><span style=\"font-size:14.0pt;\">1\u2013a, 2\u2013c, 3\u2013d, 4\u2013b, 5\u2013e</span></p>"
      },
      {
        "id": 371562,
        "text": "<p><span style=\"font-size:14.0pt;\">1\u2013c, 2\u2013a, 3\u2013b, 4\u2013d, 5\u2013e&nbsp;</span></p>"
      },
      {
        "id": 371563,
        "text": "<p><span style=\"font-size:14.0pt;\">1\u2013d, 2\u2013e, 3\u2013c, 4\u2013a, 5\u2013b</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following immunodeficiency disorders in newborns and young infants (0\u20136 months) with their characteristic features:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A \u2013 Diagnosis</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">DiGeorge anomaly</span></li><li><span style=\"font-size:14.0pt;\">Leukocyte adhesion defect</span></li><li><span style=\"font-size:14.0pt;\">Severe combined immunodeficiency (SCID)</span></li><li><span style=\"font-size:14.0pt;\">Wiskott\u2013Aldrich syndrome</span></li><li><span style=\"font-size:14.0pt;\">Hyper IgM syndrome</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B \u2013 Features</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:14.0pt;\">Delayed umbilical cord detachment, leukocytosis, recurrent infections</span></li><li><span style=\"font-size:14.0pt;\">Diarrhea, pneumonia, thrush, failure to thrive</span></li><li><span style=\"font-size:14.0pt;\">Hypocalcemia, heart disease, unusual facies</span></li><li><span style=\"font-size:14.0pt;\">Bloody stools, draining ears, eczema</span></li><li><span style=\"font-size:14.0pt;\">Mouth ulcers, neutropenia, recurrent infections</span></li></ol>",
    "unique_key": "Q4879400",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1\u2013c, 2\u2013a, 3\u2013b, 4\u2013d, 5\u2013e</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. DiGeorge anomaly \u2192 c. Hypocalcemia, heart disease, unusual facies:&nbsp;</strong>This disorder results from a 22q11.2 deletion causing thymic aplasia. Features include <strong>hypocalcemia (due to hypoparathyroidism)</strong>, congenital heart disease, recurrent viral/fungal infections, and dysmorphic facies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Leukocyte adhesion defect \u2192 a. Delayed umbilical cord detachment, leukocytosis, recurrent infections:&nbsp;</strong>Defective CD18 integrins impair leukocyte adhesion and migration. Hallmark features include <strong>delayed separation of the umbilical cord (&gt;30 days)</strong>, neutrophilia, and recurrent bacterial infections without pus formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Severe combined immunodeficiency (SCID) \u2192 b. Diarrhea, pneumonia, thrush, failure to thrive:&nbsp;</strong>SCID is characterized by defective T- and B-cell function. Infants present with <strong>persistent infections, oral thrush, chronic diarrhea, pneumonia, and growth failure</strong>, often requiring bone marrow transplantation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Wiskott\u2013Aldrich syndrome \u2192 d. Bloody stools, draining ears, eczema:&nbsp;</strong>This X-linked disorder presents with the classic triad of <strong>thrombocytopenia (bloody diarrhea, petechiae), recurrent infections, and eczema.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. Hyper IgM syndrome \u2192 e. Mouth ulcers, neutropenia, recurrent infections:&nbsp;</strong>Caused by defective CD40\u2013CD40L signaling, preventing class switching. Children present with <strong>recurrent infections, mouth ulcers, and neutropenia</strong>, while IgM levels remain elevated with low IgG/IgA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Primary immunodeficiencies in infants present with distinctive clinical patterns\u2014DiGeorge with hypocalcemia and heart defects, LAD with delayed cord separation, SCID with severe infections and failure to thrive, Wiskott\u2013Aldrich with bleeding and eczema, and Hyper IgM with mouth ulcers and recurrent infections.</span></p>",
    "correct_choice_id": 371562,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93323/NEET_PG_22_Sep_2025_PEDIATRICS_Question_7.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      13
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93323/NEET_PG_22_Sep_2025_PEDIATRICS_Question_7.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92892,
    "choices": [
      {
        "id": 369864,
        "text": "<p><span style=\"font-size:14.0pt;\">Treating psychiatrist</span></p>"
      },
      {
        "id": 369865,
        "text": "<p><span style=\"font-size:14.0pt;\">Judicial magistrate&nbsp;</span></p>"
      },
      {
        "id": 369866,
        "text": "<p><span style=\"font-size:14.0pt;\">Nominated representative</span></p>"
      },
      {
        "id": 369867,
        "text": "<p><span style=\"font-size:14.0pt;\">Medical superintendent of the hospital</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old woman with chronic schizophrenia is brought to the psychiatry emergency by her sister. The patient is refusing all treatment, including food and medication, and is unable to make decisions regarding her care. The psychiatrist determines that she currently lacks mental capacity. According to the Mental Healthcare Act (MHCA), 2017, who is legally empowered to make decisions on behalf of the patient regarding admission and treatment?</span></p>",
    "unique_key": "Q1011300",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Nominated representative</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Under the <strong>Mental Healthcare Act (MHCA), 2017</strong>, when a person with mental illness (PMI) is found to <strong>lack mental capacity</strong> to make informed decisions regarding their care, the law permits a <strong>legally designated person</strong>\u2014known as a <strong>Nominated Representative (NR)</strong>\u2014to take decisions <strong>on behalf of the patient</strong>, including decisions regarding <strong>treatment and admission</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In the current scenario, the 42-year-old woman with <strong>chronic schizophrenia</strong> is refusing <strong>all forms of treatment</strong>, including <strong>food and medication</strong>, and has been assessed by the psychiatrist as <strong>incapable of making decisions</strong>\u2014fulfilling the MHCA criteria for <strong>lack of capacity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the psychiatrist must <strong>involve the NR</strong> to act in the patient's best interest.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Treating psychiatrist</strong>: While the psychiatrist assesses <strong>capacity</strong> and provides <strong>clinical recommendations</strong>, they <strong>cannot take legal decisions</strong> on behalf of a patient who lacks capacity. The psychiatrist must <strong>seek consent from the NR</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Judicial magistrate</strong>: The magistrate may be involved in <strong>supported admissions</strong> under certain sections (e.g., 102), but <strong>not in routine decisions</strong> about treatment for a patient who already has an NR under the MHCA framework.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Medical superintendent of the hospital</strong>: The MS may oversee administrative operations but is <strong>not authorized to act as the NR</strong> or make personal healthcare decisions for the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-18%20160120.jpg\" width=\"834\" height=\"280\"></p>",
    "correct_choice_id": 369866,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92892/NEET_PG_22_Sep_2025_PSYCHIATRY_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      16
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92892/NEET_PG_22_Sep_2025_PSYCHIATRY_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93267,
    "choices": [
      {
        "id": 371340,
        "text": "<p><span style=\"font-size:14.0pt;\">Involves ecological disruption and demands international aid</span></p>"
      },
      {
        "id": 371341,
        "text": "<p><span style=\"font-size:14.0pt;\">Causes more than 10 deaths in a localized setting</span></p>"
      },
      {
        "id": 371342,
        "text": "<p><span style=\"font-size:14.0pt;\">Requires a response that exceeds the capacity of the affected community</span></p>"
      },
      {
        "id": 371343,
        "text": "<p><span style=\"font-size:14.0pt;\">Must involve more than 30 people needing hospital treatment simultaneously</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">According to WHO, what key criterion distinguishes a disaster from a routine public health emergency, especially in settings like the current floods in Himachal Pradesh?</span></p>",
    "unique_key": "Q3166420",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Requires a response that exceeds the capacity of the affected community</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to the <strong>WHO</strong>, a <strong>disaster</strong> is defined as: \u201cAny occurrence that causes damage, ecological disruption, loss of human life or deterioration of health and health services on a scale sufficient to warrant an extraordinary response from outside the affected community or area.\u201d</span></li><li><span style=\"font-size:14.0pt;\">The <strong>need for external support</strong> is the key feature distinguishing disasters from smaller-scale emergencies manageable with local resources.</span></li><li><span style=\"font-size:14.0pt;\">This is particularly relevant in <strong>natural disasters like floods</strong>, where local health infrastructure is often overwhelmed and higher authorities or aid agencies must intervene.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Involves ecological disruption and demands international aid:&nbsp;</strong>While ecological disruption can be a feature, <strong>international aid is not required</strong> for the definition. The emphasis is on <strong>external help</strong>, which can be local or national.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Causes more than 10 deaths in a localized setting:</strong> There's <strong>no specific death count threshold</strong> in the WHO definition. Even fewer deaths can be considered a disaster if it overwhelms local capacity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Must involve more than 30 people needing hospital treatment simultaneously:</strong> This definition is derived from <strong>Colin Grant\u2019s criteria</strong>, not WHO. While relevant, it is <strong>not the WHO-standard definition</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">\u201cA situation is classified as a disaster by WHO when it overwhelms the local community\u2019s ability to respond effectively and requires support from outside the affected area.\u201d</span></p>",
    "correct_choice_id": 371342,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93267/Neet_Pg_22_Sept_2025_Psm_Q_15.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93267/Neet_Pg_22_Sept_2025_Psm_Q_15.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93655,
    "choices": [
      {
        "id": 372856,
        "text": "<p><span style=\"font-size:14.0pt;\">TGF-\u03b2</span></p>"
      },
      {
        "id": 372857,
        "text": "<p><span style=\"font-size:14.0pt;\">\u03b2-catenin</span></p>"
      },
      {
        "id": 372858,
        "text": "<p><span style=\"font-size:14.0pt;\">MYC</span></p>"
      },
      {
        "id": 372859,
        "text": "<p><span style=\"font-size:14.0pt;\">BCL2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old man has had abdominal pain for the past year. Imaging with abdominal CT reveals a large 10-cm mass involving the pancreas. Biopsy confirms adenocarcinoma and shows inactivation of the SMAD4 gene. Which of the following regulatory pathways is most likely disrupted in this patient?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q5564415",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) TGF-\u03b2</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 72-year-old man has a pancreatic adenocarcinoma with SMAD4 gene inactivation. SMAD4 is a tumor suppressor gene that encodes a protein acting in the TGF-\u03b2 (transforming growth factor-beta) signaling pathway.</span></li><li><span style=\"font-size:14.0pt;\">Normally, TGF-\u03b2 signaling via SMAD proteins inhibits cell proliferation by inducing cell cycle arrest.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Loss or inactivation of SMAD4 disrupts this pathway, leading to uncontrolled cellular proliferation and progression of pancreatic cancer.</span></li><li><span style=\"font-size:14.0pt;\">Thus, the regulatory pathway most likely altered in this patient is the TGF-\u03b2 pathway.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>\u03b2-catenin</strong>: \u03b2-catenin is a key effector in the Wnt signaling pathway, which plays a role in colorectal cancer via APC gene mutations. While important in colon carcinogenesis, it is not the mechanism described here, since the biopsy highlights SMAD4 loss in pancreatic adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>MYC</strong>: MYC is a proto-oncogene that functions as a transcription factor promoting cell growth and proliferation. Mutations or amplification of MYC are implicated in cancers such as Burkitt lymphoma. It is not related to SMAD4 or pancreatic adenocarcinoma in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>BCL2</strong>: BCL2 is an anti-apoptotic gene, commonly overexpressed in follicular lymphoma due to the t(14;18) translocation. It prevents programmed cell death but is not linked to SMAD4 inactivation or pancreatic carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">SMAD4 is a tumor suppressor gene that functions in the TGF-\u03b2 signaling pathway.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Inactivation of SMAD4 is a hallmark of pancreatic adenocarcinoma and leads to loss of growth inhibition and uncontrolled proliferation.</span></li></ul>",
    "correct_choice_id": 372856,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93655/NEET_PG_22_Sep_2025_Pathology_Question_9.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93655/NEET_PG_22_Sep_2025_Pathology_Question_9.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92955,
    "choices": [
      {
        "id": 370112,
        "text": "<p><span style=\"font-size:14.0pt;\">3, 5</span></p>"
      },
      {
        "id": 370113,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2</span></p>"
      },
      {
        "id": 370114,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 5&nbsp;</span></p>"
      },
      {
        "id": 370115,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 4&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:14.0pt;\">Risk factor(s) for Legg-calve-Perthe\u2019s disease is/are:&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"color:black;font-size:14.0pt;\">Accelerated skeletal growth</span></li><li><span style=\"color:black;font-size:14.0pt;\">Growth hormone abnormalities</span></li><li><span style=\"color:black;font-size:14.0pt;\">Positive family history</span></li><li><span style=\"color:black;font-size:14.0pt;\">Female sex</span></li><li><span style=\"color:black;font-size:14.0pt;\">Passive smoking</span></li></ol>",
    "unique_key": "Q8228969",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"color:black;font-size:14.0pt;\"><strong>Ans.&nbsp;A) 3, 5&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"color:black;font-size:14.0pt;\"><strong>Legg-Calv\u00e9-Perthes disease</strong> is a rare childhood condition that occurs when the blood supply to the femoral head is temporarily disrupted, causing the bone to die and collapse (avascular necrosis).&nbsp;</span></li><li><span style=\"color:black;font-size:14.0pt;\">The exact cause is unknown, but several risk factors are associated with it.</span></li><li><span style=\"color:black;font-size:14.0pt;\"><strong>Statement 3. Positive family history:</strong> There is a genetic predisposition, with a positive family history increasing the risk.</span></li><li><span style=\"color:black;font-size:14.0pt;\"><strong>Statement 5. Passive smoking:</strong> Studies have shown a strong association between <strong>passive smoking</strong> and the development of Perthes disease, likely due to its effect on blood vessels and coagulation.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:14.0pt;\"><strong>Statement 1. Accelerated skeletal growth:</strong> Perthes disease is more common in children with&nbsp;delayed skeletal maturation and a lower height-for-age.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:14.0pt;\"><strong>Statement 2. Growth hormone abnormalities:</strong> Growth hormone deficiencies and abnormalities have been linked to the disease, but the primary link is to delayed growth, not an excess.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:14.0pt;\"><strong>Statement 4. Female sex:</strong> Perthes disease is much more common in <strong>males</strong> (approximately a 4:1 ratio).</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:14.0pt;\">The prognosis for Legg-Calv\u00e9-Perthes disease is generally <strong>good</strong>, especially with early diagnosis and proper management.&nbsp;</span></li><li><span style=\"color:black;font-size:14.0pt;\">Most children recover completely, but the long-term outcome largely depends on several key factors.</span></li></ul>",
    "correct_choice_id": 370112,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92955/NEET_PG_22_Sep_2025_Orthopedics_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      15
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92955/NEET_PG_22_Sep_2025_Orthopedics_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93603,
    "choices": [
      {
        "id": 372652,
        "text": "<p><span style=\"font-size:14.0pt;\">ABOi kidney transplant is not possible.</span></p>"
      },
      {
        "id": 372653,
        "text": "<p><span style=\"font-size:14.0pt;\">In a comprehensive database analysis, three-year graft survival was better for ABOi transplant.</span></p>"
      },
      {
        "id": 372654,
        "text": "<p><span style=\"font-size:14.0pt;\">ABOi kidney transplant is a new development in transplantation, and we do not have much information on outcomes.</span></p>"
      },
      {
        "id": 372655,
        "text": "<p><span style=\"font-size:14.0pt;\">Risk of infections and hemorrhagic complications is significantly higher in ABOi transplant.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man with ESRD due to diabetes, on hemodialysis for five years, is evaluated for a kidney transplant. His wife, willing to donate, is ABO-incompatible (patient: O positive, wife: A). They seek information on ABOi kidney transplant outcomes. Which of the following statements is true?</span></p>",
    "unique_key": "Q7996743",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Risk of infections and hemorrhagic complications is significantly higher in ABOi transplant.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s blood group (O positive) and his wife\u2019s (A) indicate ABO incompatibility, as O can only receive from O, while A can donate to A or AB. ABOi transplantation is feasible with desensitization protocols (e.g., plasmapheresis, IVIG, rituximab) to remove anti-A/B antibodies, a practice increasingly utilized since the 2000s.</span></li><li><span style=\"font-size:14.0pt;\">Data from the US Renal Data System and Medicare (2000\u20132007) on 119 <strong>ABOi transplant recipients</strong> show significantly <strong>higher risks</strong> compared to ABO-compatible recipients: 2.2-fold higher risk of pneumonia, 3.6-fold <strong>higher risk of wound infections</strong>, 56% higher risk of pyelonephritis, and nearly 2-fold higher risk of hemorrhage. These complications arise due to immunosuppression and desensitization-related immune activation, making this statement accurate.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Supporting Evidence</strong>: The increased infectious and hemorrhagic risks are attributed to intensified immunosuppression and antibody-mediated injury, a well-documented challenge in ABOi transplants.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. ABOi kidney transplant is not possible</strong>: False. ABOi kidney transplantation is possible and has been successfully performed since the early 2000s with desensitization protocols. It is an established option for incompatible donor-recipient pairs, contradicting this statement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. In a comprehensive database analysis, three-year graft survival was better for ABOi transplant</strong>: False. Comprehensive data (e.g., 1420 ABOi vs. ABO-matched living donor transplants from 2005\u20132012) show that three-year graft survival is identical, not better, for ABOi transplants compared to ABO-compatible ones, refuting this claim.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. ABOi kidney transplant is a new development in transplantation, and we do not have much information on outcomes</strong>: False. ABOi transplantation has been practiced since the mid-2000s, with extensive data from 101 centers (1420 ABOi transplants) showing comparable graft and patient survival to ABO-matched transplants, indicating robust outcome information is available.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">ABOi kidney transplant carries a significantly higher risk of infections (pneumonia, wound infections, pyelonephritis) and hemorrhagic complications due to immunosuppression.</span></li><li><span style=\"font-size:14.0pt;\">Three-year graft survival in ABOi transplants is equivalent to ABO-compatible transplants, not superior.</span></li><li><span style=\"font-size:14.0pt;\">ABOi transplantation is an established procedure with extensive outcome data, feasible via desensitization since the 2000s.</span></li></ul>",
    "correct_choice_id": 372655,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93603/Neet_Pg_22_Sep_2025_Medicine_Question_151.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93603/Neet_Pg_22_Sep_2025_Medicine_Question_151.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93597,
    "choices": [
      {
        "id": 372628,
        "text": "<p><span style=\"font-size:14.0pt;\">Old age</span></p>"
      },
      {
        "id": 372629,
        "text": "<p><span style=\"font-size:14.0pt;\">Hypertension</span></p>"
      },
      {
        "id": 372630,
        "text": "<p><span style=\"font-size:14.0pt;\">Atrial fibrillation</span></p>"
      },
      {
        "id": 372631,
        "text": "<p><span style=\"font-size:14.0pt;\">Ejection fraction</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old woman presents with dyspnea on exertion, fatigue, and bilateral leg edema for 3 months. You are suspecting heart failure with preserved ejection fraction (HFpEF). Which of the following is not a component of the H2FPEF score for diagnosing HFpEF?</span></p>",
    "unique_key": "Q7402701",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Ejection fraction</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s presentation (dyspnea, fatigue, leg edema, hypertension, atrial fibrillation, LVEF 55%, diastolic dysfunction) is consistent with <strong>heart failure with preserved ejection fraction (HFpEF)</strong>, a condition characterized by heart failure symptoms with normal or near-normal LVEF (\u226550%) and evidence of diastolic dysfunction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>H2FPEF score</strong> is a diagnostic tool to estimate the probability of HFpEF in patients with unexplained dyspnea, incorporating six weighted components: <strong>H</strong>eavy (BMI &gt;30 kg/m\u00b2, 2 points), <strong>H</strong>ypertension (\u22652 antihypertensive medications, 1 point), <strong>F</strong>ibrillation (paroxysmal or persistent atrial fibrillation, 3 points), <strong>P</strong>ulmonary hypertension (echocardiographic pulmonary artery systolic pressure &gt;35 mmHg, 1 point), <strong>E</strong>lderly (age &gt;60 years, 1 point), and <strong>F</strong>illing pressure (elevated E/e\u2019 ratio &gt;9 on echocardiography, 1 point).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A score \u22656 indicates high probability of HFpEF.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ejection fraction</strong> is not part of the H2FPEF score. While LVEF \u226550% is a diagnostic criterion for HFpEF itself, the H2FPEF score focuses on clinical and echocardiographic variables that predict HFpEF likelihood in ambiguous cases, not LVEF, which is already assumed to be preserved.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Old age</strong>: Included. Age &gt;60 years is a component of the H2FPEF score (1 point), as elderly patients are at higher risk for HFpEF due to age-related diastolic dysfunction. This patient, at 62 years, meets this criterion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hypertension</strong>: Included. Use of \u22652 antihypertensive medications is a component of the H2FPEF score (1 point), reflecting the strong association between chronic hypertension and left ventricular hypertrophy/diastolic dysfunction in HFpEF. This patient\u2019s history of hypertension likely contributes to her score.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Atrial fibrillation</strong>: Included. Paroxysmal or persistent atrial fibrillation is a major component of the H2FPEF score (3 points), as it exacerbates diastolic dysfunction and contributes to heart failure symptoms. This patient\u2019s atrial fibrillation is a key scoring factor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Old age (&gt;60 years) contributes 1 point to the H2FPEF score for HFpEF diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">Hypertension (\u22652 antihypertensive medications) and atrial fibrillation (paroxysmal/persistent) are weighted components of the H2FPEF score.</span></li><li><span style=\"font-size:14.0pt;\">Ejection fraction is not part of the H2FPEF score, though LVEF \u226550% defines HFpEF.</span></li></ul>",
    "correct_choice_id": 372631,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93597/NEET_PG_22_Sep_2025_MEDICINE_Question_11.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93597/NEET_PG_22_Sep_2025_MEDICINE_Question_11.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 23008,
    "choices": [
      {
        "id": 91995,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Clopidogrel</span></p>"
      },
      {
        "id": 91996,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Prasugrel</span></p>"
      },
      {
        "id": 91997,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Ticagrelor</span></p>"
      },
      {
        "id": 91998,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Ticlopidine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following drugs reversibly binds the site labelled as B in the given figure?&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/07/whatsapp-image-2023-06-12-at-190121011010202.jpg\" alt=\"\" width=\"400\" height=\"320\"></p>",
    "unique_key": "Q2788290",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ticagrelor</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The figure shows a platelet activation and aggregation pathway involving the COX-1 enzyme, thromboxane, ADP, the P2Y12 receptor, and the GPIIb/IIIa receptor.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The site labelled \"B\" is the P2Y12 receptor, which is targeted by antiplatelet drugs.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ticagrelor</strong>&nbsp;is unique because it&nbsp;<strong>reversibly</strong>&nbsp;binds to the P2Y12 receptor.</span></li><li><span style=\"font-size:14.0pt;\">Thus, the drug that reversibly binds the site labelled \"B\" (P2Y12 receptor) is ticagrelor.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Site A:&nbsp;</strong>The site labelled \"A\" in the figure corresponds to the COX-1 enzyme. COX-1 is responsible for the production of thromboxane A2, a potent promoter of platelet aggregation. The primary drug that targets this site is&nbsp;<strong>aspirin</strong>, which irreversibly inhibits COX-1, leading to a decrease in thromboxane A2 production and thus reduced platelet aggregation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Site C:&nbsp;</strong>The site labelled \"C\" in the figure corresponds to the GPIIb/IIIa receptor. This receptor is crucial for platelet aggregation because it binds fibrinogen, which links platelets together. Drugs that target this receptor, known as GPIIb/IIIa inhibitors, include&nbsp;<strong>abciximab</strong>,&nbsp;<strong>eptifibatide</strong>, and&nbsp;<strong>tirofiban</strong>. These drugs prevent fibrinogen binding to the GPIIb/IIIa receptor, thereby inhibiting platelet aggregation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. B and D. Clopidogrel</strong>,&nbsp;<strong>Prasugrel</strong>, and&nbsp;<strong>Ticlopidine:</strong>&nbsp;Irreversibly bind to the P2Y12 receptor to inhibit ADP-induced platelet aggregation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Understanding the mechanisms of action of antiplatelet drugs is crucial for their effective use in preventing thrombotic events.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Ticagrelor is a reversible P2Y12 receptor antagonist, which distinguishes it from other P2Y12 inhibitors like clopidogrel, prasugrel, and ticlopidine, which bind irreversibly.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Aspirin targets the COX-1 enzyme, reducing thromboxane A2 production, while GPIIb/IIIa inhibitors prevent platelet aggregation by blocking fibrinogen binding.&nbsp;</span></li></ul>",
    "correct_choice_id": 91997,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/23008/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_19.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [
      "ImageBased"
    ],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/23008/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_19.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93604,
    "choices": [
      {
        "id": 372656,
        "text": "<p><span style=\"font-size:14.0pt;\">The sympathetic nervous system is overactive.</span></p>"
      },
      {
        "id": 372657,
        "text": "<p><span style=\"font-size:14.0pt;\">This illness generally occurs only with advanced chronic kidney disease.</span></p>"
      },
      {
        "id": 372658,
        "text": "<p><span style=\"font-size:14.0pt;\">In going from supine to standing, heart rate will remain unchanged.</span></p>"
      },
      {
        "id": 372659,
        "text": "<p><span style=\"font-size:14.0pt;\">Baroreceptor sensitivity remains normal.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old male with a history of end-stage renal disease currently on hemodialysis presents to your office for a follow-up visit. He reports a history of impotence, dyspepsia, and dizziness. Which of the following is true about his illness?</span></p>",
    "unique_key": "Q7946600",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) The sympathetic nervous system is overactive.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s ESRD, managed with hemodialysis, and symptoms (impotence, dyspepsia, dizziness) suggest complications of chronic kidney disease (CKD), potentially including uremic autonomic neuropathy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition affects the autonomic nervous system due to uremic toxins and is common in ESRD patients.</span></li><li><span style=\"font-size:14.0pt;\">In uremic autonomic neuropathy, the <strong>sympathetic nervous system is overactive</strong>, while the parasympathetic nervous system is hypoactive.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This imbalance contributes to symptoms like hypertension, dizziness (due to orthostatic instability), and autonomic dysfunction, aligning with the patient\u2019s presentation.</span></li><li><span style=\"font-size:14.0pt;\">Overactivity of the sympathetic nervous system is a well-documented feature in CKD, driven by uremic toxin accumulation and renal ischemia, exacerbating cardiovascular and autonomic symptoms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. This illness generally occurs only with advanced chronic kidney disease</strong>: False. Uremic autonomic neuropathy can manifest early in the course of chronic renal failure, contrasting with uremic encephalopathy and uremic neuropathy, which typically occur with advanced disease (e.g., glomerular filtration rate &lt;10 mL/min). The patient\u2019s ESRD (advanced stage) supports this condition, but it is not exclusive to this stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. In going from supine to standing, heart rate will remain unchanged</strong>: False. Patients with uremic autonomic neuropathy typically show a <strong>normal increase in heart rate</strong> when transitioning from supine to standing, as the sympathetic overactivity can still elicit a compensatory response, unlike in severe autonomic failure where the response is blunted.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Baroreceptor sensitivity remains normal</strong>: False. Uremic autonomic neuropathy is associated with <strong>impaired baroreceptor sensitivity</strong>, leading to poor regulation of blood pressure and contributing to dizziness and orthostatic hypotension, consistent with the patient\u2019s symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sympathetic nervous system overactivity characterizes uremic autonomic neuropathy in ESRD, contributing to symptoms like dizziness and impotence.</span></li><li><span style=\"font-size:14.0pt;\">Uremic autonomic neuropathy can occur early in CKD, unlike uremic encephalopathy/neuropathy, which require advanced disease.</span></li><li><span style=\"font-size:14.0pt;\">Impaired baroreceptor sensitivity and a normal heart rate increase on standing are typical findings in this condition</span></li></ul>",
    "correct_choice_id": 372656,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93604/NEET_PG_22_Sep_2025_MEDICINE_Question_16.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93604/NEET_PG_22_Sep_2025_MEDICINE_Question_16.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92896,
    "choices": [
      {
        "id": 369880,
        "text": "<p><span style=\"font-size:14.0pt;\">COPD</span></p>"
      },
      {
        "id": 369881,
        "text": "<p><span style=\"font-size:14.0pt;\">ARDS</span></p>"
      },
      {
        "id": 369882,
        "text": "<p><span style=\"font-size:14.0pt;\">Circulatory shock</span></p>"
      },
      {
        "id": 369883,
        "text": "<p><span style=\"font-size:14.0pt;\">Lung atelectasis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 48-year-old man with severe hypoxemic respiratory failure due to viral pneumonia is admitted to the ICU. Despite low tidal volume ventilation (6 mL/kg IBW), FiO\u2082 0.8, and PEEP 12 cm H\u2082O, his PaO\u2082/FiO\u2082 ratio remains &lt;100 mmHg. The ICU team decides to change his position, as shown in the image, to optimize oxygenation while continuing invasive mechanical ventilation. This ventilation strategy is primarily indicated in the management of which condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20121424.jpg\" width=\"685\" height=\"413\"></span></p>",
    "unique_key": "Q6953242",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) ARDS</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows a patient in <strong>prone positioning</strong> while receiving invasive mechanical ventilation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Prone ventilation is not a mode of ventilation but a supportive strategy used in <strong>severe ARDS</strong> to improve oxygenation when lung-protective ventilation fails.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It improves gas exchange by reducing dorsal lung compression, redistributing perfusion, and reducing ventral-dorsal transpulmonary pressure differences.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clinical trials (e.g., PROSEVA) have shown a survival benefit in severe ARDS with prolonged prone ventilation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. COPD:&nbsp;</strong>Patients with COPD usually benefit from noninvasive ventilation, controlled oxygen delivery, and permissive hypercapnia. Prone positioning is not standard management in COPD exacerbations, as their hypoxemia is not due to diffuse alveolar collapse as in ARDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Circulatory shock:&nbsp;</strong>Management of shock focuses on fluids, vasopressors, and treating the underlying cause. Prone positioning does not play a therapeutic role and may worsen hemodynamics due to increased intrathoracic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lung atelectasis:&nbsp;</strong>While body positioning can help in postoperative atelectasis, prone positioning is not the standard approach. Techniques like incentive spirometry, CPAP, and physiotherapy are more relevant. Prone ventilation is reserved for diffuse severe lung injury, not isolated atelectasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Prone ventilation</strong> is a supportive strategy in <strong>severe ARDS</strong> to improve oxygenation when conventional lung-protective ventilation fails, by enhancing alveolar recruitment, reducing dorsal lung compression, and improving ventilation\u2013perfusion matching.</span></p>",
    "correct_choice_id": 369881,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92896/NEET_PG_22_Sep_2025_Anesthesia_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      19
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92896/NEET_PG_22_Sep_2025_Anesthesia_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93654,
    "choices": [
      {
        "id": 372852,
        "text": "<p><span style=\"font-size:14.0pt;\">Trisomy of chromosome 21</span></p>"
      },
      {
        "id": 372853,
        "text": "<p><span style=\"font-size:14.0pt;\">Mutation in the FMR1 gene</span></p>"
      },
      {
        "id": 372854,
        "text": "<p><span style=\"font-size:14.0pt;\">Deletion of the maternal chromosome 15</span></p>"
      },
      {
        "id": 372855,
        "text": "<p><span style=\"font-size:14.0pt;\">Deletion of the paternal chromosome 15</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old child is brought for evaluation due to delayed milestones, ataxic gait, seizures, and a happy demeanor characterized by frequent laughter. The child also has severe developmental delay and absence of speech. On examination, there is microcephaly and a prominent chin. Genetic testing demonstrates a deletion on chromosome 15q11\u2013q13. Which of the following is the most likely genetic cause of this presentation?&nbsp;</span></p>",
    "unique_key": "Q4468126",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Deletion of the maternal chromosome 15</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 3-year-old child presents with a triad of delayed milestones, ataxic gait, and seizures, together with a happy demeanor with frequent laughter.</span></li><li><span style=\"font-size:14.0pt;\">Additional findings include severe developmental delay, absence of speech, microcephaly, and a prominent chin.</span></li><li><span style=\"font-size:14.0pt;\">The key clue is the genetic testing revealing a deletion on chromosome 15q11\u2013q13.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">When this deletion occurs on the maternal chromosome, the result is Angelman syndrome.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hallmark features include:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Severe intellectual disability and developmental delay</span></li><li><span style=\"font-size:14.0pt;\">Seizures</span></li><li><span style=\"font-size:14.0pt;\">Ataxia</span></li><li><span style=\"font-size:14.0pt;\">A happy/excitable disposition, often described as frequent inappropriate laughter (\u201chappy puppet\u201d phenotype)</span></li><li><span style=\"font-size:14.0pt;\">Microcephaly and craniofacial findings (e.g., prominent chin)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">By contrast, a paternal deletion in the same region results in Prader\u2013Willi syndrome (characterized by hypotonia, obesity, and hypogonadism).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thus, the most likely genetic cause of the observed features is deletion of the maternal chromosome 15.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-09-20%20at%2017.43.47.jpeg\" width=\"773\" height=\"434\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Trisomy of chromosome 21:&nbsp;</strong>Presents with hypotonia in infancy, intellectual disability, characteristic facies (upslanting palpebral fissures, epicanthal folds), single palmar crease, congenital heart disease (AV canal), and increased risk of leukemia/Alzheimer disease\u2014not the happy demeanor with laughter, ataxia, and seizures classically tied to maternal 15q11\u2013q13 deletion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Mutation in the FMR1 gene</strong>: This mutation causes Fragile X syndrome, the most common inherited cause of intellectual disability. Clinical findings include macroorchidism, long face, large ears, and developmental delay. However, ataxia, frequent laughter, and maternal chromosome 15q11\u2013q13 deletion are not features of Fragile X.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D</strong>. <strong>Deletion of the paternal chromosome 15</strong>: A paternal deletion in chromosome 15q11\u2013q13 causes Prader\u2013Willi syndrome, presenting with neonatal hypotonia, hyperphagia leading to obesity, short stature, and hypogonadism. The described features (frequent laughter, ataxia, seizures, microcephaly) fit Angelman syndrome, which arises from the maternal deletion, not the paternal one.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Angelman syndrome results from a maternal deletion on chromosome 15q11\u2013q13 and presents with developmental delay, seizures, ataxia, microcephaly, and a happy disposition with frequent laughter.</span></p>",
    "correct_choice_id": 372854,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93654/NEET_PG_22_Sep_2025_Pathology_Question_8.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93654/NEET_PG_22_Sep_2025_Pathology_Question_8.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93525,
    "choices": [
      {
        "id": 372352,
        "text": "<p><span style=\"font-size:14.0pt;\">70%</span></p>"
      },
      {
        "id": 372353,
        "text": "<p><span style=\"font-size:14.0pt;\">60%</span></p>"
      },
      {
        "id": 372354,
        "text": "<p><span style=\"font-size:14.0pt;\">66%</span></p>"
      },
      {
        "id": 372355,
        "text": "<p><span style=\"font-size:14.0pt;\">50%</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">From the given pressure\u2013volume loop of the left ventricle, calculate the ejection fraction (EF):</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Image%20Sep%2010%2C%202025%2C%2010_16_03%20AM.jpg\" width=\"1180\" height=\"877\"></p>",
    "unique_key": "Q5886414",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 66%</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>To calculate ejection fraction (EF), use the formula:</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20161513.jpg\" width=\"986\" height=\"164\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>From the PV loop:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>EDV (End-Diastolic Volume) =&nbsp;</strong>~150 mL (point 1 on the loop \u2014 when the ventricle is full)</span></li><li><span style=\"font-size:14.0pt;\"><strong>ESV (End-Systolic Volume) =&nbsp;</strong>~50 mL (point 2 on the loop \u2014 after contraction)&nbsp;</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Now, stroke volume is to be calculated by:</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20162049.jpg\" width=\"1003\" height=\"206\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Interpretation of Loop Points:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Point 1 \u2192 2: Isovolumetric contraction</span></li><li><span style=\"font-size:14.0pt;\">Point 2 \u2192 3: Ejection phase</span></li><li><span style=\"font-size:14.0pt;\">Point 3 \u2192 4: Isovolumetric relaxation</span></li><li><span style=\"font-size:14.0pt;\">Point 4 \u2192 1: Filling phase</span></li></ul></li></ul><p><span style=\"font-size:14.0pt;\">This value is within the normal range (55\u201370%) and shows effective ventricular contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ejection fraction is calculated as stroke volume divided by end-diastolic volume.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">From the loop (EDV = 150 mL, ESV = 50 mL), EF = 66%.</span></li></ul>",
    "correct_choice_id": 372354,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93525/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_9.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      2
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93525/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_9.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93533,
    "choices": [
      {
        "id": 372384,
        "text": "<p><span style=\"font-size:14.0pt;\">Ulnar nerve injury at the cubital tunnel</span></p>"
      },
      {
        "id": 372385,
        "text": "<p><span style=\"font-size:14.0pt;\">Ulnar nerve injury at the arcade of Struthers</span></p>"
      },
      {
        "id": 372386,
        "text": "<p><span style=\"font-size:14.0pt;\">Ulnar nerve injury at Guyon\u2019s canal</span></p>"
      },
      {
        "id": 372387,
        "text": "<p><span style=\"font-size:14.0pt;\">C8 radiculopathy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old person with long-standing diabetes develops progressive weakness of hand grip. Exam shows clawing of the ring and little fingers and hollowing of the hypothenar eminence. Wrist flexion strength is normal, and sensation over the dorsal ulnar hand is preserved. What is the most likely site of the lesion?</span></p>",
    "unique_key": "Q6196010",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ulnar nerve injury at Guyon\u2019s canal</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The presentation localizes to a <strong>distal ulnar nerve lesion at Guyon\u2019s canal</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Clawing of digits 4\u20135</strong> with hypothenar wasting \u2192 intrinsic hand muscle denervation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Normal wrist flexion</strong> \u2192 flexor carpi ulnaris (FCU) intact.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Preserved DIP flexion</strong> of digits 4\u20135 \u2192 ulnar half of flexor digitorum profundus intact.</span></li><li><span style=\"font-size:14.0pt;\"><strong>No dorsal sensory loss</strong> \u2192 dorsal cutaneous branch of ulnar nerve spared (branches proximal to canal).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These findings indicate the lesion is <strong>distal to FCU/FDP branches but proximal to palmar sensory branches</strong>, i.e., at <strong>Guyon\u2019s canal</strong>.</span></li></ul><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_HD7GUpU.jpeg\" alt=\"Guyon Canal Syndrome - Physiopedia\" width=\"274\" height=\"280\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ulnar nerve injury at the cubital tunnel</strong>: Proximal lesion that weakens FCU and ulnar FDP, leading to impaired wrist/DIP flexion and dorsal sensory loss. The patient's intact wrist flexion and preserved dorsal sensation rule this out.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ulnar nerve injury at the arcade of Struthers</strong>: A proximal compression site above the medial epicondyle; would cause weakness of FCU/FDP and dorsal sensory loss, which are not present here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. C8 radiculopathy</strong>: Would affect multiple nerve distributions (including median-innervated muscles) and cause sensory changes along the medial forearm and hand, not isolated ulnar motor deficits with preserved dorsal sensation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Guyon\u2019s canal syndrome</strong> presents with ulnar claw and hypothenar wasting while sparing FCU, ulnar FDP, and dorsal ulnar hand sensation because the lesion occurs distal to motor/sensory branches supplying those areas.</span></p>",
    "correct_choice_id": 372386,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93533/NEET_PG_22_Sep_2025_Anatomy_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      3
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93533/NEET_PG_22_Sep_2025_Anatomy_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93322,
    "choices": [
      {
        "id": 371556,
        "text": "<p><span style=\"font-size:14.0pt;\">Autosomal inheritance</span></p>"
      },
      {
        "id": 371557,
        "text": "<p><span style=\"font-size:14.0pt;\">X-linked inheritance</span></p>"
      },
      {
        "id": 371558,
        "text": "<p><span style=\"font-size:14.0pt;\">Sporadic gene mutation</span></p>"
      },
      {
        "id": 371559,
        "text": "<p><span style=\"font-size:14.0pt;\">Uniparental disomy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Russell-Silver syndrome is a rare growth disorder characterized by severe intrauterine growth retardation, postnatal short stature, and characteristic dysmorphic features. Which of the following genetic mechanisms is most commonly associated with this syndrome?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q8525166",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Uniparental disomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Russell-Silver syndrome is strongly associated with <strong>maternal uniparental disomy of chromosome 7</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This means both copies of chromosome 7 come from the mother, leading to disrupted genomic imprinting and abnormal growth regulation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Other imprinting disorders include Prader-Willi, Angelman, and Beckwith-Wiedemann syndromes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Autosomal inheritance:&nbsp;</strong>The syndrome is not transmitted via a straightforward autosomal dominant or recessive pattern. Familial cases are extremely rare.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. X-linked inheritance:&nbsp;</strong>There is no X-linked basis for Russell-Silver syndrome; both genders are affected equally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sporadic gene mutation:&nbsp;</strong>Although some epigenetic alterations and rare chromosomal abnormalities have been reported, <strong>sporadic single-gene mutations are not the main mechanism</strong> in Russell-Silver syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Russell-Silver syndrome is an imprinting disorder most often caused by maternal uniparental disomy of chromosome 7, highlighting the role of genomic imprinting in growth regulation.</span></p>",
    "correct_choice_id": 371559,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93322/NEET_PG_22_Sep_2025_PEDIATRICS_Question_6.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      13
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93322/NEET_PG_22_Sep_2025_PEDIATRICS_Question_6.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93502,
    "choices": [
      {
        "id": 372264,
        "text": "<p><span style=\"font-size:14.0pt;\">The swelling should be operated on after the child turns two years of age with mesh</span></p>"
      },
      {
        "id": 372265,
        "text": "<p><span style=\"font-size:14.0pt;\">The swelling lies above and medial to the pubic tubercle</span></p>"
      },
      {
        "id": 372266,
        "text": "<p><span style=\"font-size:14.0pt;\">It develops due to a patent processus vaginalis</span></p>"
      },
      {
        "id": 372267,
        "text": "<p><span style=\"font-size:14.0pt;\">It contains the intestine inside the sac</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 1-year-old boy presents with a swelling in the right groin that becomes prominent while crying. On gentle reduction of the swelling, a characteristic gurgling sound is heard. Which of the following statements about this condition is incorrect?</span></p>",
    "unique_key": "Q8712153",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)</strong> <strong>The swelling should be operated on after the child turns two years of age with mesh</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Inguinal hernias should be operated promptly due to risk of strangulation. Waiting till 2 years of age is not recommended.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Mesh repair is not required and herniotomy is sufficient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The swelling lies above and medial to pubic tubercle:&nbsp;</strong>This is correct. An <strong>indirect inguinal hernia</strong> always lies <strong>above and medial</strong> to the pubic tubercle, following the path of the inguinal canal. This anatomical relationship helps distinguish it from femoral hernias, which lie below and lateral to the pubic tubercle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It develops due to a patent processus vaginalis:&nbsp;</strong>This is correct. In children, indirect inguinal hernia occurs due to failure of closure of the processus vaginalis, allowing abdominal contents to protrude into the inguinal canal or scrotum. This embryological defect is the hallmark of pediatric inguinal hernias.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>It contains the intestine inside the sac:&nbsp;</strong>This is correct because the gurgling sound on reduction strongly indicates that the <strong>hernia sac contains bowel loops</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In children, an indirect inguinal hernia results from a patent processus vaginalis, lies above and medial to the pubic tubercle, and often contains bowel that produces a gurgling sound on reduction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Inguinal hernias should be operated promptly due to risk of strangulation.</span></li></ul>",
    "correct_choice_id": 372264,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93502/NEET_PG_22_Sep_2025_Surgery_Question_13.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93502/NEET_PG_22_Sep_2025_Surgery_Question_13.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93314,
    "choices": [
      {
        "id": 371524,
        "text": "<p><span style=\"font-size:14.0pt;\">L5</span></p>"
      },
      {
        "id": 371525,
        "text": "<p><span style=\"font-size:14.0pt;\">S1</span></p>"
      },
      {
        "id": 371526,
        "text": "<p><span style=\"font-size:14.0pt;\">L4</span></p>"
      },
      {
        "id": 371527,
        "text": "<p><span style=\"font-size:14.0pt;\">L3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old female presents with low back pain radiating down her left leg to the foot. She has numbness in the dorsum of her foot and weakness in Extensor Hallucis Longus. What nerve root is most likely compressed?&nbsp;</span></p>",
    "unique_key": "Q9255652",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) L5</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The L5 nerve root controls EHL muscle and is responsible for sensation on the <strong>dorsum of the foot</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The radiating pain that follows the path of this nerve is often called <strong>sciatica</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">All these symptoms are present in the patient's case.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. S1:</strong> An S1 nerve root compression would typically cause a loss of sensation on the <strong>lateral side of the foot</strong> and weakness in <strong>plantar flexion</strong>, which is tested by asking the patient to walk on their tiptoes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. L4:</strong> L4 nerve root compression can cause pain and numbness along the medial side of the leg and foot. It can also cause weakness in ankle dorsiflexion and the quadriceps muscle, which may be apparent when squatting.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. L3:</strong> L3 nerve root compression affects the sensation in the anterior thigh and medial knee and can cause weakness in the hip flexors and knee extensors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Recognized by low back pain radiating down the leg, numbness in the top of the foot, and weakness in ankle dorsiflexion, all pointing to compression of the L5 nerve root.</span></p>",
    "correct_choice_id": 371524,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93314/NEET_PG_22_Sep_2025_Orthopedics_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      15
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93314/NEET_PG_22_Sep_2025_Orthopedics_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93320,
    "choices": [
      {
        "id": 371548,
        "text": "<p><span style=\"font-size:14.0pt;\">1 year</span></p>"
      },
      {
        "id": 371549,
        "text": "<p><span style=\"font-size:14.0pt;\">2 years</span></p>"
      },
      {
        "id": 371550,
        "text": "<p><span style=\"font-size:14.0pt;\">2 \u00bd years</span></p>"
      },
      {
        "id": 371551,
        "text": "<p><span style=\"font-size:14.0pt;\">3 years</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A mother brings her child for a routine developmental checkup. On observation, the child is able to copy a circle on paper and builds a tower of seven cubes without assistance. Based on these developmental milestones, what is the most likely age of the child?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q2640899",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 3 years</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At <strong>3 years</strong>, a child is expected to copy a circle and build a tower of <strong>9 cubes</strong> (7\u20139 cubes is within range).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Other fine motor milestones at this age include dressing with help and improved hand\u2013eye coordination.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Gross motor milestones include riding a tricycle and climbing stairs with alternate feet.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 1 year:&nbsp;</strong>By 12 months, a child achieves a <strong>mature pincer grasp</strong>, stands without support, and says 1\u20132 meaningful words. They cannot yet copy shapes or build tall block towers\u2014only small towers (2\u20133 blocks by 15\u201318 months).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. 2 years:</strong> At 2 years, children can build a <strong>tower of 6 cubes</strong> and make vertical and circular scribbles. They can also undress themselves and walk up stairs with two feet per step. However, they are still too young to copy a circle correctly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. 2 \u00bd years:&nbsp;</strong>Around 2\u00bd years, a child may build slightly taller block structures (6\u20137 blocks), but the ability to accurately <strong>copy a circle</strong> is not seen until about <strong>3 years</strong>. At this age, language development is still at the stage of short 2\u20133 word sentences.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Copying a circle and building a tower of 7\u20139 cubes are developmental milestones achieved at approximately 3 years of age.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>DEVELOPMENTAL MILESTONES:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Gross Motor</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EKIkCpM.png\" width=\"726\" height=\"613\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Fine Motor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_uIfNY6o.png\" width=\"966\" height=\"598\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Social and Adaptive</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_FNTTEQw.png\" width=\"853\" height=\"615\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Language</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_AjaUruO.png\" width=\"853\" height=\"613\"></strong></span></p>",
    "correct_choice_id": 371551,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93320/NEET_PG_22_Sep_2025_PEDIATRICS_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      13
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93320/NEET_PG_22_Sep_2025_PEDIATRICS_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93552,
    "choices": [
      {
        "id": 372460,
        "text": "<p><span style=\"font-size:14.0pt;\">Interval intra-uterine device insertion</span></p>"
      },
      {
        "id": 372461,
        "text": "<p><span style=\"font-size:14.0pt;\">Post-placental intra-uterine device insertion</span></p>"
      },
      {
        "id": 372462,
        "text": "<p><span style=\"font-size:14.0pt;\">Intra-cesarean intra-uterine device insertion</span></p>"
      },
      {
        "id": 372463,
        "text": "<p><span style=\"font-size:14.0pt;\">Post-abortal intra-uterine device insertion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following procedure is being planned in the image shown below?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_12xwnLz.png\" width=\"245\" height=\"459\"></span></p>",
    "unique_key": "Q9293541",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Post-placental intra-uterine device insertion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The kit in the image shows the <strong>long placental (Kelly/ring) forceps</strong> used to grasp and guide a Copper-T to the <strong>fundus within 10 minutes of placental delivery</strong>\u2014the defining steps of <strong>post-placental intra-uterine device insertion</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This immediate postpartum technique does <strong>not</strong> use the standard plastic inserter, uterine sound, or tenaculum; instead, the IUCD is placed from the vaginal side with the long forceps to achieve high <strong>fundal</strong> placement and reduce expulsion.</span></li><li><span style=\"font-size:14.0pt;\">The question stem\u2019s clues\u2014vaginal birth, immediate timing, long forceps, device advanced to fundus\u2014match <strong>post-placental intra-uterine device insertion</strong>, not interval, intra-cesarean, or post-abortal settings.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Interval intra-uterine device insertion:&nbsp;</strong>Incorrect. \u201cInterval\u201d placement is performed <strong>weeks after delivery</strong> (typically \u22654\u20136 weeks) in a clinic setting using the <strong>standard IUCD inserter</strong>, cervical stabilization with a <strong>tenaculum</strong>, and <strong>uterine sounding</strong>\u2014not a long placental/ring forceps as shown.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Intra-cesarean intra-uterine device insertion.&nbsp;</strong>Incorrect. In <strong>intra-cesarean intra-uterine device insertion</strong>, the IUCD is placed <strong>through the uterine incision</strong> during <strong>cesarean</strong> delivery, often by hand or with forceps from the <strong>abdominal</strong> side; the bedside vaginal kit in the image does not correspond to this technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Post-abortal intra-uterine device insertion:&nbsp;</strong>Incorrect. Post-abortal insertion (after suction evacuation) typically uses the <strong>standard IUCD inserter</strong> once the uterus is empty and is <strong>not</strong> characterized by the immediate postpartum placental setting or the use of <strong>long placental forceps</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Post-placental IUCD insertion</strong> is identified by <strong>immediate postpartum</strong> timing and use of <strong>long placental/ring forceps</strong> to place the device at the <strong>uterine fundus</strong> through the vagina within minutes after placental delivery.</span></p>",
    "correct_choice_id": 372461,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93552/NEET_PG_22_Sep_2025_OBG_Question_13.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93552/NEET_PG_22_Sep_2025_OBG_Question_13.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93527,
    "choices": [
      {
        "id": 372360,
        "text": "<p><span style=\"font-size:14.0pt;\">1 and 2</span></p>"
      },
      {
        "id": 372361,
        "text": "<p><span style=\"font-size:14.0pt;\">2 and 4</span></p>"
      },
      {
        "id": 372362,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4</span></p>"
      },
      {
        "id": 372363,
        "text": "<p><span style=\"font-size:14.0pt;\">3 and 5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Regarding the branches of the mandibular division of the trigeminal nerve (V3):</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The auriculotemporal nerve (ATN) arises from the anterior division of the mandibular nerve.</span></li><li><span style=\"font-size:14.0pt;\">The buccal nerve is derived from the posterior division of the mandibular nerve.</span></li><li><span style=\"font-size:14.0pt;\">The medial pterygoid muscle is supplied directly by a branch from the main trunk of the mandibular nerve.</span></li><li><span style=\"font-size:14.0pt;\">The posterior division of the mandibular nerve contains only sensory branches.</span></li><li><span style=\"font-size:14.0pt;\">The anterior division of the mandibular nerve is primarily motor, except for the buccal nerve which is sensory.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the above statements are incorrect?&nbsp;</span></p>",
    "unique_key": "Q7296836",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;1,&nbsp;2 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.&nbsp;The auriculotemporal nerve (ATN) arises from the anterior division of the mandibular nerve:&nbsp;</strong>Incorrect. The auriculotemporal nerve (ATN) is indeed a branch of the <strong>posterior division</strong>, not the anterior. Hence this statement is false. (Wait we must check correctness carefully)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-17%20164025.jpg\" width=\"939\" height=\"504\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. The buccal nerve is derived from the posterior division of the mandibular nerve:&nbsp;</strong>Incorrect. The <strong>buccal nerve</strong> is from the <strong>anterior division</strong> (sensory), not posterior.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong></span>&nbsp;<span style=\"font-size:14.0pt;\"><strong>The posterior division of the mandibular nerve contains only sensory branches:&nbsp;</strong>Incorrect. The <strong>posterior division</strong> is <strong>mainly sensory</strong> (auriculotemporal, lingual, inferior alveolar) but does have a <strong>motor branch (nerve to mylohyoid)</strong>. Hence not exclusively sensory.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. The medial pterygoid muscle is supplied directly by a branch from the main trunk of the mandibular nerve:&nbsp;</strong>Correct. The <strong>medial pterygoid muscle</strong> receives its nerve directly from the <strong>main trunk</strong> before the mandibular nerve divides.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5. The anterior division of the mandibular nerve is primarily motor, except for the buccal nerve which is sensory:&nbsp;</strong>Correct. The <strong>anterior division</strong> is largely motor to muscles of mastication, except the <strong>buccal nerve</strong>, which is sensory.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The buccal nerve arises from the anterior division of the mandibular nerve (sensory), the medial pterygoid is innervated from the main trunk, and the posterior division is predominantly\u2014but not exclusively\u2014sensory (nerve to mylohyoid is motor).</span></p>",
    "correct_choice_id": 372362,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93527/NEET_PG_22_Sep_2025_Anatomy_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      3
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93527/NEET_PG_22_Sep_2025_Anatomy_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92876,
    "choices": [
      {
        "id": 369800,
        "text": "<p><span style=\"font-size:14.0pt;\">Presence of mecC gene encoding PBP2c with sequence divergence&nbsp;</span></p>"
      },
      {
        "id": 369801,
        "text": "<p><span style=\"font-size:14.0pt;\">Hyperproduction of \u03b2-lactamase causing false resistance&nbsp;</span></p>"
      },
      {
        "id": 369802,
        "text": "<p><span style=\"font-size:14.0pt;\">Modification of mecA gene by IS1272 insertion element&nbsp;</span></p>"
      },
      {
        "id": 369803,
        "text": "<p><span style=\"font-size:14.0pt;\">Expression of mecB gene from Macrococcus species</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A clinical microbiology laboratory receives a S. aureus isolate showing oxacillin resistance but tests negative for mecA gene by PCR. The isolate shows positive results with PBP2a latex agglutination test. What is the most likely explanation for this discrepancy?</span></p>",
    "unique_key": "Q4213159",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Presence of mecC gene encoding PBP2c with sequence divergence</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Oxacillin resistance is \u03b2 lactam resistance &nbsp;</span></li><li><span style=\"font-size:14.0pt;\">mecC gene (formerly mecALGA251) was discovered in 2011 and shows only 70% nucleotide sequence identity with mecA, causing false-negative results with mecA-specific PCR primers.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, mecC encodes a PBP2a variant (sometimes called PBP2c) that cross-reacts with anti-PBP2a antibodies in latex agglutination tests, giving positive results.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">mecC-MRSA strains are found in &lt;1% of human MRSA isolates but are more common in livestock-associated MRSA.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These strains typically carry SCCmec type XI and are often missed by routine mecA PCR.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Laboratories should use primers detecting both mecA and mecC or perform phenotypic testing for comprehensive MRSA detection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Hyperproduction of \u03b2-lactamase causing false resistance:</strong> \u03b2-lactamase hyperproduction causes borderline resistance but wouldn't give positive PBP2a latex test</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Modification of mecA gene by IS1272 insertion element:</strong> IS1272 insertion might affect mecA expression but wouldn't cause PCR negativity with intact primers</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Expression of mecB gene from Macrococcus species:</strong> mecB is found in Macrococcus but doesn't naturally occur in S. aureus</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">mecC gene encodes PBP2c causing methicillin resistance with negative mecA PCR but positive PBP2a latex agglutination due to cross-reactivity.</span></p>",
    "correct_choice_id": 369800,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92876/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92876/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92947,
    "choices": [
      {
        "id": 370080,
        "text": "<p><span style=\"font-size:14.0pt;\">Allosteric inhibition</span></p>"
      },
      {
        "id": 370081,
        "text": "<p><span style=\"font-size:14.0pt;\">Repression</span></p>"
      },
      {
        "id": 370082,
        "text": "<p><span style=\"font-size:14.0pt;\">Competitive inhibition</span></p>"
      },
      {
        "id": 370083,
        "text": "<p><span style=\"font-size:14.0pt;\">Covalent modification</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man is started on a medication that alters the activity of key metabolic enzymes in his liver by adding or removing phosphate groups. These changes in enzyme activity occur rapidly without altering the amount of enzyme present. Which of the following mechanisms best describes this form of regulation?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q1017012",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Covalent modification</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The enzyme regulation via <strong>phosphorylation</strong> (addition of phosphate) or <strong>dephosphorylation</strong> (removal of phosphate).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is a form of <strong>covalent modification</strong>, where a functional group is added to or removed from an enzyme through a covalent bond, resulting in a reversible change in enzyme activity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Phosphorylation</strong> is carried out by <strong>kinases</strong>, while <strong>dephosphorylation</strong> is mediated by <strong>phosphatases</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This process <strong>does not change the concentration</strong> of the enzyme; it changes <strong>its activity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Covalent modification is a <strong>rapid and reversible</strong> regulatory mechanism, critical in pathways like glycogen metabolism, gluconeogenesis, and signal transduction.</span></li><li><span style=\"font-size:14.0pt;\">Depending on the enzyme, phosphorylation may <strong>activate</strong> (e.g., glycogen phosphorylase) or <strong>inhibit</strong> (e.g., glycogen synthase) its activity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Allosteric inhibition:</strong> Incorrect. In allosteric inhibition, a molecule binds to a site other than the active site, causing a conformational change in the enzyme. It does not involve the formation or breaking of covalent bonds (e.g., phosphate linkage) and is independent of phosphorylation/dephosphorylation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Repression:</strong> Incorrect. Repression is a <strong>genetic regulation</strong> process in which the synthesis of an enzyme is decreased at the transcriptional level. It changes enzyme <strong>amount</strong>, not immediate activity, and does not involve phosphorylation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Competitive inhibition:</strong> Incorrect. Competitive inhibitors bind reversibly to the <strong>active site</strong> of an enzyme, competing with the substrate. This is a non-covalent process and does not involve phosphate group addition or removal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Phosphorylation and dephosphorylation</strong> regulate enzyme activity through <strong>covalent modification</strong>, a rapid, reversible process that alters enzyme activity without changing enzyme concentration.</span></p>",
    "correct_choice_id": 370083,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92947/NEET_PG_22_Sep_2025_Biochemistry_Question_7.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      1
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92947/NEET_PG_22_Sep_2025_Biochemistry_Question_7.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93632,
    "choices": [
      {
        "id": 372764,
        "text": "<p><span style=\"font-size:14.0pt;\">Melphalan</span></p>"
      },
      {
        "id": 372765,
        "text": "<p><span style=\"font-size:14.0pt;\">Imatinib</span></p>"
      },
      {
        "id": 372766,
        "text": "<p><span style=\"font-size:14.0pt;\">Bortezomib</span></p>"
      },
      {
        "id": 372767,
        "text": "<p><span style=\"font-size:14.0pt;\">Lenalidomide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old man presents with progressive fatigue, bone pain, and recurrent infections. Laboratory studies show elevated serum calcium, anemia, and renal impairment. Serum protein electrophoresis reveals an M-spike, and bone marrow biopsy demonstrates &gt;10% clonal plasma cells. He is diagnosed with multiple myeloma. The patient is started on a chemotherapeutic regimen that includes a first-generation proteasome inhibitor administered by intravenous infusion. Which of the following drugs was most likely used in this patient?</span></p>",
    "unique_key": "Q4729586",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Bortezomib</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Bortezomib</strong> is a <strong>first-generation proteasome inhibitor</strong>, administered <strong>intravenously</strong> (or subcutaneously).</span></li><li><span style=\"font-size:14.0pt;\">It works by <strong>inhibiting the 26S proteasome</strong>, leading to accumulation of misfolded proteins and apoptosis of malignant plasma cells.</span></li><li><span style=\"font-size:14.0pt;\">It is a cornerstone in <strong>multiple myeloma</strong> therapy, often combined with lenalidomide or dexamethasone.</span></li><li><span style=\"font-size:14.0pt;\">Side effects include <strong>peripheral neuropathy</strong> and <strong>myelosuppression</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Melphalan:</strong> It is an alkylating agent, also used in multiple myeloma, but not a proteasome inhibitor as described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Imatinib:</strong> A <strong>tyrosine kinase inhibitor</strong> targeting BCR-ABL, used in <strong>chronic myeloid leukemia (CML)</strong>, not multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lenalidomide:</strong> An <strong>immunomodulatory drug (IMiD)</strong> used in multiple myeloma, but not a proteasome inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bortezomib is a first-generation proteasome inhibitor given by intravenous infusion, used primarily in the treatment of multiple myeloma and mantle cell lymphoma.</span></p>",
    "correct_choice_id": 372766,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93632/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_11.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93632/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_11.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93506,
    "choices": [
      {
        "id": 372280,
        "text": "<p><span style=\"font-size:14.0pt;\">By stimulating osteoblastic activity</span></p>"
      },
      {
        "id": 372281,
        "text": "<p><span style=\"font-size:14.0pt;\">By promoting calcium absorption in the intestines</span></p>"
      },
      {
        "id": 372282,
        "text": "<p><span style=\"font-size:14.0pt;\">By increasing both osteoclastic activity and reducing renal calcium excretion&nbsp;</span></p>"
      },
      {
        "id": 372283,
        "text": "<p><span style=\"font-size:14.0pt;\">By enhancing phosphate absorption in the intestine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old patient presents with symptoms of hyperparathyroidism. Laboratory analysis shows elevated levels of parathyroid hormone (PTH). The accompanying graph shows changes in plasma calcium and phosphate levels after administration of PTH. Which of the following mechanisms explains how PTH increases plasma calcium levels?&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20154950.jpg\" width=\"589\" height=\"348\"></p>",
    "unique_key": "Q5163136",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) By increasing both osteoclastic activity and reducing renal calcium excretion&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Parathyroid hormone (PTH) is a key regulator of calcium and phosphate levels in the blood.</span></li><li><span style=\"font-size:14.0pt;\">When PTH is released, it works through several mechanisms to increase plasma calcium levels.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The following processes are involved:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Bone resorption:</strong> PTH <strong>stimulates osteoclasts</strong> (cells responsible for breaking down bone) and inhibits osteoblasts (cells responsible for bone formation). This increases the release of calcium from bones into the bloodstream.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Kidney function:</strong> PTH increases calcium reabsorption in the kidneys, <strong>reducing the amount of calcium excreted</strong> in the urine. Simultaneously, PTH increases phosphate excretion in the urine (to help maintain a balance in the blood).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intestinal absorption:</strong> PTH indirectly increases calcium absorption from the intestine by enhancing the activation of vitamin D in the kidneys, which then boosts calcium absorption in the intestines.</span></li></ol></li><li><span style=\"font-size:14.0pt;\">PTH directly increases osteoclastic activity (bone resorption) and reduces calcium excretion by the kidneys.</span></li><li><span style=\"font-size:14.0pt;\">These actions are the primary mechanisms through which PTH raises plasma calcium levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. By stimulating osteoblastic activity:&nbsp;</strong>This is incorrect because PTH actually inhibits osteoblastic (bone-forming) activity and stimulates osteoclastic (bone-resorbing) activity to release calcium from bones.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. By promoting calcium absorption in the intestines:&nbsp;</strong>Although PTH indirectly increases intestinal calcium absorption via vitamin D activation, this is not the primary mechanism. The primary effect of PTH is on bone resorption and kidney calcium reabsorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. By enhancing phosphate absorption in the intestine:&nbsp;</strong>This is incorrect because PTH decreases phosphate levels in the blood by promoting its excretion in the urine, not by enhancing phosphate absorption in the intestine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">PTH's main action to increase plasma calcium levels is through increasing osteoclastic activity and reducing renal calcium excretion.</span></p>",
    "correct_choice_id": 372282,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93506/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      2
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93506/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92915,
    "choices": [
      {
        "id": 369956,
        "text": "<p><span style=\"font-size:14.0pt;\">Fuller\u2019s tracheostomy tube</span></p>"
      },
      {
        "id": 369957,
        "text": "<p><span style=\"font-size:14.0pt;\">Jackson\u2019s tracheostomy tube</span></p>"
      },
      {
        "id": 369958,
        "text": "<p><span style=\"font-size:14.0pt;\">Cuffed tracheostomy tube</span></p>"
      },
      {
        "id": 369959,
        "text": "<p><span style=\"font-size:14.0pt;\">Cuffed suction aid tracheostomy tube</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old man is admitted to the ICU following a road traffic accident and requires prolonged ventilatory support. The surgical team places a tracheostomy tube. Which of the following is the correct name of this instrument?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20173846.jpg\" width=\"658\" height=\"461\"></strong></span></p>",
    "unique_key": "Q2245946",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Cuffed suction aid tracheostomy tube</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This device is designed like a regular cuffed tracheostomy tube but incorporates a suction port above the cuff.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its purpose is to aspirate pharyngeal secretions that collect above the cuff, thereby preventing aspiration into the trachea during cuff deflation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is especially valuable in patients at high risk of aspiration, such as those on long-term ventilation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fuller\u2019s tracheostomy tube:&nbsp;</strong>Fuller\u2019s tube is a metal double-cannula tracheostomy tube, often used in earlier practice. It lacks a cuff and suction mechanism, making it unsuitable for preventing aspiration in ventilated patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20124110.jpg\" width=\"312\" height=\"340\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Jackson\u2019s tracheostomy tube:&nbsp;</strong>Jackson\u2019s tube is another metal tracheostomy tube, often uncuffed, mainly used for maintaining an airway but not for mechanical ventilation. It cannot provide aspiration protection since it lacks a cuff and suction channel.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20124120.jpg\" width=\"338\" height=\"260\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cuffed tracheostomy tube:&nbsp;</strong>A cuffed tracheostomy tube provides airway protection by sealing the trachea and preventing aspiration during ventilation. However, it does not have an additional suction channel to clear secretions above the cuff, which is the distinguishing feature of the suction-aid design.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A cuffed suction aid tracheostomy tube combines the airway-sealing function of a cuff with an extra suction channel above it, reducing the risk of aspiration by allowing clearance of pooled secretions before cuff deflation.</span></p>",
    "correct_choice_id": 369959,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92915/Neet_Pg_22_Sep_2025_Ent_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      9
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92915/Neet_Pg_22_Sep_2025_Ent_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93505,
    "choices": [
      {
        "id": 372276,
        "text": "<p><span style=\"font-size:14.0pt;\">Point A</span></p>"
      },
      {
        "id": 372277,
        "text": "<p><span style=\"font-size:14.0pt;\">Point B</span></p>"
      },
      {
        "id": 372278,
        "text": "<p><span style=\"font-size:14.0pt;\">Point C</span></p>"
      },
      {
        "id": 372279,
        "text": "<p><span style=\"font-size:14.0pt;\">Point E</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man presents with mild hemorrhage following a road traffic accident. To assess the hemodynamic changes, his cardiac function is analyzed using the Frank\u2013Starling curve, which plots cardiac output against central venous pressure. At baseline, his heart is functioning at point X. Considering the reduction in preload caused by blood loss and the compensatory increase in sympathetic activity, to which point is the stroke volume most likely to shift?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2rfvUcT.png\" width=\"459\" height=\"404\"></span></p>",
    "unique_key": "Q6436675",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Point A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mild hemorrhage leads to <strong>reduced preload</strong> due to decreased venous return.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The body responds by activating the sympathetic nervous system, which increases contractility and heart rate.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This compensation shifts the Frank\u2013Starling curve upward, maintaining cardiac output despite reduced preload. The new equilibrium is represented by <strong>Point A</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Point B:&nbsp;</strong>Incorrect. Point B reflects an <strong>increase in preload</strong>, which is the opposite of what occurs in hemorrhage. Since blood volume is reduced, preload cannot increase in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Point C:&nbsp;</strong>Incorrect. Point C represents an <strong>excessive increase in contractility</strong> beyond what is typically expected in mild hemorrhage. It overestimates the physiological response.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Point E:&nbsp;</strong>Incorrect. Point E indicates <strong>decreased contractility</strong>, which contradicts the expected sympathetic response. Hemorrhage stimulates increased contractility, not reduced.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mild hemorrhage reduces preload, but sympathetic compensation increases contractility, shifting the stroke volume to Point A on the Frank\u2013Starling curve.</span></p>",
    "correct_choice_id": 372276,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93505/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      2
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93505/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93656,
    "choices": [
      {
        "id": 372860,
        "text": "<p><span style=\"font-size:14.0pt;\">Commissural fusion and scarring due to prior group A streptococcal infection</span></p>"
      },
      {
        "id": 372861,
        "text": "<p><span style=\"font-size:14.0pt;\">Large, friable vegetations that frequently embolize and destroy valves</span></p>"
      },
      {
        "id": 372862,
        "text": "<p><span style=\"font-size:14.0pt;\">Vegetations composed of immune complexes that may occur on either side of the valve leaflets</span></p>"
      },
      {
        "id": 372863,
        "text": "<p><span style=\"font-size:14.0pt;\">Small sterile vegetations limited to the lines of valve closure in hypercoagulable states</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A patient with a known history of systemic lupus erythematosus is found at autopsy to have sterile valvular involvement consistent with Libman-Sacks endocarditis. Which of the following best characterizes this condition?&nbsp;</span></p>",
    "unique_key": "Q1207658",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Vegetations composed of immune complexes that may occur on either side of the valve leaflets</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient had a history of systemic lupus erythematosus (SLE) and was found at autopsy to have sterile valvular involvement, which is consistent with Libman-Sacks endocarditis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>This condition is characterized by:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Sterile vegetations made up of immune complexes, fibrin, and inflammatory cells</span></li><li><span style=\"font-size:14.0pt;\">They can form on either side of valve leaflets, chordae tendineae, or endocardial surfaces</span></li><li><span style=\"font-size:14.0pt;\">Most often involve the mitral and aortic valves</span></li><li><span style=\"font-size:14.0pt;\">Typically do not embolize and are usually clinically silent</span></li><li><span style=\"font-size:14.0pt;\">Occur in about 4% of patients with SLE</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, the correct answer is that these vegetations are immune complex\u2013mediated and may appear on either side of the valve leaflets.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7aeX7yD.png\" width=\"602\" height=\"393\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Commissural fusion and scarring due to prior group A streptococcal infection</strong>: This describes rheumatic heart disease, which causes chronic valvular deformity, fusion of commissures, and shortened chordae. While the patient\u2019s background shows old rheumatic changes, the valve vegetations in SLE are specifically Libman-Sacks endocarditis, not rheumatic disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Large, friable vegetations that frequently embolize and destroy valves</strong>: This is typical of infective endocarditis, caused by bacterial or fungal infection. Unlike Libman-Sacks, these vegetations are infectious, destructive, and embolic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Small sterile vegetations limited to the lines of valve closure in hypercoagulable states</strong>: This describes Marantic endocarditis or nonbacterial thrombotic endocarditis (NBTE), often linked to malignancy or chronic wasting disease. In contrast, Libman-Sacks vegetations occur in SLE, and are not confined to the lines of closure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Libman-Sacks endocarditis occurs in systemic lupus erythematosus and is characterized by sterile vegetations composed of immune complexes that may occur on either side of valve leaflets or endocardial surfaces.</span></p>",
    "correct_choice_id": 372862,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93656/NEET_PG_22_Sep_2025_Pathology_Question_10.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93656/NEET_PG_22_Sep_2025_Pathology_Question_10.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93653,
    "choices": [
      {
        "id": 372848,
        "text": "<p><span style=\"font-size:14.0pt;\">Frequent involvement of mesenteric and Waldeyer\u2019s ring lymph nodes</span></p>"
      },
      {
        "id": 372849,
        "text": "<p><span style=\"font-size:14.0pt;\">Localized nodal disease, often without mediastinal involvement</span></p>"
      },
      {
        "id": 372850,
        "text": "<p><span style=\"font-size:14.0pt;\">Extranodal involvement with early dissemination to the spleen</span></p>"
      },
      {
        "id": 372851,
        "text": "<p><span style=\"font-size:14.0pt;\">Contiguous spread through lymphatic chains</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old woman presents with a painless enlarged cervical lymph node. An excisional biopsy of the node is shown below. Which of the following best describes the pattern of lymph node involvement in this condition?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_sGICyos.png\" width=\"567\" height=\"427\"></span></p>",
    "unique_key": "Q2711509",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Localized nodal disease, often without mediastinal</strong> <strong>involvement</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient is a 42-year-old woman with a painless enlarged cervical lymph node. The biopsy image provided demonstrates histological findings consistent with Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).</span></li><li><span style=\"font-size:14.0pt;\">NLPHL is characterized by LP (\u201cpopcorn\u201d) cells surrounded by a nodular background of small lymphocytes, and an immunophenotype of CD20+, CD30\u2212, CD15\u2212, and BCL6+.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This immunoprofile distinguishes NLPHL from classical Hodgkin lymphoma.</span></li><li><span style=\"font-size:14.0pt;\">The pattern of lymph node involvement in NLPHL is typically localized disease, most often affecting cervical or axillary lymph nodes, with minimal or absent mediastinal involvement.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Compared with classical Hodgkin lymphoma, which spreads contiguously through lymphatic chains, NLPHL tends to remain localized and follow an indolent course.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the best description of the lymph node involvement is localized nodal disease, often without mediastinal involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Frequent involvement of mesenteric and Waldeyer\u2019s ring lymph nodes</strong>: This pattern is more characteristic of non-Hodgkin lymphomas, particularly diffuse large B-cell lymphoma or other extranodal variants. NLPHL typically involves peripheral nodes (cervical/axillary) and not mesenteric nodes or Waldeyer\u2019s ring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Extranodal involvement with early dissemination to the spleen:</strong> Extranodal spread with early dissemination is also a hallmark of non-Hodgkin lymphomas, not NLPHL. In NLPHL, disease is usually nodal and localized at presentation, with a slow progression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Contiguous spread through lymphatic chains</strong>: This describes the classical spread of classical Hodgkin lymphoma, which characteristically progresses from one lymph node group to the next adjacent group. NLPHL does not follow this stepwise contiguous pattern and more commonly shows isolated localized nodal disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is distinguished by LP (\u201cpopcorn\u201d) cells with CD20+, CD30\u2212, CD15\u2212, and BCL6+ phenotype, and typically presents with localized nodal disease, often without mediastinal involvement.</span></p>",
    "correct_choice_id": 372849,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93653/NEET_PG_22_Sep_2025_Pathology_Question_7.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93653/NEET_PG_22_Sep_2025_Pathology_Question_7.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92893,
    "choices": [
      {
        "id": 369868,
        "text": "<p><span style=\"font-size:14.0pt;\">Increase tidal volume to improve ventilation</span></p>"
      },
      {
        "id": 369869,
        "text": "<p><span style=\"font-size:14.0pt;\">Decrease tidal volume to improve ventilation</span></p>"
      },
      {
        "id": 369870,
        "text": "<p><span style=\"font-size:14.0pt;\">Switch to high-frequency oscillatory ventilation immediately</span></p>"
      },
      {
        "id": 369871,
        "text": "<p><span style=\"font-size:14.0pt;\">Increase plateau pressure goal above 40 cm H\u2082O for better oxygenation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old man with severe community-acquired pneumonia is admitted to the ICU with acute hypoxemic respiratory failure. He is intubated and placed on mechanical ventilation. His height is 175 cm (69 inches) and weight is 95 kg. The intensivist plans to use a lung-protective ventilation strategy. After calculating his predicted body weight, the team sets an initial tidal volume of 10 mL/kg IBW. Thirty minutes later, his plateau pressure is measured at 32 cm H\u2082O. Which of the following is the next best step according to ARDSnet lung-protective ventilation protocol?&nbsp;</span></p>",
    "unique_key": "Q2337269",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Decrease tidal volume to improve ventilation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">ARDSnet recommends lung-protective ventilation using <strong>low tidal volumes (4\u20138 mL/kg predicted body weight)</strong> and keeping <strong>plateau pressure \u226430 cm H\u2082O</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Since this patient\u2019s plateau pressure is &gt;30 cm H\u2082O, the tidal volume should be reduced to 4\u20138 mL/kg IBW, even if permissive hypercapnia occurs, to minimize ventilator-induced lung injury.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increase tidal volume to improve ventilation:&nbsp;</strong>Increasing tidal volume would raise plateau pressure further, worsening volutrauma and barotrauma. Although ventilation might improve transiently, this contradicts lung-protective strategy and increases mortality risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Switch to high-frequency oscillatory ventilation immediately:&nbsp;</strong>HFOV is not first-line and has not shown mortality benefit in large ARDS trials. It is only considered in refractory hypoxemia unresponsive to optimized lung-protective ventilation and adjuncts such as prone positioning.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increase plateau pressure goal above 40 cm H\u2082O for better oxygenation:&nbsp;</strong>Permitting higher plateau pressures worsens barotrauma risk and is contraindicated. The recommended plateau pressure threshold is \u226430 cm H\u2082O; higher pressures are only cautiously considered in very obese or stiff chest wall cases, not as the first step.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The ARDSnet protocol advocates <strong>tidal volumes of 4\u20138 mL/kg predicted body weight</strong> and <strong>plateau pressures \u226430 cm H\u2082O</strong>; when plateau pressure exceeds 30, tidal volume must be reduced to 4\u20136 mL/kg IBW to minimize ventilator-induced lung injury.</span></p>",
    "correct_choice_id": 369869,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92893/NEET_PG_22_Sep_2025_Anesthesia_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      19
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92893/NEET_PG_22_Sep_2025_Anesthesia_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92937,
    "choices": [
      {
        "id": 370040,
        "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, and R is the correct explanation of A.</span></p>"
      },
      {
        "id": 370041,
        "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, but R is not the correct explanation of A.</span></p>"
      },
      {
        "id": 370042,
        "text": "<p><span style=\"font-size:14.0pt;\">A is true, but R is false.</span></p>"
      },
      {
        "id": 370043,
        "text": "<p><span style=\"font-size:14.0pt;\">A is false, but R is true.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Assertion (A): Amphetamines can cause hypertension and tachycardia due to peripheral sympathetic stimulation.</span></p><p><br><span style=\"font-size:14.0pt;\">Reason (R): They directly stimulate beta-2 adrenergic receptors in vascular smooth muscle.</span></p>",
    "unique_key": "Q9306979",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) A is true, but R is false.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Assertion (A) is true</strong>: Amphetamines are <strong>central and peripheral sympathomimetic agents</strong>. They <strong>increase the release of norepinephrine</strong> and <strong>dopamine</strong>, leading to <strong>alpha-1\u2013mediated vasoconstriction</strong> and <strong>beta-1\u2013mediated tachycardia</strong>, thus causing <strong>hypertension and tachycardia</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Reason (R) is false</strong>: <strong>Beta-2 adrenergic receptors</strong>, when stimulated, cause <strong>vasodilation</strong> in vascular smooth muscle\u2014not vasoconstriction. Therefore, stimulation of beta-2 receptors would actually <strong>reduce blood pressure</strong>, not raise it. Thus, the reason does not support the assertion and is incorrect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Amphetamine-induced hypertension</strong> is due to <strong>alpha-1 vasoconstriction</strong>, not beta-2 activity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Beta-2 receptors</strong> promote <strong>vasodilation</strong>, not increased blood pressure.</span></li><li><span style=\"font-size:14.0pt;\">Clinical signs of amphetamine overdose include <strong>tachycardia, hypertension, hyperthermia, and mydriasis</strong>.</span></li></ul>",
    "correct_choice_id": 370042,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92937/NEET_PG_22_Sep_2025_FMT_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      10
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92937/NEET_PG_22_Sep_2025_FMT_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93607,
    "choices": [
      {
        "id": 372668,
        "text": "<p><span style=\"font-size:14.0pt;\">The serum ammonia level correlates with the severity of hepatic encephalopathy.</span></p>"
      },
      {
        "id": 372669,
        "text": "<p><span style=\"font-size:14.0pt;\">The diagnosis is made by electroencephalograph.</span></p>"
      },
      {
        "id": 372670,
        "text": "<p><span style=\"font-size:14.0pt;\">Precipitants for this condition are present in over 80% of patients.</span></p>"
      },
      {
        "id": 372671,
        "text": "<p><span style=\"font-size:14.0pt;\">TIPS placement is a second-line treatment.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old male with cirrhosis associated with hepatitis C infection is evaluated for confusion. Examination reveals asterixis, ascites, and a sweet odor to his breath. Which of the following is true?</span></p>",
    "unique_key": "Q2102247",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Precipitants for this condition are present in over 80% of patients.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s cirrhosis (from hepatitis C), confusion, asterixis (flapping tremor), ascites, and fetor hepaticus (sweet breath odor due to dimethyl sulfide) are classic features of <strong>hepatic encephalopathy (HE)</strong>, a brain dysfunction caused by liver insufficiency and portosystemic shunting. HE is graded by the West Haven criteria (I\u2013IV), with this presentation suggesting at least grade II.</span></li><li><span style=\"font-size:14.0pt;\">Precipitants (e.g., infection, gastrointestinal bleeding, electrolyte imbalances, constipation, medications like benzodiazepines, or portosystemic shunt) are identified in over 80% of HE cases.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Identifying and treating these (e.g., antibiotics for infection, lactulose for ammonia reduction) is the mainstay of management, supporting this statement.</span></li><li><span style=\"font-size:14.0pt;\">The high prevalence of precipitants underscores the multifactorial nature of HE, making their detection and correction critical for effective treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The serum ammonia level correlates with the severity of hepatic encephalopathy</strong>: False. Serum ammonia levels are elevated in HE but do not reliably correlate with disease severity, as clinical symptoms and West Haven grades are better indicators. Ammonia reduction (e.g., with lactulose) is therapeutic, but levels alone are not diagnostic or prognostic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The diagnosis is made by electroencephalograph</strong>: False. HE is primarily a <strong>clinical diagnosis</strong> based on history (cirrhosis) and findings (confusion, asterixis, fetor hepaticus). Electroencephalography (EEG) shows nonspecific slowing (e.g., theta/delta waves) in advanced stages but is not diagnostic; it may support severity assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. TIPS placement is a second-line treatment</strong>: False. Transjugular intrahepatic portosystemic shunt (TIPS) is not a treatment for HE; it is used for variceal bleeding or refractory ascites. TIPS can <strong>worsen HE</strong> by increasing portosystemic shunting, and in refractory cases, shunt reduction/occlusion may be considered, contradicting this statement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Precipitants are identified in over 80% of hepatic encephalopathy cases, guiding primary treatment with lactulose and precipitant correction.</span></li><li><span style=\"font-size:14.0pt;\">Serum ammonia levels do not correlate with HE severity; diagnosis relies on clinical findings, not EEG.</span></li><li><span style=\"font-size:14.0pt;\">TIPS placement can exacerbate HE and is not a therapeutic option for this condition.</span></li></ul>",
    "correct_choice_id": 372670,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93607/Neet_Pg_22_Sep_2025_Medicine_Question_191.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93607/Neet_Pg_22_Sep_2025_Medicine_Question_191.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93253,
    "choices": [
      {
        "id": 371284,
        "text": "<p><span style=\"font-size:14.0pt;\">It uses retrospective data only without follow-up</span></p>"
      },
      {
        "id": 371285,
        "text": "<p><span style=\"font-size:14.0pt;\">Cohort is selected after disease develops</span></p>"
      },
      {
        "id": 371286,
        "text": "<p><span style=\"font-size:14.0pt;\">Only cases and controls are assessed for expensive testing</span></p>"
      },
      {
        "id": 371287,
        "text": "<p><span style=\"font-size:14.0pt;\">Baseline interviews are conducted after diagnosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following statements about the structure of a Nested Case-Control study are incorrect, except:&nbsp;</span></p>",
    "unique_key": "Q6856115",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Only cases and controls are assessed for expensive testing</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Nested Case-Control Study</strong>, a hybrid design that combines the strengths of cohort and case-control methodologies.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is especially useful in situations where biological or genetic tests are expensive.</span></li><li><span style=\"font-size:14.0pt;\">In this design, <strong>baseline data is collected at the start of the cohort study</strong>, and subjects are followed over time.</span></li><li><span style=\"font-size:14.0pt;\"><strong>When cases of the disease develop</strong>, they are matched with controls from the same cohort, and only these individuals undergo further expensive testing (e.g., genetic, biomarker, etc.).</span></li><li><span style=\"font-size:14.0pt;\">Thus, <strong>option C is correct</strong> (i.e., the only statement that is NOT incorrect).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>It uses retrospective data only without follow-up:</strong> Is incorrect. Nested case-control studies are not purely retrospective. They involve prospective follow-up from baseline to the occurrence of disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Cohort is selected after disease develops:</strong> Is incorrect: The cohort is defined <strong>before</strong> the disease develops; the whole idea is to follow exposure-to-outcome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Baseline interviews are conducted after diagnosis:</strong> Is incorrect: Data collection (including interviews and biological samples) is done <strong>at baseline</strong>, i.e., before the disease develops, reducing <strong>recall bias</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Nested Case-Control studies</strong> are <strong>efficient, cost-effective</strong> designs conducted within a cohort, where <strong>only cases and matched controls</strong> undergo expensive diagnostic testing, and <strong>baseline data</strong> is already available \u2014 minimizing recall bias and maintaining temporal validity.</span></p>",
    "correct_choice_id": 371286,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93253/Neet_Pg_22_Sept_2025_Psm_Q_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93253/Neet_Pg_22_Sept_2025_Psm_Q_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93311,
    "choices": [
      {
        "id": 371512,
        "text": "<p><span style=\"font-size:14.0pt;\">Patients have the right to request deletion of their digital medical records under specific conditions</span></p>"
      },
      {
        "id": 371513,
        "text": "<p><span style=\"font-size:14.0pt;\">Health records collected for one scheme can be automatically reused for another without fresh consent</span></p>"
      },
      {
        "id": 371514,
        "text": "<p><span style=\"font-size:14.0pt;\">Public hospitals must notify authorities and affected individuals in case of a health data breach</span></p>"
      },
      {
        "id": 371515,
        "text": "<p><span style=\"font-size:14.0pt;\">The scope of the law includes telemedicine platforms used in public health interventions</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A government hospital participating in the Ayushman Bharat Digital Mission (ABDM) initiates digital record-keeping for patients enrolled under a maternal health scheme. Later, the hospital administrator plans to use this data for a non-communicable disease screening program. As per the Digital Personal Data Protection (DPDP) Act, 2023, all of the following statements about such practices are consistent with the law, except?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q1705650",
    "difficulty_level": "difficult",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Health records collected for one scheme can be automatically reused for another without fresh consent</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Under the <strong>DPDP Act 2023</strong>, <strong>data collected for a specific purpose (e.g., maternal health program)</strong> cannot be reused for a <strong>different purpose (e.g., NCD screening)</strong> <strong>without obtaining fresh, informed, and explicit consent</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This aligns with the principle of <strong>purpose limitation</strong>, which ensures that personal health data is used only for the reason it was collected.</span></li><li><span style=\"font-size:14.0pt;\">The reuse of digital health data across programs without consent <strong>violates the autonomy and rights of individuals</strong> and <strong>increases the risk of misuse or privacy breaches</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Patients have the right to request deletion of their digital medical records under specific conditions:</strong> True. The DPDP Act provides the right to erasure when data is no longer necessary, or consent is withdrawn, <strong>provided it does not conflict with legal or public health obligations</strong> (e.g., mandatory disease reporting).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Public hospitals must notify authorities and affected individuals in case of a health data breach:</strong> True. The law mandates <strong>timely breach notification</strong> to the <strong>Data Protection Board of India</strong> and to the affected individuals <strong>if there\u2019s a risk of harm</strong>, such as identity theft or unauthorized disclosure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The scope of the law includes telemedicine platforms used in public health interventions:</strong> True. The DPDP Act explicitly <strong>includes digital health platforms</strong>, <strong>mobile health apps</strong>, and <strong>telemedicine systems</strong> under its purview. These entities must implement <strong>security, consent, and privacy protections</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Under the <strong>Digital Personal Data Protection Act (DPDP) 2023</strong>, health data collected for <strong>one purpose</strong> cannot be reused for <strong>another</strong> without <strong>fresh informed consent</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The Act upholds principles like <strong>purpose limitation</strong>, <strong>user rights</strong>, and <strong>data breach accountability</strong>, making it vital for all <strong>public health digital systems</strong> in India.</span></li></ul>",
    "correct_choice_id": 371513,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93311/Neet_Pg_22_Sept_2025_Psm_Q_18.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93311/Neet_Pg_22_Sept_2025_Psm_Q_18.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93647,
    "choices": [
      {
        "id": 372824,
        "text": "<p><span style=\"font-size:14.0pt;\">Extracellular trafficking</span></p>"
      },
      {
        "id": 372825,
        "text": "<p><span style=\"font-size:14.0pt;\">Phagosome-lysosome fusion</span></p>"
      },
      {
        "id": 372826,
        "text": "<p><span style=\"font-size:14.0pt;\">Oxidative burst activity</span></p>"
      },
      {
        "id": 372827,
        "text": "<p><span style=\"font-size:14.0pt;\">Chemotaxis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 12-year-old boy is brought to OPD due to frequent respiratory and skin infections, easy bruising, and increased sensitivity to light. On examination, he has pale skin, light-colored hair, and involuntary rapid eye movements. Laboratory studies demonstrate prolonged bleeding time and peripheral smear reveals large coarse cytoplasmic granules in leukocytes. Genetic analysis identifies a mutation in the LYST gene. Which of the following normal cellular processes is most likely impaired in this patient?&nbsp;</span></p>",
    "unique_key": "Q7198739",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Phagosome-lysosome fusion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This boy has recurrent infections, easy bruising, light sensitivity, fair skin, light-colored hair, nystagmus, prolonged bleeding time, and large coarse cytoplasmic granules in leukocytes, together with a mutation in the LYST gene.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These findings are classic for Chediak\u2013Higashi syndrome (CHL).</span></li><li><span style=\"font-size:14.0pt;\">The LYST gene encodes a lysosomal trafficking regulator protein. Mutation causes failure of phagosome-lysosome fusion, leading to defective microbial killing by neutrophils and macrophages.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This defect also explains the large abnormal granules seen in leukocytes and the increased susceptibility to infections.</span></li><li><span style=\"font-size:14.0pt;\">Thus, the impaired cellular process is phagosome-lysosome fusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Extracellular trafficking</strong>: While trafficking of vesicles is indeed influenced by LYST, the extracellular trafficking is not affected.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Oxidative burst activity</strong>: Oxidative burst is impaired in chronic granulomatous disease (CGD) due to NADPH oxidase deficiency, not in CHL. Patients with CGD cannot generate reactive oxygen species to kill pathogens, whereas in CHL the problem is fusion, not ROS generation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Chemotaxis</strong>: Defective chemotaxis is seen in leukocyte adhesion deficiency (LAD), due to impaired integrin function. CHL patients can recruit neutrophils, but those neutrophils fail to kill effectively due to defective lysosomal fusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Chediak\u2013Higashi syndrome is due to LYST gene mutation, leading to impaired phagosome-lysosome fusion, giant cytoplasmic granules in leukocytes, recurrent infections, bleeding tendency, and light sensitivity.</span></p>",
    "correct_choice_id": 372825,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93647/NEET_PG_22_Sep_2025_Pathology_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93647/NEET_PG_22_Sep_2025_Pathology_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93319,
    "choices": [
      {
        "id": 371544,
        "text": "<p><span style=\"font-size:14.0pt;\">Rickets</span></p>"
      },
      {
        "id": 371545,
        "text": "<p><span style=\"font-size:14.0pt;\">Scurvy</span></p>"
      },
      {
        "id": 371546,
        "text": "<p><span style=\"font-size:14.0pt;\">Congenital anomaly</span></p>"
      },
      {
        "id": 371547,
        "text": "<p><span style=\"font-size:14.0pt;\">Trauma to epiphysis causing degeneration</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 4-year-old boy is brought by his parents with bowing of the legs noted over the past year. The deformity is painless, and developmental milestones are otherwise normal. X-ray of both knees is shown below. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_fNqWJNr.png\" width=\"391\" height=\"512\"></strong></span></p>",
    "unique_key": "Q6690834",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Rickets</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The radiograph shows <strong>cupping, fraying, and splaying of the metaphysis</strong>, along with widening of the growth plate.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In a growing child, these findings with painless genu varum strongly suggest <strong>nutritional rickets</strong> due to defective mineralization of bone.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clinical features like craniotabes, frontal bossing, delayed dentition, and genu varum/valgum further support the diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Scurvy:&nbsp;</strong>Scurvy, caused by vitamin C deficiency, presents with painful pseudoparalysis, bleeding gums, and subperiosteal hemorrhages. Radiology shows the <strong>white line of Frankel, Pelkan spurs, and corner sign</strong>, not metaphyseal cupping and splaying as seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Congenital anomaly:&nbsp;</strong>Congenital anomalies such as Blount disease or skeletal dysplasias can present with bowing, but they usually have characteristic asymmetric involvement or dysplastic changes, not the classical rachitic changes seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Trauma to epiphysis causing degeneration:&nbsp;</strong>Trauma involving the epiphysis (e.g., Salter-Harris fractures) results in localized growth plate damage, irregularity, or premature closure, not the diffuse metaphyseal changes with splaying and cupping that are hallmarks of rickets.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Painless genu varum with X-ray features of metaphyseal cupping and splaying is diagnostic of rickets, a disease of defective bone mineralization in children.</span></p>",
    "correct_choice_id": 371544,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93319/NEET_PG_22_Sep_2025_PEDIATRICS_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      13
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93319/NEET_PG_22_Sep_2025_PEDIATRICS_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93504,
    "choices": [
      {
        "id": 372272,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 372273,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4, 5</span></p>"
      },
      {
        "id": 372274,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 5</span></p>"
      },
      {
        "id": 372275,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4, 5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about Acute Pancreatitis are true?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Necrosis can occur in severe acute pancreatitis</span></li><li><span style=\"font-size:14.0pt;\">Conservative management is the mainstay of treatment</span></li><li><span style=\"font-size:14.0pt;\">The most common cause is biliary calculi</span></li><li><span style=\"font-size:14.0pt;\">BISAP scoring system is used for severity assessment</span></li><li><span style=\"font-size:14.0pt;\">Pseudocyst occurs within 4 weeks of acute pancreatitis</span></li></ol>",
    "unique_key": "Q8913891",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Necrosis can occur in severe acute pancreatitis:&nbsp;</strong>True. Necrosis does occur in severe acute pancreatitis due to autodigestion of pancreatic tissue by enzymes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Conservative management is the mainstay of treatment:</strong> True. Most patients are treated conservatively with fluids, analgesia, and supportive care.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>The most common cause is biliary calculi:&nbsp;</strong>True. Gallstones are the most common cause of acute pancreatitis worldwide.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>BISAP scoring system is used for severity assessment:&nbsp;</strong>True. BISAP (Bedside index of severity in acute pancreatitis) is a well-known scoring system used to assess severity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>Pseudocyst occurs within 4 weeks of acute pancreatitis:&nbsp;</strong>False.<strong>&nbsp;</strong>Pseudocyst is a late complication, occurs due to persistence of acute peripancreatic fluid collection for more than 4 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Acute pancreatitis is most often caused by gallstones, managed conservatively, may lead to necrosis, and severity is graded by BISAP score.</span></p>",
    "correct_choice_id": 372272,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93504/NEET_PG_22_Sep_2025_Surgery_Question_15.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93504/NEET_PG_22_Sep_2025_Surgery_Question_15.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93545,
    "choices": [
      {
        "id": 372432,
        "text": "<p><span style=\"font-size:14.0pt;\">There is absence of the decidua basalis and Nitabuch layer</span></p>"
      },
      {
        "id": 372433,
        "text": "<p><span style=\"font-size:14.0pt;\">MRI is useful in diagnosing accreta in posterior placentas</span></p>"
      },
      {
        "id": 372434,
        "text": "<p><span style=\"font-size:14.0pt;\">During cesarean, a gentle attempt is made at delivering the placenta and abandoned if there is no separation</span></p>"
      },
      {
        "id": 372435,
        "text": "<p><span style=\"font-size:14.0pt;\">Upper segment cesarean is usually performed to deliver the baby</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All are true regarding morbidly adherent placenta except:</span></p>",
    "unique_key": "Q3890383",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) During cesarean, a gentle attempt is made at delivering the placenta and abandoned if there is no separation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In cases of <strong>morbidly adherent placenta</strong> (placenta accreta, increta, or percreta), <strong>attempting to manually deliver the placenta</strong> can lead to catastrophic <strong>hemorrhage</strong> and should <strong>not</strong> be attempted.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Instead, if a <strong>placenta accreta</strong> is suspected, the recommended approach is to leave the placenta in situ and proceed with further interventions such as a <strong>hysterectomy</strong> if necessary.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Trying to remove the placenta forcibly could result in severe blood loss due to the abnormal adherence of the placenta to the uterine wall.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20163917.jpg\" width=\"532\" height=\"529\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. There is absence of the decidua basalis and Nitabuch layer:&nbsp;</strong>This is correct. The absence of the <strong>decidua basalis</strong> and <strong>Nitabuch layer</strong> is characteristic of <strong>placenta accreta</strong>, allowing the placenta to abnormally adhere to the myometrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. MRI is useful in diagnosing accreta in posterior placentas:&nbsp;</strong>This is correct. <strong>MRI</strong> is especially useful in diagnosing <strong>placenta accreta</strong> when the placenta is located in the <strong>posterior</strong> aspect, as ultrasound imaging may be inadequate due to interference from maternal bony structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Upper segment cesarean is usually performed to deliver the baby:&nbsp;</strong>This is incorrect. In most cases of <strong>morbidly adherent placenta</strong>, a <strong>lower segment cesarean section</strong> is preferred. A <strong>classical cesarean</strong> (upper segment) may be considered in specific cases, but it is generally avoided due to the risk of complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For patients with <strong>morbidly adherent placenta</strong>, it is crucial <strong>not to attempt manual removal</strong> of the placenta during cesarean delivery.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Instead, the placenta is often left in situ, and further interventions like <strong>hysterectomy</strong> are planned to prevent life-threatening hemorrhage.</span></li></ul>",
    "correct_choice_id": 372434,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93545/NEET_PG_22_Sep_2025_OBG_Question_6.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93545/NEET_PG_22_Sep_2025_OBG_Question_6.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93260,
    "choices": [
      {
        "id": 371312,
        "text": "<p><span style=\"font-size:14.0pt;\">Diagnostic studies \u2013 STARD</span></p>"
      },
      {
        "id": 371313,
        "text": "<p><span style=\"font-size:14.0pt;\">Case Reports \u2013 CARE</span></p>"
      },
      {
        "id": 371314,
        "text": "<p><span style=\"font-size:14.0pt;\">Qualitative Research \u2013 SRQR</span></p>"
      },
      {
        "id": 371315,
        "text": "<p><span style=\"font-size:14.0pt;\">Quality Improvement Studies \u2013 STROBE&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is a mismatched pair between the study type and its corresponding reporting guideline?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q8421457",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Quality Improvement Studies \u2013 STROBE</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>STROBE</strong> (Strengthening the Reporting of Observational Studies in Epidemiology) is specifically designed for <strong>observational studies</strong>, such as <strong>cohort, case-control, and cross-sectional studies</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>not</strong> the appropriate guideline for <strong>Quality Improvement (QI) studies</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The correct guideline for <strong>Quality Improvement Studies</strong> is <strong>SQUIRE</strong> (Standards for QUality Improvement Reporting Excellence)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Diagnostic studies \u2013 STARD:&nbsp;</strong>Correct pairing. <strong>STARD</strong> (Standards for Reporting Diagnostic Accuracy Studies) is the correct guideline for reporting <strong>diagnostic and prognostic accuracy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Case Reports \u2013 CARE:&nbsp;</strong>Correct. <strong>CARE</strong> (CAse REport) guidelines are used for writing and reporting <strong>case reports</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Qualitative Research \u2013 SRQR:&nbsp;</strong>Correct. <strong>SRQR</strong> (Standards for Reporting Qualitative Research) applies to <strong>qualitative research methodologies</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Specific reporting guidelines</strong> tailored to the study type:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>STROBE</strong> \u2013 Observational studies</span></li><li><span style=\"font-size:14.0pt;\"><strong>SQUIRE</strong> \u2013 Quality improvement</span></li><li><span style=\"font-size:14.0pt;\"><strong>PRISMA</strong> \u2013 Systematic reviews/meta-analyses</span></li><li><span style=\"font-size:14.0pt;\"><strong>CONSORT</strong> \u2013 Randomized controlled trials</span></li><li><span style=\"font-size:14.0pt;\"><strong>STARD</strong> \u2013 Diagnostic accuracy</span></li><li><span style=\"font-size:14.0pt;\"><strong>CARE</strong> \u2013 Case reports</span></li><li><span style=\"font-size:14.0pt;\"><strong>SRQR</strong> \u2013 Qualitative research</span></li><li><span style=\"font-size:14.0pt;\"><strong>MOOSE&nbsp;</strong>- Meta-analysis&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>SPIRIT&nbsp;</strong>\u2013 Intervention trials (Standard Protocols)</span></li></ul>",
    "correct_choice_id": 371315,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93260/Neet_Pg_22_Sept_2025_Psm_Q_8.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93260/Neet_Pg_22_Sept_2025_Psm_Q_8.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93619,
    "choices": [
      {
        "id": 372716,
        "text": "<p><span style=\"font-size:14.0pt;\">Hydroxylation</span></p>"
      },
      {
        "id": 372717,
        "text": "<p><span style=\"font-size:14.0pt;\">Methylation</span></p>"
      },
      {
        "id": 372718,
        "text": "<p><span style=\"font-size:14.0pt;\">Glucuronidation</span></p>"
      },
      {
        "id": 372719,
        "text": "<p><span style=\"font-size:14.0pt;\">Glutathione conjugation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following represents a Phase I metabolic transformation that typically introduces a polar functional group into a drug molecule?</span></p>",
    "unique_key": "Q3705579",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Hydroxylation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Drug metabolism consists of two stages:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Phase I (functionalization reactions):&nbsp;</strong>These reactions involve <strong>oxidation, reduction, or hydrolysis</strong> and are mainly mediated by the <strong>cytochrome P450 enzyme system</strong> in the liver. They introduce or expose a <strong>polar functional group</strong> (such as hydroxyl, amino, or sulfhydryl groups). <strong>Hydroxylation</strong> is the classic Phase I reaction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Phase II (conjugation reactions):&nbsp;</strong>These reactions involve <strong>methylation, glucuronidation, sulfation, and glutathione conjugation</strong>, which couple drugs with endogenous substrates to increase water solubility and enhance renal or biliary excretion.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, <strong>hydroxylation</strong> is the only Phase I reaction listed here.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Methylation:</strong> A <strong>Phase II conjugation reaction</strong> that transfers a methyl group (\u2013CH3). It does not introduce polarity but may inactivate drugs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Glucuronidation:</strong> A <strong>Phase II reaction</strong> mediated by UDP-glucuronyl transferase, essential in metabolism of bilirubin and drugs like morphine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Glutathione conjugation:</strong> Another <strong>Phase II reaction</strong> where glutathione binds to toxic electrophiles, important in detoxifying drugs like acetaminophen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hydroxylation is a Phase I metabolic transformation (via cytochrome P450 enzymes) that introduces polar functional groups.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In contrast, Phase II reactions such as methylation, glucuronidation, and glutathione conjugation are conjugation processes that enhance solubility for elimination.</span></li></ul>",
    "correct_choice_id": 372716,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93619/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93619/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93259,
    "choices": [
      {
        "id": 371308,
        "text": "<p><span style=\"font-size:14.0pt;\">DALE has replaced HALE</span></p>"
      },
      {
        "id": 371309,
        "text": "<p><span style=\"font-size:14.0pt;\">HALE is equivalent to crude life expectancy</span></p>"
      },
      {
        "id": 371310,
        "text": "<p><span style=\"font-size:14.0pt;\">YPLL emphasizes deaths occurring at younger ages&nbsp;</span></p>"
      },
      {
        "id": 371311,
        "text": "<p><span style=\"font-size:14.0pt;\">Socio-economic indicators exclude dependency ratio</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is correct?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q6401630",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) YPLL emphasizes deaths occurring at younger ages</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>YPLL (Years of Potential Life Lost)</strong> is a measure that quantifies premature mortality by emphasizing deaths that occur <strong>before a predetermined age threshold</strong> (e.g., 70 years).</span></li><li><span style=\"font-size:14.0pt;\">It assigns <strong>more weight to deaths at younger ages</strong>, hence highlighting <strong>conditions and injuries affecting children and young adults</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. DALE has replaced HALE:&nbsp;</strong>Incorrect. <strong>HALE (Health-Adjusted Life Expectancy)</strong> is currently the accepted term used by WHO. <strong>DALE (Disability-Adjusted Life Expectancy)</strong> was an older term previously used but was replaced by HALE.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. HALE is equivalent to crude life expectancy:&nbsp;</strong>Incorrect. <strong>HALE</strong> adjusts <strong>life expectancy</strong> by accounting for <strong>years lived in less than full health</strong> due to disease or disability. Crude life expectancy does not consider the quality of life.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Socio-economic indicators exclude dependency ratio:&nbsp;</strong>Incorrect. <strong>Dependency ratio</strong> is a <strong>key socio-economic indicator</strong>, used to assess the burden of non-working (dependent) population on the working-age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>YPLL focuses on premature mortality,</strong> especially deaths occurring at <strong>younger ages</strong>, making it crucial for identifying preventable causes of death and targeting public health interventions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note -</strong> <strong>Socio-economic Indicators [Mnemonic: He FLAGGED]</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Housing</span></li><li><span style=\"font-size:14.0pt;\">Family size</span></li><li><span style=\"font-size:14.0pt;\">Literacy rate</span></li><li><span style=\"font-size:14.0pt;\">Availability per capita calorie</span></li><li><span style=\"font-size:14.0pt;\">GNP per capita</span></li><li><span style=\"font-size:14.0pt;\">Growth rate</span></li><li><span style=\"font-size:14.0pt;\">UnEmployment level</span></li><li><span style=\"font-size:14.0pt;\">Dependency ratio</span></li></ul>",
    "correct_choice_id": 371310,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93259/Neet_Pg_22_Sept_2025_Psm_Q_7.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93259/Neet_Pg_22_Sept_2025_Psm_Q_7.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93325,
    "choices": [
      {
        "id": 371568,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2</span></p>"
      },
      {
        "id": 371569,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
      },
      {
        "id": 371570,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 371571,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about atrial septal defect (ASD) are true?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Ostium primum is the most common type of ASD</span></li><li><span style=\"font-size:14.0pt;\">Surgery is usually done before 3 years of age</span></li><li><span style=\"font-size:14.0pt;\">The second heart sound is wide and fixed in splitting</span></li><li><span style=\"font-size:14.0pt;\">A soft mid-diastolic rumble may be heard at the lower left sternal border</span></li></ol>",
    "unique_key": "Q7184637",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Surgery is usually done before 3 years of age:&nbsp;</strong>Elective surgical or device closure is ideally performed in early childhood, typically between 2\u20135 years, to prevent long-term complications such as arrhythmias, pulmonary hypertension, and right heart failure. Repair in adulthood carries higher risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. The second heart sound is wide and fixed in splitting:&nbsp;</strong>Auscultation in ASD characteristically reveals a <strong>widely split and fixed second heart sound (S2)</strong> that does not vary with respiration. This is a hallmark clinical finding of ASD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. A soft mid-diastolic rumble at the lower left sternal border:&nbsp;</strong>A short, rumbling mid-diastolic murmur may be heard due to <strong>increased tricuspid valve flow</strong> from left-to-right shunting across the atrial septum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Ostium primum is the most common type of ASD): </strong>False. The most common type is <strong>ostium secundum ASD</strong> (about 70%), located at the region of the fossa ovalis. Ostium primum is less common and associated with AV valve abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ostium secundum is the most common type of ASD; the classic signs include a fixed wide split of S2 and a mid-diastolic murmur at the left sternal border, with surgical correction recommended in early childhood.</span></p>",
    "correct_choice_id": 371569,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93325/NEET_PG_22_Sep_2025_PEDIATRICS_Question_9.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      13
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93325/NEET_PG_22_Sep_2025_PEDIATRICS_Question_9.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93512,
    "choices": [
      {
        "id": 372304,
        "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-b, 3-c, 4-a</span></p>"
      },
      {
        "id": 372305,
        "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-c, 3-a, 4-d</span></p>"
      },
      {
        "id": 372306,
        "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-d, 3-b, 4-a</span></p>"
      },
      {
        "id": 372307,
        "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-b, 3-d, 4-c</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following reflexes with their correct explanation:&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-18%20131304.jpg\" width=\"995\" height=\"429\"></p>",
    "unique_key": "Q8092878",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1-c, 2-d, 3-b, 4-a</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>1-c. Bezold\u2013Jarisch reflex- Triggered by myocardial ischemia, causes bradycardia and hypotension:</strong> Caused by stimulation of ventricular receptors (especially during ischemia), leading to bradycardia and hypotension.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2-d. Hering\u2013Breuer reflex-</strong> <strong>Triggered by lung inflation, regulates depth and frequency of breathing:</strong> Triggered by lung inflation; regulates depth and frequency of respiration, preventing overinflation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3-b. Bainbridge reflex-</strong> <strong>Triggered by increased venous return, causes increased heart rate to accommodate blood volume:</strong> Triggered by increased venous return; increases heart rate to handle the extra blood volume.</span></li><li><p><span style=\"font-size:14.0pt;\"><strong>4-a. Cushing\u2019s reflex-</strong> <strong>Triggered by increased intracranial pressure, produces hypertension, bradycardia, and irregular respiration:</strong> Triggered by raised intracranial pressure; produces the classic triad of hypertension, bradycardia, and irregular respiration.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bezold\u2013Jarisch \u2192 MI-induced vagal bradycardia.</span></li><li><span style=\"font-size:14.0pt;\">Hering\u2013Breuer \u2192 Lung stretch regulates breathing.</span></li><li><span style=\"font-size:14.0pt;\">Bainbridge \u2192 Increased venous return raises heart rate.</span></li><li><span style=\"font-size:14.0pt;\">Cushing\u2019s \u2192 ICP \u2191 leads to HTN, bradycardia, abnormal breathing.</span></li></ul>",
    "correct_choice_id": 372306,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93512/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      2
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93512/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93326,
    "choices": [
      {
        "id": 371572,
        "text": "<p><span style=\"font-size:14.0pt;\">Mantoux syringe</span></p>"
      },
      {
        "id": 371573,
        "text": "<p><span style=\"font-size:14.0pt;\">BCG syringe</span></p>"
      },
      {
        "id": 371574,
        "text": "<p><span style=\"font-size:14.0pt;\">Tuberculin syringe</span></p>"
      },
      {
        "id": 371575,
        "text": "<p><span style=\"font-size:14.0pt;\">DOT syringe</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">What is the name of this instrument?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20132218.jpg\" width=\"772\" height=\"214\"></p>",
    "unique_key": "Q6456549",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Tuberculin syringe</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The syringe shown is a <strong>1 mL tuberculin syringe</strong>, calibrated in 0.01 mL increments.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is specifically designed for intradermal administration of tuberculin for the Mantoux test and is also used for BCG vaccination, both of which utilize tuberculin.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its precision makes it ideal for very small-volume injections.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mantoux syringe:&nbsp;</strong>The Mantoux test is performed using a <strong>tuberculin syringe</strong>, but the term \"Mantoux syringe\" is not correct terminology. The syringe itself is universally called a tuberculin syringe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. BCG syringe:&nbsp;</strong>Although BCG vaccine is administered intradermally with a tuberculin syringe, there is no separate entity called a \"BCG syringe.\" The same tuberculin syringe is used for both BCG vaccination and Mantoux testing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. DOT syringe:&nbsp;</strong>This option is a distractor. \"DOT\" refers to <strong>Directly Observed Treatment</strong> for tuberculosis, which does not require a specific syringe type. Standard disposable syringes are used for injectable drugs, not tuberculin syringes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A tuberculin syringe is a 1 mL syringe marked in 0.01 mL increments, used for precise intradermal injections such as Mantoux testing and BCG vaccination.</span></p>",
    "correct_choice_id": 371574,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93326/NEET_PG_22_Sep_2025_PEDIATRICS_Question_10.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      13
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93326/NEET_PG_22_Sep_2025_PEDIATRICS_Question_10.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93256,
    "choices": [
      {
        "id": 371296,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 3</span></p>"
      },
      {
        "id": 371297,
        "text": "<p><span style=\"font-size:14.0pt;\">2 and 4</span></p>"
      },
      {
        "id": 371298,
        "text": "<p><span style=\"font-size:14.0pt;\">1 and 4</span></p>"
      },
      {
        "id": 371299,
        "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following commonly used methods for evaluating protein quality are based on nitrogen balance or retention principles?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Protein Efficiency Ratio (PER)</span></li><li><span style=\"font-size:14.0pt;\">Biological Value (BV)</span></li><li><span style=\"font-size:14.0pt;\">Net Protein Utilization (NPU)</span></li><li><span style=\"font-size:14.0pt;\">Amino Acid Score (AAS)</span></li></ol>",
    "unique_key": "Q4361369",
    "difficulty_level": "difficult",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 2, and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Protein Efficiency Ratio (PER):&nbsp;</strong>Although PER is a growth-based method, it <strong>depends on the weight gain per unit protein intake</strong>, which indirectly reflects <strong>nitrogen retention</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Biological Value (BV):&nbsp;</strong>Measures how much <strong>nitrogen absorbed</strong> from protein is <strong>retained in the body</strong>, thus directly related to nitrogen metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Net Protein Utilization (NPU):&nbsp;</strong>Calculates the <strong>percentage of nitrogen ingested that is retained</strong> for tissue formation. It is a direct nitrogen-based measure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Amino Acid Score (AAS):</strong> This is a <strong>chemical method</strong>, based on comparing <strong>amino acid composition</strong> with a reference protein. <strong>No nitrogen-based calculation</strong> is involved.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Protein Quality Assessment:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>DIAAS</strong>: FAO-recommended; measures digestible essential amino acids. <strong>Most accurate</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>PDCAAS</strong>: AAS + digestibility; now outdated.</span></li><li><span style=\"font-size:14.0pt;\"><strong>AAS</strong>: Based on most limiting essential amino acid.</span></li><li><span style=\"font-size:14.0pt;\"><strong>PER</strong>: Weight gain per gram protein; <strong>not ideal for adults</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>BV</strong>: Nitrogen retained vs. absorbed.</span></li><li><span style=\"font-size:14.0pt;\"><strong>NPU</strong>: Nitrogen used for tissue vs. digested.</span></li></ul>",
    "correct_choice_id": 371296,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93256/Neet_Pg_22_Sept_2025_Psm_Q_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93256/Neet_Pg_22_Sept_2025_Psm_Q_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93610,
    "choices": [
      {
        "id": 372680,
        "text": "<p><span style=\"font-size:14.0pt;\">It indicates epithelial rejection, best treated with surface steroids</span></p>"
      },
      {
        "id": 372681,
        "text": "<p><span style=\"font-size:14.0pt;\">This sign is pathognomonic of subepithelial immune infiltration</span></p>"
      },
      {
        "id": 372682,
        "text": "<p><span style=\"font-size:14.0pt;\">It represents a leading edge of endothelial rejection requiring urgent systemic immunosuppression</span></p>"
      },
      {
        "id": 372683,
        "text": "<p><span style=\"font-size:14.0pt;\">It confirms active endothelial rejection and requires intensive topical corticosteroids</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is most accurate about the finding shown in the image?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_fiU4cmu.png\" width=\"439\" height=\"319\"></span></p>",
    "unique_key": "Q6422026",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) It confirms active endothelial rejection and requires intensive topical corticosteroids</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows a classic <strong>Khodadoust line</strong>, a <strong>linear aggregation of inflammatory cells</strong> at the <strong>endothelial level</strong> of a corneal graft.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is a hallmark of <strong>acute endothelial graft rejection</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The line typically starts from the graft-host junction and progresses centrally.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Progression \u2192 \u201cMOVE\u201d</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">M \u2013 Moving centrally (line advances toward visual axis)</span></li><li><span style=\"font-size:14.0pt;\">O \u2013 Opacity increases (stromal/epithelial edema worsens)</span></li><li><span style=\"font-size:14.0pt;\">V \u2013 Vision worsens (increasing blur/haloes)</span></li><li><p><span style=\"font-size:14.0pt;\">E \u2013 Exudates rise (more KPs + AC cells/flare)</span></p><p>&nbsp;</p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\">Regression \u2192 \u201cCLEAR\u201d</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">C \u2013 Clearing starts (edema reduces from periphery)</span></li><li><span style=\"font-size:14.0pt;\">L \u2013 Line halts (no further central movement)</span></li><li><span style=\"font-size:14.0pt;\">E \u2013 Edema subsides (corneal clarity improves)</span></li><li><span style=\"font-size:14.0pt;\">A \u2013 AC reaction decreases (fewer cells/flare)</span></li><li><span style=\"font-size:14.0pt;\">R \u2013 Recovery of vision (subjective improvement)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">So</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">\u201cProgression is identified if the Khodadoust line moves centrally with increasing edema and worsening vision; regression is noted when the line halts and the cornea begins to clear from the periphery inward.\u201d</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20165218.jpg\" width=\"358\" height=\"357\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Prompt treatment is crucial to prevent <strong>permanent endothelial loss</strong> and <strong>graft failure</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Treatment</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hourly topical corticosteroids</strong> (e.g., prednisolone acetate 1%)</span></li><li><span style=\"font-size:14.0pt;\">Consider systemic steroids <strong>only in recurrent or resistant cases</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>It indicates epithelial rejection, best treated with surface steroids:</strong> Epithelial rejection shows <strong>Krachmer spots</strong> (subepithelial infiltrates), not this endothelial pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ZE6pRKp.png\" width=\"361\" height=\"353\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>This sign is pathognomonic of subepithelial immune infiltration:</strong> Subepithelial infiltration appears as <strong>diffuse hazy patches</strong>, not a linear band.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>It represents a leading edge of endothelial rejection requiring urgent systemic immunosuppression:&nbsp;</strong>Systemic immunosuppression is not first-line; topical therapy is effective in most cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Khodadoust line</strong> is the classic slit-lamp finding in <strong>corneal endothelial graft rejection</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It requires <strong>urgent intensive topical corticosteroids</strong> to preserve graft clarity and function.</span></li></ul>",
    "correct_choice_id": 372683,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93610/NEET_PG_22_Sep_2025_Opthalmology_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      8
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93610/NEET_PG_22_Sep_2025_Opthalmology_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93255,
    "choices": [
      {
        "id": 371292,
        "text": "<p><span style=\"font-size:14.0pt;\">Cronbach\u2019s alpha</span></p>"
      },
      {
        "id": 371293,
        "text": "<p><span style=\"font-size:14.0pt;\">Pearson correlation coefficient</span></p>"
      },
      {
        "id": 371294,
        "text": "<p><span style=\"font-size:14.0pt;\">Kappa statistic</span></p>"
      },
      {
        "id": 371295,
        "text": "<p><span style=\"font-size:14.0pt;\">Bland-Altman plot</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">In a clinical trial comparing blood pressure measurements, two nurses independently record systolic pressures for the same patients. The values differ systematically between observers. Which of the following statistical tools best quantifies the degree of agreement in this context?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q2071654",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Bland-Altman plot</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Bland-Altman plot</strong> is the gold standard for assessing <strong>agreement between two quantitative measurement methods or raters</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It plots the <strong>difference between the two measurements</strong> against their <strong>mean</strong>, allowing visualization of:</span><ul><li><span style=\"font-size:14.0pt;\">Systematic bias (e.g., one nurse consistently reading higher)</span></li><li><span style=\"font-size:14.0pt;\">Random variation (scatter of differences)</span></li><li><span style=\"font-size:14.0pt;\">Limits of agreement (typically mean \u00b1 2 SD of the difference)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In this case, where the <strong>difference is consistent and numeric</strong>, Bland-Altman is preferred over correlation-based methods.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cronbach\u2019s alpha:&nbsp;</strong>Measures <strong>internal consistency</strong> of items within a scale (e.g., questionnaire reliability), not inter-observer agreement for continuous variables.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pearson correlation coefficient:&nbsp;</strong>Assesses <strong>linear correlation</strong>, not agreement. Two observers could have a high Pearson\u2019s r but poor agreement (i.e., one always reads 10 mmHg higher).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Kappa statistic:</strong> Used to assess <strong>inter-rater agreement</strong> for <strong>categorical variables</strong>, not continuous numeric data like systolic BP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Bland-Altman plot is used to evaluate agreement between two quantitative measurement methods or observers, detecting both systematic bias and variability.</span></p>",
    "correct_choice_id": 371295,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93255/Neet_Pg_22_Sept_2025_Psm_Q_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93255/Neet_Pg_22_Sept_2025_Psm_Q_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93334,
    "choices": [
      {
        "id": 371600,
        "text": "<p><span style=\"font-size:14.0pt;\">Variceal banding</span></p>"
      },
      {
        "id": 371601,
        "text": "<p><span style=\"font-size:14.0pt;\">Injection of adrenaline into the lesion</span></p>"
      },
      {
        "id": 371602,
        "text": "<p><span style=\"font-size:14.0pt;\">Argon plasma coagulation</span></p>"
      },
      {
        "id": 371603,
        "text": "<p><span style=\"font-size:14.0pt;\">Balloon tamponade</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 49-year-old man, with a history of long-standing abdominal distension presents to the emergency department with massive hematemesis. He is hemodynamically stabilized with IV fluids and blood products. Upper GI endoscopy shows the following. What is the next immediate step in management?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_PiFYUbA.png\" width=\"406\" height=\"331\"></strong></span></p><p>&nbsp;</p>",
    "unique_key": "Q8794053",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Variceal banding</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Endoscopic variceal ligation (banding) is the first-line treatment for actively bleeding esophageal varices once the patient is stabilized.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It directly controls bleeding by mechanically strangulating varices, is safer than sclerotherapy, and has fewer complications.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is considered the immediate step in management after initial resuscitation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Injection of adrenaline into the lesion:&nbsp;</strong>This is performed for a bleeding peptic ulcer as a part of dual endotherapy</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong>&nbsp;<strong>Argon plasma coagulation:&nbsp;</strong>This is performed so vascular lesions like GAVE.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Balloon tamponade: </strong>Balloon tamponade (e.g., using a Sengstaken\u2013Blakemore tube) is a temporary measure for uncontrolled variceal bleeding when endoscopic therapy is not available. It has a high risk of aspiration, ulceration, and esophageal rupture, so it is only used as a bridge until definitive therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Endoscopic variceal ligation (banding) is the immediate next step in the management of actively bleeding esophageal varices after stabilization, while TIPSS, devascularization, and balloon tamponade are reserved for refractory or rescue situations.</span></p>",
    "correct_choice_id": 371600,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93334/NEET_PG_22_Sep_2025_Surgery_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93334/NEET_PG_22_Sep_2025_Surgery_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92938,
    "choices": [
      {
        "id": 370044,
        "text": "<p><span style=\"font-size:14.0pt;\">Stillbirth (in utero death)</span></p>"
      },
      {
        "id": 370045,
        "text": "<p><span style=\"font-size:14.0pt;\">2\u20133 days postnatal</span></p>"
      },
      {
        "id": 370046,
        "text": "<p><span style=\"font-size:14.0pt;\">30 days postnatal</span></p>"
      },
      {
        "id": 370047,
        "text": "<p><span style=\"font-size:14.0pt;\">12 weeks postnatal</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A dental sample from an unidentified dead infant is examined under microscopy. A neonatal line is detected, and 30 cross striations are counted between the neonatal line and the surface. What is the most likely age of the infant at the time of death?</span></p>",
    "unique_key": "Q9028940",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) 30 days postnatal</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is based on <strong>Boyde\u2019s method</strong> of age estimation, which relies on the <strong>microscopic counting of daily cross striations</strong> (incremental growth lines) in the enamel of developing teeth:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The <strong>neonatal line</strong> marks the boundary between <strong>prenatal and postnatal enamel</strong>, and forms <strong>within 1\u20133 days after birth</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Each <strong>cross striation</strong> represents <strong>one day</strong> of enamel formation.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>30 striations beyond the neonatal line</strong> indicate that the child <strong>lived for approximately 30 days</strong> after birth.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Boyde\u2019s method</strong> is a microscopic forensic technique that estimates the <strong>postnatal age</strong> of infants by <strong>counting cross striations in the enamel beyond the neonatal line</strong>, with each striation representing <strong>one day</strong> of life after birth.</span></p>",
    "correct_choice_id": 370046,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92938/NEET_PG_22_Sep_2025_FMT_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      10
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92938/NEET_PG_22_Sep_2025_FMT_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93649,
    "choices": [
      {
        "id": 372832,
        "text": "<p><span style=\"font-size:14.0pt;\">Complement-mediated lysis</span></p>"
      },
      {
        "id": 372833,
        "text": "<p><span style=\"font-size:14.0pt;\">IgG-mediated opsonization of RBCs in the spleen</span></p>"
      },
      {
        "id": 372834,
        "text": "<p><span style=\"font-size:14.0pt;\">Drug-induced antibody formation against RBC membrane antigens</span></p>"
      },
      {
        "id": 372835,
        "text": "<p><span style=\"font-size:14.0pt;\">Membrane attack complex (MAC)-mediated intravascular hemolysis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman with a known history of chronic lymphocytic leukemia (CLL) presents with progressive fatigue and jaundice. Laboratory findings show:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hemoglobin: 7.9 g/dL</span></li><li><span style=\"font-size:14.0pt;\">Reticulocyte count: elevated</span></li><li><span style=\"font-size:14.0pt;\">Bilirubin: indirect hyperbilirubinemia</span></li><li><span style=\"font-size:14.0pt;\">LDH: elevated</span></li><li><span style=\"font-size:14.0pt;\">Direct Coombs test: positive</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is the most likely pathophysiologic mechanism?&nbsp;</span></p>",
    "unique_key": "Q9972651",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) IgG-mediated opsonization of RBCs in the spleen</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient with chronic lymphocytic leukemia (CLL) presents with anemia, jaundice, and laboratory evidence of hemolysis:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Low hemoglobin (8.2 g/dL)</span></li><li><span style=\"font-size:14.0pt;\">Elevated reticulocyte count (compensatory marrow response)</span></li><li><span style=\"font-size:14.0pt;\">Indirect hyperbilirubinemia (from heme breakdown)</span></li><li><span style=\"font-size:14.0pt;\">Elevated LDH (released from lysed red cells)</span></li><li><span style=\"font-size:14.0pt;\">Positive direct Coombs test (confirming autoimmune hemolysis)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These findings point toward warm autoimmune hemolytic anemia (warm AIHA), which is strongly associated with CLL. In warm AIHA, IgG antibodies bind RBCs at body temperature.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The IgG-coated RBCs are then recognized by splenic macrophages through Fc receptors, leading to extravascular hemolysis in the spleen.</span></li><li><span style=\"font-size:14.0pt;\">Thus, the most likely mechanism is IgG-mediated opsonization of RBCs in the spleen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Complement-mediated lysis:&nbsp;</strong>Paroxysmal nocturnal hemoglobinuria is caused by PIGA gene mutation, leading to deficient GPI-anchored proteins (CD55/CD59) that normally protect RBCs from complement. This results in chronic intravascular hemolysis, not a Coombs-positive hemolytic anemia, and it is not directly associated with CLL in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Drug-induced antibody formation against RBC membrane antigens:&nbsp;</strong>Certain drugs (e.g., penicillin, methyldopa) can trigger drug-induced immune hemolytic anemia, leading to Coombs positivity. However, in this case, the patient\u2019s history of CLL and absence of drug exposure history strongly favor warm autoimmune hemolysis due to IgG rather than drug-induced hemolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Membrane attack complex (MAC)-mediated intravascular hemolysis:&nbsp;</strong>Complement-mediated MAC lysis results in intravascular hemolysis, as seen in conditions like cold agglutinin disease (IgM-mediated) or PNH. However, this patient\u2019s findings (warm setting, IgG-mediated opsonization, splenic hemolysis) indicate warm AIHA, not complement-driven MAC destruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Warm autoimmune hemolytic anemia, often associated with chronic lymphocytic leukemia, is caused by IgG autoantibodies that opsonize red blood cells, leading to splenic sequestration and extravascular hemolysis.</span></p>",
    "correct_choice_id": 372833,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93649/NEET_PG_22_Sep_2025_Pathology_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93649/NEET_PG_22_Sep_2025_Pathology_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92948,
    "choices": [
      {
        "id": 370084,
        "text": "<p><span style=\"font-size:14.0pt;\">Insulin</span></p>"
      },
      {
        "id": 370085,
        "text": "<p><span style=\"font-size:14.0pt;\">Glucose 6-phosphate</span></p>"
      },
      {
        "id": 370086,
        "text": "<p><span style=\"font-size:14.0pt;\">Calcium</span></p>"
      },
      {
        "id": 370087,
        "text": "<p><span style=\"font-size:14.0pt;\">Glucose</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old competitive sprinter begins a 100-meter dash. Within seconds of the first powerful muscle contractions, intracellular signals trigger rapid glycogen phosphorylase activation in skeletal muscle to meet acute ATP demand. Which of the following molecules most directly activates glycogen phosphorylase during this contraction?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q7215212",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Calcium</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During sudden, intense skeletal muscle contraction, <strong>calcium</strong> is released from the sarcoplasmic reticulum.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Cytosolic <strong>calcium</strong> binds <strong>calmodulin</strong> on <strong>phosphorylase kinase</strong>, activating it even in the absence of hormonal input.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Activated phosphorylase kinase converts <strong>glycogen phosphorylase b \u2192 glycogen phosphorylase a</strong>, thereby <strong>activating</strong> <strong>glycogen phosphorylase</strong> and accelerating glycogenolysis to supply glucose-1-phosphate for rapid ATP production.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thus, <strong>calcium</strong> directly couples excitation\u2013contraction to <strong>activation</strong> of <strong>glycogen phosphorylase</strong> in muscle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key phrases covered:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Activates / activation</strong>: Calcium-triggered activation via calmodulin\u2013phosphorylase kinase turns glycogen phosphorylase into its active \u201ca\u201d form.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Glycogen phosphorylase</strong>: The enzyme that cleaves \u03b1-1,4 glycosidic bonds during glycogenolysis in contracting muscle.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Calcium</strong>: The correct molecule linking contraction to metabolic response.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Glucose 6-phosphate, insulin, glucose</strong>: Addressed below as incorrect alternatives.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Insulin:</strong> Incorrect. <strong>Insulin</strong> promotes the dephosphorylation (via protein phosphatase-1) and <strong>inactivation</strong> of <strong>glycogen phosphorylase</strong>, while favoring glycogen <strong>synthesis</strong> (activates glycogen synthase). Therefore, insulin does <strong>not activate</strong> glycogen phosphorylase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Glucose 6-phosphate:</strong> Incorrect. <strong>Glucose 6-phosphate</strong> is an <strong>allosteric inhibitor</strong> of hepatic <strong>glycogen phosphorylase</strong> and an activator of <strong>glycogen synthase</strong>; it does not <strong>activate</strong> glycogen phosphorylase. Thus, glucose 6-phosphate does not serve as the activating signal described.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Glucose:</strong> Incorrect. <strong>Glucose</strong> (especially in liver) allosterically favors the <strong>inactive</strong> state of <strong>glycogen phosphorylase a</strong> by promoting its dephosphorylation; it does not <strong>activate</strong> glycogen phosphorylase. In the contracting muscle setting, glucose is not the direct activator.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Calcium</strong> released during muscle contraction binds calmodulin to activate <strong>phosphorylase kinase</strong>, which <strong>activates glycogen phosphorylase</strong> and drives glycogenolysis.</span></p>",
    "correct_choice_id": 370086,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92948/NEET_PG_22_Sep_2025_Biochemistry_Question_8.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      1
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92948/NEET_PG_22_Sep_2025_Biochemistry_Question_8.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93612,
    "choices": [
      {
        "id": 372688,
        "text": "<p><span style=\"font-size:14.0pt;\">24D</span></p>"
      },
      {
        "id": 372689,
        "text": "<p><span style=\"font-size:14.0pt;\">21.5D</span></p>"
      },
      {
        "id": 372690,
        "text": "<p><span style=\"font-size:14.0pt;\">19.0D</span></p>"
      },
      {
        "id": 372691,
        "text": "<p><span style=\"font-size:14.0pt;\">22.0D</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 1-year-old child is undergoing cataract surgery with primary intraocular lens (IOL) implantation. Biometry reveals an ideal IOL power of 24 diopters (D) based on axial length and keratometry. To account for future ocular growth and the expected myopic shift, the surgeon plans to under-correct the IOL. What power of IOL should ideally be implanted?</span></p>",
    "unique_key": "Q8173033",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 19.0D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In paediatric cataract surgery, the <strong>implanted IOL power is intentionally under-corrected</strong> to account for the <strong>myopic shift</strong> that occurs as the child\u2019s eye grows.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Unlike adults, children\u2019s eyes <strong>increase in axial length</strong> significantly in the first few years of life, causing a natural shift toward <strong>myopia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A commonly used rule is to <strong>reduce IOL power by a percentage based on age</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>20% under-correction at age 1 year</strong> is typically recommended.</span></li><li><span style=\"font-size:14.0pt;\"><strong>For a calculated power of 24D:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">20% of 24D = 4.8D</span></li><li><span style=\"font-size:14.0pt;\">24D \u2013 4.8D = <strong>19.2D, so closest power is 19.0 D</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">This approach minimizes the risk of <strong>postoperative high myopia</strong> in later childhood.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In infants undergoing IOL implantation for congenital cataract, <strong>IOL power must be under-corrected</strong> to compensate for <strong>future axial eye growth and the resulting myopic shift</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A <strong>20% reduction</strong> from calculated power is commonly used at <strong>1 year of age</strong>.</span></li></ul>",
    "correct_choice_id": 372690,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93612/NEET_PG_22_Sep_2025_Opthalmology_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      8
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93612/NEET_PG_22_Sep_2025_Opthalmology_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93535,
    "choices": [
      {
        "id": 372392,
        "text": "<p><span style=\"font-size:14.0pt;\">Anterior compartment: Femoral nerve; Medial compartment: Sciatic nerve; Posterior compartment: Obturator nerve</span></p>"
      },
      {
        "id": 372393,
        "text": "<p><span style=\"font-size:14.0pt;\">Anterior compartment: Sciatic nerve; Medial compartment: Femoral nerve; Posterior compartment: Obturator nerve</span></p>"
      },
      {
        "id": 372394,
        "text": "<p><span style=\"font-size:14.0pt;\">Anterior compartment: Femoral nerve; Medial compartment: Obturator nerve; Posterior compartment: Sciatic nerve</span></p>"
      },
      {
        "id": 372395,
        "text": "<p><span style=\"font-size:14.0pt;\">Anterior compartment: Obturator nerve; Medial compartment: Sciatic nerve; Posterior compartment: Femoral nerve</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Based on the anatomy of thigh compartments and their nerve supply, which of the following correctly matches the three main compartments of the thigh with their respective primary innervating nerves?</span></p>",
    "unique_key": "Q1303931",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Anterior compartment: Femoral nerve; Medial compartment: Obturator nerve; Posterior compartment: Sciatic nerve</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The thigh is divided into three compartments, each with its own primary nerve supply:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Anterior compartment</strong>: Innervated by the <strong>femoral nerve</strong>, responsible for hip flexion and knee extension. Key muscles include quadriceps femoris, sartorius, and pectineus (partially by obturator nerve).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Medial compartment</strong>: Innervated mainly by the <strong>obturator nerve</strong>, responsible for thigh adduction. Muscles include adductor longus, adductor brevis, adductor magnus (adductor part), and gracilis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Posterior compartment</strong>: Innervated primarily by the <strong>sciatic nerve</strong> (tibial division for most muscles, common fibular division for short head of biceps femoris), responsible for hip extension and knee flexion.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_pTWkVfT.jpeg\" alt=\"image\" width=\"319\" height=\"567\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>femoral nerve</strong> supplies the anterior thigh compartment, the <strong>obturator nerve</strong> supplies the medial compartment, and the <strong>sciatic nerve</strong> supplies the posterior compartment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This organization is essential for understanding motor deficits following nerve injuries in the thigh.</span></li></ul>",
    "correct_choice_id": 372394,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93535/NEET_PG_22_Sep_2025_Anatomy_Question_6.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      3
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93535/NEET_PG_22_Sep_2025_Anatomy_Question_6.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93566,
    "choices": [
      {
        "id": 372512,
        "text": "<p><span style=\"font-size:14.0pt;\">Twin concordance is more with ulcerative colitis than Crohn\u2019s disease.</span></p>"
      },
      {
        "id": 372513,
        "text": "<p><span style=\"font-size:14.0pt;\">Very early onset IBD has a strong family history and is resistant to therapy.</span></p>"
      },
      {
        "id": 372514,
        "text": "<p><span style=\"font-size:14.0pt;\">Reduced biodiversity of intestinal microbiota is common.</span></p>"
      },
      {
        "id": 372515,
        "text": "<p><span style=\"font-size:14.0pt;\">Breastfeeding confers protection against the development of IBD.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old man presents with chronic diarrhea and abdominal pain. Colonoscopy and biopsy confirm Crohn\u2019s disease. He has a family history of ulcerative colitis in his mother. Regarding the risk factors for IBD, which of the following statements is incorrect?</span></p>",
    "unique_key": "Q5636327",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Twin concordance is more with ulcerative colitis than Crohn\u2019s disease.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Twin concordance rates reflect the genetic contribution to a disease. Studies consistently show that <strong>Crohn\u2019s disease (CD)</strong> has a higher twin concordance rate than <strong>ulcerative colitis (UC)</strong>, indicating a stronger genetic predisposition in CD.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">For monozygotic twins, concordance for CD is approximately 40-60%, while for UC, it is around 14\u201319%. &nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Dizygotic twin concordance is lower for both (4\u20137% for CD, 0\u20132% for UC), but the gap is more pronounced in CD, suggesting a greater genetic influence.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, stating that twin concordance is higher in UC than CD is false.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Very early onset IBD has a strong family history and is resistant to therapy</strong>: Correct. VEO-IBD (onset &lt;6 years) is often linked to genetic mutations (e.g., IL10RA, NOD2), leading to a strong family history. Its aggressive course and monogenic etiology make it resistant to standard therapies like aminosalicylates, often requiring biologics or surgical intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Reduced biodiversity of intestinal microbiota is common</strong>: Correct. Dysbiosis, characterized by reduced microbial diversity, is well-documented in IBD. Loss of beneficial bacteria (e.g., Faecalibacterium prausnitzii) and overgrowth of pro-inflammatory species contribute to chronic inflammation in CD and UC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Breastfeeding confers protection against the development of IBD</strong>: Correct. Breastfeeding is protective against IBD, with studies showing a reduced risk of both CD and UC in breastfed individuals, likely due to early microbial colonization and immune modulation from breast milk components.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Crohn\u2019s disease has higher twin concordance (50\u201358%) than ulcerative colitis (14\u201319%), reflecting a stronger genetic predisposition.</span></li><li><span style=\"font-size:14.0pt;\">Very early onset IBD is associated with strong family history and therapy resistance due to genetic factors.</span></li><li><span style=\"font-size:14.0pt;\">Breastfeeding reduces IBD risk by fostering a protective gut microbiome, while reduced microbial biodiversity is a common feature of IBD.</span></li></ul>",
    "correct_choice_id": 372512,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93566/Neet_Pg_22_Sep_2025_Medicine_Question_31.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93566/Neet_Pg_22_Sep_2025_Medicine_Question_31.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92941,
    "choices": [
      {
        "id": 370056,
        "text": "<p><span style=\"font-size:14.0pt;\">D-ribulose</span></p>"
      },
      {
        "id": 370057,
        "text": "<p><span style=\"font-size:14.0pt;\">L-xylulose</span></p>"
      },
      {
        "id": 370058,
        "text": "<p><span style=\"font-size:14.0pt;\">D-lactose</span></p>"
      },
      {
        "id": 370059,
        "text": "<p><span style=\"font-size:14.0pt;\">D-ribose</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old man undergoes routine occupational health screening. Urinalysis detects a reducing substance. His fasting blood glucose level is normal, and he denies any history of diabetes mellitus. He mentions that his father had a similar finding on testing but remained healthy throughout life. Which of the following sugars is most likely to be present in his urine?&nbsp;&nbsp;</span></p>",
    "unique_key": "Q2882461",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) L-xylulose&nbsp;&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This presentation is characteristic of essential pentosuria, a rare autosomal recessive disorder of pentose metabolism caused by L-xylulose reductase deficiency.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Biochemical basis:</strong> L-xylulose is an intermediate in the uronic acid pathway. A deficiency of L-xylulose reductase leads to its accumulation and subsequent urinary excretion.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clinical clues in the stem:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Reducing substance in urine: Detected by Benedict\u2019s or Fehling\u2019s test.</span></li><li><span style=\"font-size:14.0pt;\">Normal glucose: Excludes diabetes mellitus and renal glycosuria.</span></li><li><span style=\"font-size:14.0pt;\">Positive family history: Suggests inherited enzyme deficiency.</span></li><li><span style=\"font-size:14.0pt;\">Pentose metabolism defect: Directs focus away from common disaccharides or hexoses.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Course: Benign, with no systemic manifestations. Recognition prevents unnecessary workup for glycosuria causes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. D-ribulose:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A ketopentose in the pentose phosphate pathway.</span></li><li><span style=\"font-size:14.0pt;\">Not involved in essential pentosuria.</span></li><li><span style=\"font-size:14.0pt;\">No benign familial disorder exists with isolated urinary excretion of D-ribulose.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. D-lactose:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A disaccharide of glucose and galactose, present in milk.</span></li><li><span style=\"font-size:14.0pt;\">Urinary excretion is not seen in pentose metabolism defects; occurs only in rare renal or metabolic disorders unrelated to L-xylulose reductase deficiency.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. D-ribose:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An aldopentose critical for nucleic acid synthesis.</span></li><li><span style=\"font-size:14.0pt;\">Excretion is linked to certain nucleoside metabolism defects, not essential pentosuria.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Essential pentosuria is a benign, autosomal recessive disorder due to L-xylulose reductase deficiency, leading to persistent urinary excretion of L-xylulose despite normal blood glucose levels.</span></p>",
    "correct_choice_id": 370057,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92941/NEET_PG_22_Sep_2025_Biochemistry_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      1
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92941/NEET_PG_22_Sep_2025_Biochemistry_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92886,
    "choices": [
      {
        "id": 369840,
        "text": "<p><span style=\"font-size:14.0pt;\">Only Patient A's organism exhibits cyst formation in tissues</span></p>"
      },
      {
        "id": 369841,
        "text": "<p><span style=\"font-size:14.0pt;\">Only Patient B's organism has a flagellated form</span></p>"
      },
      {
        "id": 369842,
        "text": "<p><span style=\"font-size:14.0pt;\">Patient A's organism is associated with neutrophilic CSF, while Patient B's with lymphocytic CSF</span></p>"
      },
      {
        "id": 369843,
        "text": "<p><span style=\"font-size:14.0pt;\">Patient B's disease has a more acute, rapidly fatal course than Patient A's</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">You are reviewing CSF wet mounts of two patients: Patient A\u2019s sample is shown in Image A and Patient B\u2019s sample is shown in Image B. Which of the following statements correctly differentiates these organisms?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20121024.jpg\" width=\"715\" height=\"351\"></strong></span></p>",
    "unique_key": "Q5956937",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Patient A's organism is associated with neutrophilic CSF, while Patient B's with lymphocytic CSF</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Patient A's image</strong> is consistent with Naegleria fowleri trophozoite: Trophozoites are typically 10-25 \u00b5m in diameter, broadly rounded, and move using lobopodia (broad, finger-like projections).&nbsp; It has single nucleus with central karyosome, consistent with <strong>Primary Amoebic Meningoencephalitis (PAM)</strong>. The CSF response is <strong>neutrophilic</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Patient B's image</strong> shows Acanthamoeba trophozoite with spiny <strong>acanthopodia</strong>\u2014seen in <strong>Granulomatous Amoebic Encephalitis (GAE)</strong>, which elicits a <strong>lymphocytic</strong> CSF response due to its chronic course.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Only Patient A's organism exhibits cyst formation in tissues:&nbsp;</strong>Incorrect. Naegleria fowleri <strong>does not form cysts</strong> in tissues or CSF. <strong>Acanthamoeba</strong> does form cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Only Patient B's organism has a flagellated form:&nbsp;</strong>Incorrect. Naegleria fowleri has a <strong>flagellated form</strong>; Acanthamoeba <strong>does not</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Patient B's disease has a more acute, rapidly fatal course than Patient A's:</strong> Incorrect. Naegleria causes a <strong>rapidly fatal</strong> course (acute), while Acanthamoeba is <strong>slowly progressive</strong> (subacute to chronic).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Naegleria fowleri causes acute, rapidly progressive meningoencephalitis with <strong>neutrophilic CSF</strong>, while Acanthamoeba causes chronic granulomatous encephalitis with <strong>lymphocytic CSF</strong>.</span></p>",
    "correct_choice_id": 369842,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92886/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_13.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92886/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_13.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93342,
    "choices": [
      {
        "id": 371632,
        "text": "<p><span style=\"font-size:14.0pt;\">Silk</span></p>"
      },
      {
        "id": 371633,
        "text": "<p><span style=\"font-size:14.0pt;\">Polypropylene (Prolene)</span></p>"
      },
      {
        "id": 371634,
        "text": "<p><span style=\"font-size:14.0pt;\">Poliglecaprone (Monocryl)</span></p>"
      },
      {
        "id": 371635,
        "text": "<p><span style=\"font-size:14.0pt;\">Polyglactin 910 (Vicryl)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of these suture materials is known as the \u201cWork horse\u201d suture in general surgery?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q3401591",
    "difficulty_level": "intermediate",
    "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Ans. D) Polyglactin 910 (Vicryl)</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Polyglactin 910 (Vicryl) is a synthetic, absorbable, braided suture.</span></li><li><span style=\"font-size:14.0pt;\">It offers excellent handling, secure knotting, and predictable absorption (~60 days).</span></li><li><span style=\"font-size:14.0pt;\">Used widely for soft tissue approximation, bowel anastomosis, fascia closure, and subcutaneous suturing.</span></li><li><span style=\"font-size:14.0pt;\">Its versatility across multiple tissue types and surgical scenarios makes it the go-to or \u201cworkhorse\u201d suture in general surgery.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_V9JsJGN.png\" width=\"1041\" height=\"563\"></strong></span></p>",
    "correct_choice_id": 371635,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93342/NEET_PG_22_Sep_2025_Surgery_Question_10.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93342/NEET_PG_22_Sep_2025_Surgery_Question_10.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93606,
    "choices": [
      {
        "id": 372664,
        "text": "<p><span style=\"font-size:14.0pt;\">Indomethacin</span></p>"
      },
      {
        "id": 372665,
        "text": "<p><span style=\"font-size:14.0pt;\">Lamotrigine&nbsp;</span></p>"
      },
      {
        "id": 372666,
        "text": "<p><span style=\"font-size:14.0pt;\">Neurosurgical consultation&nbsp;</span></p>"
      },
      {
        "id": 372667,
        "text": "<p><span style=\"font-size:14.0pt;\">Melatonin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old male presents with severe pain on the left side of his face, describing each attack as a sharp \"stab\" lasting seconds, occurring above his left eye at a frequency of 5\u20136 times per minute. Attacks are sometimes triggered by neck movement, with redness and tearing of the left eye during episodes. He has been on carbamazepine, titrated to a high dose, without relief, and seeks a second opinion. Which of the following is a potential next step in treatment?</span></p>",
    "unique_key": "Q7753347",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Lamotrigine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s symptoms - short-lasting (seconds) unilateral facial pain with conjunctival injection (redness) and tearing, triggered by neck movement, and occurring frequently (5-6/min) - are characteristic of <strong>SUNCT</strong>, a rare trigeminal autonomic cephalalgia (TAC).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Carbamazepine, a first-line treatment for trigeminal neuralgia, has failed, indicating refractoriness, a known feature of SUNCT.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lamotrigine</strong> is a potential next step.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is one of the most commonly used treatments for SUNCT, alongside gabapentin and topiramate, due to its efficacy in stabilizing neuronal hyperexcitability.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Dosing typically starts at 25\u201350 mg/day, titrated to 100\u2013400 mg/day based on response and tolerance, making it a reasonable option after carbamazepine failure.</span></li><li><span style=\"font-size:14.0pt;\">The patient\u2019s clinical profile and lack of response to carbamazepine support trialing lamotrigine, as SUNCT is notoriously refractory, and alternative anticonvulsants are guideline-supported next-line therapies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Indomethacin</strong>: Incorrect. Indomethacin is highly effective for paroxysmal hemicrania and hemicrania continua (other TACs), but SUNCT and cluster headache do not respond to it. The patient\u2019s profile (SUNCT) makes this inappropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Neurosurgical consultation:&nbsp;</strong>Incorrect. While neuroimaging is recommended to rule out structural causes (e.g., tumors, vascular anomalies), neurosurgical intervention (e.g., microvascular decompression) is not the next step unless a correctable lesion is identified or medical therapy fails after multiple trials. Current evidence supports further medical management first.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Melatonin:</strong> Incorrect. Melatonin has no established efficacy for SUNCT or other TACs. It is sometimes explored for cluster headache prophylaxis, but there is no data supporting its use in SUNCT, making it unsuitable here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lamotrigine (25\u2013400 mg/day) is a first-line alternative for SUNCT after carbamazepine failure, targeting neuronal hyperexcitability.</span></li><li><span style=\"font-size:14.0pt;\">Indomethacin is ineffective for SUNCT, reserved for paroxysmal hemicrania/hemicrania continua.</span></li><li><span style=\"font-size:14.0pt;\">Neurosurgical consultation is premature unless structural causes are confirmed or medical options exhaust.</span></li></ul>",
    "correct_choice_id": 372665,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93606/Neet_Pg_22_Sep_2025_Medicine_Question_181.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93606/Neet_Pg_22_Sep_2025_Medicine_Question_181.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93553,
    "choices": [
      {
        "id": 372464,
        "text": "<p><span style=\"font-size:14.0pt;\">NuvaRing (combined ethinyl-estradiol/etonogestrel vaginal ring)</span></p>"
      },
      {
        "id": 372465,
        "text": "<p><span style=\"font-size:14.0pt;\">Levonorgestrel intrauterine device (LNG-IUD)</span></p>"
      },
      {
        "id": 372466,
        "text": "<p><span style=\"font-size:14.0pt;\">Etonogestrel implant (Implanon)</span></p>"
      },
      {
        "id": 372467,
        "text": "<p><span style=\"font-size:14.0pt;\">Depot medroxyprogesterone acetate (DMPA/Depot Provera)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old parous woman (P1L1) is being treated with warfarin for a recent deep-vein thrombosis (DVT). She asks for contraception. Which method should be avoided?</span></p>",
    "unique_key": "Q7149699",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) NuvaRing (combined ethinyl-estradiol/etonogestrel vaginal ring)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a patient with <strong>DVT</strong> who is currently on <strong>warfarin</strong>, <strong>estrogen-containing contraception</strong> is <strong>contraindicated</strong> due to the increased risk of <strong>venous thromboembolism (VTE)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Per CDC/WHO <strong>Medical Eligibility Criteria (MEC)</strong>, <strong>combined hormonal contraception (CHC)</strong>\u2014which includes the <strong>NuvaRing</strong> (ethinyl-estradiol + etonogestrel)\u2014is <strong>Category 4 (unacceptable health risk)</strong> in women with <strong>current DVT/PE</strong>, even when receiving therapeutic anticoagulation.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the method to <strong>avoid</strong> is the <strong>NuvaRing</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20163732.jpg\" width=\"989\" height=\"399\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Levonorgestrel intrauterine device (LNG-IUD):&nbsp;</strong>Levonorgestrel-releasing IUD is <strong>progestin-only</strong> and MEC <strong>Category 2</strong> in women with <strong>current DVT on anticoagulation</strong>. It also <strong>reduces menstrual blood loss</strong>, which can be beneficial for patients on <strong>warfarin</strong> who may otherwise experience heavy bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Etonogestrel implant (Implanon):&nbsp;</strong>The implant is <strong>progestin-only</strong> and is <strong>Category 2</strong> for <strong>DVT on treatment</strong>. It does <strong>not contain estrogen</strong> and is acceptable in this setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Depot medroxyprogesterone acetate (DMPA/Depot Provera):&nbsp;</strong>Depot medroxyprogesterone acetate is <strong>progestin-only</strong>. For women with <strong>current DVT/PE on anticoagulation</strong>, it is <strong>Category 2</strong>. Although some studies discuss small VTE signals with DMPA, guidelines still allow its use when <strong>estrogen must be avoided</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In women with <strong>current or recent DVT/PE</strong>\u2014including those <strong>on warfarin</strong>\u2014<strong>avoid estrogen-containing methods (CHC: pills, patch, ring)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Progestin-only options</strong> (LNG-IUD, implant, DMPA) are generally acceptable (MEC Category 2) and the <strong>LNG-IUD</strong> can help mitigate <strong>anticoagulation-related bleeding</strong>.</span></li></ul>",
    "correct_choice_id": 372464,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93553/NEET_PG_22_Sep_2025_OBG_Question_14.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93553/NEET_PG_22_Sep_2025_OBG_Question_14.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92889,
    "choices": [
      {
        "id": 369852,
        "text": "<p><span style=\"font-size:14.0pt;\">Somatization disorder</span></p>"
      },
      {
        "id": 369853,
        "text": "<p><span style=\"font-size:14.0pt;\">Hypochondriasis</span></p>"
      },
      {
        "id": 369854,
        "text": "<p><span style=\"font-size:14.0pt;\">Dhat syndrome</span></p>"
      },
      {
        "id": 369855,
        "text": "<p><span style=\"font-size:14.0pt;\">Generalized anxiety disorder</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old unmarried man from a rural background presents to the psychiatry OPD with complaints of fatigue, weakness, anxiety, and sleep disturbance. He attributes his symptoms to frequent loss of semen in urine and during masturbation. What is the most likely diagnosis?&nbsp;</span></p>",
    "unique_key": "Q2694135",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Dhat syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient presents with <strong>somatic symptoms</strong> like <strong>fatigue, weakness, anxiety, and sleep disturbance</strong>, which he <strong>attributes to semen loss</strong> through <strong>urine or masturbation</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This presentation is characteristic of <strong>Dhat syndrome</strong>, a <strong>culture-bound syndrome</strong> seen primarily in <strong>South Asian countries</strong>, especially <strong>India</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It involves the <strong>belief that semen is a vital fluid</strong>, and its loss leads to physical and psychological symptoms.</span></li><li><span style=\"font-size:14.0pt;\">Dhat syndrome is often seen in <strong>young, unmarried men</strong> from <strong>rural or conservative backgrounds</strong>, reflecting <strong>cultural beliefs about masculinity, virility, and sexuality</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Somatization disorder</strong>: Involves <strong>multiple, medically unexplained somatic complaints</strong> across various systems over a longer period, without a specific cultural attribution to semen loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hypochondriasis</strong>: Involves <strong>preoccupation with having a serious illness</strong>, despite medical reassurance. This patient attributes his symptoms specifically to <strong>semen loss</strong>, not disease fear.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Generalized anxiety disorder</strong>: While anxiety is present, GAD is not characterized by <strong>fixed cultural beliefs</strong> about bodily fluids. The <strong>focus on semen loss</strong> points away from GAD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Dhat syndrome</strong> is a <strong>culture-bound syndrome</strong> commonly seen in Indian subcontinent. Patients believe that they are losing \u2018dhat\u2019 or semen in urine or stools, and attribute multiple physical (such as weakness, fatigue and sexual symptoms) and psychological symptoms (anxiety, depressive symptoms) to this \u2018semen loss\u2019.</span></p>",
    "correct_choice_id": 369854,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92889/NEET_PG_22_Sep_2025_PSYCHIATRY_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      16
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92889/NEET_PG_22_Sep_2025_PSYCHIATRY_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93509,
    "choices": [
      {
        "id": 372292,
        "text": "<p><span style=\"font-size:14.0pt;\">Decreased heart rate and blood pressure</span></p>"
      },
      {
        "id": 372293,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased parasympathetic discharge</span></p>"
      },
      {
        "id": 372294,
        "text": "<p><span style=\"font-size:14.0pt;\">Decreased baroreceptor sensitivity</span></p>"
      },
      {
        "id": 372295,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased activity of the vasomotor center</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old man is undergoing carotid endarterectomy for severe carotid artery stenosis. During the procedure, the surgeon accidentally places a clamp just below the carotid sinus. Which of the following physiological responses is most likely to occur in this situation?</span></p>",
    "unique_key": "Q2793492",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Increased activity of the vasomotor center</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Clamping below the carotid sinus reduces perfusion pressure sensed by baroreceptors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The reduced stretch causes decreased baroreceptor firing, which the brainstem interprets as hypotension.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This leads to increased sympathetic output from the vasomotor center, causing vasoconstriction, increased heart rate, and elevated blood pressure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Decreased heart rate and blood pressure:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>A fall in baroreceptor firing increases sympathetic outflow. Thus, heart rate and blood pressure rise, not fall.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Increased parasympathetic discharge:</strong> Incorrect.<strong>&nbsp;</strong>The response is sympathetic activation with reduced parasympathetic activity, so this is opposite of the actual effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Decreased baroreceptor sensitivity:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>The sensitivity of the receptors is unchanged. The decreased afferent firing is due to reduced stretch from lower pressure, not a change in receptor sensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clamping below the carotid sinus decreases baroreceptor firing, leading to increased vasomotor center activity, sympathetic outflow, and a compensatory rise in blood pressure and heart rate.</span></p>",
    "correct_choice_id": 372295,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93509/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      2
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93509/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93544,
    "choices": [
      {
        "id": 372428,
        "text": "<p><span style=\"font-size:14.0pt;\">Outlet forceps can be applied</span></p>"
      },
      {
        "id": 372429,
        "text": "<p><span style=\"font-size:14.0pt;\">Best time to give episiotomy</span></p>"
      },
      {
        "id": 372430,
        "text": "<p><span style=\"font-size:14.0pt;\">Called as crowning</span></p>"
      },
      {
        "id": 372431,
        "text": "<p><span style=\"font-size:14.0pt;\">May lead to deep transverse arrest</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old in the second stage of labor has the fetal head at the perineum, and the examiner notes the skull has reached the pelvic floor with the sagittal suture in an anteroposterior diameter. Which statement is most accurate in this situation?</span></p>",
    "unique_key": "Q6510510",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Outlet forceps can be applied</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When the <strong>fetal head is at the perineum</strong> and the <strong>skull has reached the pelvic floor</strong>, the delivery is at the <strong>outlet</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Classical criteria for <strong>outlet forceps</strong> include:&nbsp;</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Fetal skull at the pelvic floor</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Head at or on the perineum</strong></span></li><li><span style=\"font-size:14.0pt;\">Sagittal suture in the <strong>AP diameter</strong> or slight obliquity, and&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Scalp visible at the introitus</strong> (often without manually separating the labia).&nbsp;</span></li></ol></li><li><span style=\"font-size:14.0pt;\">This clinical picture satisfies those outlet criteria; therefore, <strong>outlet forceps can be applied</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20164008.jpg\" width=\"641\" height=\"360\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Best time to give episiotomy</strong>: Incorrect as stated. Although an episiotomy, when <strong>indicated</strong>, is typically performed <strong>late</strong> (when the perineum is thinned and just prior to delivery), modern guidance avoids routine episiotomy. The phrase \u201c<strong>best time</strong>\u201d suggests a blanket recommendation, which is <strong>not</strong> appropriate; episiotomy is performed selectively, not automatically, even when the head is at the perineum and the skull has reached the pelvic floor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Called as crowning</strong>: Incorrect in this vignette. <strong>Crowning</strong> is when the fetal head <strong>remains visible between contractions</strong> as it distends the perineum. Here, the stem explicitly states the scalp is <strong>not</strong> visible between contractions, so this is <strong>not crowning</strong>, despite the head being at the perineum and the skull on the pelvic floor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. May lead to deep transverse arrest</strong>: Incorrect. <strong>Deep transverse arrest</strong> is a malrotation problem occurring <strong>earlier</strong> at the mid-pelvis/ischial spines when the head is <strong>deeply engaged</strong> but fails to rotate anteriorly. Once the <strong>skull has reached the pelvic floor</strong> and the <strong>head is at the perineum</strong>, the scenario is past the stage at which deep transverse arrest typically occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When the <strong>head is at the perineum</strong> and the <strong>skull has reached the pelvic floor</strong> with appropriate rotation, the delivery is an <strong>outlet</strong> presentation, and <strong>outlet forceps can be applied</strong> if indicated.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Crowning requires the head to <strong>remain visible between contractions</strong>, and routine episiotomy is <strong>not</strong> recommended.</span></li></ul>",
    "correct_choice_id": 372428,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93544/NEET_PG_22_Sep_2025_OBG_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93544/NEET_PG_22_Sep_2025_OBG_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93265,
    "choices": [
      {
        "id": 371332,
        "text": "<p><span style=\"font-size:14.0pt;\">Skip the missed dose and proceed to Day 14 dose</span></p>"
      },
      {
        "id": 371333,
        "text": "<p><span style=\"font-size:14.0pt;\">Restart the entire Essen regimen</span></p>"
      },
      {
        "id": 371334,
        "text": "<p><span style=\"font-size:14.0pt;\">Administer the missed dose as soon as possible and continue the remaining doses as per original schedule</span></p>"
      },
      {
        "id": 371335,
        "text": "<p><span style=\"font-size:14.0pt;\">Convert to intradermal Thai Red Cross regimen</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old veterinary worker is bitten by a monkey. He is promptly administered human rabies immunoglobulin (HRIG) and started on the Essen regimen for post-exposure prophylaxis. However, due to unforeseen circumstances, he misses his Day 7 dose. What is the most appropriate next step in management?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q8807548",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Administer the missed dose as soon as possible and continue the remaining doses as per original schedule</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Essen regimen</strong> is a <strong>5-dose intramuscular schedule</strong> administered on <strong>Days 0, 3, 7, 14, and 28 on deltoid</strong></span></li><li><span style=\"font-size:14.0pt;\">If any dose is missed, the recommendation is to <strong>administer the missed dose as soon as possible</strong> and then <strong>continue the remaining doses as originally scheduled</strong>, without restarting the entire course.</span></li><li><span style=\"font-size:14.0pt;\">This approach is backed by WHO and NCDC guidelines, which emphasize <strong>maintaining immunity continuity</strong> while ensuring <strong>patient adherence and practicality</strong>, especially in post-exposure scenarios.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Skip the missed dose and proceed to Day 14 dose:</strong> Skipping any dose compromises immunity and increases risk of incomplete prophylaxis, especially for high-risk exposures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Restart the entire Essen regimen:</strong> Restarting is <strong>not necessary</strong>; this leads to unnecessary vaccine doses and costs without added benefit.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Convert to intradermal Thai Red Cross regimen:</strong> Switching regimens mid-course is <strong>not advised</strong> and lacks validation for effective seroconversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In the <strong>Essen regimen</strong> (1-1-1-1-1), <strong>missed doses should be given as soon as possible</strong>, and subsequent doses should continue as originally scheduled. Restarting or switching regimens is <strong>not necessary</strong> unless a significant lapse occurs.</span></p>",
    "correct_choice_id": 371334,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93265/Neet_Pg_22_Sept_2025_Psm_Q_13.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93265/Neet_Pg_22_Sept_2025_Psm_Q_13.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92880,
    "choices": [
      {
        "id": 369816,
        "text": "<p><span style=\"font-size:14.0pt;\">Bacterial flagellin activates B-cells monoclonally, while tetanus toxoid activates them polyclonally.</span></p>"
      },
      {
        "id": 369817,
        "text": "<p><span style=\"font-size:14.0pt;\">Bacterial flagellin does not require antigen processing, whereas tetanus toxoid does.</span></p>"
      },
      {
        "id": 369818,
        "text": "<p><span style=\"font-size:14.0pt;\">Bacterial flagellin induces affinity maturation and class switching, whereas tetanus toxoid does not.</span></p>"
      },
      {
        "id": 369819,
        "text": "<p><span style=\"font-size:14.0pt;\">Bacterial flagellin generates immunological memory, while tetanus toxoid does not.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A research study is conducted to investigate the antibody response to two different antigens: bacterial flagellin and tetanus toxoid. Which of the following best describes the difference between these antigens?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q5016159",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Bacterial flagellin does not require antigen processing, whereas tetanus toxoid does.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bacterial flagellin is a T-independent antigen that directly stimulates B-cells without requiring antigen processing or presentation by APCs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In contrast, tetanus toxoid is a T-dependent antigen, which requires antigen processing, presentation on MHC-II molecules, and T-cell help to stimulate B-cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Bacterial flagellin activates B-cells monoclonally, while tetanus toxoid activates them polyclonally:</strong> Incorrect. Bacterial flagellin activates B-cells polyclonally, not monoclonally. Tetanus toxoid activates B-cells monoclonally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Bacterial flagellin induces affinity maturation and class switching, whereas tetanus toxoid does not:</strong> Incorrect. Tetanus toxoid, as a T-dependent antigen, induces affinity maturation and class switching, while flagellin does not.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Bacterial flagellin generates immunological memory, while tetanus toxoid does not:</strong> Incorrect. Immunological memory is generated by T-dependent antigens like tetanus toxoid but not by T-independent antigens like flagellin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">T-independent antigens, such as bacterial flagellin, do not require antigen processing and presentation, whereas T-dependent antigens like tetanus toxoid require T-cell help for activation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>T-Independent Antigen vs. T-Dependent Antigen:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:11.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20120940.jpg\" width=\"990\" height=\"730\"></strong></span></p>",
    "correct_choice_id": 369817,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92880/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_7.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92880/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_7.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93547,
    "choices": [
      {
        "id": 372440,
        "text": "<p><span style=\"font-size:14.0pt;\">Endocervical curettage</span></p>"
      },
      {
        "id": 372441,
        "text": "<p><span style=\"font-size:14.0pt;\">Loop electrosurgical excision procedure (LEEP)</span></p>"
      },
      {
        "id": 372442,
        "text": "<p><span style=\"font-size:14.0pt;\">Cold knife conization</span></p>"
      },
      {
        "id": 372443,
        "text": "<p><span style=\"font-size:14.0pt;\">Directed cervical biopsy from acetowhite areas</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 47-year-old postmenopausal woman presents with postcoital bleeding. On pelvic examination, the cervix appears grossly normal. A Pap smear reveals high-grade squamous intraepithelial lesion (HSIL). Colposcopic evaluation demonstrates dense acetowhite epithelium with abnormal vascular patterns. What is the most appropriate next step in management?</span></p>",
    "unique_key": "Q8387738",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Directed cervical biopsy from acetowhite areas</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a <strong>postmenopausal woman</strong> with <strong>HSIL</strong> on cytology and <strong>colposcopy showing dense acetowhite lesions with abnormal vascularity</strong>, the <strong>next best step</strong> is to obtain a <strong>directed biopsy</strong> from the abnormal colposcopic areas.</span></li><li><span style=\"font-size:14.0pt;\">HSIL warrants <strong>histopathologic confirmation</strong> before initiating definitive excisional treatment, especially in <strong>postmenopausal women</strong> where atrophy, chronic inflammation, or even invasive disease may alter management.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>dense acetowhite changes and abnormal vascular patterns</strong> on colposcopy are suspicious for <strong>high-grade CIN or invasive carcinoma</strong>, so targeted biopsies ensure accurate diagnosis and staging before treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20163840.jpg\" width=\"551\" height=\"423\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Endocervical curettage</strong>: Incorrect. While ECC is performed when the <strong>transformation zone is not fully visible</strong> or when lesions extend into the canal, in this case the abnormal acetowhite lesions are visible and can be biopsied directly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Loop electrosurgical excision procedure (LEEP)</strong>: Incorrect as the <strong>first step</strong> here. LEEP is an excisional treatment for confirmed CIN 2/3 or when colposcopic assessment is inadequate. Since the patient has a visible lesion with abnormal vascularity, histologic confirmation by biopsy is essential before proceeding to excision, especially in postmenopausal women where invasive carcinoma risk is higher.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cold knife conization:</strong> Incorrect at this stage. Cold knife conization is indicated when there is suspicion of adenocarcinoma in situ, discordance between cytology and colposcopy, or inadequate colposcopic assessment. Here, colposcopy is adequate, so directed biopsy is preferred first.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In women with <strong>HSIL on Pap smear</strong> and <strong>visible colposcopic lesions</strong>, the next step is <strong>directed biopsy from the abnormal areas</strong> to confirm the diagnosis before initiating treatment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is especially critical in <strong>postmenopausal women</strong>, where histology guides the choice between ablative, excisional, or radical procedures.</span></li></ul>",
    "correct_choice_id": 372443,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93547/NEET_PG_22_Sep_2025_OBG_Question_8.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93547/NEET_PG_22_Sep_2025_OBG_Question_8.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92953,
    "choices": [
      {
        "id": 370104,
        "text": "<p><span style=\"font-size:14.0pt;\">Sprengel deformity</span></p>"
      },
      {
        "id": 370105,
        "text": "<p><span style=\"font-size:14.0pt;\">Klippel-Feil syndrome</span></p>"
      },
      {
        "id": 370106,
        "text": "<p><span style=\"font-size:14.0pt;\">Atlantoaxial dislocation</span></p>"
      },
      {
        "id": 370107,
        "text": "<p><span style=\"font-size:14.0pt;\">Arnold-Chiari malformation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 15-year-old girl presents with a short neck, limited range of neck<strong>&nbsp;</strong>movement, and a low posterior hairline. She has no recent trauma or systemic illness. A sagittal CT scan of the cervical spine is shown below. Which of the following diagnoses is most consistent with these findings?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-11%20134210.jpg\" width=\"413\" height=\"412\"></strong></span></p>",
    "unique_key": "Q7820940",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Klippel-Feil syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The CT image shows <strong>congenital fusion of cervical vertebrae</strong>, typically seen in <strong>Klippel-Feil syndrome (KFS)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The hallmark radiologic finding is the <strong>failure of segmentation of cervical somites</strong>, leading to <strong>fused vertebral bodies</strong>, most often involving C2\u2013C3. This matches the patient\u2019s clinical triad:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Short neck</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Limited cervical mobility</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Low posterior hairline</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">These features, in conjunction with imaging, make <strong>KFS</strong> the most likely diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sprengel deformity:&nbsp;</strong>This refers to a <strong>congenital elevation of the scapula</strong>, often associated with KFS, but not diagnosed by cervical spine CT alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Atlantoaxial dislocation:&nbsp;</strong>Involves abnormal motion or alignment between the atlas (C1) and axis (C2), usually seen in trauma, Down syndrome, or rheumatoid arthritis. It presents with <strong>instability</strong>, not fusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Arnold-Chiari malformation:&nbsp;</strong>Involves <strong>herniation of cerebellar tonsils through the foramen magnum</strong>, best seen on <strong>MRI brain/spine</strong>, not CT cervical spine. Associated symptoms include ataxia and headache\u2014not limited neck motion or vertebral fusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Klippel-Feil syndrome</strong> is diagnosed radiologically by <strong>congenital fusion of cervical vertebrae</strong>, often presenting with a <strong>short, stiff neck and low posterior hairline</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It arises from <strong>failure of segmentation of cervical somites</strong> and may be associated with scoliosis, Sprengel deformity, renal anomalies, or hearing loss.</span></li></ul>",
    "correct_choice_id": 370105,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92953/NEET_PG_22_Sep_2025_RADIOLOGY_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      17
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92953/NEET_PG_22_Sep_2025_RADIOLOGY_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92942,
    "choices": [
      {
        "id": 370060,
        "text": "<p><span style=\"font-size:14.0pt;\">Von Gierke\u2019s disease</span></p>"
      },
      {
        "id": 370061,
        "text": "<p><span style=\"font-size:14.0pt;\">Pompe\u2019s disease</span></p>"
      },
      {
        "id": 370062,
        "text": "<p><span style=\"font-size:14.0pt;\">Cori\u2019s disease</span></p>"
      },
      {
        "id": 370063,
        "text": "<p><span style=\"font-size:14.0pt;\">McArdle\u2019s disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old boy is brought to the emergency department after being found lethargic in the morning. His parents report that he has frequent episodes of low blood sugar, especially after missing meals, and his abdomen has been progressively enlarging over the past year. Physical examination confirms hepatomegaly. Laboratory testing reveals hypoglycemia. A liver biopsy shows glycogen deposits with abnormally short outer chains. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q6529822",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>&nbsp;Ans. C) Cori\u2019s disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This child presents with <strong>hypoglycemia</strong>, <strong>hepatomegaly</strong>, and <strong>abnormal glycogen accumulation</strong> seen on <strong>liver biopsy</strong>, specifically described as glycogen with <strong>short outer chains</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is diagnostic of <strong>Cori\u2019s disease</strong> (Glycogen Storage Disease type III), caused by <strong>debranching enzyme (\u03b1-1,6-glucosidase) deficiency</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Debranching enzyme deficiency results in incomplete glycogen degradation.</span></li><li><span style=\"font-size:14.0pt;\">The abnormal glycogen has short outer branches because \u03b1-1,6 linkages cannot be fully cleaved.</span></li><li><span style=\"font-size:14.0pt;\">Hypoglycemia occurs due to limited glycogenolysis, but is <strong>less severe</strong> than in Von Gierke\u2019s disease because gluconeogenesis remains intact.</span></li><li><span style=\"font-size:14.0pt;\">Glycogen accumulates in liver, skeletal muscle, and sometimes heart, causing hepatomegaly, muscle weakness, and growth delay.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key points from question included here:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Child</strong> \u2013 Pediatric onset is common.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hypoglycemia</strong> \u2013 Fasting intolerance due to impaired glycogen breakdown.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hepatomegaly</strong> \u2013 From glycogen accumulation in liver.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Accumulation of abnormal glycogen</strong> \u2013 Hallmark feature.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Liver biopsy</strong> \u2013 Confirms short-branched glycogen</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Von Gierke\u2019s disease</strong> <strong>(GSD type I):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Deficiency: <strong>Glucose-6-phosphatase</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Presents with severe fasting hypoglycemia, lactic acidosis, hyperuricemia, hyperlipidemia, and hepatomegaly.</span></li><li><span style=\"font-size:14.0pt;\">Glycogen structure is <strong>normal</strong>, unlike the abnormal short outer branches in Cori\u2019s disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pompe\u2019s disease</strong> <strong>(GSD type II):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Deficiency: <strong>Lysosomal&nbsp;\u03b1-1,4-glucosidase (acid maltase)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Presents with cardiomegaly, hypotonia, and muscle weakness.</span></li><li><span style=\"font-size:14.0pt;\">Does <strong>not</strong> cause fasting hypoglycemia; glycogen accumulates in lysosomes, not as short-branched cytoplasmic glycogen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. McArdle\u2019s disease</strong> <strong>(GSD type V):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Deficiency: <strong>Muscle glycogen phosphorylase</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Presents with exercise intolerance, muscle cramps, and myoglobinuria after exertion.</span></li><li><span style=\"font-size:14.0pt;\">Does <strong>not</strong> cause hepatomegaly or fasting hypoglycemia because the liver is unaffected.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cori\u2019s disease (GSD type III)</strong> results from <strong>debranching enzyme deficiency</strong>, leading to hypoglycemia, hepatomegaly, and accumulation of <strong>abnormally structured glycogen with short outer branches</strong> on liver biopsy.</span></p>",
    "correct_choice_id": 370062,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92942/NEET_PG_22_Sep_2025_Biochemistry_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      1
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92942/NEET_PG_22_Sep_2025_Biochemistry_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93537,
    "choices": [
      {
        "id": 372400,
        "text": "<p><span style=\"font-size:14.0pt;\">Rectus sheath</span></p>"
      },
      {
        "id": 372401,
        "text": "<p><span style=\"font-size:14.0pt;\">Inguinal ligament</span></p>"
      },
      {
        "id": 372402,
        "text": "<p><span style=\"font-size:14.0pt;\">Arcuate line</span></p>"
      },
      {
        "id": 372403,
        "text": "<p><span style=\"font-size:14.0pt;\">Deep inguinal ring</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">The inferior border of the external oblique aponeurosis thickens and folds backward on itself, forming an important anatomical landmark that extends from the anterior superior iliac spine to the pubic tubercle. Which of the following structures is formed by this process?</span></p>",
    "unique_key": "Q1868685",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Inguinal ligament</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>inguinal ligament</strong> is formed when the <strong>inferior margin of the external oblique aponeurosis</strong> thickens and folds back on itself, running between the <strong>anterior superior iliac spine (ASIS)</strong> and the <strong>pubic tubercle</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This structure forms the base of the inguinal canal and serves as an important landmark in hernia anatomy.</span></li><li><span style=\"font-size:14.0pt;\">In this case, the reducible hernia lies above the inguinal ligament, consistent with an inguinal hernia.&nbsp;</span></li><li><p><span style=\"font-size:14.0pt;\">The surgeon\u2019s description points directly to the anatomical formation of this ligament from the external oblique aponeurosis.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ojhz9l6.jpeg\" alt=\"The Inguinal Canal - Boundaries - Contents - TeachMeAnatomy\" width=\"399\" height=\"295\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rectus sheath:</strong> Incorrect. This is a fibrous compartment containing the rectus abdominis and pyramidalis muscles. It is formed by the aponeuroses of the external oblique, internal oblique, and transversus abdominis but is not specifically created by folding back of the inferior margin of the external oblique aponeurosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Arcuate line:</strong> Incorrect. This marks the lower limit of the posterior layer of the rectus sheath, located around the lower abdomen. It is unrelated to the folding of the external oblique aponeurosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Deep inguinal ring:</strong> Incorrect. This is an opening in the <strong>transversalis fascia</strong>, not formed by the external oblique aponeurosis. It is the internal entrance to the inguinal canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>inguinal ligament</strong> is created when the inferior margin of the <strong>external oblique aponeurosis</strong> thickens and folds back on itself, extending from the ASIS to the pubic tubercle and forming the lower boundary of the inguinal canal.</span></p>",
    "correct_choice_id": 372401,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93537/NEET_PG_22_Sep_2025_Anatomy_Question_8.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      3
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93537/NEET_PG_22_Sep_2025_Anatomy_Question_8.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93343,
    "choices": [
      {
        "id": 371636,
        "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B1 deficiency</span></p>"
      },
      {
        "id": 371637,
        "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B12 deficiency</span></p>"
      },
      {
        "id": 371638,
        "text": "<p><span style=\"font-size:14.0pt;\">Folic acid deficiency</span></p>"
      },
      {
        "id": 371639,
        "text": "<p><span style=\"font-size:14.0pt;\">Calcium deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A patient who is a known case of Crohn's disease underwent terminal ileal resection for the presence of a stricture. Several months later, he presents to the clinic with a history of a tingling sensation of his hands and the peripheral smear shows the presence of macrocytic anemia. What is the most likely cause?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q9492654",
    "difficulty_level": "difficult",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Vitamin B12 deficiency</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The most likely cause of tingling sensation in the hands and macrocytic anemia following ileal resection is vitamin B12 deficiency.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The terminal ileum is the site for vitamin B12 absorption.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Resection of this part of the bowel can lead to vitamin B12 deficiency, which may result in neurological symptoms like tingling and macrocytic anemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option A. Vitamin B1 (thiamine) deficiency:</strong> Can cause neurological and cardiac symptoms, but it is not typically associated with macrocytic anemia.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option C. Folic acid deficiency:</strong> Can cause macrocytic anemia, it doesn't typically cause the neurological symptoms described and is more often linked to dietary deficiencies or malabsorption syndromes not specific to the terminal ileum.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option D. Calcium deficiency:</strong> Can lead to neuromuscular irritability and osteoporosis but is not typically associated with macrocytic anemia.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Following resection of the terminal ileum, a patient may develop vitamin B12 deficiency due to the loss of specific receptors located there, which can lead to macrocytic anemia and neurological symptoms like paresthesias.</span></p>",
    "correct_choice_id": 371637,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93343/NEET_PG_22_Sep_2025_Surgery_Question_11.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93343/NEET_PG_22_Sep_2025_Surgery_Question_11.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92945,
    "choices": [
      {
        "id": 370072,
        "text": "<p><span style=\"font-size:14.0pt;\">They inhibit intestinal absorption of dietary cholesterol.</span></p>"
      },
      {
        "id": 370073,
        "text": "<p><span style=\"font-size:14.0pt;\">They prevent degradation of LDL receptors, thereby increasing hepatic clearance of LDL.</span></p>"
      },
      {
        "id": 370074,
        "text": "<p><span style=\"font-size:14.0pt;\">They inhibit HMG-CoA reductase, reducing endogenous cholesterol synthesis.</span></p>"
      },
      {
        "id": 370075,
        "text": "<p><span style=\"font-size:14.0pt;\">They increase bile acid excretion, lowering cholesterol reabsorption.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old man with a history of hypercholesterolemia is not achieving adequate LDL cholesterol reduction despite high-intensity statin therapy. His physician considers adding a PCSK9 inhibitor. Which of the following best explains the mechanism of action of PCSK9 inhibitors?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q2949077",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) They prevent degradation of LDL receptors, thereby increasing hepatic clearance of LDL.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PCSK9 normally promotes degradation of LDL receptors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">PCSK9 inhibitors (alirocumab, evolocumab) are monoclonal antibodies that block this action, leading to increased LDL receptor recycling and enhanced LDL clearance from the bloodstream.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. They inhibit intestinal absorption of dietary cholesterol:</strong> This is the mechanism of <strong>ezetimibe</strong>, not PCSK9 inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. They inhibit HMG-CoA reductase, reducing endogenous cholesterol synthesis:</strong> This describes <strong>statins</strong>, not PCSK9 inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. They increase bile acid excretion, lowering cholesterol reabsorption:</strong> This is the mechanism of <strong>bile acid sequestrants</strong> like cholestyramine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PCSK9 inhibitors lower LDL cholesterol by preventing LDL receptor degradation, increasing hepatic LDL clearance.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They are used as adjuncts to statin therapy in high-risk patients or in those with familial hypercholesterolemia.</span></li></ul>",
    "correct_choice_id": 370073,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92945/NEET_PG_22_Sep_2025_Biochemistry_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      1
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92945/NEET_PG_22_Sep_2025_Biochemistry_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93536,
    "choices": [
      {
        "id": 372396,
        "text": "<p><span style=\"font-size:14.0pt;\">Sural nerve</span></p>"
      },
      {
        "id": 372397,
        "text": "<p><span style=\"font-size:14.0pt;\">Common peroneal nerve</span></p>"
      },
      {
        "id": 372398,
        "text": "<p><span style=\"font-size:14.0pt;\">Tibial nerve</span></p>"
      },
      {
        "id": 372399,
        "text": "<p><span style=\"font-size:14.0pt;\">Deep peroneal nerve</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A middle-aged man sustains a severe injury to his lower limb in a high-speed collision. On examination, he cannot perform plantar flexion, and his ankle jerk reflex is absent. Dorsiflexion remains intact, and sensory testing reveals complete loss of sensation over the sole of the foot. Which nerve is most likely affected?</span></p>",
    "unique_key": "Q1506256",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Tibial nerve</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>tibial nerve</strong> supplies:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Motor:</strong> Posterior compartment of the leg, responsible for <strong>plantar flexion</strong> (gastrocnemius, soleus) and <strong>toe flexion</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Reflex:</strong> Mediates the <strong>ankle jerk</strong> (S1-S2).</span></li><li><p><span style=\"font-size:14.0pt;\"><strong>Sensory:</strong> Sole of the foot via medial and lateral plantar branches.</span></p><p>&nbsp;</p></li></ul></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Injury effects:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Loss of plantar flexion</strong> \u2192 due to paralysis of posterior leg muscles.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Absent ankle jerk</strong> \u2192 tibial nerve carries afferent and efferent limbs for S1 reflex.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Preserved dorsiflexion</strong> \u2192 anterior compartment (deep peroneal nerve) intact.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sensory loss over sole</strong> \u2192 hallmark of tibial nerve injury.</span></li><li><span style=\"font-size:14.0pt;\">These findings exactly match this case.</span></li></ul><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QoDp19o.jpeg\" alt=\"Tibial Nerve - WikiSM (Sports Medicine Wiki)\" width=\"472\" height=\"318\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sural nerve</strong>: Provides cutaneous sensation to the posterolateral leg and lateral foot. Lesion does <strong>not</strong> cause motor loss or affect the ankle jerk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Common peroneal nerve</strong>: Supplies muscles for dorsiflexion and eversion; injury would cause <strong>foot drop</strong>, not isolated plantar flexion loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Deep peroneal nerve</strong>: Innervates anterior compartment of the leg for dorsiflexion; injury results in foot drop and sensory loss in the first web space, not loss of plantar flexion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Tibial nerve injury</strong> results in loss of plantar flexion, absent ankle jerk, and sensory loss over the sole, while dorsiflexion remains intact because the anterior compartment (deep peroneal nerve) is unaffected.</span></p>",
    "correct_choice_id": 372398,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93536/NEET_PG_22_Sep_2025_Anatomy_Question_7.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      3
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93536/NEET_PG_22_Sep_2025_Anatomy_Question_7.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92954,
    "choices": [
      {
        "id": 370108,
        "text": "<p><span style=\"font-size:14.0pt;\">Dilated colon &gt;6cm</span></p>"
      },
      {
        "id": 370109,
        "text": "<p><span style=\"font-size:14.0pt;\">Air-fluid levels within cecum</span></p>"
      },
      {
        "id": 370110,
        "text": "<p><span style=\"font-size:14.0pt;\">Pneumatosis intestinalis and portal venous gas</span></p>"
      },
      {
        "id": 370111,
        "text": "<p><span style=\"font-size:14.0pt;\">Gasless abdomen</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">What CT finding, if present in the setting of cecal volvulus, would indicate bowel ischemia or impending gangrene, requiring emergent surgery?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q2007226",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Pneumatosis intestinalis and portal venous gas</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In patients with <strong>cecal volvulus</strong>, timely diagnosis is critical to avoid <strong>bowel necrosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The most ominous signs on CT that suggest <strong>ischemia or impending gangrene</strong> are:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Pneumatosis intestinalis</strong>: Air within the bowel wall due to ischemic mucosal injury</span></li><li><span style=\"font-size:14.0pt;\"><strong>Portal venous gas</strong>: Air tracking into the portal system, secondary to transmural bowel infarction</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Both are urgent red flags for <strong>emergency laparotomy</strong>, as endoscopic decompression is contraindicated when ischemia is present.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Dilated colon &gt;6 cm:&nbsp;</strong>This may suggest high-risk volvulus, but in isolation, does not confirm ischemia. Many volvulus cases present with this finding <strong>without necrosis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Air-fluid levels within the cecum:&nbsp;</strong>Common in obstructive bowel pathology, but <strong>nonspecific</strong>. Does not distinguish viable vs ischemic bowel.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Gasless abdomen</strong>: Seen in early postoperative ileus or poor imaging window; <strong>not diagnostic</strong> of ischemia or volvulus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In cecal volvulus, <strong>pneumatosis intestinalis and portal venous gas</strong> on CT are <strong>specific indicators of bowel wall ischemia or necrosis</strong>, mandating <strong>urgent surgical intervention</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early recognition improves outcomes by avoiding delay in definitive care.</span></li></ul>",
    "correct_choice_id": 370110,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92954/NEET_PG_22_Sep_2025_RADIOLOGY_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      17
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92954/NEET_PG_22_Sep_2025_RADIOLOGY_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93623,
    "choices": [
      {
        "id": 372732,
        "text": "<p><span style=\"font-size:14.0pt;\">Ketorolac</span></p>"
      },
      {
        "id": 372733,
        "text": "<p><span style=\"font-size:14.0pt;\">Parecoxib</span></p>"
      },
      {
        "id": 372734,
        "text": "<p><span style=\"font-size:14.0pt;\">Indomethacin</span></p>"
      },
      {
        "id": 372735,
        "text": "<p><span style=\"font-size:14.0pt;\">Ibuprofen</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman undergoes a total abdominal hysterectomy. In the immediate postoperative period, she reports moderate-to-severe pain. Her past medical history includes peptic ulcer disease and she developed gastric bleeding few years ago while taking NSAIDs for arthritis. The surgical team considers giving her an analgesic that:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Provides postoperative pain control</span></li><li><span style=\"font-size:14.0pt;\">Is available as a parenteral formulation</span></li><li><span style=\"font-size:14.0pt;\">Has a lower risk of gastrointestinal ulceration and bleeding&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following medications best fits this profile?</span></p>",
    "unique_key": "Q1050055",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Parecoxib</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Parecoxib</strong> is a <strong>selective COX-2 inhibitor</strong> used for <strong>short-term management of acute postoperative pain</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is unique because it is given <strong>parenterally (IV/IM injection)</strong>, unlike most other COX-2 inhibitors (celecoxib is oral).</span></li><li><span style=\"font-size:14.0pt;\">Its COX-2 selectivity provides analgesia and anti-inflammatory effects with <strong>reduced gastrointestinal toxicity</strong>, making it suitable for patients with a history of peptic ulcer disease or GI bleeding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ketorolac:</strong> A potent parenteral NSAID, but it is <strong>non-selective COX inhibitor</strong>, associated with <strong>significant GI bleeding risk</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Indomethacin:</strong>&nbsp; Another <strong>non-selective NSAID</strong>, commonly used in gout and PDA closure, but not preferred for postoperative pain in patients with GI bleeding risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ibuprofen:</strong> Oral NSAID, non-selective COX inhibitor, not typically used parenterally for immediate postoperative pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Parecoxib is the only parenteral selective COX-2 inhibitor, used for short-term postoperative pain management with reduced gastrointestinal side effects compared to traditional NSAIDs.</span></p>",
    "correct_choice_id": 372733,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93623/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93623/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93523,
    "choices": [
      {
        "id": 372344,
        "text": "<p><span style=\"font-size:14.0pt;\">Sweating</span></p>"
      },
      {
        "id": 372345,
        "text": "<p><span style=\"font-size:14.0pt;\">Shivering</span></p>"
      },
      {
        "id": 372346,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased blood flow to the skin</span></p>"
      },
      {
        "id": 372347,
        "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of chemical thermogenesis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old man develops fever due to a bacterial infection. As his hypothalamic set point for temperature regulation is suddenly raised, his body temperature begins to rise from baseline to the new higher level. On the graph shown, this corresponds to the transition from stage V to stage W. Which of the following physiological responses is most likely to occur during stage W?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_SKt793P.png\" width=\"802\" height=\"610\"></span></p>",
    "unique_key": "Q4497242",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Shivering</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At stage W, the hypothalamus has reset the body\u2019s thermostat to a higher set point.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The body perceives itself as being colder than the new target and initiates <strong>heat-generating mechanisms</strong> such as shivering, vasoconstriction, and piloerection to increase temperature toward the new set point.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sweating:&nbsp;</strong>Incorrect. Sweating occurs later, at stage Y, when the set point returns to normal and the body attempts to lose excess heat.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Increased blood flow to the skin:&nbsp;</strong>Incorrect. Skin vasodilation occurs in stage Y to dissipate heat, not during stage W.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Inhibition of chemical thermogenesis:&nbsp;</strong>Incorrect. Heat production is <strong>stimulated</strong> in stage W, not suppressed. Inhibition of thermogenesis occurs during the cooling phase (stage Y).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">During the rising phase of fever (stage W), shivering and other heat-generating mechanisms are activated to elevate body temperature toward the new hypothalamic set point.</span></p>",
    "correct_choice_id": 372345,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93523/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_8.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      2
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93523/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_8.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93636,
    "choices": [
      {
        "id": 372780,
        "text": "<p><span style=\"font-size:14.0pt;\">Cefixime</span></p>"
      },
      {
        "id": 372781,
        "text": "<p><span style=\"font-size:14.0pt;\">Clarithromycin</span></p>"
      },
      {
        "id": 372782,
        "text": "<p><span style=\"font-size:14.0pt;\">Linezolide</span></p>"
      },
      {
        "id": 372783,
        "text": "<p><span style=\"font-size:14.0pt;\">Faropenem</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old man with a history of hyperlipidemia is being treated with rosuvastatin for cholesterol management. He develops a respiratory tract infection and requires antibiotic therapy. The physician is considering additional medications, but one of the following should be avoided due to the risk of serious drug interaction with his current statin therapy. Which of the following agents should not be prescribed in this patient?</span></p>",
    "unique_key": "Q7404269",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Clarithromycin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rosuvastatin</strong> is a statin used to lower LDL cholesterol and reduce cardiovascular risk.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Statins are metabolized via the <strong>CYP450 system</strong> (especially CYP3A4 for many, though rosuvastatin is less dependent compared to simvastatin or atorvastatin).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clarithromycin</strong> is a <strong>macrolide antibiotic</strong> and a strong <strong>CYP3A4 inhibitor</strong>. When combined with statins, it increases statin serum levels, significantly raising the risk of <strong>statin-induced myopathy and rhabdomyolysis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, clarithromycin should <strong>not</strong> be co-administered with rosuvastatin.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Contraindicated/should be avoided.</strong>&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clarithromycin is a strong&nbsp;<strong>CYP3A4 inhibitor</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While rosuvastatin is less dependent on CYP3A4 metabolism compared to simvastatin or atorvastatin, it still undergoes partial metabolism and transporter-mediated clearance (OATP1B1/1B3, BCRP).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clarithromycin can&nbsp;<strong>increase plasma concentrations of rosuvastatin</strong>, raising the risk of&nbsp;<strong>statin-induced myopathy and rhabdomyolysis</strong>. Hence, it should be avoided.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cefixime:&nbsp;</strong>Safe.&nbsp;A third-generation oral cephalosporin; it has no significant interaction with rosuvastatin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Linezolid:&nbsp;</strong>Safe.&nbsp;An oxazolidinone antibiotic with MAO-inhibitor activity, but it does not interfere with statin metabolism. No significant interaction with rosuvastatin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Faropenem:&nbsp;</strong>Safe.&nbsp;An oral carbapenem antibiotic; no cytochrome P450 interaction with statins.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clarithromycin, a macrolide antibiotic and CYP3A4 inhibitor, should not be co-administered with statins such as rosuvastatin because of the increased risk of statin-induced myopathy and rhabdomyolysis.</span></p>",
    "correct_choice_id": 372781,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93636/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_14.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93636/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_14.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93542,
    "choices": [
      {
        "id": 372420,
        "text": "<p><span style=\"font-size:14.0pt;\">Repeat VDRL after 2 weeks</span></p>"
      },
      {
        "id": 372421,
        "text": "<p><span style=\"font-size:14.0pt;\">Send a fluorescent treponemal antibody-absorption test (FTA-ABS)</span></p>"
      },
      {
        "id": 372422,
        "text": "<p><span style=\"font-size:14.0pt;\">Termination of pregnancy</span></p>"
      },
      {
        "id": 372423,
        "text": "<p><span style=\"font-size:14.0pt;\">Benzathine penicillin G 2.4 million units IM single dose</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old primi at her 8-week routine antenatal visit has a reactive VDRL on screening. She is asymptomatic. What is the next best step in management?</span></p>",
    "unique_key": "Q5138719",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Send a fluorescent treponemal antibody-absorption test (FTA-ABS)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>reactive VDRL</strong> in an <strong>8-week</strong> pregnant <strong>26-year-old</strong> detected on <strong>routine antenatal</strong> screening requires <strong>confirmation</strong> because VDRL (a <strong>nontreponemal</strong> test) is <strong>not specific</strong> and can yield <strong>biologic false positives</strong> (including in <strong>pregnancy</strong>).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>next best step in management</strong> is to send a <strong>treponemal-specific</strong> confirmatory test such as <strong>FTA-ABS</strong> (or TPHA).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If the treponemal test is <strong>positive</strong>, treat <strong>during pregnancy</strong> with <strong>benzathine penicillin G 2.4 million units IM</strong> (single dose for <strong>early</strong> syphilis).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Immediate <strong>termination of pregnancy</strong> is <strong>not</strong> indicated because syphilis is <strong>treatable</strong>, and <strong>repeating VDRL</strong> only delays definitive care.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thus, the immediate action is <strong>confirmatory treponemal testing</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Repeat VDRL after 2 weeks</strong>: Incorrect. While titers are later used for <strong>follow-up</strong>, repeating a <strong>nonspecific</strong> screen first delays care. After a <strong>reactive VDRL</strong> on <strong>routine antenatal</strong> testing in an <strong>asymptomatic</strong> patient, confirm immediately with a <strong>treponemal-specific</strong> assay (e.g., <strong>FTA-ABS</strong>) rather than waiting 2 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Termination of pregnancy</strong>: Incorrect. <strong>Termination</strong> is <strong>not</strong> indicated solely for a positive <strong>VDRL</strong>. Syphilis in pregnancy is <strong>treatable</strong>; proper <strong>confirmation</strong> and <strong>benzathine penicillin</strong> therapy markedly reduce the risk of congenital infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Benzathine penicillin G 2.4 million units IM single dose:</strong> Incorrect. This is the <strong>correct treatment</strong> for <strong>confirmed</strong> <strong>early</strong> syphilis, but therapy should <strong>follow</strong> a <strong>treponemal-specific</strong> confirmation (e.g., <strong>FTA-ABS</strong>). Empiric treatment prior to confirmation can lead to <strong>unnecessary</strong> antibiotic exposure and mislabeling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">After a <strong>reactive VDRL</strong> during <strong>pregnancy</strong>, the <strong>next best step</strong> is <strong>confirmation with a treponemal-specific test (FTA-ABS/TPHA)</strong>; if confirmed, treat with <strong>benzathine penicillin G 2.4 million units IM</strong> to prevent <strong>congenital syphilis.</strong></span></p>",
    "correct_choice_id": 372421,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93542/NEET_PG_22_Sep_2025_OBG_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93542/NEET_PG_22_Sep_2025_OBG_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93534,
    "choices": [
      {
        "id": 372388,
        "text": "<p><span style=\"font-size:14.0pt;\">Internal carotid artery</span></p>"
      },
      {
        "id": 372389,
        "text": "<p><span style=\"font-size:14.0pt;\">Anterior cerebral artery</span></p>"
      },
      {
        "id": 372390,
        "text": "<p><span style=\"font-size:14.0pt;\">Vertebral artery</span></p>"
      },
      {
        "id": 372391,
        "text": "<p><span style=\"font-size:14.0pt;\">Middle cerebral artery</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old man sustains a penetrating head injury involving the structure pointed by arrow. Which artery is the primary source of blood supply to this region?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20162741.jpg\" width=\"511\" height=\"333\"></p>",
    "unique_key": "Q5877304",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Anterior cerebral artery</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The region marked in the question corresponds to the medial aspect of the frontal lobe, making the ACA the primary artery responsible for its perfusion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>anterior cerebral artery (ACA)</strong> is a branch of the internal carotid artery that supplies the medial and superior aspects of the frontal and parietal lobes, as well as the anterior four-fifths of the corpus callosum.&nbsp;</span></li><li><p><span style=\"font-size:14.0pt;\">Damage to this artery can result in contralateral lower limb weakness and sensory deficits due to involvement of the medial motor and sensory cortices.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8t9SD9J.png\" alt=\"Anterior cerebral artery | Radiology Reference Article | Radiopaedia.org\" width=\"494\" height=\"437\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Internal carotid artery:</strong> While the ACA originates from the internal carotid artery, the internal carotid itself is a proximal vessel that supplies several cerebral branches. It does not directly supply the specific medial frontal lobe territory marked in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Vertebral artery:</strong> This artery supplies the posterior circulation of the brain, including the brainstem, cerebellum, and occipital lobes via the posterior cerebral arteries. It has no role in the vascularization of the medial frontal lobe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Middle cerebral artery:</strong> The <strong>Middle cerebral artery (MCA)</strong> supplies the lateral surfaces of the cerebral hemispheres, including the primary motor and sensory cortices for the face and upper limb, but not the medial frontal lobe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>anterior cerebral artery</strong> supplies the medial portions of the frontal and parietal lobes, including the paracentral lobule, which contains the motor and sensory representations of the contralateral lower limb.</span></p>",
    "correct_choice_id": 372389,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93534/NEET_PG_22_Sep_2025_Anatomy_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      3
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93534/NEET_PG_22_Sep_2025_Anatomy_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93627,
    "choices": [
      {
        "id": 372748,
        "text": "<p><span style=\"font-size:14.0pt;\">It requires routine monitoring with PT/INR levels</span></p>"
      },
      {
        "id": 372749,
        "text": "<p><span style=\"font-size:14.0pt;\">It is a synthetic pentasaccharide that selectively inhibits Factor Xa</span></p>"
      },
      {
        "id": 372750,
        "text": "<p><span style=\"font-size:14.0pt;\">It acts as a direct thrombin inhibitor when given orally</span></p>"
      },
      {
        "id": 372751,
        "text": "<p><span style=\"font-size:14.0pt;\">It is metabolized extensively in the liver before excretion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statement is true about fondaparinux?</span></p>",
    "unique_key": "Q4311892",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) It is a synthetic pentasaccharide that selectively inhibits Factor Xa</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fondaparinux is an <strong>anticoagulant</strong> that works as a <strong>synthetic pentasaccharide</strong>, binding <strong>antithrombin III</strong> and causing potent, selective inhibition of <strong>Factor Xa</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is given <strong>subcutaneously</strong> and does not inhibit thrombin directly.</span></li><li><span style=\"font-size:14.0pt;\">It has <strong>predictable pharmacokinetics</strong>, so routine laboratory monitoring (like APTT or PT/INR) is not required.</span></li><li><span style=\"font-size:14.0pt;\">It is mainly excreted <strong>unchanged by the kidneys</strong>, not metabolized by the liver.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It requires routine monitoring with PT/INR levels:&nbsp;</strong>False. Fondaparinux does <strong>not require routine coagulation monitoring</strong> due to its predictable effect, unlike unfractionated heparin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It acts as a direct thrombin inhibitor when given orally:&nbsp;</strong>False. Fondaparinux is <strong>not a thrombin inhibitor</strong> and it is not given orally; it is a <strong>parenteral Factor Xa inhibitor</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is metabolized extensively in the liver before excretion:&nbsp;</strong>False. Fondaparinux is <strong>excreted renally without significant hepatic metabolism</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Fondaparinux is a synthetic pentasaccharide that selectively inhibits Factor Xa via antithrombin III, has predictable pharmacokinetics, is excreted by the kidneys, and does not require routine coagulation monitoring.</span></p>",
    "correct_choice_id": 372749,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93627/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_9.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93627/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_9.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93556,
    "choices": [
      {
        "id": 372476,
        "text": "<p><span style=\"font-size:14.0pt;\">Cervical length measurement on ultrasound</span></p>"
      },
      {
        "id": 372477,
        "text": "<p><span style=\"font-size:14.0pt;\">Cervical cerclage</span></p>"
      },
      {
        "id": 372478,
        "text": "<p><span style=\"font-size:14.0pt;\">Complete bed rest</span></p>"
      },
      {
        "id": 372479,
        "text": "<p><span style=\"font-size:14.0pt;\">Abdominal cerclage</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A pregnant woman (G3P2L0) presented at 9 weeks gestation. She has a history of conization 1 year ago for CIN3 and is currently on follow-up with no recurrence on PAP smear. She also has a history of preterm births at 30 and 32 weeks during her last 2 pregnancies. What is your next step in the management of this patient?</span></p>",
    "unique_key": "Q7812954",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Cervical length measurement on ultrasound</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has a history of <strong>conization</strong> (a procedure that can weaken the cervix) and <strong>preterm births</strong>, which raises concerns about <strong>cervical insufficiency</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The next appropriate step in managing this patient is to perform a <strong>cervical length measurement on transvaginal ultrasound</strong> to assess the risk of preterm labor.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cervical length</strong> measured via ultrasound is the best way to determine whether the cervix is shortening or opening prematurely, which could indicate the need for intervention to prevent preterm birth.</span></li><li><span style=\"font-size:14.0pt;\">If the cervical length is found to be shortened (&lt;25 mm) before 24 weeks gestation, then <strong>cervical cerclage</strong> may be indicated to mechanically support the cervix and prevent premature dilation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cervical cerclage:&nbsp;</strong>Cervical cerclage is a procedure used to reinforce the cervix in cases of cervical insufficiency. However, this is not the immediate next step. First, the cervical length should be assessed via ultrasound to determine whether cerclage is needed. Cerclage is recommended if cervical shortening is detected.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Complete bed rest:&nbsp;</strong>Bed rest is generally not recommended as the primary intervention for preventing preterm birth due to limited evidence of its effectiveness. The first step should be assessing cervical length.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Abdominal cerclage:&nbsp;</strong>Abdominal cerclage is typically reserved for cases of <strong>failed transvaginal cerclage</strong> or in patients with a very short or absent cervix, often detected in earlier pregnancies. It is not the first-line intervention at this stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a pregnant woman with a history of <strong>cervical conization</strong> and <strong>preterm births</strong>, the next step in management is to measure the <strong>cervical length via transvaginal ultrasound</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If the cervix is shortened, interventions like <strong>cervical cerclage</strong> may be considered to prevent preterm birth.</span></li></ul>",
    "correct_choice_id": 372476,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93556/NEET_PG_22_Sep_2025_OBG_Question_17.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93556/NEET_PG_22_Sep_2025_OBG_Question_17.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93530,
    "choices": [
      {
        "id": 372372,
        "text": "<p><span style=\"font-size:14.0pt;\">Lateral plate mesoderm</span></p>"
      },
      {
        "id": 372373,
        "text": "<p><span style=\"font-size:14.0pt;\">Paraxial mesoderm</span></p>"
      },
      {
        "id": 372374,
        "text": "<p><span style=\"font-size:14.0pt;\">Intermediate mesoderm</span></p>"
      },
      {
        "id": 372375,
        "text": "<p><span style=\"font-size:14.0pt;\">Surface ectoderm</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A newborn is noted to have bilateral renal agenesis on prenatal ultrasound, and postnatal examination confirms the absence of internal genital structures. These abnormalities are most likely due to defective development of which embryologic tissue?</span></p>",
    "unique_key": "Q8203409",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Intermediate mesoderm</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>intermediate mesoderm</strong> is the embryonic tissue that gives rise to the urogenital system, including the kidneys, ureters, and much of the internal genital tract.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Failure of intermediate mesoderm development results in anomalies such as <strong>renal agenesis</strong> and <strong>absence of internal genital structures</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This tissue develops along the dorsal body wall between the paraxial and lateral plate mesoderm.</span></li><li><span style=\"font-size:14.0pt;\">Renal agenesis can lead to <strong>Potter sequence</strong> due to oligohydramnios, but in this case, the focus is on the <strong>embryologic origin</strong> of the involved structures.</span></li></ul><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_awZWCT8.jpeg\" alt=\"Mesoderm Development Extraembryonic Intraembryonic\" width=\"445\" height=\"291\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lateral plate mesoderm</strong>: Forms structures such as the heart, blood vessels, spleen, and the lining of body cavities. It is not involved in kidney or internal genital formation, so defects here would not explain renal agenesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Paraxial mesoderm</strong>: Gives rise to somites, which differentiate into skeletal muscle, dermis, and axial skeleton. It is unrelated to the urinary or genital systems.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Surface ectoderm</strong>: Differentiates into epidermis, hair, nails, sweat glands, and mammary glands, as well as the lens of the eye. It plays no role in urinary tract or internal genital development.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>intermediate mesoderm</strong> forms the kidneys, ureters, and most internal genital structures. Defective development of this tissue can result in both <strong>renal agenesis</strong> and absence of internal genitalia.</span></p>",
    "correct_choice_id": 372374,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93530/NEET_PG_22_Sep_2025_Anatomy_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      3
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93530/NEET_PG_22_Sep_2025_Anatomy_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92875,
    "choices": [
      {
        "id": 369796,
        "text": "<p><span style=\"font-size:14.0pt;\">Lacks cytochrome oxidase system for electron transport&nbsp;</span></p>"
      },
      {
        "id": 369797,
        "text": "<p><span style=\"font-size:14.0pt;\">Possesses superoxide dismutase but lacks catalase&nbsp;</span></p>"
      },
      {
        "id": 369798,
        "text": "<p><span style=\"font-size:14.0pt;\">Utilizes nitrate as terminal electron acceptor</span></p>"
      },
      {
        "id": 369799,
        "text": "<p><span style=\"font-size:14.0pt;\">Contains flavoprotein oxidase for oxygen reduction</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman with diabetes presents with a foul-smelling foot ulcer. Gram stain shows gram-positive cocci in chains. The organism grows equally well in anaerobic jar and candle jar but shows negative catalase test. Which metabolic characteristic distinguishes this organism from facultative anaerobes?</span></p>",
    "unique_key": "Q5953034",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Possesses superoxide dismutase but lacks catalase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation and microbiology suggest Enterococcus species or aerotolerant streptococci causing diabetic foot infection.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Aerotolerant anaerobes are unique in that they can tolerate oxygen but cannot use it for respiration.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They possess superoxide dismutase (SOD) which converts toxic superoxide radicals to hydrogen peroxide and oxygen, but lack catalase to break down hydrogen peroxide.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This distinguishes them from facultative anaerobes which have both SOD and catalase, and from obligate anaerobes which typically lack both enzymes.</span></li><li><span style=\"font-size:14.0pt;\">These organisms rely exclusively on fermentation for ATP production regardless of oxygen presence, explaining equal growth in both aerobic and anaerobic conditions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Lacks cytochrome oxidase system for electron transport:</strong> While aerotolerant anaerobes lack cytochrome oxidase, this alone doesn't distinguish them from obligate anaerobes</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Utilizes nitrate as terminal electron acceptor:</strong> Nitrate respiration is characteristic of some facultative anaerobes, not aerotolerant anaerobes</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Contains flavoprotein oxidase for oxygen reduction:</strong> Flavoprotein oxidases that use oxygen are found in some aerobic bacteria, not aerotolerant anaerobes</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Aerotolerant anaerobes possess superoxide dismutase but lack catalase, allowing oxygen tolerance without oxygen utilization for energy metabolism.</span></p>",
    "correct_choice_id": 369797,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92875/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92875/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93624,
    "choices": [
      {
        "id": 372736,
        "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-B, 4-A</span></p>"
      },
      {
        "id": 372737,
        "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-C, 3-A, 4-D</span></p>"
      },
      {
        "id": 372738,
        "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-A, 3-C, 4-B</span></p>"
      },
      {
        "id": 372739,
        "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-A, 4-C</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following diuretics with their mechanisms of action:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20120739.jpg\" width=\"850\" height=\"322\"></span></p>",
    "unique_key": "Q3318024",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1-D, 2-A, 3-C, 4-B</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1. Triamterene \u2192 D. Block epithelial sodium channels (ENaC): </strong>Triamterene is a <strong>potassium-sparing diuretic</strong> acting in the <strong>collecting duct</strong>, where it <strong>blocks ENaC</strong> (epithelial sodium channels). This reduces Na\u207a reabsorption and limits K\u207a secretion, fitting the mechanism \u201c<strong>Block epithelial sodium channels (collecting duct)</strong>.\u201d</span></li><li><span style=\"font-size:14.0pt;\"><strong>2. Brinzolamide \u2192 A. Inhibit carbonic anhydrase (proximal tubule): </strong>Brinzolamide is a <strong>carbonic anhydrase inhibitor</strong>. By inhibiting <strong>carbonic anhydrase</strong> in the <strong>proximal tubule</strong>, it decreases H\u207a formation and <strong>NaHCO\u2083 reabsorption</strong>, matching \u201c<strong>Inhibit carbonic anhydrase (proximal tubule)</strong>.\u201d</span></li><li><span style=\"font-size:14.0pt;\"><strong>3. Metolazone \u2192 C. Inhibit Na\u207a-Cl\u207b pump (distal convoluted tubule): </strong>Metolazone is a <strong>thiazide-like diuretic</strong> that blocks the <strong>Na\u207a-Cl\u207b cotransporter (NCC)</strong> in the <strong>distal convoluted tubule</strong>, exactly the mechanism \u201c<strong>Inhibit Na\u207a-Cl\u207b pump (distal convoluted tubule)</strong>.\u201d</span></li><li><span style=\"font-size:14.0pt;\"><strong>4. Bumetanide \u2192 B. Inhibit Na\u207a-K\u207a-2Cl\u207b pump (thick ascending limb): </strong>Bumetanide is a <strong>loop diuretic</strong> that inhibits the <strong>NKCC2</strong> cotransporter in the <strong>thick ascending limb of the loop of Henle</strong>, matching \u201c<strong>Inhibit Na\u207a-K\u207a-2Cl\u207b pump (thick ascending limb)</strong>.\u201d</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Triamterene \u2192 ENaC block (collecting duct, potassium-sparing)</span></li><li><span style=\"font-size:14.0pt;\">Brinzolamide \u2192 carbonic anhydrase inhibition (proximal tubule)</span></li><li><span style=\"font-size:14.0pt;\">Metolazone \u2192 Na\u207a-Cl\u207b cotransporter inhibition (distal convoluted tubule)</span></li><li><span style=\"font-size:14.0pt;\">Bumetanide \u2192 Na\u207a-K\u207a-2Cl\u207b cotransporter inhibition (thick ascending limb)</span></li></ul>",
    "correct_choice_id": 372738,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93624/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_6.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93624/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_6.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93538,
    "choices": [
      {
        "id": 372404,
        "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
      },
      {
        "id": 372405,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 3</span></p>"
      },
      {
        "id": 372406,
        "text": "<p><span style=\"font-size:14.0pt;\">1 only</span></p>"
      },
      {
        "id": 372407,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4, and 5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Consider the following statements regarding the sternal angle (angle of Louis):&nbsp;</span></p><ol><li><span style=\"font-size:14.0pt;\">It lies at the level of the intervertebral disc between the T4 and T5 vertebrae.</span></li><li><span style=\"font-size:14.0pt;\">It marks the level where the trachea bifurcates into the right and left main bronchi.</span></li><li><span style=\"font-size:14.0pt;\">It is flanked by the costal cartilages of the 3rd pair of ribs.</span></li><li><span style=\"font-size:14.0pt;\">It is crossed by the superior epigastric artery.</span></li><li><span style=\"font-size:14.0pt;\">It lies in the epigastric fossa.</span></li></ol><p><span style=\"font-size:14.0pt;\">Which of the above statements is/ are correct?</span></p>",
    "unique_key": "Q2751973",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1 and 2 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>sternal angle (angle of Louis)</strong> is a palpable ridge at the junction between the <strong>manubrium</strong> and the <strong>body of the sternum</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>It lies at the level of the intervertebral disc between the T4 and T5 vertebrae:&nbsp;</strong>Correct. The sternal angle lies at the level of the <strong>intervertebral disc between T4 and T5</strong> vertebrae. This level is a key anatomical landmark for various thoracic structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>It marks the level where the trachea bifurcates into the right and left main bronchi:&nbsp;</strong>Correct. It corresponds to the level where the <strong>trachea bifurcates</strong> into the right and left main bronchi, an important reference point for airway anatomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gJIA3cM.jpeg\" alt=\"The Thoracic Cage | Anatomy and Physiology I | Study Guides\" width=\"659\" height=\"389\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>It is flanked by the costal cartilages of the 3rd pair of ribs:&nbsp;</strong>Incorrect. because the sternal angle is flanked by the <strong>costal cartilages of the 2nd pair of ribs</strong>, not the 3rd pair. This is an important surface landmark used for rib counting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. It is crossed by the superior epigastric artery:&nbsp;</strong>Incorrect. The <strong>superior epigastric artery</strong> passes through the rectus sheath to supply the anterior abdominal wall; it does not cross the sternal angle. The sternal angle is crossed by the internal mammillary artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>It lies in the epigastric fossa:&nbsp;</strong>Incorrect. The sternal angle does not lie in the <strong>epigastric fossa</strong>; it is located in the anterior thoracic wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>sternal angle</strong> is located at the level of the <strong>T4/T5 intervertebral disc</strong> and marks the site of <strong>tracheal bifurcation</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is flanked by the costal cartilages of the <strong>second ribs</strong> and serves as an essential landmark in thoracic anatomy and clinical examination.</span></li></ul>",
    "correct_choice_id": 372404,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93538/NEET_PG_22_Sep_2025_Anatomy_Question_9.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      3
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93538/NEET_PG_22_Sep_2025_Anatomy_Question_9.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92897,
    "choices": [
      {
        "id": 369884,
        "text": "<p><span style=\"font-size:14.0pt;\">Interscalene brachial plexus block</span></p>"
      },
      {
        "id": 369885,
        "text": "<p><span style=\"font-size:14.0pt;\">Supraclavicular brachial plexus block</span></p>"
      },
      {
        "id": 369886,
        "text": "<p><span style=\"font-size:14.0pt;\">Infraclavicular brachial plexus block</span></p>"
      },
      {
        "id": 369887,
        "text": "<p><span style=\"font-size:14.0pt;\">Axillary brachial plexus block</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man is scheduled for open reduction and internal fixation of a distal radius fracture. Under ultrasound guidance, which nerve block is being performed?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20121441.jpg\" width=\"796\" height=\"313\"></strong></span></p>",
    "unique_key": "Q3437163",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Supraclavicular brachial plexus block</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The supraclavicular block targets the brachial plexus at the level of the <strong>trunks/divisions</strong>, seen as a \u201ccluster of grapes\u201d lateral and superior to the subclavian artery on ultrasound.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It provides dense anesthesia of the entire upper limb distal to the shoulder and is often called the \u201cspinal of the upper limb\u201d due to its rapid, complete blockade.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20121501.jpg\" width=\"652\" height=\"500\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Interscalene brachial plexus block:&nbsp;</strong>The interscalene block is performed higher up in the neck, between the anterior and middle scalene muscles, targeting the roots of the brachial plexus. It is best suited for shoulder and upper arm surgeries but often spares the ulnar nerve distribution.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Infraclavicular brachial plexus block:&nbsp;</strong>This block targets the cords of the brachial plexus, located deeper beneath the clavicle around the axillary artery. On ultrasound, the artery is seen beneath the pectoral muscles, not in the supraclavicular fossa.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Axillary brachial plexus block:&nbsp;</strong>The axillary block is done distally in the axilla at the level of the terminal branches. On ultrasound, nerves appear around the axillary artery. It is used for hand and forearm surgery but does not reliably cover the musculocutaneous nerve unless separately targeted.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>supraclavicular brachial plexus block</strong> is performed under ultrasound guidance at the level of the trunks/divisions, visualized as a cluster lateral to the subclavian artery, and provides dense anesthesia for surgeries of the upper limb below the shoulder.</span></p>",
    "correct_choice_id": 369885,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92897/NEET_PG_22_Sep_2025_Anesthesia_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      19
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92897/NEET_PG_22_Sep_2025_Anesthesia_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93635,
    "choices": [
      {
        "id": 372776,
        "text": "<p><span style=\"font-size:14.0pt;\">Ceftazidime</span></p>"
      },
      {
        "id": 372777,
        "text": "<p><span style=\"font-size:14.0pt;\">Vancomycin</span></p>"
      },
      {
        "id": 372778,
        "text": "<p><span style=\"font-size:14.0pt;\">Cefoperazone</span></p>"
      },
      {
        "id": 372779,
        "text": "<p><span style=\"font-size:14.0pt;\">Piperacillin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man with a history of intravenous drug use presents to the emergency department with fever, chills, productive cough with greenish sputum, and pleuritic chest pain for 3 days. On examination, his temperature is 39.2\u00b0C, blood pressure 100/60 mmHg, pulse 118/min, and respiratory rate 28/min. Auscultation reveals coarse crackles over the right lower lung field. Chest X-ray shows right lower lobe consolidation. Sputum Gram stain reveals Gram-negative rods, and&nbsp;Pseudomonas aeruginosa&nbsp;infection is strongly suspected. Which of the following antibiotics would&nbsp;not&nbsp;be appropriate for treating this infection?</span></p>",
    "unique_key": "Q8819028",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Vancomycin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Active only against&nbsp;<strong>Gram-positive organisms</strong>&nbsp;(MRSA, enterococci).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It has no activity against Gram-negative bacteria including&nbsp;Pseudomonas.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ceftazidime:&nbsp;</strong>Appropriate.&nbsp;A third-generation cephalosporin with good antipseudomonal activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cefoperazone:&nbsp;</strong>Appropriate.&nbsp;A third-generation cephalosporin with reliable antipseudomonal coverage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Piperacillin:&nbsp;</strong>Appropriate.&nbsp;An extended-spectrum ureidopenicillin highly active against&nbsp;Pseudomonas aeruginosa.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Vancomycin, a glycopeptide is effective only against gram positive bacteria and lacks activity against gram negative bacteria like Pseudomonas aeruginosa.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In suspected Pseudomonas infections, appropriate choices include piperacillin, cefoperazone, and ceftazidime.</span></li></ul>",
    "correct_choice_id": 372777,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93635/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_13.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93635/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_13.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92881,
    "choices": [
      {
        "id": 369820,
        "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, and Reason is the correct explanation of Assertion</span></p>"
      },
      {
        "id": 369821,
        "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, but Reason is not the correct explanation of Assertion</span></p>"
      },
      {
        "id": 369822,
        "text": "<p><span style=\"font-size:14.0pt;\">Assertion is true but Reason is false</span></p>"
      },
      {
        "id": 369823,
        "text": "<p><span style=\"font-size:14.0pt;\">Assertion is false but Reason is true</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Assertion: Mannose-binding lectin (MBL) deficiency increases susceptibility to recurrent bacterial infections in infancy but not in adulthood.<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Reason: The lectin pathway represents an innate immune response that becomes redundant once adaptive immunity through the classical pathway develops with age.</span></p>",
    "unique_key": "Q4926821",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Assertion is true but Reason is false&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>assertion</strong> is <strong>true</strong>. MBL deficiency significantly increases infection risk in infancy (especially 6 months to 2 years) when maternal antibodies wane but the child's adaptive immunity is immature.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Adults with MBL deficiency rarely have increased infections unless immunocompromised.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This age-dependent phenotype makes MBL deficiency one of the most common immunodeficiencies that often goes undiagnosed.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>reason&nbsp;</strong>is <strong>false</strong> because it contains a fundamental error.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Both the lectin and alternative pathways are innate immune responses, while only the classical pathway participates in adaptive immunity (through antibodies).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The lectin pathway doesn't become \"redundant\" - rather, the developing adaptive immune system (antibody production) provides alternative mechanisms for opsonization and complement activation through the classical pathway.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Additionally, the alternative pathway amplification loop remains intact in MBL deficiency, providing backup complement activation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The reduced infection susceptibility with age reflects maturation of multiple immune mechanisms, not redundancy of the lectin pathway itself.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">MBL deficiency causes age-dependent immunodeficiency most severe in infancy because mature adaptive immunity compensates through antibody-mediated classical pathway activation, not because the lectin pathway becomes redundant.</span></p>",
    "correct_choice_id": 369822,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92881/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_8.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92881/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_8.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92952,
    "choices": [
      {
        "id": 370100,
        "text": "<p><span style=\"font-size:14.0pt;\">Neck ultrasound</span></p>"
      },
      {
        "id": 370101,
        "text": "<p><span style=\"font-size:14.0pt;\">Thyroid function test</span></p>"
      },
      {
        "id": 370102,
        "text": "<p><span style=\"font-size:14.0pt;\">FDG-PET scan</span></p>"
      },
      {
        "id": 370103,
        "text": "<p><span style=\"font-size:14.0pt;\">4D CT of the neck</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old woman with persistent hypercalcemia and low serum phosphate is suspected to have a parathyroid adenoma. Her Tc-99m Sestamibi scan is inconclusive. To aid in surgical planning, the physician wants to identify the exact anatomical location of the suspected lesion. Which of the following investigations is most appropriate for anatomical localization in this scenario?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q3437708",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 4D CT of the neck</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While <strong>Tc-99m Sestamibi scan</strong> is the <strong>investigation of choice (IOC)</strong> for parathyroid adenoma, it may be <strong>inconclusive</strong> in cases of:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Small adenomas</span></li><li><span style=\"font-size:14.0pt;\">Ectopic or retrotracheal glands</span></li><li><span style=\"font-size:14.0pt;\">Multiglandular disease</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In such cases, a <strong>contrast-enhanced CT of the neck</strong>, especially <strong>4D-CT</strong>, provides <strong>precise anatomical localization</strong> by assessing:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Perfusion patterns</span></li><li><span style=\"font-size:14.0pt;\">Washout characteristics</span></li><li><span style=\"font-size:14.0pt;\">Exact relationship to surrounding structures</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This is particularly helpful in <strong>pre-operative planning</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Neck ultrasound:&nbsp;</strong>Good for superficial parathyroid adenomas, but limited for deep/ectopic glands and operator-dependent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Thyroid function test:&nbsp;</strong>Has <strong>no role</strong> in localization of parathyroid adenomas; used for thyroid disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. FDG-PET scan:&nbsp;</strong>Used for <strong>malignancy workup</strong>; not the standard modality for parathyroid adenoma detection due to low sensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In patients with inconclusive sestamibi scans, <strong>contrast-enhanced CT or 4D-CT neck</strong> provides the most accurate <strong>anatomical localization</strong> of parathyroid adenomas and is crucial for guiding surgery.</span></p>",
    "correct_choice_id": 370103,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92952/NEET_PG_22_Sep_2025_RADIOLOGY_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      17
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92952/NEET_PG_22_Sep_2025_RADIOLOGY_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93602,
    "choices": [
      {
        "id": 372648,
        "text": "<p><span style=\"font-size:14.0pt;\">Positive rheumatoid factor</span></p>"
      },
      {
        "id": 372649,
        "text": "<p><span style=\"font-size:14.0pt;\">Mouse ear sign on X-ray</span></p>"
      },
      {
        "id": 372650,
        "text": "<p><span style=\"font-size:14.0pt;\">Bilateral symmetric disease</span></p>"
      },
      {
        "id": 372651,
        "text": "<p><span style=\"font-size:14.0pt;\">Involvement of only the proximal interphalangeal joints of a digit</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man with a 10-year history of psoriasis presents with dactylitis and tenderness in the sacroiliac joints. Which of the following findings suggest a diagnosis of psoriatic arthritis in this patient?</span></p>",
    "unique_key": "Q9253245",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Mouse ear sign on X-ray</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient has psoriasis, dactylitis (sausage digits), and sacroiliac joint tenderness, which are consistent with psoriatic arthritis (PsA).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">PsA is a seronegative spondyloarthropathy often associated with psoriasis, presenting with asymmetrical oligoarthritis, dactylitis, enthesitis, and sometimes axial involvement (e.g., sacroiliitis). Radiographic findings are key to diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>mouse ear sign</strong> on X-ray is a characteristic radiographic feature of PsA. It describes erosions with fluffy periostitis (new bone formation), resembling mouse ears, due to bone proliferation and enthesitis. This sign, along with the \"ray sign\" (involvement of all joints in one digit), supports the diagnosis in this patient with dactylitis and sacroiliac tenderness.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Supporting Features</strong>: PsA typically involves distal interphalangeal (DIP) joints, is asymmetrical (except in ~15% of cases), and is seronegative (negative rheumatoid factor). Dactylitis and sacroiliitis further align with PsA.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Positive rheumatoid factor</strong>: False. PsA is a seronegative spondyloarthropathy, meaning rheumatoid factor (RF) is typically negative. A positive RF would suggest rheumatoid arthritis (RA) rather than PsA, making this finding inconsistent with the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Bilateral symmetric disease</strong>: False. While PsA can occasionally present with symmetric arthritis (in ~15% of cases), the most common presentation is <strong>asymmetrical oligoarthritis</strong>. Bilateral symmetric disease is more characteristic of RA, not PsA, and thus does not strongly suggest PsA in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Involvement of only the proximal interphalangeal joints of a digit</strong>: False. PsA predominantly affects the <strong>distal interphalangeal (DIP) joints</strong> of the hands and feet, often with dactylitis (sausage digits). Isolated involvement of the proximal interphalangeal (PIP) joints is more typical of RA, not PsA, and contradicts the patient\u2019s dactylitis presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The mouse ear sign on X-ray, indicating erosions with periostitis, is a diagnostic feature of psoriatic arthritis.</span></li><li><span style=\"font-size:14.0pt;\">Psoriatic arthritis is characterized by negative rheumatoid factor and predominantly asymmetrical joint involvement.</span></li><li><span style=\"font-size:14.0pt;\">Dactylitis and sacroiliac tenderness support psoriatic arthritis, with DIP joint predominance over PIP joints.</span></li></ul>",
    "correct_choice_id": 372649,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93602/NEET_PG_22_Sep_2025_MEDICINE_Question_14.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93602/NEET_PG_22_Sep_2025_MEDICINE_Question_14.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93310,
    "choices": [
      {
        "id": 371508,
        "text": "<p><span style=\"font-size:14.0pt;\">The proportion of true negatives correctly identified</span></p>"
      },
      {
        "id": 371509,
        "text": "<p><span style=\"font-size:14.0pt;\">The prevalence of the disease</span></p>"
      },
      {
        "id": 371510,
        "text": "<p><span style=\"font-size:14.0pt;\">The model\u2019s accuracy in balanced datasets</span></p>"
      },
      {
        "id": 371511,
        "text": "<p><span style=\"font-size:14.0pt;\">The overall improvement in prediction over random chance</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old woman presents with worsening fatigue and weight loss. Initial laboratory testing reveals normocytic anemia. Her physician suspects an underlying malignancy and orders a tumor marker panel, which includes a logistic regression\u2013based risk model. The lab presents the results along with a Receiver Operating Characteristic (ROC) curve comparing the model (orange curve) to a no-skill classifier (blue dashed line). Based on the ROC curve shown, what does the area between the model\u2019s curve and the diagonal line most accurately represent?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_hfO1uRZ.png\" width=\"691\" height=\"428\"></strong></span></p>",
    "unique_key": "Q7741732",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) The overall improvement in prediction over random chance</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>ROC curve</strong> plots the <strong>true positive rate (sensitivity)</strong> against the <strong>false positive rate (1-specificity)</strong> for various threshold settings of a diagnostic test or predictive model.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>diagonal line</strong> (No Skill) represents a model with <strong>no discriminative ability</strong>\u2014essentially, random guessing.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>area under the ROC curve (AUC)</strong> reflects the <strong>probability that a randomly chosen positive case will be ranked higher than a randomly chosen negative case.</strong></span></li><li><span style=\"font-size:14.0pt;\">Therefore, the <strong>area between the model\u2019s curve and the diagonal line</strong> represents how much <strong>better the model performs than random chance.</strong></span></li><li><span style=\"font-size:14.0pt;\">In this image, the logistic regression model shows <strong>excellent discriminative performance</strong> with an AUC likely &gt;0.9.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The proportion of true negatives correctly identified:</strong> This refers to <strong>specificity</strong>, which is only one point on the ROC curve, not the area under or between curves.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The prevalence of the disease:&nbsp;</strong>Prevalence impacts <strong>positive predictive value (PPV)</strong> and <strong>negative predictive value (NPV)</strong> but not the shape or interpretation of the ROC curve, which is <strong>prevalence-independent</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The model\u2019s accuracy in balanced datasets:&nbsp;</strong>Accuracy considers both false positives and false negatives but is not directly represented by the ROC curve. Also, <strong>ROC does not require balanced datasets</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>area between a predictive model\u2019s ROC curve and the diagonal line (no-skill)</strong> reflects the <strong>model\u2019s improvement over random guessing</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The greater this area, the <strong>better the model\u2019s discriminative ability</strong>.</span></li></ul>",
    "correct_choice_id": 371511,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93310/Neet_Pg_22_Sept_2025_Psm_Q_17.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93310/Neet_Pg_22_Sept_2025_Psm_Q_17.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93268,
    "choices": [
      {
        "id": 371344,
        "text": "<p><span style=\"font-size:14.0pt;\">Culex larvae have evolved genetic resistance to Paris Green</span></p>"
      },
      {
        "id": 371345,
        "text": "<p><span style=\"font-size:14.0pt;\">Anopheles larvae are bottom feeders that ingest more poison</span></p>"
      },
      {
        "id": 371346,
        "text": "<p><span style=\"font-size:14.0pt;\">Paris Green is a surface-active contact insecticide</span></p>"
      },
      {
        "id": 371347,
        "text": "<p><span style=\"font-size:14.0pt;\">Anopheles larvae feed near the surface, increasing exposure to ingested toxin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A public health team is conducting a vector control program in a malaria-endemic region. They decide to use Paris Green as a larvicide to control mosquito populations. After several days, the team notes significant reduction in Anopheles larvae but not much impact on Culex larvae. Which of the following best explains why Paris Green is more effective against Anopheles larvae than Culex larvae?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q9727941",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Anopheles larvae feed near the surface, increasing exposure to ingested toxin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Paris Green is a <strong>stomach poison</strong> larvicide, most effective when <strong>ingested by mosquito larvae</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Anopheles larvae typically feed at the <strong>surface of stagnant water</strong>, where Paris Green particles accumulate, leading to <strong>greater ingestion and mortality</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This feeding behavior enhances the effectiveness of the larvicide specifically against Anopheles mosquitoes, which are vectors of malaria.</span></li><li><span style=\"font-size:14.0pt;\">In contrast, Culex larvae are <strong>bottom feeders</strong>, making them less exposed to Paris Green unless a <strong>special granular formulation</strong> is used to target bottom dwellers.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20131046.jpg\" width=\"651\" height=\"463\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Culex larvae have evolved genetic resistance</strong> <strong>to Paris Green</strong>: Incorrect. The reduced efficacy of Paris Green against Culex is due to <strong>behavioral feeding differences</strong>, not resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Anopheles larvae are bottom feeders that ingest more poison:&nbsp;</strong>Incorrect. This is the opposite of what is true. Anopheles larvae feed near the surface, not the bottom.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Paris Green is a surface-active contact insecticide:</strong> Incorrect. Paris Green acts as a <strong>stomach poison</strong>, not a contact insecticide. Its action depends on <strong>ingestion</strong>, not surface contact.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Paris Green</strong> is a <strong>stomach poison</strong> larvicide that is <strong>most effective against surface-feeding mosquito larvae</strong>, such as Anopheles, due to their feeding behavior at the water surface.</span></p>",
    "correct_choice_id": 371347,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93268/Neet_Pg_22_Sept_2025_Psm_Q_16.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93268/Neet_Pg_22_Sept_2025_Psm_Q_16.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93605,
    "choices": [
      {
        "id": 372660,
        "text": "<p><span style=\"font-size:14.0pt;\">Tirzepatide</span></p>"
      },
      {
        "id": 372661,
        "text": "<p><span style=\"font-size:14.0pt;\">Metformin</span></p>"
      },
      {
        "id": 372662,
        "text": "<p><span style=\"font-size:14.0pt;\">Insulin glargine</span></p>"
      },
      {
        "id": 372663,
        "text": "<p><span style=\"font-size:14.0pt;\">Spironolactone</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old woman with type 2 diabetes mellitus, a BMI of 34 kg/m\u00b2, presents with exercise intolerance.&nbsp; On evaluation she is found to have heart failure with preserved ejection fraction (HFpEF). Which of the following can be beneficial in this patient?</span></p>",
    "unique_key": "Q2202271",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Tirzepatide</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient has type 2 diabetes (BMI 34 kg/m\u00b2 indicates obesity), a known risk factor for HFpEF, which is characterized by left ventricular ejection fraction (LVEF) \u226550% with diastolic dysfunction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Tirzepatide, a dual GIP/GLP-1 receptor agonist, is approved for glycemic control and weight loss, with emerging evidence for cardiovascular benefits.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tirzepatide</strong> can be beneficial.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clinical trials (e.g., SURPASS program, SURPASS-CVOT) demonstrate significant HbA1c reduction, weight loss (up to 15\u201320% of body weight), and cardiovascular risk reduction in type 2 diabetes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Subgroup analyses and ongoing studies (e.g., SUMMIT trial) suggest potential benefits in HFpEF by improving metabolic health, reducing inflammation, and alleviating volume overload, making it a promising option for this obese diabetic patient with HFpEF.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Dosing starts at 2.5 mg weekly, titrated to 5\u201315 mg based on tolerance.</span></li><li><span style=\"font-size:14.0pt;\">The patient\u2019s obesity (BMI 34) and diabetes align with tirzepatide\u2019s indications, and its cardiorenal protective effects are under investigation, supporting its use in HFpEF management.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Metformin</strong>: Not optimal here. While metformin is a first-line therapy for type 2 diabetes, it is less effective for weight loss (minimal effect, ~2\u20133 kg) and has no direct benefit in HFpEF. It is contraindicated in severe heart failure (NYHA IV) or unstable conditions due to lactic acidosis risk, though this patient\u2019s stability is unspecified. Its benefit is limited compared to tirzepatide in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Insulin glargine</strong>: Not optimal here. Insulin glargine controls hyperglycemia but often leads to weight gain (1\u20133 kg), which could worsen HFpEF in this obese patient. It lacks evidence for improving HFpEF outcomes and is less preferred when weight loss is a goal, unlike tirzepatide.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Spironolactone</strong>: Not optimal here. Spironolactone, a mineralocorticoid receptor antagonist, is beneficial in HFpEF (e.g., TOPCAT trial showed reduced hospitalizations), but it primarily manages fluid overload and has no direct effect on diabetes or weight. It complements but does not address the patient\u2019s metabolic needs as effectively as tirzepatide.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tirzepatide improves glycemic control and promotes weight loss (5\u201315 mg weekly), benefiting obese diabetic patients with HFpEF.</span></li><li><span style=\"font-size:14.0pt;\">Metformin and insulin glargine address diabetes but lack weight loss benefits and HFpEF-specific effects.</span></li><li><span style=\"font-size:14.0pt;\">Spironolactone reduces HFpEF hospitalizations but does not target diabetes or obesity.</span></li></ul>",
    "correct_choice_id": 372660,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93605/NEET_PG_22_Sep_2025_MEDICINE_Question_17.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93605/NEET_PG_22_Sep_2025_MEDICINE_Question_17.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92887,
    "choices": [
      {
        "id": 369844,
        "text": "<p><span style=\"font-size:14.0pt;\">S. mansoni \u2013 Terminal-spined eggs in stool</span></p>"
      },
      {
        "id": 369845,
        "text": "<p><span style=\"font-size:14.0pt;\">S. japonicum \u2013 Acid-fast, lateral-spined eggs in urine</span></p>"
      },
      {
        "id": 369846,
        "text": "<p><span style=\"font-size:14.0pt;\">S. haematobium \u2013 Terminal-spined eggs in urine</span></p>"
      },
      {
        "id": 369847,
        "text": "<p><span style=\"font-size:14.0pt;\">S. mansoni \u2013 Rudimentary lateral spine and stool-negative</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following Schistosoma species is correctly paired with its diagnostic feature?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q7770986",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) S. haematobium \u2013 Terminal-spined eggs in urine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Schistosoma haematobium</strong> is the only Schistosoma species that resides in the <strong>vesical venous plexus</strong> and sheds eggs with a <strong>terminal spine</strong> into the <strong>urine</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Its clinical manifestations include <strong>urinary schistosomiasis</strong>, hematuria, and <strong>increased risk of squamous cell carcinoma</strong> of the bladder.</span></li><li><span style=\"font-size:14.0pt;\">Eggs are most accurately detected in urine <strong>around midday</strong>, and antigen tests (e.g., <strong>CCA detection</strong>) may support recent infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. S. mansoni \u2013 Terminal-spined eggs instool:</strong> Incorrect. This species produces <strong>lateral-spined</strong> eggs excreted in <strong>stool</strong>, not urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. S. japonicum \u2013 Acid-fast, lateral-spined eggs in urine:</strong> Incorrect. Eggs are found in <strong>stool</strong>, have a <strong>rudimentary Knob</strong>, and are <strong>not acid-fast</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. S. mansoni \u2013 Rudimentary lateral spine and stool-negative:</strong> Incorrect \u2013 Eggs of S. mansoni have a well-developed <strong>lateral spine</strong>, not rudimentary, and are <strong>stool-positive</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Egg morphology</strong> and <strong>route of excretion</strong> (urine vs. stool) are key to differentiating Schistosoma species:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">S. haematobium \u2192 <strong>Terminal spine</strong>, <strong>urine</strong></span></li><li><span style=\"font-size:14.0pt;\">S. mansoni \u2192 <strong>Lateral spine</strong>, <strong>stool</strong></span></li><li><span style=\"font-size:14.0pt;\">S. japonicum \u2192 <strong>Rudimentary knob</strong>, <strong>stool</strong></span></li></ul></li></ul>",
    "correct_choice_id": 369846,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92887/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_14.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92887/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_14.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93266,
    "choices": [
      {
        "id": 371336,
        "text": "<p><span style=\"font-size:14.0pt;\">Epidemic curves always show multiple peaks per year</span></p>"
      },
      {
        "id": 371337,
        "text": "<p><span style=\"font-size:14.0pt;\">Endemic curves have a flat baseline when incidence is low</span></p>"
      },
      {
        "id": 371338,
        "text": "<p><span style=\"font-size:14.0pt;\">Endemic curves never touch zero, while epidemic curves may begin at or return to zero</span></p>"
      },
      {
        "id": 371339,
        "text": "<p><span style=\"font-size:14.0pt;\">Epidemic curves cannot display seasonal variation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best describes a feature that distinguishes an endemic curve from an epidemic curve?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q7124645",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Endemic curves never touch zero, while epidemic curves may begin at or return to zero</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An <strong>endemic disease</strong> is one that is constantly present within a given population or geographic area.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">As a result, the <strong>incidence line</strong> on a graph <strong>never touches zero</strong>, reflecting <strong>ongoing transmission</strong> at a stable baseline level.</span></li><li><span style=\"font-size:14.0pt;\">In contrast, an <strong>epidemic</strong> refers to an <strong>unusual rise</strong> in the number of cases above the expected level.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">An <strong>epidemic curve</strong> typically begins at or near <strong>zero</strong>, shows a <strong>sharp rise</strong>, and then <strong>returns to zero or baseline</strong> once the outbreak is controlled.</span></li><li><span style=\"font-size:14.0pt;\">This fundamental difference in <strong>baseline presence</strong> vs <strong>transient spike</strong> is a key graphical feature.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20130923.jpg\" width=\"894\" height=\"445\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Epidemic curves always show multiple peaks per year:&nbsp;</strong>Incorrect. Epidemic curves <strong>can be single-peaked</strong> (point-source outbreaks) or <strong>multi-peaked</strong> (continuous or propagated outbreaks), but <strong>not always</strong> multiple peaks per year. The number of peaks is <strong>not a reliable distinguishing factor</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Endemic curves have a flat baseline when incidence is low:</strong> Incorrect. The baseline may fluctuate slightly due to <strong>seasonal variation</strong>, population dynamics, or surveillance sensitivity. \"Flat\" is not necessarily a distinguishing term. The key is <strong>consistency</strong>, not flatness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Epidemic curves cannot display seasonal variation:</strong> Incorrect. Epidemics can certainly show <strong>seasonal patterns</strong>, such as flu outbreaks in winter. Seasonal epidemics still qualify as epidemics if they <strong>exceed the expected threshold</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Endemic diseases persist in a population at a stable rate with seasonal fluctuations but do not disappear.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Holoendemic diseases primarily affect young children due to early-life exposure, whereas hyperendemic diseases affect all age groups at high prevalence.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The product of R0 and the proportion susceptible (S) being equal to 1 defines a steady endemic state.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Endemic curves fluctuate over time but never drop to zero.</span></li></ul>",
    "correct_choice_id": 371338,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93266/Neet_Pg_22_Sept_2025_Psm_Q_14.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93266/Neet_Pg_22_Sept_2025_Psm_Q_14.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93558,
    "choices": [
      {
        "id": 372484,
        "text": "<p><span style=\"font-size:14.0pt;\">Immediately reposit the cord</span></p>"
      },
      {
        "id": 372485,
        "text": "<p><span style=\"font-size:14.0pt;\">Lift the presenting part up</span></p>"
      },
      {
        "id": 372486,
        "text": "<p><span style=\"font-size:14.0pt;\">Apply forceps</span></p>"
      },
      {
        "id": 372487,
        "text": "<p><span style=\"font-size:14.0pt;\">Cord blood sampling</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old woman presents at 37 weeks in early labor. After a few hours, the patient complains of leaking per vaginum. The CTG shows a prolonged deceleration, and on vaginal examination, the cord is felt in the vagina. The cervix is 8 cm dilated. What is the next best step?</span></p>",
    "unique_key": "Q2677645",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Lift the presenting part up</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient is experiencing a <strong>cord prolapse</strong>, a <strong>true obstetric emergency</strong> where the umbilical cord descends into the vagina ahead of the presenting part of the fetus, leading to <strong>cord compression</strong> and fetal distress (as evidenced by the prolonged deceleration on CTG).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Immediate intervention is necessary to relieve pressure on the cord and maintain fetal oxygenation until delivery.</span></li><li><span style=\"font-size:14.0pt;\">The next best step is to <strong>lift the presenting part up manually</strong>, which will relieve pressure on the prolapsed cord and restore blood flow.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is a temporary measure to prevent cord compression while preparing for <strong>immediate delivery</strong>, typically via <strong>emergency cesarean section</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Repositioning the presenting part should be done <strong>gently</strong>, and the patient should be placed in the <strong>knee-chest position or Trendelenburg position</strong> to use gravity to further relieve cord compression.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Immediately reposit the cord:&nbsp;</strong>This is incorrect. Attempting to reposit the cord can cause further trauma to the cord and worsen the situation. The focus should be on relieving the pressure on the cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Apply forceps:&nbsp;</strong>Forceps are used for assisted vaginal delivery but are not appropriate here, as the cervix is only 8 cm dilated. Additionally, an emergency cesarean section is the preferred mode of delivery in the case of cord prolapse with fetal distress.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cord blood sampling:&nbsp;</strong>This is not appropriate in the acute management of cord prolapse. The priority is to relieve the pressure on the cord and deliver the baby as soon as possible.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In cases of <strong>umbilical cord prolapse</strong> with fetal distress, the immediate priority is to <strong>lift the presenting part</strong> to relieve pressure on the cord and maintain blood flow.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient should then be prepared for <strong>emergency cesarean section</strong> to expedite delivery and prevent fetal hypoxia.</span></li></ul>",
    "correct_choice_id": 372485,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93558/NEET_PG_22_Sep_2025_OBG_Question_19.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93558/NEET_PG_22_Sep_2025_OBG_Question_19.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93258,
    "choices": [
      {
        "id": 371304,
        "text": "<p><span style=\"font-size:14.0pt;\">Jungalwalla&nbsp;</span></p>"
      },
      {
        "id": 371305,
        "text": "<p><span style=\"font-size:14.0pt;\">Shrivastava</span></p>"
      },
      {
        "id": 371306,
        "text": "<p><span style=\"font-size:14.0pt;\">Kartar Singh</span></p>"
      },
      {
        "id": 371307,
        "text": "<p><span style=\"font-size:14.0pt;\">Mudaliar</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A medical officer at a block PHC is instructed to enforce the following administrative measures:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Abolition of private practice among government-employed doctors</span></li><li><span style=\"font-size:14.0pt;\">Ensuring equal pay for equal work among health personnel</span></li><li><span style=\"font-size:14.0pt;\">Integration of medical and paramedical staff into a unified service structure</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which committee's recommendations are being implemented through these reforms?</span></p>",
    "unique_key": "Q7080395",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Jungalwalla</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Jungalwalla Committee (1967) specifically focused on the integration of health services in India and made recommendations to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Abolish private practice among government doctors</span></li><li><span style=\"font-size:14.0pt;\">Implement equal pay for equal work</span></li><li><span style=\"font-size:14.0pt;\">Create a unified cadre of health personnel under a single administrative structure</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These structural reforms were aimed at streamlining public health delivery and reducing fragmentation across various vertical programs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Shrivastava:</strong> Focused on creating a cadre of para-professionals and health volunteers at the village level and recommended the creation of health manpower planning and medical education reforms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Kartar Singh:</strong> Known for introducing multipurpose health workers (MPWs) and establishing norms for subcenter staffing (1 male + 1 female MPW per 5,000 population).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mudaliar:</strong> Primarily aimed at strengthening secondary-level health care (1 PHC for 40,000), AIHS (All India Health Services) and improving quality of services after the Bhore Committee.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Jungalwalla Committee (1967)</strong> is pivotal for:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Advocating <strong>equal pay</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Banning private practice</strong> in public health, and</span></li><li><span style=\"font-size:14.0pt;\">Creating a <strong>unified health service</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">It worked <strong>in conjunction</strong> with the <strong>Chadah</strong> and <strong>Kartar Singh Committees</strong>, which shaped <strong>staffing patterns and multipurpose worker deployment</strong> at PHC and sub-centre levels.</span></li></ul>",
    "correct_choice_id": 371304,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93258/Neet_Pg_22_Sept_2025_Psm_Q_6.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93258/Neet_Pg_22_Sept_2025_Psm_Q_6.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93551,
    "choices": [
      {
        "id": 372456,
        "text": "<p><span style=\"font-size:14.0pt;\">Etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine (EMA-CO)</span></p>"
      },
      {
        "id": 372457,
        "text": "<p><span style=\"font-size:14.0pt;\">Carboplatin, paclitaxel</span></p>"
      },
      {
        "id": 372458,
        "text": "<p><span style=\"font-size:14.0pt;\">Bleomycin, etoposide, cisplatin (BEP)</span></p>"
      },
      {
        "id": 372459,
        "text": "<p><span style=\"font-size:14.0pt;\">Paclitaxel, doxorubicin, cisplatin (TAP)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old woman undergoes exploratory laparotomy for a pelvic mass. Intraoperatively, she is found to have bilateral ovarian tumors with extensive omental involvement. Frozen section confirms advanced epithelial ovarian carcinoma. Following optimal cytoreductive surgery, she is scheduled to begin adjuvant chemotherapy. Which of the following regimens is most appropriate for this patient?</span></p>",
    "unique_key": "Q9419047",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Carboplatin, paclitaxel</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Advanced epithelial ovarian cancer</strong> (stages II\u2013IV), especially with <strong>extensive omental involvement</strong> as in this case, requires <strong>combined modality treatment</strong>:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Primary cytoreductive surgery:</strong> Goal is to remove as much visible tumor as possible (optimal debulking).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Adjuvant chemotherapy:</strong> Standard regimen is a <strong>platinum compound</strong> plus a <strong>taxane</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Carboplatin</strong> (preferred over cisplatin for less nephrotoxicity, neurotoxicity, and emetogenicity)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Paclitaxel</strong> (Taxol)</span></li></ul></li></ol></li><li><span style=\"font-size:14.0pt;\">Multiple randomized controlled trials have demonstrated that <strong>carboplatin + paclitaxel</strong> improves <strong>progression-free survival</strong> and <strong>overall survival</strong> in women with epithelial ovarian carcinoma after optimal debulking.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This combination is used as <strong>first-line adjuvant therapy</strong> for <strong>Stage IC and above</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine (EMA-CO)</strong>: Incorrect. The combination of etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine is used for <strong>high-risk gestational trophoblastic neoplasia (GTN)</strong>, not epithelial ovarian cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Bleomycin, etoposide, cisplatin (BEP)</strong>: Incorrect. This regimen is the treatment of choice for <strong>malignant ovarian germ cell tumors</strong> (e.g., dysgerminoma, yolk sac tumor), not epithelial ovarian carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Paclitaxel, doxorubicin, cisplatin (TAP):&nbsp;</strong>Incorrect. Although TAP has been studied for ovarian carcinoma, it is associated with higher toxicity and has not shown superiority over carboplatin + paclitaxel. Current guidelines recommend <strong>carboplatin + paclitaxel</strong> as the preferred first-line regimen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For <strong>advanced epithelial ovarian carcinoma</strong> after optimal cytoreductive surgery, the standard adjuvant chemotherapy is <strong>carboplatin plus paclitaxel</strong>, which has proven survival benefit and lower toxicity compared to older regimens.</span></p>",
    "correct_choice_id": 372457,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93551/NEET_PG_22_Sep_2025_OBG_Question_12.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93551/NEET_PG_22_Sep_2025_OBG_Question_12.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92951,
    "choices": [
      {
        "id": 370096,
        "text": "<p><span style=\"font-size:14.0pt;\">Carotid-cavernous fistula (CCF)</span></p>"
      },
      {
        "id": 370097,
        "text": "<p><span style=\"font-size:14.0pt;\">Cavernous sinus thrombosis</span></p>"
      },
      {
        "id": 370098,
        "text": "<p><span style=\"font-size:14.0pt;\">Orbital cellulitis</span></p>"
      },
      {
        "id": 370099,
        "text": "<p><span style=\"font-size:14.0pt;\">Internal carotid artery dissection</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old man presents with pulsatile proptosis, conjunctival chemosis, and an audible orbital bruit. His symptoms developed gradually after a history of head trauma 3 months ago. Digital Subtraction Angiography (DSA) findings are shown in the image below. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-11%20134156.jpg\" width=\"467\" height=\"396\"></span></p>",
    "unique_key": "Q9198959",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Carotid-cavernous fistula (CCF)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>The clinical triad of:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Pulsatile proptosis</span></li><li><span style=\"font-size:14.0pt;\">Chemosis</span></li><li><span style=\"font-size:14.0pt;\">Orbital bruit</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Combined with the DSA finding of <strong>early contrast opacification of the cavernous sinus</strong> with drainage into an <strong>enlarged superior ophthalmic vein</strong> (seen in the image) is diagnostic of <strong>carotid-cavernous fistula</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This condition typically occurs due to <strong>trauma</strong>, creating a direct high-flow communication between the <strong>intracavernous internal carotid artery</strong> and the <strong>venous cavernous sinus</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cavernous sinus thrombosis:&nbsp;</strong>Presents with fever, cranial nerve palsies, and painful ophthalmoplegia, but <strong>no pulsatile proptosis or bruit</strong>. Venous drainage is obstructed, not enhanced.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Orbital cellulitis:&nbsp;</strong>Causes painful eye movements, eyelid erythema, and fever; usually secondary to sinusitis. No vascular findings on DSA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Internal carotid artery dissection:&nbsp;</strong>May present with headache and stroke symptoms. DSA would show a <strong>string sign or flap</strong>, not early venous filling or orbital drainage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Carotid-cavernous fistula (CCF)</strong> is an abnormal high-flow communication between the <strong>intracavernous internal carotid artery</strong> and the <strong>cavernous sinus</strong>, classically presenting with <strong>pulsatile proptosis, chemosis, and orbital bruit</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">DSA shows <strong>early venous opacification and superior ophthalmic vein engorgement</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Prompt diagnosis is essential to prevent vision loss.</span></li></ul>",
    "correct_choice_id": 370096,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92951/NEET_PG_22_Sep_2025_RADIOLOGY_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      17
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92951/NEET_PG_22_Sep_2025_RADIOLOGY_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93262,
    "choices": [
      {
        "id": 371320,
        "text": "<p><span style=\"font-size:14.0pt;\">Cohort studies are the most reliable method to understand natural history, despite being resource-intensive</span></p>"
      },
      {
        "id": 371321,
        "text": "<p><span style=\"font-size:14.0pt;\">The clinical horizon represents the point where clinical signs first appear</span></p>"
      },
      {
        "id": 371322,
        "text": "<p><span style=\"font-size:14.0pt;\">Prepathogenesis phase includes the interaction of host and agent inside the human body</span></p>"
      },
      {
        "id": 371323,
        "text": "<p><span style=\"font-size:14.0pt;\">The concept of \u201cinteraction of host, agent, and environment\u201d forms the basis of disease distribution</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following statements regarding the natural history of disease are correct, except?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q5980836",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Prepathogenesis phase includes the interaction of host and agent inside the human body</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>prepathogenesis phase</strong> refers to the stage <strong>before the disease enters the host\u2019s body</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">At this stage, there may be interactions among the <strong>host, agent, and environment</strong>, but <strong>no pathologic or clinical changes</strong> have begun inside the body.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>interaction is external</strong>, and this is the stage where <strong>primary prevention</strong> strategies (like vaccination or health education) are most effective.</span></li><li><span style=\"font-size:14.0pt;\">In contrast, <strong>pathogenesis begins when the agent successfully invades the host</strong>, leading to subclinical and eventually clinical disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cohort studies are the most reliable method to understand natural history, despite being resource-intensive:</strong> Correct. Cohort studies allow for observation of disease progression over time, from exposure to outcome, and are ideal for studying natural history.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The clinical horizon represents the point where clinical signs first appear:</strong> Correct. The clinical horizon is the boundary between the subclinical and clinical phases of disease. Before this, the disease is asymptomatic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The concept of \u201cinteraction of host, agent, and environment\u201d forms the basis of disease distribution:</strong> Correct. This is the cornerstone of the epidemiologic triad and is fundamental in public health for understanding and preventing disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The prepathogenesis phase involves interaction between agent, host, and environment before disease enters the host's body.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It does not include internal pathologic changes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20130310.jpg\" width=\"927\" height=\"716\"></span></p>",
    "correct_choice_id": 371322,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93262/Neet_Pg_22_Sept_2025_Psm_Q_10.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93262/Neet_Pg_22_Sept_2025_Psm_Q_10.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93562,
    "choices": [
      {
        "id": 372496,
        "text": "<p><span style=\"font-size:14.0pt;\">A normal heart rate in anorexia nervosa may indicate heart failure.</span></p>"
      },
      {
        "id": 372497,
        "text": "<p><span style=\"font-size:14.0pt;\">Thiamine should be given before refeeding.</span></p>"
      },
      {
        "id": 372498,
        "text": "<p><span style=\"font-size:14.0pt;\">Start with 1400\u20131600 kcal/day, avoid rapid caloric increases, and monitor electrolytes.</span></p>"
      },
      {
        "id": 372499,
        "text": "<p><span style=\"font-size:14.0pt;\">Respiratory complications are the leading cause of mortality.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old woman with anorexia nervosa (BMI 12.8 kg/m\u00b2, 66% ideal body weight) is admitted for nutritional rehabilitation. On day 3, she develops dyspnea, and leg edema with jugular venous distension and bibasilar crackles. Which statement about the condition in this patient is false?</span></p>",
    "unique_key": "Q5150561",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Respiratory complications are the leading cause of mortality.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s severe malnutrition (BMI 12.8 kg/m\u00b2, &lt;70% ideal body weight) indicate high refeeding syndrome risk.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Day 3 symptoms (dyspnea, edema, jugular venous distension, crackles) suggest <strong>congestive heart failure</strong> from fluid overload and hypophosphatemia-induced myocardial dysfunction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cardiac complications</strong> (heart failure, arrhythmias) are the primary cause of mortality in refeeding syndrome due to hypophosphatemia and volume overload in a starved, atrophied heart.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Respiratory complications (e.g., diaphragmatic weakness) are rare and usually secondary to heart failure; no primary respiratory failure is noted here.</span></li><li><span style=\"font-size:14.0pt;\">Management includes reducing calories, administering IV furosemide for heart failure, and correcting phosphorus/potassium with close monitoring.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. A normal heart rate in anorexia nervosa may indicate heart failure</strong>: True. Bradycardia is typical in anorexia nervosa (baseline 55/min); a rise to 80/min with edema and crackles signals heart failure from fluid overload or hypophosphatemia, a critical refeeding syndrome feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Thiamine should be given before refeeding</strong>: True. Thiamine (<strong>100\u2013200 mg daily for 3\u20135 days)&nbsp;</strong>prevents Wernicke encephalopathy during refeeding, as carbohydrate metabolism increases thiamine demand. The patient received 100 mg IV appropriately, with no Wernicke symptoms (e.g., confusion, nystagmus).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Start with 1400\u20131600 kcal/day, avoid rapid caloric increases, and monitor electrolytes</strong>: True. Starting at 1400\u20131600 kcal/day is standard, though 1200 kcal/day is cautious for severe malnutrition. Avoiding rapid caloric increases and daily electrolyte monitoring (especially phosphorus) are critical to prevent shifts, given the low-normal baseline phosphorus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cardiac complications</strong> are the leading cause of mortality in refeeding syndrome in severely malnourished anorexia nervosa patients.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Cautious refeeding (\u22641400 kcal/day), pre-refeeding thiamine, and vigilant electrolyte monitoring is important to prevent life-threatening complications.</span></li></ul>",
    "correct_choice_id": 372499,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93562/Neet_Pg_22_Sep_2025_Medicine_Question_11.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93562/Neet_Pg_22_Sep_2025_Medicine_Question_11.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92878,
    "choices": [
      {
        "id": 369808,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
      },
      {
        "id": 369809,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
      },
      {
        "id": 369810,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 5 only</span></p>"
      },
      {
        "id": 369811,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4 and 5 only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old child presents with multiple papules along the forearm and axillary lymphadenopathy 10 days after playing with neighborhood cats. Which of the following organisms can be transmitted through cat scratches or bites?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Bartonella henselae</span></li><li><span style=\"font-size:14.0pt;\">Bartonella bacilliformis</span></li><li><span style=\"font-size:14.0pt;\">Pasteurella multocida</span></li><li><span style=\"font-size:14.0pt;\">Bartonella vinsonii</span></li><li><span style=\"font-size:14.0pt;\">Yersinia pestis</span></li></ol>",
    "unique_key": "Q5751198",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 3 and 5 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cat bites and scratches can transmit specific pathogens from their oral flora or contaminated claws.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Bartonella henselae:</strong> Is the causative agent of cat scratch disease, residing in cat erythrocytes and transmitted via scratches contaminated with infected flea feces. The organism causes regional lymphadenopathy with papules at inoculation sites.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Pasteurella multocida:&nbsp;</strong>Is present in oral flora of 70-90% of cats and causes rapidly progressive cellulitis within 24 hours of bites or deep scratches.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5. Yersinia pestis:</strong> Can be transmitted by cats that hunt plague-infected rodents, either through bites from infected cats or via their fleas, particularly in endemic areas of southwestern United States. Cats can develop pneumonic plague and transmit it through respiratory droplets or bites.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Bartonella bacilliformis:</strong> Causes Carrion's disease (Oroya fever and verruga peruana), transmitted exclusively by Lutzomyia sandflies in Andean regions of South America, not associated with cats</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Bartonella vinsonii:</strong> Primarily a canine pathogen with subspecies berkhoffii affecting dogs; not transmitted by cats</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cat bites and scratches transmit Bartonella henselae (cat scratch disease), Pasteurella multocida (cellulitis), and potentially Yersinia pestis (plague in endemic areas).</span></p>",
    "correct_choice_id": 369810,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92878/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92878/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93264,
    "choices": [
      {
        "id": 371328,
        "text": "<p><span style=\"font-size:14.0pt;\">It is a blood-sucking bug using cyclo-propagative transmission</span></p>"
      },
      {
        "id": 371329,
        "text": "<p><span style=\"font-size:14.0pt;\">It is a reduviid bug using mechanical transmission</span></p>"
      },
      {
        "id": 371330,
        "text": "<p><span style=\"font-size:14.0pt;\">It is a reduviid bug using cyclo-developmental transmission&nbsp;</span></p>"
      },
      {
        "id": 371331,
        "text": "<p><span style=\"font-size:14.0pt;\">It is a sandfly using propagative transmission</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old child presents with fever, periorbital edema, and signs of congestive heart failure. He is diagnosed with Chagas disease. If a researcher is studying the vector responsible for this disease, which of the following is most accurate regarding the vector\u2019s classification and mode of transmission?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q7878006",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) It is a reduviid bug using cyclo-developmental transmission</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chagas disease is caused by the protozoan parasite <strong>Trypanosoma cruzi</strong>, and the <strong>vector</strong> responsible is the <strong>reduviid bug</strong>, also known as the <strong>\"kissing bug\"</strong> or <strong>Triatomine bug</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Vector Classification: Reduviid bug</strong> (Triatoma species)</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Belongs to the family Reduviidae</span></li><li><span style=\"font-size:14.0pt;\">Hematophagous (blood-sucking) insect</span></li><li><span style=\"font-size:14.0pt;\">Nocturnal, bites typically near the lips and eyes</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Transmission Type: Cyclo-developmental transmission</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The parasite <strong>undergoes development but no multiplication</strong> in the vector.</span></li><li><span style=\"font-size:14.0pt;\">Trypanosoma cruzi matures in the <strong>hindgut</strong> of the bug.</span></li><li><span style=\"font-size:14.0pt;\">Transmission occurs via <strong>contamination of the bite wound with bug feces</strong>, not via saliva (unlike mosquitoes).</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is a blood-sucking bug using cyclo-propagative transmission:</strong> Incorrect. This involves both <strong>development and multiplication</strong>, as seen in <strong>malaria</strong> (Plasmodium in Anopheles mosquito). Not applicable to T. cruzi.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>It is a reduviid bug using mechanical transmission</strong>: Incorrect. Chagas disease is <strong>biologically transmitted</strong>, not mechanically. Mechanical transmission means no parasite development inside the vector (e.g., flies carrying bacteria).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is a sandfly using propagative transmission:</strong> Incorrect. Sandflies are <strong>vectors of Leishmania</strong>, not T. cruzi. <strong>Propagative</strong>: multiplication without developmental changes (e.g., arboviruses in mosquitoes).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reduviid bugs</strong> transmit <strong>Trypanosoma cruzi</strong> via <strong>cyclo-developmental transmission</strong>.</span></p>",
    "correct_choice_id": 371330,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93264/Neet_Pg_22_Sept_2025_Psm_Q_12.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93264/Neet_Pg_22_Sept_2025_Psm_Q_12.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92882,
    "choices": [
      {
        "id": 369824,
        "text": "<p><span style=\"font-size:14.0pt;\">Sensitized B cells</span></p>"
      },
      {
        "id": 369825,
        "text": "<p><span style=\"font-size:14.0pt;\">Sensitized T cells</span></p>"
      },
      {
        "id": 369826,
        "text": "<p><span style=\"font-size:14.0pt;\">Myeloma cell lines</span></p>"
      },
      {
        "id": 369827,
        "text": "<p><span style=\"font-size:14.0pt;\">None of the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A researcher is working on the production of monoclonal antibodies using hybridoma technology. In the process, B cells are fused with immortal cell lines to generate hybrid cells that produce identical antibodies indefinitely. From which of the following are these monoclonal antibody-producing cells derived?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q7824211",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Sensitized B cells</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hybridoma technology is used to produce monoclonal antibodies (mAbs).</span></li><li><span style=\"font-size:14.0pt;\">The process includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Immunizing a mouse with a specific antigen</span></li><li><span style=\"font-size:14.0pt;\">Isolating sensitized (antigen-exposed) B lymphocytes from its spleen</span></li><li><span style=\"font-size:14.0pt;\">Fusing these B cells with immortal myeloma cells (which lack antibody-producing ability)</span></li><li><span style=\"font-size:14.0pt;\">Resulting in a hybridoma \u2014 a cell that combines:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\">The specific antibody-producing ability of B cells</span></li><li><span style=\"font-size:14.0pt;\">The immortality of the myeloma cell line</span></li><li><span style=\"font-size:14.0pt;\">This fusion enables continuous production of identical antibodies (monoclonal).</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Sensitized T cells:&nbsp;</strong>T cells do not produce antibodies. Their role is in cell-mediated immunity, not humoral antibody production.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Myeloma cell lines:&nbsp;</strong>These provide the immortal property, but they do not produce antibodies on their own. They are fused with B cells to enable hybridoma formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Monoclonal antibodies are generated by fusing sensitized B lymphocytes with immortal myeloma cells to form hybridomas.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The B cells contribute antibody specificity, while myeloma cells contribute&nbsp;immortality.</span></li></ul>",
    "correct_choice_id": 369824,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92882/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_9.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92882/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_9.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92944,
    "choices": [
      {
        "id": 370068,
        "text": "<p><span style=\"font-size:14.0pt;\">Fumaryl CoA</span></p>"
      },
      {
        "id": 370069,
        "text": "<p><span style=\"font-size:14.0pt;\">Acetoacetyl CoA</span></p>"
      },
      {
        "id": 370070,
        "text": "<p><span style=\"font-size:14.0pt;\">Propionyl CoA</span></p>"
      },
      {
        "id": 370071,
        "text": "<p><span style=\"font-size:14.0pt;\">Malonyl CoA</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following compounds is produced specifically from the oxidation of odd-chain fatty acids?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q9230267",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Propionyl CoA</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During \u03b2-oxidation of <strong>odd-chain fatty acids</strong>, all but the final three-carbon fragment are broken down into acetyl-CoA units.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>remaining three-carbon fragment</strong> is <strong>propionyl-CoA</strong>, a unique product not generated during even-chain fatty acid oxidation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Metabolic fate of propionyl-CoA</strong>:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Propionyl-CoA</strong> \u2192 (propionyl-CoA carboxylase, biotin-dependent) \u2192 <strong>methylmalonyl-CoA</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Methylmalonyl-CoA</strong> \u2192 (methylmalonyl-CoA mutase, vitamin B\u2081\u2082-dependent) \u2192 <strong>succinyl-CoA</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Succinyl-CoA</strong> enters the <strong>TCA cycle</strong> or can serve as a gluconeogenic precursor.</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key link</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>\"Produced as a result of oxidation of odd-chain fatty acids\"</strong> \u2192 uniquely propionyl-CoA.</span></li><li><span style=\"font-size:14.0pt;\">Even-chain fatty acids only yield <strong>acetyl-CoA</strong> and do not produce propionyl-CoA.</span></li><li><span style=\"font-size:14.0pt;\">Propionyl-CoA metabolism requires <strong>biotin</strong> and <strong>vitamin B\u2081\u2082</strong>; deficiencies in these cofactors can cause <strong>methylmalonic acidemia</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fumaryl CoA</strong>: Incorrect. Not produced by fatty acid oxidation; it is an intermediate in tyrosine and phenylalanine catabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acetoacetyl CoA:</strong> Incorrect. Formed during ketone body synthesis and degradation of certain amino acids; not the unique final product of odd-chain fatty acid oxidation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Malonyl CoA:</strong> Incorrect. Produced during fatty acid synthesis, not oxidation. It inhibits <strong>carnitine palmitoyltransferase I</strong> to prevent simultaneous fatty acid synthesis and breakdown.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Odd-chain fatty acid oxidation</strong> produces <strong>propionyl-CoA</strong> as the final three-carbon fragment, which is converted to <strong>succinyl-CoA</strong> via biotin- and vitamin B\u2081\u2082-dependent enzymes, enabling entry into the TCA cycle and gluconeogenesis.</span></p>",
    "correct_choice_id": 370070,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92944/NEET_PG_22_Sep_2025_Biochemistry_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      1
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92944/NEET_PG_22_Sep_2025_Biochemistry_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93331,
    "choices": [
      {
        "id": 371588,
        "text": "<p><span style=\"font-size:14.0pt;\">A\u20131, B\u20132, C\u20134, D\u20133</span></p>"
      },
      {
        "id": 371589,
        "text": "<p><span style=\"font-size:14.0pt;\">A\u20131, B\u20133, C\u20134, D\u20132</span></p>"
      },
      {
        "id": 371590,
        "text": "<p><span style=\"font-size:14.0pt;\">A\u20131, B\u20133, C\u20132, D\u20134</span></p>"
      },
      {
        "id": 371591,
        "text": "<p><span style=\"font-size:14.0pt;\">A\u20131, B\u20132, C\u20133, D\u20134</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the type of discharge/condition (A\u2013D) with the appropriate color-coded NACO STI/RTI kit:&nbsp;</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">Urethral, anorectal, or cervical discharge</span></li><li><span style=\"font-size:14.0pt;\">Vaginal discharge (Vaginitis)</span></li><li><span style=\"font-size:14.0pt;\">Lower abdominal pain (Pelvic inflammatory disease)</span></li><li><span style=\"font-size:14.0pt;\">Inguinal bubo</span></li></ol><p>&nbsp;</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20133636.jpg\" width=\"703\" height=\"745\"></p>",
    "unique_key": "Q1072046",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) A\u20131, B\u20132, C\u20133, D\u20134</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A\u20131. Urethral, anorectal, or cervical discharge \u2013 Kit 1 (Grey):&nbsp;</strong>Contains <strong>Azithromycin 1 g</strong> and <strong>Cefixime 800 mg</strong>. Used for gonorrhea and chlamydia syndromes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B\u20132. Vaginal discharge \u2013 Kit 2 (Green):&nbsp;</strong>Contains <strong>Secnidazole 2 g</strong> and <strong>Fluconazole 150 mg</strong>. Targets bacterial vaginosis, trichomoniasis, and candidiasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C\u20133. Lower abdominal pain (PID) \u2013 Kit 6 (Yellow):&nbsp;</strong>Contains <strong>Cefixime 800 mg</strong> (single dose),&nbsp;Cap. <strong>Doxycycline</strong> 100 mg (28 capsules) as twice day dose for 14 days and <strong>Metronidazole 400 mg BD for 14 days</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D\u20134. Inguinal bubo \u2013 Kit 7 (Black):&nbsp;</strong>Contains <strong>Doxycycline 100 mg BD for 21 days</strong>. Used for lymphogranuloma venereum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>NACO color-coded STI kits</strong> provide syndromic management: <strong>Grey (discharge), Green (vaginitis), Yellow (PID), Black (inguinal bubo)</strong>, ensuring standardized treatment at all levels of healthcare.</span></p>",
    "correct_choice_id": 371591,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93331/NEET_PG_22_Sep_2025_Derma_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      18
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93331/NEET_PG_22_Sep_2025_Derma_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93658,
    "choices": [
      {
        "id": 372868,
        "text": "<p><span style=\"font-size:14.0pt;\">Wilson disease</span></p>"
      },
      {
        "id": 372869,
        "text": "<p><span style=\"font-size:14.0pt;\">Biliary atresia</span></p>"
      },
      {
        "id": 372870,
        "text": "<p><span style=\"font-size:14.0pt;\">\u03b11-Antitrypsin deficiency</span></p>"
      },
      {
        "id": 372871,
        "text": "<p><span style=\"font-size:14.0pt;\">Neonatal hemochromatosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 4-week-old neonate presents with progressive jaundice, hepatomegaly, and pale stools. A liver biopsy demonstrates marked proliferation of bile ducts, portal tract edema and fibrosis, and extensive intrahepatic and canalicular bile stasis. Despite supportive care, the jaundice worsens, and the infant dies of liver failure at 9 months of age. Which of the following is the most likely diagnosis?&nbsp;</span></p>",
    "unique_key": "Q5963735",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Biliary atresia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 3-week-old neonate with progressive jaundice, hepatomegaly, and pale stools plus biopsy findings of marked bile duct proliferation, portal tract edema and fibrosis, and extensive intrahepatic/canalicular bile stasis is most consistent with biliary atresia.</span></li><li><span style=\"font-size:14.0pt;\">Biliary atresia is a progressive fibro-obliterative disease of the extrahepatic bile ducts.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>It presents in early infancy with:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Persistent conjugated hyperbilirubinemia (cholestasis)</span></li><li><span style=\"font-size:14.0pt;\">Pale (acholic) stools due to lack of bile pigment in stool</span></li><li><span style=\"font-size:14.0pt;\">Dark urine due to increased conjugated bilirubin excretion</span></li><li><span style=\"font-size:14.0pt;\">Hepatomegaly and progressive portal fibrosis \u2192 cirrhosis \u2192 liver failure</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Death usually occurs within the first year of life if not surgically corrected (Kasai procedure or transplant).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Wilson disease:&nbsp;</strong>An autosomal recessive disorder of copper metabolism, presenting later in childhood/adolescence with neurologic dysfunction, hemolytic anemia, and Kayser-Fleischer rings. It does not present in early infancy with biliary obstruction findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>\u03b11-Antitrypsin deficiency:&nbsp;</strong>Can present in neonates with cholestasis and later in adults with panacinar emphysema and cirrhosis, but the classic histology shows PAS-positive, diastase-resistant globules in hepatocytes, not the bile duct proliferation and portal fibrosis seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Neonatal hemochromatosis:&nbsp;</strong>A rare cause of neonatal liver failure due to iron overload, showing iron deposition in hepatocytes and extrahepatic tissues. It does not cause the ductal proliferation and fibrosis described.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Biliary atresia is a progressive fibro-obliterative disease of the extrahepatic bile ducts in neonates, causing conjugated hyperbilirubinemia, pale stools, hepatomegaly, and ultimately liver failure within the first year of life.</span></p>",
    "correct_choice_id": 372869,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93658/NEET_PG_22_Sep_2025_Pathology_Question_12.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93658/NEET_PG_22_Sep_2025_Pathology_Question_12.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92949,
    "choices": [
      {
        "id": 370088,
        "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B2</span></p>"
      },
      {
        "id": 370089,
        "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B9</span></p>"
      },
      {
        "id": 370090,
        "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B1</span></p>"
      },
      {
        "id": 370091,
        "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B12</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Genetic analysis reveals misincorporation of uracil into DNA in place of thymine. This defect results from impaired conversion of deoxyuridylate (dUMP) to thymidylate (dTMP) due to a deficiency in a vitamin. Which vitamin deficiency is most likely responsible?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q1636913",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Vitamin B9</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Uracil misincorporation occurs when <strong>thymidylate synthase</strong> activity is impaired.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This enzyme requires <strong>methylene tetrahydrofolate</strong> as a methyl donor, derived from <strong>tetrahydrofolate (THF)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Vitamin B9 (folate)</strong> is essential for THF production.</span></li><li><span style=\"font-size:14.0pt;\">Folate deficiency \u2192 \u2193 methylene THF \u2192 dUMP cannot be methylated to dTMP \u2192 uracil replaces thymine in DNA.</span></li><li><span style=\"font-size:14.0pt;\">This leads to defective DNA synthesis and megaloblastic changes in rapidly dividing cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Vitamin B2:</strong> Riboflavin is a precursor of FAD and FMN, important in redox reactions, but not directly involved in thymidylate synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Vitamin B1:</strong> Thiamine is a cofactor in carbohydrate metabolism (pyruvate dehydrogenase, \u03b1-ketoglutarate dehydrogenase, transketolase) and is unrelated to uracil incorporation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Vitamin B12:</strong> B12 deficiency also causes megaloblastic anemia, but uracil misincorporation is primarily due to folate-dependent thymidylate synthesis failure; B12 deficiency causes folate trapping indirectly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Vitamin B9 (folate) deficiency</strong> impairs the conversion of dUMP to dTMP by thymidylate synthase, leading to <strong>uracil incorporation into DNA</strong> and defective DNA synthesis.</span></p>",
    "correct_choice_id": 370089,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92949/NEET_PG_22_Sep_2025_Biochemistry_Question_9.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      1
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92949/NEET_PG_22_Sep_2025_Biochemistry_Question_9.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93337,
    "choices": [
      {
        "id": 371612,
        "text": "<p><span style=\"font-size:14.0pt;\">Open inguinal hernia repair: Clean wound</span></p>"
      },
      {
        "id": 371613,
        "text": "<p><span style=\"font-size:14.0pt;\">Incision and drainage of breast abscess: Clean-contaminated wound</span></p>"
      },
      {
        "id": 371614,
        "text": "<p><span style=\"font-size:14.0pt;\">Open cardiac massage: Contaminated wound</span></p>"
      },
      {
        "id": 371615,
        "text": "<p><span style=\"font-size:14.0pt;\">Diabetic wet gangrene: Dirty wound</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the mismatched type of surgical wound.</span></p>",
    "unique_key": "Q8411424",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Incision and drainage of breast abscess: Clean-contaminated wound</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An abscess already contains pus, which means <strong>active infection is present</strong>.</span></li><li><span style=\"font-size:14.0pt;\">By definition, wounds with existing clinical infection or gross contamination are <strong>Class IV (Dirty)</strong>, not clean-contaminated.</span></li><li><span style=\"font-size:14.0pt;\">Hence, this option is <strong>mismatched</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Open inguinal hernia repair: Clean wound:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hernia repair does not involve entry into the respiratory, alimentary, or genitourinary tract.</span></li><li><span style=\"font-size:14.0pt;\">It is performed under sterile conditions without infection \u2192 <strong>Class I (Clean)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is correctly matched.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Open cardiac massage: Contaminated wound:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This involves opening the chest in an emergency (often non-sterile circumstances).</span></li><li><span style=\"font-size:14.0pt;\">Such emergency operations without sterile preparation are considered <strong>Class III (Contaminated)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is correctly matched.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Diabetic wet gangrene: Dirty wound:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Presence of necrotic, devitalized tissue with infection is <strong>Class IV (Dirty)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is correctly matched.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Clean wounds have no infection or entry into viscera, clean-contaminated wounds involve controlled entry into viscera, contaminated wounds include fresh accidental or emergency surgeries with contamination, and dirty<strong>&nbsp;</strong>wounds involve existing infection or devitalized tissue.</span></li><li><span style=\"font-size:14.0pt;\">Incision and drainage of an abscess is always a <strong>dirty wound</strong>, not clean-contaminated.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Qb5SR2t.png\" width=\"857\" height=\"599\"></strong></span></p>",
    "correct_choice_id": 371613,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93337/NEET_PG_22_Sep_2025_Surgery_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93337/NEET_PG_22_Sep_2025_Surgery_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93648,
    "choices": [
      {
        "id": 372828,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 5</span></p>"
      },
      {
        "id": 372829,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 372830,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4, 5</span></p>"
      },
      {
        "id": 372831,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following mediators are primarily involved in the early phase of type I hypersensitivity reaction?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Mast cells</span></li><li><span style=\"font-size:14.0pt;\">Histamine</span></li><li><span style=\"font-size:14.0pt;\">Neutrophils</span></li><li><span style=\"font-size:14.0pt;\">Prostaglandins</span></li><li><span style=\"font-size:14.0pt;\">Leukotrienes</span></li></ol>",
    "unique_key": "Q8295020",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 2, 4, 5</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The early phase of type I hypersensitivity (minutes after allergen exposure) is mediated by mast cell degranulation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>1 and 2: Mast cells and</strong> <strong>Histamine:</strong> Mast cells release \u2192&nbsp; Histamine<strong>&nbsp;</strong>\u2192 causes vasodilation, increased vascular permeability, and bronchoconstriction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4. Prostaglandins:</strong> Contribute to vasodilation and edema.</span></li><li><span style=\"font-size:14.0pt;\"><strong>5. Leukotrienes:</strong> Cause prolonged bronchoconstriction and vascular permeability.</span></li><li><span style=\"font-size:14.0pt;\">These mediators explain acute allergic manifestations such as urticaria, bronchospasm, and angioedema.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Neutrophils:</strong> Incorrect. Are not early mediators. Neutrophils participate in <strong>late phase reactions</strong>, several hours after allergen exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The early phase of type I hypersensitivity is mediated by mast cell degranulation releasing histamine, prostaglandins, and leukotrienes.</span></li><li><span style=\"font-size:14.0pt;\">Neutrophils are not involved in the early phase but play a role in late-phase responses.</span></li></ul>",
    "correct_choice_id": 372830,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93648/NEET_PG_22_Sep_2025_Pathology_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93648/NEET_PG_22_Sep_2025_Pathology_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93335,
    "choices": [
      {
        "id": 371604,
        "text": "<p><span style=\"font-size:14.0pt;\">No further treatment</span></p>"
      },
      {
        "id": 371605,
        "text": "<p><span style=\"font-size:14.0pt;\">Perform extended cholecystectomy&nbsp;</span></p>"
      },
      {
        "id": 371606,
        "text": "<p><span style=\"font-size:14.0pt;\">Adjuvant chemotherapy</span></p>"
      },
      {
        "id": 371607,
        "text": "<p><span style=\"font-size:14.0pt;\">Radiation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A patient underwent a laparoscopic cholecystectomy for cholelithiasis. Histopathology of the resected gall bladder is reported as Stage T1a of gallbladder cancer, without perineural invasion. What would be the next line of management?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q9495415",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) No further treatment</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cholecystectomy is sufficient for gallbladder carcinoma with T1a lesions, wherein the tumour penetrates the lamina propria but does not invade the muscle layer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Perform extended cholecystectomy:&nbsp;</strong>This is required for T1b (muscle invasive) Ca GB.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Adjuvant chemotherapy:&nbsp;</strong>This is required in T1b or higher stages of Ca GB.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Radiation:</strong> This is not usually needed in treatment of Ca Gb.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Treatment options for carcinoma gall bladder found incidentally after cholecystectomy:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">T1a with negative margins: Standard cholecystectomy</span></li><li><span style=\"font-size:14.0pt;\">T1a with perineural/ lymphatic/ vascular invasion: Extended cholecystectomy Chemotherapy is not required in an early gall bladder cancer. Radiation has no role.</span></li><li><span style=\"font-size:14.0pt;\"><strong>T1b: Extended cholecystectomy, No need for port site excision.</strong></span></li></ul></li></ul>",
    "correct_choice_id": 371604,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93335/NEET_PG_22_Sep_2025_Surgery_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93335/NEET_PG_22_Sep_2025_Surgery_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93567,
    "choices": [
      {
        "id": 372516,
        "text": "<p><span style=\"font-size:14.0pt;\">Microorganisms that commonly cause IE isolated from 2 or more separate blood culture sets</span></p>"
      },
      {
        "id": 372517,
        "text": "<p><span style=\"font-size:14.0pt;\">Microorganisms that occasionally or rarely cause IE, isolated from 3 or more separate blood culture sets</span></p>"
      },
      {
        "id": 372518,
        "text": "<p><span style=\"font-size:14.0pt;\">Positive PCR or other nucleic acid-based technique from blood for Coxiella burnetii, Bartonella spp, or Tropheryma whipplei</span></p>"
      },
      {
        "id": 372519,
        "text": "<p><span style=\"font-size:14.0pt;\">Abnormal metabolic activity detected by <sup>18</sup>FDG PET/CT within 3 months of implantation of prosthetic valve</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old intravenous drug user presents with fever, weight loss, and a new systolic murmur. Echocardiography reveals a vegetation on the tricuspid valve, raising suspicion for infective endocarditis. Which of the following is not included in the major 2023 Duke-ISCVID IE Criteria?</span></p>",
    "unique_key": "Q4796587",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Abnormal metabolic activity detected by <sup>18</sup>FDG PET/CT within 3 months of implantation of prosthetic valve</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s presentation (fever, weight loss, systolic murmur, tricuspid valve vegetation in an intravenous drug user) strongly suggests <strong>infective endocarditis (IE)</strong>, commonly associated with Staphylococcus aureus in this population.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The 2023 Duke-ISCVID Criteria for IE include major and minor criteria to guide diagnosis, with major criteria focusing on microbiologic evidence and imaging findings.</span></li><li><span style=\"font-size:14.0pt;\">The 2023 Duke-ISCVID Criteria include <strong>[18F]-FDG PET/CT</strong> showing abnormal metabolic activity as a major criterion for <strong>prosthetic valve endocarditis</strong> or <strong>cardiac device-related IE</strong>, but only <strong>after 3 months</strong> post-implantation to avoid false positives from post-surgical inflammation. Abnormal activity within <strong>3 months</strong> of implantation is <strong>not considered a major criterion</strong>, as it lacks specificity in this timeframe.</span></li><li><span style=\"font-size:14.0pt;\">The major criteria include microbiologic evidence (options A, B, C) and specific imaging findings (e.g., echocardiography showing vegetations, abscesses, or new valvular regurgitation), but option D\u2019s timeframe makes it incorrect.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-18%20130501.jpg\" width=\"1141\" height=\"779\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Microorganisms that commonly cause IE isolated from 2 or more separate blood culture sets</strong>: Included. Common IE pathogens (e.g., Staphylococcus aureus, Streptococcus spp., Enterococcus spp.) isolated from \u22652 separate blood cultures meet a major microbiologic criterion, reflecting definite evidence of bloodstream infection, as likely in this patient with IV drug use.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Microorganisms that occasionally or rarely cause IE, isolated from 3 or more separate blood culture sets</strong>: Included. For less common pathogens (e.g., HACEK group), \u22653 separate positive blood cultures are required to confirm their role in IE, ensuring specificity for less typical organisms, a major criterion in the 2023 update.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Positive PCR or other nucleic acid-based technique from blood for Coxiella burnetii, Bartonella spp, or Tropheryma whipplei</strong>: Included. Positive PCR for fastidious organisms like Coxiella burnetii (Q fever), Bartonella spp, or Tropheryma whipplei (Whipple\u2019s disease) is a major microbiologic criterion, as these pathogens are difficult to culture and require molecular confirmation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Isolation of common IE pathogens (e.g., Staphylococcus aureus) from \u22652 blood cultures is a major Duke-ISCVID criterion.</span></li><li><span style=\"font-size:14.0pt;\">Positive PCR for Coxiella burnetii or Bartonella spp confirms IE as a major criterion for fastidious organisms.</span></li><li><span style=\"font-size:14.0pt;\">[18F]-FDG PET/CT is a major criterion for prosthetic valve IE only after 3 months post-implantation.</span></li></ul>",
    "correct_choice_id": 372519,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93567/Neet_Pg_22_Sep_2025_Medicine_Question_41.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93567/Neet_Pg_22_Sep_2025_Medicine_Question_41.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93596,
    "choices": [
      {
        "id": 372624,
        "text": "<p><span style=\"font-size:14.0pt;\">Sepsis with an increase of \u22652 points in the SOFA score</span></p>"
      },
      {
        "id": 372625,
        "text": "<p><span style=\"font-size:14.0pt;\">Requirement of vasopressors to maintain MAP \u226565 mmHg despite adequate fluid resuscitation</span></p>"
      },
      {
        "id": 372626,
        "text": "<p><span style=\"font-size:14.0pt;\">Serum lactate &gt;2 mmol/L</span></p>"
      },
      {
        "id": 372627,
        "text": "<p><span style=\"font-size:14.0pt;\">Heart rate &gt;100 beats per minute</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with diabetes mellitus presents with fever, tachycardia, and hypotension. He is diagnosed with urosepsis due to Escherichia coli bacteremia. Despite 30 mL/kg of intravenous fluids, his blood pressure remains low. Which of the following is not used to define septic shock?</span></p>",
    "unique_key": "Q3622966",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Heart rate &gt;100 beats per minute</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The patient\u2019s presentation (fever, tachycardia, hypotension, E. coli bacteremia from urosepsis) and persistent low blood pressure despite adequate fluid resuscitation (30 mL/kg) suggest <strong>septic shock</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Per the 2016 Sepsis-3 definitions, <strong>sepsis</strong> is life-threatening organ dysfunction due to a dysregulated host response to infection, defined by an increase of \u22652 points in the Sequential Organ Failure Assessment (SOFA) score.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Septic shock</strong> is a subset of sepsis with circulatory, cellular, and metabolic abnormalities, identified by:&nbsp;</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">Meeting sepsis criteria (SOFA score increase \u22652),&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Need for vasopressors to maintain mean arterial pressure (MAP) \u226565 mmHg despite adequate fluid resuscitation, and</span></li><li><span style=\"font-size:14.0pt;\">Serum lactate &gt;2 mmol/L.</span></li></ol></li><li><span style=\"font-size:14.0pt;\"><strong>Heart rate &gt;100 beats per minute</strong> is part of the older systemic inflammatory response syndrome (SIRS) criteria (pre-2016) but is <strong>not</strong> a specific <strong>component</strong> of the <strong>Sepsis-3 septic shock</strong> definition.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While tachycardia is common in sepsis and septic shock, the Sepsis-3 criteria prioritize organ dysfunction (SOFA score), vasopressor need, and lactate levels for diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">Management includes broad-spectrum antibiotics (e.g., ceftriaxone for E. coli urosepsis), vasopressors (e.g., norepinephrine), source control, and ICU monitoring, but the question focuses on diagnostic criteria.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sepsis with an increase of \u22652 points in the SOFA score</strong>: Used in<strong>&nbsp;</strong>definition. Septic shock requires meeting the criteria for sepsis, defined by a SOFA score increase of \u22652 points due to infection-induced organ dysfunction (e.g., hypotension, renal impairment). This criterion is foundational for diagnosing septic shock in this patient with urosepsis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Requirement of vasopressors to maintain MAP \u226565 mmHg despite adequate fluid resuscitation</strong>: Used in definition. Persistent hypotension requiring vasopressors (e.g., norepinephrine) to maintain MAP \u226565 mmHg after adequate fluid resuscitation (30 mL/kg in this case) is a core criterion for septic shock, indicating circulatory failure, as seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Serum lactate &gt;2 mmol/L</strong>: Used in definition. A lactate level &gt;2 mmol/L reflects cellular and metabolic dysfunction, a hallmark of septic shock, distinguishing it from sepsis alone and indicating higher mortality risk. This criterion applies to this patient\u2019s severe presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sepsis with a SOFA score increase of \u22652 points is required to diagnose septic shock.</span></li><li><span style=\"font-size:14.0pt;\">Vasopressor need to maintain MAP \u226565 mmHg after fluid resuscitation is a key septic shock criterion.</span></li><li><span style=\"font-size:14.0pt;\">Serum lactate &gt;2 mmol/L defines metabolic dysfunction in septic shock, unlike heart rate.</span></li></ul>",
    "correct_choice_id": 372627,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93596/NEET_PG_22_Sep_2025_MEDICINE_Question_10.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93596/NEET_PG_22_Sep_2025_MEDICINE_Question_10.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92883,
    "choices": [
      {
        "id": 369828,
        "text": "<p><span style=\"font-size:14.0pt;\">Primary dengue infection in early phase</span></p>"
      },
      {
        "id": 369829,
        "text": "<p><span style=\"font-size:14.0pt;\">Cross-reactivity with other flaviviruses</span></p>"
      },
      {
        "id": 369830,
        "text": "<p><span style=\"font-size:14.0pt;\">Past infection with unrelated flavivirus</span></p>"
      },
      {
        "id": 369831,
        "text": "<p><span style=\"font-size:14.0pt;\">Secondary dengue infection</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old female with a history of prior dengue infection presents with symptoms of fever and rash. Serologic testing shows a 4-fold rise in IgG titers without significant IgM levels. What is the most likely interpretation of this finding?</span></p>",
    "unique_key": "Q7696408",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Secondary dengue infection</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>secondary dengue infection</strong>, the <strong>immune system mounts a rapid and robust IgG response</strong>, due to prior sensitization to a dengue serotype.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A <strong>fourfold rise in IgG titers</strong> without a corresponding IgM rise is <strong>diagnostic of a secondary infection</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is due to <strong>anamnestic response</strong> (memory cell activation), where <strong>IgG rises rapidly within the first few days</strong>, often before IgM has a chance to become significantly detectable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Primary dengue infection in early phase:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Incorrect because in <strong>primary infection</strong>, <strong>IgM is the first antibody to appear</strong>, usually after <strong>day 5</strong>, followed by IgG after <strong>day 14\u201321</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A fourfold IgG rise early on <strong>without IgM</strong> is not characteristic of primary infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cross-reactivity with other flaviviruses:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While flaviviruses share some antigenic components, <strong>cross-reactivity does not typically result in a significant (\u22654-fold) rise in IgG titers</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Additionally, there's <strong>clinical context and past dengue history</strong>, making cross-reactivity unlikely here.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Past infection with unrelated flavivirus:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Past flavivirus infection (e.g., Zika or Yellow fever) would <strong>not show a fourfold rise in dengue-specific IgG titers</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Moreover, the patient is <strong>currently symptomatic</strong>, indicating an active infection, not a past one.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>fourfold rise in IgG titers without IgM</strong> strongly suggests a <strong>secondary dengue infection</strong>, particularly in patients with prior exposure to dengue virus.</span></li><li><span style=\"font-size:14.0pt;\">This reflects <strong>immunological memory</strong> and is a key diagnostic clue in dengue-endemic regions.</span></li></ul>",
    "correct_choice_id": 369831,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92883/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_10.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92883/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_10.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93628,
    "choices": [
      {
        "id": 372752,
        "text": "<p><span style=\"font-size:14.0pt;\">Bosentan</span></p>"
      },
      {
        "id": 372753,
        "text": "<p><span style=\"font-size:14.0pt;\">Sildenafil</span></p>"
      },
      {
        "id": 372754,
        "text": "<p><span style=\"font-size:14.0pt;\">Selexipag</span></p>"
      },
      {
        "id": 372755,
        "text": "<p><span style=\"font-size:14.0pt;\">Epoprostenol</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old woman presents with progressive shortness of breath and fatigue over the last year. Echocardiography shows right ventricular hypertrophy and elevated pulmonary artery pressures. Right heart catheterization confirms pulmonary arterial hypertension (PAH). She has been started on therapy including endothelin receptor antagonists and phosphodiesterase-5 inhibitors, but her symptoms persist. The physician now prescribes an oral agent that is a prostacyclin (IP) receptor agonist to reduce pulmonary vascular resistance and improve exercise capacity. Which of the following medications was most likely prescribed?</span></p>",
    "unique_key": "Q1209986",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Selexipag</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Selexipag</strong> is an <strong>oral prostacyclin (IP) receptor agonist</strong>, approved for <strong>pulmonary arterial hypertension (PAH)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Prostacyclin analogues and receptor agonists cause <strong>vasodilation</strong>, inhibit <strong>smooth muscle proliferation</strong>, and reduce <strong>pulmonary vascular resistance</strong>, improving exercise tolerance and delaying disease progression.</span></li><li><span style=\"font-size:14.0pt;\">It provides an <strong>oral alternative</strong> to intravenous or inhaled prostacyclin analogs like <strong>epoprostenol</strong> and <strong>iloprost</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bosentan:</strong> Endothelin receptor antagonist; used in PAH, but acts by blocking endothelin-1, not via prostacyclin receptor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Sildenafil:</strong> Phosphodiesterase-5 inhibitor; increases cGMP and vasodilation, also used in PAH, but not a prostacyclin receptor agonist.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Epoprostenol:</strong> Prostacyclin analogue; used in PAH but is given <strong>intravenously</strong>, not orally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Selexipag is an oral prostacyclin (IP) receptor agonist used in pulmonary arterial hypertension to reduce pulmonary vascular resistance, improve exercise capacity, and delay disease progression.</span></p>",
    "correct_choice_id": 372754,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93628/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_10.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93628/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_10.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 22238,
    "choices": [
      {
        "id": 88916,
        "text": "<p><span style=\"font-size:18px;\">It is a gonadotropin release hormone antagonist</span></p>"
      },
      {
        "id": 88917,
        "text": "<p><span style=\"font-size:18px;\">It is not effective orally</span></p>"
      },
      {
        "id": 88918,
        "text": "<p><span style=\"font-size:18px;\">It is approved for treatment of pain due to endometriosis</span></p>"
      },
      {
        "id": 88919,
        "text": "<p><span style=\"font-size:18px;\">It can cause hot flashes as adverse effect</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">Which of the following statements about elagolix is false?</span></p>",
    "unique_key": "Q5905645",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) It is not effective orally</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">Elagolix is an orally active gonadotropin-releasing hormone (GnRH) antagonist.&nbsp;</span></li><li><span style=\"font-size:18px;\">It is effective when taken by mouth, which makes it a convenient option for patients.&nbsp;</span></li><li><span style=\"font-size:18px;\">This statement is false because elagolix is indeed effective when administered orally.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. It is a gonadotropin release hormone antagonist:&nbsp;</strong>This statement is true. Elagolix works as a GnRH antagonist, which means it inhibits the action of GnRH and reduces the production of gonadotropins (LH and FSH).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. It is approved for treatment of pain due to endometriosis:&nbsp;</strong>This statement is true. Elagolix has been approved by the FDA for the treatment of moderate to severe pain associated with endometriosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. It can cause hot flashes as adverse effect:&nbsp;</strong>This statement is true. One of the known adverse effects of elagolix is the occurrence of hot flashes, which is related to its mechanism of reducing estrogen levels in the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">Elagolix is an orally active gonadotropin-releasing hormone (GnRH) antagonist approved for the treatment of moderate to severe pain associated with endometriosis.&nbsp;</span></li><li><span style=\"font-size:18px;\">It effectively reduces the production of gonadotropins and estrogen, which can alleviate endometriosis-related pain.&nbsp;</span></li><li><span style=\"font-size:18px;\">However, its estrogen-lowering effect can lead to side effects such as hot flashes.&nbsp;</span></li><li><span style=\"font-size:18px;\">Understanding the pharmacokinetics, therapeutic indications, and potential adverse effects of elagolix is crucial for its appropriate use in clinical practice.</span></li></ul>",
    "correct_choice_id": 88917,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/22238/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_16.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/22238/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_16.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93549,
    "choices": [
      {
        "id": 372448,
        "text": "<p><span style=\"font-size:14.0pt;\">Endometriosis ablation due to an increased rate of endometriosis</span></p>"
      },
      {
        "id": 372449,
        "text": "<p><span style=\"font-size:14.0pt;\">To rule out M\u00fcllerian agenesis</span></p>"
      },
      {
        "id": 372450,
        "text": "<p><span style=\"font-size:14.0pt;\">Gonadectomy because retained gonads with Y-chromosome material carry an increased risk of malignant transformation</span></p>"
      },
      {
        "id": 372451,
        "text": "<p><span style=\"font-size:14.0pt;\">Oophoropexy due to an increased rate of torsion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old phenotypic female with gonadal dysgenesis is found on karyotyping to have 45X/46XY mosaicism. She is counseled regarding laparoscopy. The procedure is planned primarily for which reason?</span></p>",
    "unique_key": "Q4001597",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Gonadectomy because retained gonads with Y-chromosome material carry an increased risk of malignant transformation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a <strong>20-year-old</strong> with <strong>gonadal dysgenesis</strong> and <strong>45X/46XY mosaicism</strong>, the presence of <strong>Y-chromosome material</strong> in <strong>retained gonads</strong> (streak/dysgenetic gonads or undescended testicular tissue) confers a <strong>substantial risk of malignant transformation</strong> (classically <strong>gonadoblastoma</strong> and <strong>dysgerminoma</strong>).</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the <strong>next step</strong> is <strong>laparoscopic bilateral gonadectomy</strong> to eliminate this <strong>increased risk</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is standard management once the diagnosis is established, particularly in a phenotypic female with <strong>45X/46XY</strong> mosaicism, and addresses the precise indication: <strong>malignancy prevention</strong> in <strong>retained gonads</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Endometriosis ablation due to an increased rate of endometriosis</strong>: Incorrect. <strong>Gonadal dysgenesis</strong> with hypoestrogenism/amenorrhea does <strong>not</strong> confer an <strong>increased rate of endometriosis</strong>; ablation is <strong>not</strong> the primary reason for <strong>laparoscopy</strong> in this setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. To rule out M\u00fcllerian agenesis</strong>: Incorrect. <strong>M\u00fcllerian agenesis</strong> (MRKH) is a different diagnosis (typically <strong>46, XX</strong> with normal secondary sexual characteristics). In <strong>gonadal dysgenesis</strong> with <strong>45X/46XY mosaicism</strong>, <strong>laparoscopy</strong> is <strong>not</strong> performed to \u201crule out M\u00fcllerian agenesis\u201d; imaging (US/MRI) delineates M\u00fcllerian structures. The indication here is <strong>gonadectomy</strong> for malignancy risk, not ruling out agenesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Oophoropexy due to an increased rate of torsion</strong>: Incorrect. There is no recognized <strong>increased rate of torsion</strong> in <strong>streak/dysgenetic gonads</strong> that would justify <strong>oophoropexy</strong>. The urgent concern in <strong>45X/46XY</strong> is <strong>malignant transformation</strong>, not torsion, making <strong>oophoropexy</strong> the wrong rationale for <strong>laparoscopy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>gonadal dysgenesis</strong> with <strong>45X/46XY mosaicism</strong>, the presence of <strong>Y-chromosome material</strong> in <strong>retained gonads</strong> markedly increases the risk of <strong>gonadal malignancy</strong>; thus, <strong>prophylactic laparoscopic gonadectomy</strong> is indicated.</span></p>",
    "correct_choice_id": 372450,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93549/NEET_PG_22_Sep_2025_OBG_Question_10.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93549/NEET_PG_22_Sep_2025_OBG_Question_10.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93550,
    "choices": [
      {
        "id": 372452,
        "text": "<p><span style=\"font-size:14.0pt;\">Gonadotropin ovulation induction</span></p>"
      },
      {
        "id": 372453,
        "text": "<p><span style=\"font-size:14.0pt;\">Donor egg in vitro fertilization (IVF)</span></p>"
      },
      {
        "id": 372454,
        "text": "<p><span style=\"font-size:14.0pt;\">Clomiphene citrate ovulation induction</span></p>"
      },
      {
        "id": 372455,
        "text": "<p><span style=\"font-size:14.0pt;\">Conventional IVF with intracytoplasmic sperm injection (ICSI) using her own oocytes</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 39-year-old woman presents with a 2-year history of infertility. She reports regular menstrual cycles but has not conceived despite timed intercourse. Laboratory evaluation reveals very low anti-M\u00fcllerian hormone (AMH), elevated day-3 FSH, and low antral follicle count on transvaginal ultrasound, consistent with significantly diminished ovarian reserve. Her partner\u2019s semen analysis is normal. Which of the following is the most effective treatment option to help her conceive?</span></p>",
    "unique_key": "Q4086547",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Donor egg in vitro fertilization (IVF)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>significant decline in ovarian reserve</strong>\u2014as indicated by <strong>low AMH</strong>, <strong>elevated FSH</strong>, and <strong>low antral follicle count</strong>\u2014which reflects <strong>very poor quantity and likely reduced quality of her remaining oocytes</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In such cases, conventional ovulation induction or IVF using the patient\u2019s own eggs is associated with <strong>extremely low success rates</strong> due to poor follicular recruitment and higher rates of aneuploidy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Donor egg IVF</strong> bypasses the problem of diminished oocyte quantity and quality by using oocytes from a <strong>younger donor</strong> with <strong>normal ovarian reserve</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These donor eggs are fertilized with sperm from the patient\u2019s partner (or a donor), and the resulting embryos are transferred into the patient\u2019s uterus.</span></li><li><span style=\"font-size:14.0pt;\">This approach offers the <strong>highest chance of pregnancy</strong> for women with severely diminished ovarian reserve while still allowing them to carry the pregnancy and experience childbirth.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Gonadotropin ovulation induction</strong>: Incorrect. While high-dose gonadotropins can stimulate follicular development in women with mild to moderate decline in ovarian reserve, they are typically ineffective in cases of <strong>severe ovarian depletion</strong> where only a few follicles remain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Clomiphene citrate ovulation induction</strong>: Incorrect. Clomiphene works by blocking estrogen receptors, increasing endogenous FSH secretion, and promoting follicular development. In women with <strong>very few responsive follicles</strong>, this strategy is unlikely to produce viable eggs and thus has poor pregnancy rates in this scenario. Clomiphene is given in patients with anovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Conventional IVF with intracytoplasmic sperm injection (ICSI) using her own oocytes</strong>: Incorrect. While IVF with ICSI can overcome male factor infertility or fertilization issues, it does not address the <strong>severe oocyte quantity/quality deficit</strong>. Using the patient\u2019s own oocytes in this setting is associated with very low live birth rates.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In women with <strong>severely diminished ovarian reserve</strong>, the most effective fertility treatment is <strong>donor egg IVF</strong>, which replaces the poor-quality, low-quantity oocytes with those from a younger donor, thereby maximizing pregnancy and live birth rates while allowing the patient to carry the pregnancy herself.</span></p>",
    "correct_choice_id": 372453,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93550/NEET_PG_22_Sep_2025_OBG_Question_11.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93550/NEET_PG_22_Sep_2025_OBG_Question_11.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93657,
    "choices": [
      {
        "id": 372864,
        "text": "<p><span style=\"font-size:14.0pt;\">Diffuse alveolar damage</span></p>"
      },
      {
        "id": 372865,
        "text": "<p><span style=\"font-size:14.0pt;\">Idiopathic pulmonary fibrosis</span></p>"
      },
      {
        "id": 372866,
        "text": "<p><span style=\"font-size:14.0pt;\">Scleroderma</span></p>"
      },
      {
        "id": 372867,
        "text": "<p><span style=\"font-size:14.0pt;\">Sarcoidosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 57-year-old man presents with a progressive history of shortness of breath over the past 18 months. Physical examination is unremarkable. Pulmonary function testing demonstrates normal FEV1 but reduced FVC. A chest X-ray shows diffuse interstitial markings without evidence of masses or hilar lymphadenopathy. Laboratory testing for ANA and anti-DNA topoisomerase I antibodies is negative. Which of the following is the most likely diagnosis?&nbsp;</span></p>",
    "unique_key": "Q5021320",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Idiopathic pulmonary fibrosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 57-year-old man has progressive dyspnea for 18 months, with pulmonary function tests showing normal FEV1 but diminished FVC \u2014 a restrictive pattern.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The chest radiograph demonstrates diffuse interstitial disease without hilar adenopathy or masses, and autoimmune serologies (ANA, anti-DNA topoisomerase I) are negative.</span></li><li><span style=\"font-size:14.0pt;\">This clinical picture is most consistent with idiopathic pulmonary fibrosis (IPF), a chronic progressive fibrosing interstitial pneumonia of older adults.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key features include:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Gradual worsening of exertional dyspnea and dry cough</span></li><li><span style=\"font-size:14.0pt;\">Restrictive physiology on PFTs</span></li><li><span style=\"font-size:14.0pt;\">Interstitial markings on imaging without masses or nodal enlargement</span></li><li><span style=\"font-size:14.0pt;\">Negative autoimmune testing (excludes scleroderma/other connective tissue disease)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Therefore, the most likely diagnosis is idiopathic pulmonary fibrosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Diffuse alveolar damage:</strong> Represents the acute phase of ARDS, with rapid respiratory failure due to causes such as sepsis or trauma. The chronic 18-month history excludes this.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Scleroderma:</strong> Can cause interstitial lung disease (restrictive lung disease), but is associated with positive ANA or anti-Scl-70 antibodies and systemic findings such as skin thickening, Raynaud phenomenon, which are absent here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Sarcoidosis:&nbsp;</strong>Classically shows bilateral hilar lymphadenopathy, noncaseating granulomas, and systemic involvement (skin, eyes, joints). This patient\u2019s imaging showed no hilar adenopathy, making sarcoidosis unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Idiopathic pulmonary fibrosis presents in older adults with gradually progressive dyspnea, restrictive lung function, interstitial changes on imaging, and absence of autoimmune markers or hilar lymphadenopathy.</span></p>",
    "correct_choice_id": 372865,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93657/NEET_PG_22_Sep_2025_Pathology_Question_11.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93657/NEET_PG_22_Sep_2025_Pathology_Question_11.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92956,
    "choices": [
      {
        "id": 370116,
        "text": "<p><span style=\"font-size:14.0pt;\">Galeazzi fracture</span></p>"
      },
      {
        "id": 370117,
        "text": "<p><span style=\"font-size:14.0pt;\">Boxer's fracture</span></p>"
      },
      {
        "id": 370118,
        "text": "<p><span style=\"font-size:14.0pt;\">Colles' fracture</span></p>"
      },
      {
        "id": 370119,
        "text": "<p><span style=\"font-size:14.0pt;\">Scaphoid fracture</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old female falls at home and lands on her outstretched hand. She has wrist pain and swelling. Radiograph is shown below. What is this classic deformity associated with?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-12%20095009.jpg\" width=\"337\" height=\"567\"></span></p>",
    "unique_key": "Q9482124",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Colles' fracture</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A Colles' fracture is a fracture of the distal radius with a characteristic <strong>dorsal displacement</strong> and <strong>angulation</strong> of the wrist fragment.</span></li><li><span style=\"font-size:14.0pt;\">This creates a \"dinner fork\" deformity on physical examination.</span></li><li><span style=\"font-size:14.0pt;\">The patient's age and mechanism of injury (fall onto an outstretched hand) are a classic match.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A. Galeazzi fracture:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A Galeazzi fracture involves a fracture of the <strong>distal radius</strong> and a <strong>dislocation of the distal radioulnar joint (DRUJ)</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-12%20095050.jpg\" width=\"484\" height=\"480\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While it also involves a fall on an outstretched hand, the specific deformity of a Colles' fracture is not present.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Boxer's fracture:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">A Boxer's fracture is a fracture of the neck of the <strong>fifth metacarpal bone</strong> in the hand.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-12%20095125.jpg\" width=\"322\" height=\"462\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">It is typically caused by punching an object with a closed fist.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Scaphoid fracture:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A scaphoid fracture is a break in the scaphoid bone in the wrist, also caused by a fall on an outstretched hand.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-12%20095159.jpg\" width=\"391\" height=\"349\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">However, it does not typically present with the \"dinner fork\" deformity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Pain is localized to the anatomical snuffbox, and the fracture is often difficult to see on a plain radiograph.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Colles' fracture is a very common fracture of the distal radius, which occurs when a person falls onto an outstretched hand (FOOSH).</span></p>",
    "correct_choice_id": 370118,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92956/NEET_PG_22_Sep_2025_Orthopedics_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      15
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92956/NEET_PG_22_Sep_2025_Orthopedics_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93598,
    "choices": [
      {
        "id": 372632,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 372633,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
      },
      {
        "id": 372634,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 372635,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old man presents with recurrent oral ulcers, genital ulcers, and painful red eye for the past 6 months. He also reports joint pain and skin lesions on his legs. Regarding Beh\u00e7et's disease, which of the following is true?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Uveitis is bilateral, episodic, and may not resolve completely between episodes.</span></li><li><span style=\"font-size:14.0pt;\">Arthritis is usually asymmetric and non-erosive.</span></li><li><span style=\"font-size:14.0pt;\">Biopsy of the skin lesions can confirm the diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">Apremilast can be tried for aphthous ulcers as an alternative to colchicine.</span></li></ol>",
    "unique_key": "Q2491569",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 1, 2, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Uveitis is bilateral, episodic, and may not resolve completely between episodes:&nbsp;</strong>True. Uveitis in Beh\u00e7et's disease is a common and serious manifestation, often involving the anterior, posterior, or panuveitis. It is typically bilateral (though not always simultaneously) and occurs in episodic flares. Unlike some other uveitic conditions, the inflammation in Beh\u00e7et's disease often leaves residual damage (e.g., synechiae, cataracts), meaning it does not fully resolve between episodes, supporting this statement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Arthritis is usually asymmetric and non-erosive:&nbsp;</strong>True. Arthritis in Beh\u00e7et's disease affects approximately 50% of patients, typically involving large joints (e.g., knees, ankles) in an asymmetric pattern. It is generally non-erosive, distinguishing it from rheumatoid arthritis, and tends to be self-limiting, aligning with this statement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Apremilast can be tried for aphthous ulcers as an alternative to colchicine: </strong>True. Aphthous ulcers are a hallmark of Beh\u00e7et's disease, and colchicine is a first-line treatment to reduce their frequency and severity. Apremilast, a phosphodiesterase-4 inhibitor, has emerged as an alternative therapy, showing efficacy in reducing oral ulcers in clinical trials (e.g., RELIEF study), making it a viable option when colchicine is ineffective or contraindicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Biopsy of the skin lesions can confirm the diagnosis:&nbsp;</strong>False. Skin lesions (e.g., erythema nodosum, papulopustular lesions) are a diagnostic criterion for Beh\u00e7et's disease, but biopsy is not definitive for confirmation. Histopathology may show nonspecific inflammation (e.g., vasculitis, perivascular lymphocytic infiltrate), but the diagnosis relies on clinical criteria (e.g., International Criteria for Beh\u00e7et's Disease [ICBD]) rather than biopsy alone, as findings are not specific enough to confirm the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Uveitis in Beh\u00e7et's disease is bilateral and episodic with incomplete resolution.</span></li><li><span style=\"font-size:14.0pt;\">Arthritis presents as asymmetric and non-erosive, typical of the disease.</span></li><li><span style=\"font-size:14.0pt;\">Apremilast serves as an effective alternative to colchicine for managing aphthous ulcers.</span></li></ul>",
    "correct_choice_id": 372635,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93598/Neet_Pg_22_Sep_2025_Medicine_Question_121.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93598/Neet_Pg_22_Sep_2025_Medicine_Question_121.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92885,
    "choices": [
      {
        "id": 369836,
        "text": "<p><span style=\"font-size:14.0pt;\">Conidia arising only from the upper third of vesicle</span></p>"
      },
      {
        "id": 369837,
        "text": "<p><span style=\"font-size:14.0pt;\">Vesicle globular with black conidia</span></p>"
      },
      {
        "id": 369838,
        "text": "<p><span style=\"font-size:14.0pt;\">Phialides arranged only in a single row</span></p>"
      },
      {
        "id": 369839,
        "text": "<p><span style=\"font-size:14.0pt;\">Conidia arising from entire vesicle; phialides in 1 or 2 rows</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following features best helps to distinguish Aspergillus flavus from Aspergillus fumigatus on LPCB microscopy?</span></p>",
    "unique_key": "Q2152158",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Conidia arising from entire vesicle; phialides in 1 or 2 rows</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aspergillus flavus is characterized on LPCB microscopy by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Globular vesicle</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Conidia arising from the entire surface of the vesicle</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Phialides arranged in one or two rows</strong> (uniseriate or biseriate)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hyaline conidia</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">In contrast, Aspergillus fumigatus displays:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Conical vesicle</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Phialides arranged in a single row (uniseriate)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Conidia arise only from the upper third of the vesicle</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">These morphological distinctions are key in differentiating species during laboratory identification, especially in clinical settings involving immunocompromised patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20121010.jpg\" width=\"1048\" height=\"465\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Conidia arising only from the upper third of vesicle:&nbsp;</strong>This is a hallmark feature of Aspergillus fumigatus, not flavus. In flavus, conidia cover the entire vesicle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Vesicle globular with black conidia:&nbsp;</strong>While flavus has a globular vesicle, its conidia are <strong>hyaline</strong>, not black. Black conidia are seen in Aspergillus niger.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Phialides arranged only in a single row:</strong>This is again a feature of Aspergillus fumigatus, not flavus, which shows phialides in one or two rows.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aspergillus flavus shows <strong>conidia arising from the entire globular vesicle</strong> and <strong>phialides arranged in one or two rows</strong> (uniseriate or biseriate) on LPCB mount.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This distinguishes it from Aspergillus fumigatus, which has a conical vesicle with uniseriate phialides restricted to the upper third.</span></li></ul>",
    "correct_choice_id": 369839,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92885/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_12.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92885/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_12.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93572,
    "choices": [
      {
        "id": 372536,
        "text": "<p><span style=\"font-size:14.0pt;\">Meropenem</span></p>"
      },
      {
        "id": 372537,
        "text": "<p><span style=\"font-size:14.0pt;\">Cefiderocol</span></p>"
      },
      {
        "id": 372538,
        "text": "<p><span style=\"font-size:14.0pt;\">Ceftazidime-avibactam</span></p>"
      },
      {
        "id": 372539,
        "text": "<p><span style=\"font-size:14.0pt;\">Imipenem-cilastatin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 48-year-old woman admitted with severe acute respiratory distress syndrome (ARDS) due to COVID-19 develops ventilator-associated pneumonia (VAP) on day 6. Endotracheal aspirate grows Acinetobacter baumannii resistant to most antibiotics. Which of the following antibiotics is suitable for treatment?</span></p>",
    "unique_key": "Q6317510",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cefiderocol</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s severe ARDS due to COVID-19 and development of VAP on day 6 with <strong>multidrug-resistant (MDR) Acinetobacter baumannii</strong> indicate a critical care scenario requiring targeted antibiotic therapy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Acinetobacter baumannii is a gram-negative, nosocomial pathogen notorious for extensive drug resistance, including to carbapenems, making treatment challenging.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cefiderocol</strong> is a novel siderophore cephalosporin designed to combat MDR gram-negative bacteria, including carbapenem-resistant Acinetobacter baumannii.</span></li><li><span style=\"font-size:14.0pt;\">It binds to bacterial iron transport systems, facilitating entry into cells, and is effective against strains resistant to meropenem, imipenem, and ceftazidime-avibactam.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clinical trials (e.g., CREDIBLE-CR) support its use in VAP caused by MDR Acinetobacter, making it suitable for this patient, especially given the resistance profile.</span></li><li><span style=\"font-size:14.0pt;\">Treatment of MDR Acinetobacter VAP often requires combination therapy (e.g., cefiderocol with colistin or tigecycline, guided by susceptibility testing) and supportive care in the ICU, with attention to source control and resistance patterns.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Meropenem</strong>: Inappropriate. Meropenem, a carbapenem, is commonly used for gram-negative infections, but MDR Acinetobacter baumannii is frequently resistant to carbapenems (including meropenem), as stated in the stem. Without susceptibility data confirming efficacy, meropenem is not suitable for this resistant strain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ceftazidime-avibactam</strong>: Inappropriate. Ceftazidime-avibactam is effective against some carbapenem-resistant gram-negative bacteria (e.g., those with specific beta-lactamases like KPC or OXA-48). However, Acinetobacter baumannii often produces metallo-beta-lactamases (e.g., NDM) or other mechanisms not inhibited by avibactam, rendering this combination ineffective for most MDR Acinetobacter strains.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Imipenem-cilastatin</strong>: Inappropriate. Like meropenem, imipenem-cilastatin is a carbapenem, and MDR Acinetobacter baumannii is typically resistant to it. The stem\u2019s mention of resistance to most antibiotics strongly suggests carbapenem resistance, making imipenem-cilastatin unsuitable without confirmed susceptibility.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cefiderocol is effective for ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii.</span></li><li><span style=\"font-size:14.0pt;\">Meropenem and imipenem-cilastatin are ineffective against carbapenem-resistant Acinetobacter strains.</span></li><li><span style=\"font-size:14.0pt;\">Ceftazidime-avibactam lacks activity against most MDR Acinetobacter due to specific resistance mechanisms.</span></li></ul>",
    "correct_choice_id": 372537,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93572/Neet_Pg_22_Sep_2025_Medicine_Question_81.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93572/Neet_Pg_22_Sep_2025_Medicine_Question_81.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92939,
    "choices": [
      {
        "id": 370048,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
      },
      {
        "id": 370049,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
      },
      {
        "id": 370050,
        "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
      },
      {
        "id": 370051,
        "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following are functions of the cartridge case in ammunition?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Keeps components of cartridge together</span></li><li><span style=\"font-size:14.0pt;\">Allows backward escape of gases during firing</span></li><li><span style=\"font-size:14.0pt;\">Waterproofs gunpowder</span></li><li><span style=\"font-size:14.0pt;\">Aids in identification of gun type</span></li></ol>",
    "unique_key": "Q3345030",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 3 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>cartridge case</strong> is a vital component of ammunition that serves several key functions:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Keeps components of cartridge together:</strong> True. It <strong>holds the primer, propellant, and projectile (bullet or pellets)</strong> together in a single, compact unit\u2014essential for consistent firing mechanics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Waterproofs gunpowder:&nbsp;</strong>True. It provides a <strong>sealed environment</strong>, <strong>protecting the gunpowder from moisture</strong>, thereby ensuring reliable ignition and performance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Aids in identification of gun type:&nbsp;</strong>True. The <strong>base configuration</strong> (rimmed, rimless, etc.) and <strong>firing pin impressions</strong> on the cartridge case can help <strong>identify the type of firearm</strong> used, which is crucial in forensic investigations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Allows backward escape of gases during firing:&nbsp;</strong>False.The cartridge case is <strong>designed to prevent</strong> the <strong>backward escape of gases</strong> during firing by expanding and sealing the breech of the firearm. Allowing gas escape would be dangerous and reduce firing efficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cartridge cases <strong>seal</strong>, <strong>protect</strong>, and <strong>identify</strong>.</span></li><li><span style=\"font-size:14.0pt;\">They <strong>do not allow gas to escape</strong>, but instead <strong>contain the explosive force</strong> and direct it forward.</span></li><li><span style=\"font-size:14.0pt;\">Base designs and firing pin marks assist in <strong>ballistic forensics</strong>.</span></li></ul>",
    "correct_choice_id": 370048,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92939/NEET_PG_22_Sep_2025_FMT_Question_4_ZrB8h5b.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      10
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92939/NEET_PG_22_Sep_2025_FMT_Question_4_ZrB8h5b.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93595,
    "choices": [
      {
        "id": 372620,
        "text": "<p><span style=\"font-size:14.0pt;\">Use of pencil point needles has a lesser incidence of PDPH.</span></p>"
      },
      {
        "id": 372621,
        "text": "<p><span style=\"font-size:14.0pt;\">Most techniques used to prevent PDPH are ineffective.</span></p>"
      },
      {
        "id": 372622,
        "text": "<p><span style=\"font-size:14.0pt;\">Optimal blood volume for epidural blood patch is around 50 mL.</span></p>"
      },
      {
        "id": 372623,
        "text": "<p><span style=\"font-size:14.0pt;\">PDPH is typically a positional headache that increases on upright posture.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman underwent lumbar puncture for spinal anesthesia during cesarean section and presents 48 hours later with a severe headache. A diagnosis of post-dural puncture headache (PDPH) is suspected. Which of the following statements is incorrect regarding PDPH?</span></p>",
    "unique_key": "Q9147375",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Optimal blood volume for epidural blood patch is around 50 mL.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s presentation (severe headache worsened by upright posture, relieved by lying flat, onset 48 hours post-lumbar puncture for spinal anesthesia) is classic for <strong>post-dural puncture headache (PDPH)</strong>, caused by cerebrospinal fluid (CSF) leakage through the dural puncture site, leading to intracranial hypotension.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>optimal blood volume for an epidural blood patch (EBP)</strong>, the definitive treatment for PDPH, is typically <strong>10\u201320 mL</strong>, <strong>not</strong> 50 mL. Studies suggest 10\u201315 mL is often sufficient to form a clot over the dural defect, sealing the CSF leak. Volumes &gt;20 mL are rarely needed and may increase risks (e.g., back pain, nerve compression).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A volume of <strong>50 mL is excessive</strong> and <strong>not standard practice</strong>, making this statement false.</span></li><li><span style=\"font-size:14.0pt;\">PDPH management includes conservative measures (bed rest, hydration, caffeine, analgesics) for 24-48 hours, but EBP is indicated for severe or persistent symptoms.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient\u2019s lack of neurologic deficits rules out complications like subdural hematoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Use of pencil point needles has a lesser incidence of PDPH</strong>: Correct. Pencil point needles (e.g., Whitacre, Sprotte) have a non-cutting, conical tip that separates dural fibers rather than cutting them, reducing CSF leakage compared to cutting needles (e.g., Quincke). Studies show a significantly lower PDPH incidence (2\u20135% vs. 10\u201330%) with pencil point needles, especially in high-risk procedures like spinal anesthesia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Most techniques used to prevent PDPH are ineffective</strong>: Correct. Many preventive measures (e.g., bed rest, aggressive hydration, routine caffeine) lack strong evidence for reducing PDPH incidence. The most effective prevention strategies are using smaller-gauge (e.g., 25\u201327G) pencil point needles and minimizing puncture attempts, but other techniques (e.g., prophylactic EBP, prolonged supine positioning) are largely ineffective or impractical.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. PDPH is typically a positional headache that increases on upright posture</strong>: Correct. PDPH is characterized by a positional headache due to CSF leakage causing intracranial hypotension, worsened by upright posture (sitting/standing) and relieved by lying flat. This is a hallmark feature, often accompanied by nausea, neck stiffness, or photophobia, as seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pencil point needles reduce PDPH incidence compared to cutting needles.</span></li><li><span style=\"font-size:14.0pt;\">PDPH presents as a positional headache worsened by upright posture.</span></li><li><span style=\"font-size:14.0pt;\">Epidural blood patch uses 10\u201320 mL of blood, not 50 mL, for optimal treatment</span></li></ul>",
    "correct_choice_id": 372622,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93595/NEET_PG_22_Sep_2025_MEDICINE_Question_9.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93595/NEET_PG_22_Sep_2025_MEDICINE_Question_9.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93324,
    "choices": [
      {
        "id": 371564,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2</span></p>"
      },
      {
        "id": 371565,
        "text": "<p><span style=\"font-size:14.0pt;\">2 only</span></p>"
      },
      {
        "id": 371566,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3</span></p>"
      },
      {
        "id": 371567,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about congenital (transplacental) CMV infection are true?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Mothers who transmit the virus are usually symptomatic</span></li><li><span style=\"font-size:14.0pt;\">It is the most common cause of non-syndromic hearing loss</span></li><li><span style=\"font-size:14.0pt;\">It is diagnosed by persistent presence of IgM antibody after 6 months of age</span></li><li><span style=\"font-size:14.0pt;\">All affected babies are symptomatic at birth</span></li></ol>",
    "unique_key": "Q9220188",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 2 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. It is the most common cause of non-syndromic hearing loss:&nbsp;</strong>Congenital CMV infection is the <strong>leading cause of non-syndromic sensorineural hearing loss in children worldwide</strong>. Even infants who are asymptomatic at birth can later develop progressive hearing loss, making this the most important long-term complication.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Mothers who transmit the virus are usually symptomatic:</strong> False. Most mothers who transmit CMV to the fetus are <strong>asymptomatic</strong>. Transmission usually occurs during a primary infection in pregnancy, especially in the first trimester, but maternal symptoms are rare.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. It is diagnosed by persistent presence of IgM antibody after 6 months of age: </strong>False.<strong>&nbsp;</strong>IgM does not cross the placenta, so its presence in the neonate can indicate infection, but it is neither sensitive nor specific. Persistent IgM beyond 6 months is not the diagnostic standard. Diagnosis is made by <strong>PCR detection of CMV DNA</strong> or virus isolation from saliva or urine in the first 3 weeks of life.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. All affected babies are symptomatic at birth: </strong>False.&nbsp;Only <strong>10\u201315% of congenitally infected infants are symptomatic at birth</strong>. Most are asymptomatic but remain at risk for long-term sequelae like hearing loss and developmental delay.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Congenital CMV is usually transmitted by asymptomatic mothers, presents with variable features, and is the most common cause of non-syndromic sensorineural hearing loss; most affected infants are asymptomatic at birth.</span></p>",
    "correct_choice_id": 371565,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93324/NEET_PG_22_Sep_2025_PEDIATRICS_Question_8.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      13
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93324/NEET_PG_22_Sep_2025_PEDIATRICS_Question_8.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92895,
    "choices": [
      {
        "id": 369876,
        "text": "<p><span style=\"font-size:14.0pt;\">Recruitment of collapsed alveoli to improve oxygenation</span></p>"
      },
      {
        "id": 369877,
        "text": "<p><span style=\"font-size:14.0pt;\">Reduction of physiologic dead space to improve CO\u2082 clearance</span></p>"
      },
      {
        "id": 369878,
        "text": "<p><span style=\"font-size:14.0pt;\">Direct lowering of plateau pressure to reduce barotrauma</span></p>"
      },
      {
        "id": 369879,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased cardiac preload to improve systemic perfusion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with severe ARDS secondary to influenza pneumonia is on mechanical ventilation. He is sedated and paralyzed. Current ventilator settings: FiO\u2082 0.8, tidal volume 6 mL/kg predicted body weight, respiratory rate 20/min, and PEEP 5 cm H\u2082O. His PaO\u2082 remains 48 mmHg, and plateau pressure is 26 cm H\u2082O. The team considers increasing PEEP. Which of the following is the primary physiological benefit of increasing PEEP in this patient?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q3428343",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Recruitment of collapsed alveoli to improve oxygenation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In ARDS, alveoli are prone to collapse at end-expiration due to low compliance and surfactant dysfunction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Increasing PEEP prevents alveolar collapse, recruits collapsed alveoli, and improves ventilation\u2013perfusion matching, leading to better oxygenation.</span></li><li><span style=\"font-size:14.0pt;\">This is the cornerstone of ARDS management when hypoxemia persists despite low tidal volume ventilation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Reduction of physiologic dead space to improve CO\u2082 clearance:&nbsp;</strong>PEEP primarily improves oxygenation, not CO\u2082 clearance. Dead space ventilation is influenced more by tidal volume, respiratory rate, and pulmonary perfusion, not PEEP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Direct lowering of plateau pressure to reduce barotrauma:&nbsp;</strong>Increasing PEEP does not reduce plateau pressure; in fact, plateau pressure often rises with higher PEEP. Protection against barotrauma is achieved by using low tidal volumes and keeping plateau pressure \u226430 cm H\u2082O, not by PEEP adjustments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased cardiac preload to improve systemic perfusion:&nbsp;</strong>Higher PEEP actually <strong>reduces</strong> venous return by increasing intrathoracic pressure, which may lower cardiac output and systemic perfusion, especially in hypovolemic patients. It does not enhance preload.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In ARDS, <strong>PEEP improves oxygenation by preventing alveolar collapse and recruiting collapsed alveoli</strong>, but excessive PEEP can impair hemodynamics and increase barotrauma risk.</span></p>",
    "correct_choice_id": 369876,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92895/NEET_PG_22_Sep_2025_Anesthesia_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      19
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92895/NEET_PG_22_Sep_2025_Anesthesia_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93312,
    "choices": [
      {
        "id": 371516,
        "text": "<p><span style=\"font-size:14.0pt;\">Hendra virus</span></p>"
      },
      {
        "id": 371517,
        "text": "<p><span style=\"font-size:14.0pt;\">Nipah virus</span></p>"
      },
      {
        "id": 371518,
        "text": "<p><span style=\"font-size:14.0pt;\">Ebola virus</span></p>"
      },
      {
        "id": 371519,
        "text": "<p><span style=\"font-size:14.0pt;\">Japanese Encephalitis virus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following organism is best represented by the lifecycle shown in the image?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_iAui6GE.png\" width=\"794\" height=\"509\"></strong></span></p>",
    "unique_key": "Q3982866",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Nipah virus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image illustrates the <strong>transmission cycle of Nipah virus</strong>, a zoonotic virus from the Paramyxoviridae family.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fruit bats (Pteropus species)</strong> are the natural reservoir.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The virus spreads via:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Contaminated date palm sap</strong> (collected in open containers that bats lick or urinate into)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Infected fruits</strong> contaminated by bat saliva</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pig intermediates</strong>, where the virus can amplify (as seen in Malaysian outbreaks)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Direct human-to-human transmission</strong>, particularly in hospital or caregiving settings</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hendra virus:</strong> Also uses fruit bats as reservoirs but typically transmits to <strong>horses</strong>, not pigs or via date palm sap.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ebola virus:</strong> Involves bats but spreads primarily via <strong>bodily fluids</strong>; <strong>fruit or palm sap are not typical transmission modes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Japanese Encephalitis virus:</strong> Spread via <strong>Culex mosquitoes</strong> from birds/pigs; bats or palm sap not involved.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Nipah virus</strong> is transmitted from <strong>fruit bats</strong> to humans via <strong>contaminated palm sap, fruits, or pigs</strong>, and can also spread <strong>person-to-person</strong>, causing <strong>severe encephalitis outbreaks</strong> with high mortality.</span></p>",
    "correct_choice_id": 371517,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93312/Neet_Pg_22_Sept_2025_Psm_Q_19.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93312/Neet_Pg_22_Sept_2025_Psm_Q_19.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93333,
    "choices": [
      {
        "id": 371596,
        "text": "<p><span style=\"font-size:14.0pt;\">Babcock's forceps</span></p>"
      },
      {
        "id": 371597,
        "text": "<p><span style=\"font-size:14.0pt;\">Lane's tissue holding forceps</span></p>"
      },
      {
        "id": 371598,
        "text": "<p><span style=\"font-size:14.0pt;\">Kocher's clamp</span></p>"
      },
      {
        "id": 371599,
        "text": "<p><span style=\"font-size:14.0pt;\">Rampley\u2019s sponge holder</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the instrument:&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-09-20%20at%2017.21.39.jpeg\" width=\"460\" height=\"469\"></p>",
    "unique_key": "Q3386604",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Lane's tissue holding forceps</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Lane\u2019s tissue holding forceps</strong> are stout with thick distal blades and oval fenestrae. It has an opposing tooth on the tip and a lock in the proximal part.</span></li><li><span style=\"font-size:14.0pt;\">It is used to hold bulky and tough structures and lymph nodes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Babcock's forceps</strong>:&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>Babcock\u2019s forceps</strong>, the distal part of the blade is curved with a triangular fenestra, which allows soft tissues to bulge out.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The tip is non-traumatic with transverse serrations. It has a lock in the proximal part.</span></li><li><span style=\"font-size:14.0pt;\">It is used to hold tubular structures, such as parts of the bowel, fallopian tube, appendix, ureter, etc.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_h39QrBB.png\" width=\"460\" height=\"433\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Kocher's clamp:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Kocher\u2019s hemostatic forceps</strong> are identified by the opposing tooth on the tip and serrations in the distal blades.</span></li><li><span style=\"font-size:14.0pt;\">It is used to hold pedicles, tough structures, and cut ends of muscles. It can also hold ribs during rib dissection and be used for blunt dissection or resected bowel.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_p88PDlG.png\" width=\"455\" height=\"380\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Rampley\u2019s sponge holder:&nbsp;</strong>Sponge holder shows a rounded, fenestrated, but blunt tip with serrations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_heQBWPU.png\" width=\"398\" height=\"370\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Lane\u2019s tissue holding forceps</strong> are stout with thick distal blades and oval fenestrae.</span></li><li><span style=\"font-size:14.0pt;\">It has an opposing tooth on the tip and a lock in the proximal part.</span></li><li><span style=\"font-size:14.0pt;\">It is used to hold bulky and tough structures and lymph nodes.</span></li></ul>",
    "correct_choice_id": 371597,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93333/NEET_PG_22_Sep_2025_Surgery_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93333/NEET_PG_22_Sep_2025_Surgery_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93344,
    "choices": [
      {
        "id": 371640,
        "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Brought on by walking a certain distance</span></p>"
      },
      {
        "id": 371641,
        "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">It is of a cramping type</span></p>"
      },
      {
        "id": 371642,
        "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Relieved on resting for a few minutes</span></p>"
      },
      {
        "id": 371643,
        "text": "<p><span style=\"font-size:14.0pt;\">Relieved on limb elevation&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not a characteristic feature of ischemic pain that is seen in peripheral arterial occlusive diseases (PVD)?&nbsp;</span></p>",
    "unique_key": "Q5722940",
    "difficulty_level": "intermediate",
    "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Ans. D) Relieved on limb elevation&nbsp;</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ischemic pain (Rest pain) gets worse on limb elevation as blood flow reduces further.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:14.0pt;\">Ischemic pain relief by hanging their leg side of bed&nbsp;</span></p><p>&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Brought on by walking a certain distance:&nbsp;</strong>Correct. Intermittent claudication is characterized by pain brought on by walking or exercise due to inadequate blood flow to the muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. It is of a cramping type:&nbsp;</strong>Correct. The pain of ischemia of muscle is cramping or spastic type in character.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Relieved on resting for few minutes:&nbsp;</strong>Correct. The pain of intermittent claudication is usually relieved by rest within a short duration, typically within a few minutes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">It is important to recognize the key features of intermittent claudication, including pain brought on by walking, relief with rest within a short duration, and a consistent claudication distance.</span></p>",
    "correct_choice_id": 371643,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93344/NEET_PG_22_Sep_2025_Surgery_Question_12.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93344/NEET_PG_22_Sep_2025_Surgery_Question_12.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92884,
    "choices": [
      {
        "id": 369832,
        "text": "<p><span style=\"font-size:14.0pt;\">PrPSc is anchored to the cell membrane while PrPC is cytoplasmic</span></p>"
      },
      {
        "id": 369833,
        "text": "<p><span style=\"font-size:14.0pt;\">PrPSc is protease-sensitive and has rapid turnover</span></p>"
      },
      {
        "id": 369834,
        "text": "<p><span style=\"font-size:14.0pt;\">PrPSc has increased beta-sheet content and is protease-resistant</span></p>"
      },
      {
        "id": 369835,
        "text": "<p><span style=\"font-size:14.0pt;\">PrPSc is encoded on a different chromosome than PrPC</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best differentiates the disease-causing prion protein (PrPSc) from its normal cellular isoform (PrPC)?</span></p>",
    "unique_key": "Q8983741",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) PrPSc has increased beta-sheet content and is protease-resistant</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Prions are misfolded proteins, so deposited in different tissues.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The key pathological feature of prion diseases lies in the <strong>conformational change of the normal prion protein (PrPC)</strong> into the <strong>abnormal form (PrPSc)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The normal PrPC is rich in <strong>alpha-helical structure</strong>, <strong>protease-sensitive</strong>, and has a <strong>short half-life</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In contrast, PrPSc adopts a <strong>beta-sheet-rich conformation</strong>, making it <strong>resistant to protease digestion</strong> and <strong>capable of accumulating in the brain</strong>, where it forms <strong>amyloid-like plaques</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These structural differences are critical in understanding the persistence and infectivity of PrPSc.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. PrPSc is anchored to the cell membrane while PrPC is cytoplasmic: </strong>Incorrect. The <strong>normal</strong> PrPC is anchored to the <strong>cell membrane</strong>, whereas the <strong>disease-associated</strong> PrPSc tends to accumulate in <strong>cytoplasmic vesicles</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. PrPSc is protease-sensitive and has rapid turnover: </strong>Incorrect. This describes <strong>PrPC</strong>, not PrPSc. PrPSc is <strong>protease-resistant</strong> and has a <strong>much slower turnover</strong>, contributing to its accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. PrPSc is encoded on a different chromosome than PrPC: </strong>Incorrect. <strong>Both forms are encoded by the same PRNP gene on chromosome. </strong>The difference arises <strong>post-translationally</strong>, due to abnormal folding\u2014not due to different genetic encoding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The pathological prion protein PrPSc differs from its normal isoform PrPC by having a beta-sheet-rich structure, protease resistance, and prolonged persistence.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This conformational change underlies the pathogenesis of prion diseases.</span></li></ul>",
    "correct_choice_id": 369834,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92884/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_11.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92884/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_11.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92936,
    "choices": [
      {
        "id": 370036,
        "text": "<p><span style=\"font-size:14.0pt;\">Blood glucose</span></p>"
      },
      {
        "id": 370037,
        "text": "<p><span style=\"font-size:14.0pt;\">Alcohol detection</span></p>"
      },
      {
        "id": 370038,
        "text": "<p><span style=\"font-size:14.0pt;\">Complete blood count</span></p>"
      },
      {
        "id": 370039,
        "text": "<p><span style=\"font-size:14.0pt;\">Hemoglobin A1c estimation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">During the post-mortem examination of a 60-year-old man, blood is collected in a tube that contains heparin but no sodium fluoride. Which of the following analyses is most likely to yield an unreliable result because of this collection protocol?&nbsp;</span></p>",
    "unique_key": "Q6629147",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Alcohol detection</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fluoride inhibits the glycolytic enzyme enolase and suppresses microbial fermentation, both of which can otherwise produce or consume ethanol after death and lead to false-positive or false-negative results.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, blood collected <strong>without sodium fluoride</strong>\u2014regardless of which anticoagulant is used\u2014should be considered <strong>unsuitable for forensic ethanol quantification</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Blood glucose:&nbsp;</strong>Preservation of glucose requires inhibition of glycolysis. While sodium fluoride is preferred for accurate glucose levels, heparin does not majorly interfere with glucose assays in living patients, but it is not suitable for postmortem toxicology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Complete blood count:&nbsp;</strong>Heparin is actually acceptable for CBC and does not interfere with cell counts or morphology significantly, though <strong>EDTA is the preferred anticoagulant</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hemoglobin A1c estimation:&nbsp;</strong>EDTA-preserved blood is typically used, but <strong>heparinized samples</strong> may still be usable depending on the methodology. However, this is not the most compromised parameter in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Use <strong>sodium fluoride (10 mg/ml)</strong> with <strong>potassium oxalate (30 mg/10 ml)</strong> for <strong>alcohol and toxicology testing</strong> to prevent microbial ethanol formation and glycolysis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Avoid <strong>heparin</strong> and <strong>EDTA</strong> in this context due to interference with toxicological assays.</span></li></ul>",
    "correct_choice_id": 370037,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92936/NEET_PG_22_Sep_2025_FMT_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      10
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92936/NEET_PG_22_Sep_2025_FMT_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93651,
    "choices": [
      {
        "id": 372840,
        "text": "<p><span style=\"font-size:14.0pt;\">Membranoproliferative glomerulonephritis</span></p>"
      },
      {
        "id": 372841,
        "text": "<p><span style=\"font-size:14.0pt;\">Post-streptococcal glomerulonephritis</span></p>"
      },
      {
        "id": 372842,
        "text": "<p><span style=\"font-size:14.0pt;\">Acute tubular necrosis</span></p>"
      },
      {
        "id": 372843,
        "text": "<p><span style=\"font-size:14.0pt;\">Minimal change disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 9-year-old boy presents with facial and leg swelling, decreased urine output, and dark-colored urine. His parents report that he had a sore throat about 10 days ago. On examination, he has periorbital edema and elevated blood pressure. Laboratory studies reveal elevated serum creatinine and red blood cell casts on urinalysis. A renal biopsy shows the histological findings displayed in the image provided. Which of the following is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zTgy9fM.png\" width=\"397\" height=\"413\"></span></p>",
    "unique_key": "Q5313959",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Post-streptococcal glomerulonephritis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 9-year-old boy presents with edema (face, legs, periorbital swelling), dark urine, decreased urine output, and hypertension following a recent sore throat.</span></li><li><span style=\"font-size:14.0pt;\">Laboratory data show elevated creatinine and red blood cell casts, both classic for glomerulonephritis.</span></li><li><span style=\"font-size:14.0pt;\">The timeline (latent period of ~10 days after infection), combined with pediatric age and preceding streptococcal pharyngitis, strongly suggests post-streptococcal glomerulonephritis (PSGN).</span></li><li><span style=\"font-size:14.0pt;\">Histology in PSGN typically demonstrates hypercellular glomeruli with granular immune complex deposition along the basement membrane and mesangium (\"starry sky\" or lumpy-bumpy appearance on immunofluorescence).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This matches the provided biopsy image.</span></li><li><span style=\"font-size:14.0pt;\">Thus, the most likely diagnosis is post-streptococcal glomerulonephritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Membranoproliferative glomerulonephritis:</strong> This condition may cause nephritic syndrome, but it usually presents with chronic infections (e.g., hepatitis B, hepatitis C) rather than an acute sore throat followed by nephritic syndrome in a child. The biopsy appearance is different (tram-track splitting of GBM).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Acute tubular necrosis:&nbsp;</strong>ATN is usually due to ischemia or toxic injury and presents with muddy brown granular casts, not red blood cell casts. It does not follow a streptococcal throat infection and does not cause immune complex deposition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Minimal change disease:&nbsp;</strong>This is the most common cause of nephrotic syndrome in children, but it presents with massive proteinuria, hypoalbuminemia, and generalized edema. Hematuria and red blood cell casts are not typical, and it is not associated with a recent sore throat.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Post-streptococcal glomerulonephritis presents in children after a latent period following streptococcal pharyngitis or skin infection, with hematuria, hypertension, edema, red blood cell casts, and granular immune complex deposition on biopsy.</span></p>",
    "correct_choice_id": 372841,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93651/NEET_PG_22_Sep_2025_Pathology_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93651/NEET_PG_22_Sep_2025_Pathology_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93571,
    "choices": [
      {
        "id": 372532,
        "text": "<p><span style=\"font-size:14.0pt;\">Fluid restriction</span></p>"
      },
      {
        "id": 372533,
        "text": "<p><span style=\"font-size:14.0pt;\">3% NaCl</span></p>"
      },
      {
        "id": 372534,
        "text": "<p><span style=\"font-size:14.0pt;\">Loop diuretics</span></p>"
      },
      {
        "id": 372535,
        "text": "<p><span style=\"font-size:14.0pt;\">Normal saline</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old man presents with severe headache and neck stiffness. A CT scan of the head is normal, but lumbar puncture reveals xanthochromia, confirming subarachnoid hemorrhage (SAH). His serum sodium is 125 mmol/L. Which of the following should be done to manage his hyponatremia?</span></p>",
    "unique_key": "Q5670905",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 3% NaCl</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s presentation (severe headache, neck stiffness, xanthochromia on lumbar puncture) confirms <strong>subarachnoid hemorrhage (SAH)</strong>, despite a normal CT scan, which can miss small bleeds (sensitivity ~95% in the first 24 hours).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Serum sodium of 125 mmol/L</strong> indicates <strong>hyponatremia</strong>, commonly caused by the <strong>syndrome of inappropriate antidiuretic hormone secretion (SIADH)</strong> in SAH due to excessive ADH release from hypothalamic-pituitary stress or irritation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3% NaCl (hypertonic saline)</strong> is the appropriate treatment for symptomatic hyponatremia (sodium &lt;130 mmol/L, especially with neurologic symptoms like headache) in SAH-related SIADH.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hypertonic saline corrects sodium levels rapidly (target increase 4\u20136 mmol/L in 24 hours) while avoiding cerebral edema, which is critical in SAH to prevent worsening intracranial pressure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Administration requires ICU monitoring to avoid overcorrection (&gt;8\u201312 mmol/L/day, risking osmotic demyelination).</span></li><li><span style=\"font-size:14.0pt;\">SAH management also includes nimodipine to prevent vasospasm, seizure prophylaxis, and neurosurgical evaluation for aneurysm clipping or coiling, but hyponatremia correction is urgent given the low sodium and neurologic symptoms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fluid restriction</strong>: Inappropriate. Fluid restriction is a standard treatment for SIADH in non-emergent settings with mild hyponatremia (sodium &gt;130 mmol/L or asymptomatic). In SAH, fluid restriction is contraindicated because it risks cerebral ischemia from vasospasm, which requires euvolemia or slight hypervolemia. The severe hyponatremia (125 mmol/L) and neurologic symptoms necessitate active correction with hypertonic saline.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Loop diuretics</strong>: Inappropriate. Loop diuretics (e.g., furosemide) are used in SIADH with fluid overload or in cerebral salt-wasting syndrome (CSWS), which is less common in SAH and presents with hypovolemia (not evident here). Diuretics alone do not correct severe hyponatremia rapidly and may exacerbate hypovolemia, risking SAH complications like vasospasm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Normal saline</strong>: Inappropriate. Normal saline (0.9% NaCl) is ineffective for severe SIADH-related hyponatremia because it is isotonic and may worsen hyponatremia by increasing free water retention in the presence of excess ADH. Hypertonic saline (3% NaCl) is required to raise serum sodium effectively in this acute setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">3% NaCl is the treatment for severe hyponatremia (sodium &lt;130 mmol/L) in SAH-related SIADH with neurologic symptoms.</span></li><li><span style=\"font-size:14.0pt;\">Fluid restriction is contraindicated in SAH due to the need for euvolemia to prevent vasospasm.</span></li><li><span style=\"font-size:14.0pt;\">Normal saline and loop diuretics are ineffective or harmful for severe SIADH-related hyponatremia in SAH.</span></li></ul>",
    "correct_choice_id": 372533,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93571/NEET_PG_22_Sep_2025_MEDICINE_Question_7.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93571/NEET_PG_22_Sep_2025_MEDICINE_Question_7.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93546,
    "choices": [
      {
        "id": 372436,
        "text": "<p><span style=\"font-size:14.0pt;\">Male pattern hair growth on lower abdomen</span></p>"
      },
      {
        "id": 372437,
        "text": "<p><span style=\"font-size:14.0pt;\">Thickened dark skin on inner thighs</span></p>"
      },
      {
        "id": 372438,
        "text": "<p><span style=\"font-size:14.0pt;\">Abnormal glucose tolerance test results</span></p>"
      },
      {
        "id": 372439,
        "text": "<p><span style=\"font-size:14.0pt;\">High serum levels of high-density lipoproteins</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 19-year-old girl with a long-standing history of irregular menstrual cycles and amenorrhea presents with the ultrasound image shown below. Which of the following finding is least likely to be present in this patient?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2A8iN15.png\" width=\"478\" height=\"343\"></span></p>",
    "unique_key": "Q1051847",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) High serum levels of high-density lipoproteins</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The ultrasound image shows an ovary with multiple small <strong>peripheral cysts</strong>, which is highly suggestive of <strong>polycystic ovary syndrome (PCOS)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">PCOS is a common endocrine disorder in women of reproductive age, characterized by hormonal imbalances, irregular menstrual cycles, and often signs of hyperandrogenism (excess male hormones).</span></li><li><span style=\"font-size:14.0pt;\"><strong>PCOS</strong> is associated with several metabolic and reproductive features, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hirsutism</strong> (male-pattern hair growth) due to excess androgens.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Acanthosis nigricans</strong> (thickened, dark skin) often seen in insulin resistance, which commonly occurs in PCOS.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Abnormal glucose tolerance</strong> and <strong>insulin resistance</strong>, leading to a higher risk of type 2 diabetes.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>High-density lipoproteins (HDL)</strong>, the \"good cholesterol,\" are often <strong>low</strong> in PCOS, rather than high.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>high HDL levels</strong> are <strong>least likely</strong> to be seen in this patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Male pattern hair growth on lower abdomen:&nbsp;</strong>This is a common feature of <strong>hyperandrogenism</strong> in PCOS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Thickened dark skin on inner thighs:&nbsp;</strong>This describes <strong>acanthosis nigricans</strong>, a marker of <strong>insulin resistance</strong>, commonly seen in PCOS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Abnormal glucose tolerance test results: Insulin resistance</strong> and <strong>impaired glucose tolerance</strong> are common in women with PCOS, putting them at risk for type 2 diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Polycystic ovary syndrome (PCOS)</strong> is characterized by irregular menstrual cycles, hyperandrogenism, and insulin resistance.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is typically associated with <strong>low HDL</strong> levels, which makes <strong>high HDL</strong> the least likely feature in patients with PCOS.</span></li></ul>",
    "correct_choice_id": 372439,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93546/NEET_PG_22_Sep_2025_OBG_Question_7.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93546/NEET_PG_22_Sep_2025_OBG_Question_7.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92877,
    "choices": [
      {
        "id": 369804,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only&nbsp;</span></p>"
      },
      {
        "id": 369805,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only&nbsp;</span></p>"
      },
      {
        "id": 369806,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only&nbsp;</span></p>"
      },
      {
        "id": 369807,
        "text": "<p><span style=\"font-size:14.0pt;\">All statements are true</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Regarding MALDI-TOF mass spectrometry for bacterial identification, which of the following statements are true?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The technology primarily analyzes ribosomal proteins in the 2,000-20,000 Dalton range</span></li><li><span style=\"font-size:14.0pt;\">\u03b1-cyano-4-hydroxycinnamic acid matrix is required for ionization of bacterial proteins</span></li><li><span style=\"font-size:14.0pt;\">Protein fingerprinting can differentiate between methicillin-sensitive and methicillin-resistant S. aureus</span></li><li><span style=\"font-size:14.0pt;\">Multiple samples can be analyzed simultaneously on a single target plate</span></li></ol>",
    "unique_key": "Q8744437",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2 and 4 only&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>The technology primarily analyzes ribosomal proteins in the 2,000-20,000 Dalton range:&nbsp;</strong>True. MALDI-TOF predominantly detects ribosomal proteins, which comprise up to 20% of bacterial cellular proteins and are ideal identification markers due to their abundance and species-specific composition. The 2,000-20,000 Dalton range captures both 30S and 50S ribosomal subunit proteins, with most diagnostic peaks appearing between 4,000-12,000 Da. This mass range is optimal as it avoids small molecules below 2,000 Da and large proteins above 20,000 Da that ionize poorly. Each bacterial species produces a unique pattern of ribosomal protein masses in this range, creating a characteristic fingerprint for identification.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>\u03b1-cyano-4-hydroxycinnamic acid matrix is required for ionization of bacterial proteins:&nbsp;</strong>True.<strong>&nbsp;</strong>HCCA matrix is essential for MALDI-TOF because proteins cannot be directly ionized by laser without fragmentation. The matrix co-crystallizes with bacterial proteins and absorbs laser energy at 337 nm, preventing protein damage while facilitating their ionization through proton transfer. HCCA enables \"soft ionization\" where matrix molecules carry intact proteins into gas phase as charged ions. This matrix is specifically optimal for bacterial ribosomal proteins, providing the best resolution and sensitivity for bacterial identification compared to other available matrices.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Multiple samples can be analyzed simultaneously on a single target plate:&nbsp;</strong>True. MALDI-TOF target plates contain 48-96 spots (some up to 384), each holding one sample. After loading all samples with matrix, the instrument automatically analyzes each spot sequentially, taking only 1-3 seconds per spot. A 96-sample plate completes analysis in under 10 minutes. This high-throughput capability allows batch processing, multiple technicians to work simultaneously, and inclusion of quality controls on the same plate, making MALDI-TOF highly efficient and cost-effective for clinical laboratories.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Protein fingerprinting can differentiate between methicillin-sensitive and methicillin-resistant S. aureus:</strong> This is false. MALDI-TOF cannot distinguish MSSA from MRSA because methicillin resistance is mediated by the mecA gene encoding PBP2a protein, which represents less than 0.1% of total cellular proteins. This minor addition doesn't alter the dominant ribosomal protein peaks that form the identification fingerprint. Both MSSA and MRSA produce identical ribosomal protein patterns, resulting in the same spectral profile. MALDI-TOF identifies organisms at species level based on conserved proteins, not resistance mechanisms, making separate antimicrobial susceptibility testing necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">MALDI-TOF provides rapid bacterial identification through ribosomal protein analysis but cannot detect antibiotic resistance mechanisms, while offering high-throughput capability for multiple simultaneous samples.</span></p>",
    "correct_choice_id": 369805,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92877/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92877/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92874,
    "choices": [
      {
        "id": 369792,
        "text": "<p><span style=\"font-size:14.0pt;\">Internalin A binding to E-cadherin&nbsp;</span></p>"
      },
      {
        "id": 369793,
        "text": "<p><span style=\"font-size:14.0pt;\">Internalin B binding to Met receptor&nbsp;</span></p>"
      },
      {
        "id": 369794,
        "text": "<p><span style=\"font-size:14.0pt;\">Listeriolysin O mediated membrane disruption&nbsp;</span></p>"
      },
      {
        "id": 369795,
        "text": "<p><span style=\"font-size:14.0pt;\">ActA protein for actin polymerization</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A neonate develops early-onset sepsis with gram-positive rods showing tumbling motility at room temperature. The organism grows on PALCAM agar producing black colonies. Which virulence factor enables transplacental transmission of this organism?</span></p>",
    "unique_key": "Q1153149",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Internalin A binding to E-cadherin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The description indicates Listeria monocytogenes (tumbling motility at 20-25\u00b0C, black colonies on PALCAM agar).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Listeria monocytogens causes early-onset neonatal sepsis through transplacental transmission.</span></li><li><span style=\"font-size:14.0pt;\">Internalin A (InlA) specifically binds to E-cadherin on the basolateral surface of syncytiotrophoblasts in placental tissue.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This interaction is crucial for crossing the placental barrier. Notably, human E-cadherin has higher affinity for InlA compared to mouse E-cadherin, explaining why mice are relatively resistant to transplacental listeriosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">InlA-E-cadherin interaction triggers bacterial internalization into placental cells, enabling fetal infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Internalin B binding to Met receptor:</strong> InlB binds Met receptor and aids invasion but is not specific for placental transmission</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Listeriolysin O mediated membrane disruption:</strong> Listeriolysin O enables phagosomal escape after internalization, not initial placental invasion</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>ActA protein for actin polymerization:</strong> ActA mediates actin-based motility for cell-to-cell spread but doesn't initiate placental crossing</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Listeria monocytogenes crosses the placental barrier through Internalin A binding to E-cadherin on syncytiotrophoblasts, causing transplacental infection.</span></p>",
    "correct_choice_id": 369792,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92874/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92874/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93254,
    "choices": [
      {
        "id": 371288,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/A_tX7HtHu.jpg\" width=\"1151\" height=\"201\"></p>"
      },
      {
        "id": 371289,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/B_ajSdhMT.jpg\" width=\"1192\" height=\"160\"></p>"
      },
      {
        "id": 371290,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20124907.jpg\" width=\"1217\" height=\"173\"></p>"
      },
      {
        "id": 371291,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/D.jpg\" width=\"972\" height=\"164\"></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best represents the correct Bayes\u2019 theorem-based formula for Positive Predictive Value (PPV)?</span></p>",
    "unique_key": "Q3313190",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zGiEsIS.png\" width=\"758\" height=\"108\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bayes' theorem allows us to calculate the <strong>Positive Predictive Value (PPV)</strong>, which is the probability that a person who tests positive actually has the disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The correct formula is:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EsUMQSn.png\" width=\"932\" height=\"107\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This formula takes into account:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>True Positives</strong>: Sensitivity \u00d7 Prevalence</span></li><li><span style=\"font-size:14.0pt;\"><strong>False Positives</strong>: (1 - Specificity) \u00d7 (1 - Prevalence)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Positive Predictive Value (PPV)</strong> reflects the probability that a person with a positive test actually has the disease.</span></li><li><span style=\"font-size:14.0pt;\">It increases with higher <strong>prevalence</strong> and higher <strong>specificity</strong>, and is calculated using Bayes\u2019 theorem:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_sGUXOIe.png\" width=\"960\" height=\"101\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note \u2013 Prevalence is Pre-test probability and PPV is Post-test probability of a disease.&nbsp;</strong></span></p>",
    "correct_choice_id": 371290,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93254/Neet_Pg_22_Sept_2025_Psm_Q_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93254/Neet_Pg_22_Sept_2025_Psm_Q_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93569,
    "choices": [
      {
        "id": 372524,
        "text": "<p><span style=\"font-size:14.0pt;\">Headache severity correlates with the size of the adenoma.</span></p>"
      },
      {
        "id": 372525,
        "text": "<p><span style=\"font-size:14.0pt;\">Single most important test to diagnose acromegaly is serum IGF-1.</span></p>"
      },
      {
        "id": 372526,
        "text": "<p><span style=\"font-size:14.0pt;\">ADH deficiency causing central diabetes insipidus indicates a pituitary lesion.</span></p>"
      },
      {
        "id": 372527,
        "text": "<p><span style=\"font-size:14.0pt;\">Most pituitary incidentalomas are likely to be functioning.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old woman underwent an MRI for persistent headaches, revealing an 8-mm mass near the sella turcica, suggestive of a pituitary adenoma. Which of the following statements is true regarding pituitary adenoma?</span></p>",
    "unique_key": "Q4037908",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Single most important test to diagnose acromegaly is serum IGF-1.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s presentation (20-year-old woman with headaches and an 8-mm sellar mass on MRI) suggests a <strong>pituitary adenoma</strong>, likely an <strong>incidentaloma</strong> (asymptomatic mass found during imaging for unrelated symptoms).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Pituitary adenomas are classified as microadenomas (&lt;10 mm) or macroadenomas (\u226510 mm) and can be functioning (hormone-secreting) or non-functioning.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>single most important test to diagnose acromegaly</strong> is <strong>serum insulin-like growth factor-1 (IGF-1)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Acromegaly, caused by a growth hormone (GH)-secreting pituitary adenoma, leads to elevated IGF-1 levels, which reflect integrated GH secretion over time.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Elevated age- and sex-adjusted IGF-1 is highly sensitive and specific for acromegaly, with confirmation via oral glucose tolerance test (OGTT) showing failure of GH suppression (&lt;1 ng/mL).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this patient, while acromegaly is not clinically evident, IGF-1 is the key diagnostic test for suspected GH-secreting adenomas.</span></li><li><span style=\"font-size:14.0pt;\">Evaluation of an incidental pituitary adenoma includes hormonal workup (e.g., IGF-1, prolactin, ACTH, TSH) and visual field testing (less critical for microadenomas).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Management depends on whether the adenoma is functioning or causing mass effects.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Headache severity correlates with the size of the adenoma</strong>: False. Headaches in pituitary adenomas are common but do not consistently correlate with adenoma size. Microadenomas (&lt;10 mm, as in this case) can cause headaches due to dural stretch or hormonal effects, while macroadenomas may cause headaches via mass effect (e.g., optic chiasm compression). Severity varies individually and is not a reliable indicator of size.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. ADH deficiency causing central diabetes insipidus indicates a pituitary lesion</strong>: False. Central diabetes insipidus (DI) due to antidiuretic hormone (ADH, vasopressin) deficiency typically results from lesions affecting the <strong>posterior pituitary</strong> or <strong>hypothalamus</strong> (e.g., craniopharyngioma, trauma, or infiltrative diseases like sarcoidosis). Most pituitary adenomas (anterior pituitary) do not cause ADH deficiency, as ADH is produced by the hypothalamus and stored in the posterior pituitary. DI is rare in pituitary adenomas unless there is significant stalk or hypothalamic involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Most pituitary incidentalomas are likely to be functioning</strong>: False. Most pituitary incidentalomas are <strong>non-functioning adenomas</strong> (60\u201370%), not secreting hormones. Functioning adenomas (e.g., prolactinomas, GH-secreting, ACTH-secreting) are less common, with prolactinomas being the most frequent among functioning types. Hormonal workup (e.g., prolactin, IGF-1) is needed to determine functionality, but the majority of incidentalomas are non-functioning microadenomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Serum IGF-1 is the primary test for diagnosing acromegaly due to a GH-secreting pituitary adenoma.</span></li><li><span style=\"font-size:14.0pt;\">Most pituitary incidentalomas are non-functioning microadenomas, not hormone-secreting.</span></li><li><span style=\"font-size:14.0pt;\">Central diabetes insipidus is typically caused by hypothalamic or posterior pituitary lesions, not anterior pituitary adenomas.</span></li></ul>",
    "correct_choice_id": 372525,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93569/NEET_PG_22_Sep_2025_MEDICINE_Question_6.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93569/NEET_PG_22_Sep_2025_MEDICINE_Question_6.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93518,
    "choices": [
      {
        "id": 372324,
        "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-a, 3-d, 4-c</span></p>"
      },
      {
        "id": 372325,
        "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-b, 3-c, 4-a</span></p>"
      },
      {
        "id": 372326,
        "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-d, 3-b, 4-a</span></p>"
      },
      {
        "id": 372327,
        "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-c, 3-b, 4-d</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">List I (Breathing Patterns):&nbsp;</span></p><ol><li><span style=\"font-size:14.0pt;\">Cheyne\u2013Stokes respiration</span></li><li><span style=\"font-size:14.0pt;\">Kussmaul breathing</span></li><li><span style=\"font-size:14.0pt;\">Biot\u2019s breathing&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Apneustic breathing</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">List II (Causes/Associations):</span></p><ol style=\"list-style-type:lower-latin;\"><li><span style=\"font-size:14.0pt;\">Damage to the pons, causing prolonged inspiratory pauses</span></li><li><span style=\"font-size:14.0pt;\">Severe metabolic acidosis (e.g., diabetic ketoacidosis, renal failure)</span></li><li><span style=\"font-size:14.0pt;\">Increased intracranial pressure, meningitis, or medullary damage \u2192 irregular breathing with abrupt apneas</span></li><li><span style=\"font-size:14.0pt;\">Congestive heart failure or delayed central CO\u2082 detection \u2192 cyclic hyperventilation followed by apnea</span></li></ol>",
    "unique_key": "Q6309232",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1-d, 2-b, 3-c, 4-a</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1. Cheyne\u2013Stokes respiration (d):</strong> Seen in heart failure and CNS lesions. Caused by <strong>delayed detection of CO\u2082 by central chemoreceptors</strong>, leading to waxing and waning breathing.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2. Kussmaul breathing (b):</strong> Deep, rapid breathing to blow off CO\u2082 in <strong>severe metabolic acidosis</strong> such as diabetic ketoacidosis or chronic renal failure.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3. Biot\u2019s breathing (c):</strong> Irregular breathing with abrupt apneas, caused by <strong>medullary damage, meningitis, or increased intracranial pressure</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4. Apneustic breathing (a):</strong> Prolonged inspiratory pauses due to <strong>pons (lower pontine) damage</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Abnormal breathing patterns help localize pathology:&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cheyne\u2013Stokes \u2192 heart failure/CO\u2082 delay,&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Kussmaul \u2192 metabolic acidosis,&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Biot\u2019s \u2192 medullary lesions/ICP,&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Apneustic \u2192 pontine lesions.</span></li></ul>",
    "correct_choice_id": 372325,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93518/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_6.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      2
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93518/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_6.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92940,
    "choices": [
      {
        "id": 370052,
        "text": "<p><span style=\"font-size:14.0pt;\">The toxicology expert\u2019s testimony is inadmissible because they did not have first-hand knowledge of the victim\u2019s condition at the time of death.</span></p>"
      },
      {
        "id": 370053,
        "text": "<p><span style=\"font-size:14.0pt;\">The toxicology testimony is admissible as it is based on expert opinion, not on first-hand knowledge.</span></p>"
      },
      {
        "id": 370054,
        "text": "<p><span style=\"font-size:14.0pt;\">The forensic expert\u2019s testimony is admissible only if it can be corroborated by a common witness who had first-hand knowledge of the victim\u2019s condition.</span></p>"
      },
      {
        "id": 370055,
        "text": "<p><span style=\"font-size:14.0pt;\">Both A and C</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">In a case of death due to alleged poisoning, the prosecution presents a&nbsp;toxicology expert&nbsp;who testifies that the victim\u2019s body had toxic substance based on the analysis of the stomach contents.&nbsp;The defence argues that the expert\u2019s testimony should be inadmissible as toxicology expert neither examined the victim while he was alive, nor he conducted the autopsy himself. Which of the below is true?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q2158855",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) The toxicology testimony is admissible as it is based on expert opinion, not on first-hand knowledge.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Expert testimony </strong>can be based on facts or data that the expert has knowledge of, even if they weren't directly involved in gathering those facts.</span></li><li><span style=\"font-size:14.0pt;\">In this case, the toxicologist analyzed the victim's stomach contents and can provide an expert opinion about the presence of a toxic substance.</span></li><li><span style=\"font-size:14.0pt;\">The fact that the expert didn't examine the victim while alive or perform the autopsy does not necessarily make the testimony inadmissible.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>The toxicology expert\u2019s testimony is inadmissible because they did not have first-hand knowledge of the victim\u2019s condition at the time of death:</strong>&nbsp;Toxicologist doesn't need first-hand knowledge of the victim's condition at the time of death. The testimony is based on their expertise in analyzing evidence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>The forensic expert\u2019s testimony is admissible only if it can be corroborated by a common witness who had first-hand knowledge of the victim\u2019s condition:&nbsp;</strong>Expert testimony does not require corroboration from a common witness with first-hand knowledge of the victim's condition.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A toxicology expert\u2019s opinion is valid and admissible in court as long as it is scientifically grounded and within their area of expertise, regardless of whether they directly examined the victim or performed the autopsy.</span></p>",
    "correct_choice_id": 370053,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92940/NEET_PG_22_Sep_2025_FMT_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      10
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92940/NEET_PG_22_Sep_2025_FMT_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93318,
    "choices": [
      {
        "id": 371540,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2</span></p>"
      },
      {
        "id": 371541,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 371542,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 371543,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4, 5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following surgical procedures are used as palliative operations in Tetralogy of Fallot (TOF)?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Modified Blalock-Taussig shunt</span></li><li><span style=\"font-size:14.0pt;\">Waterston-Cooley shunt</span></li><li><span style=\"font-size:14.0pt;\">Potts shunt</span></li><li><span style=\"font-size:14.0pt;\">Aortoplasty</span></li><li><span style=\"font-size:14.0pt;\">Cutting and end-to-end anastomosis of the aorta</span></li></ol>",
    "unique_key": "Q4862818",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Modified Blalock-Taussig shunt:</strong> Most widely used palliative shunt for TOF, connects the subclavian artery to the pulmonary artery using a graft.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Waterston-Cooley shunt:</strong> Historical procedure connecting the ascending aorta to the right pulmonary artery, used in TOF before definitive repair techniques improved.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Potts shunt:</strong> Historical shunt connecting the descending aorta to the left pulmonary artery; increased pulmonary blood flow but is no longer commonly used.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Aortoplasty:</strong> Indicated in coarctation of the aorta, not TOF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5. Cutting and end-to-end anastomosis of the aorta:</strong> Also a surgery for coarctation of the aorta, with no role in TOF management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Palliative shunt surgeries for TOF include the modified Blalock-Taussig, Waterston, and Potts shunts, whereas aortoplasty and end-to-end anastomosis are exclusively for coarctation of the aorta.</span></p>",
    "correct_choice_id": 371541,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93318/NEET_PG_22_Sep_2025_PEDIATRICS_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      13
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93318/NEET_PG_22_Sep_2025_PEDIATRICS_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93568,
    "choices": [
      {
        "id": 372520,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
      },
      {
        "id": 372521,
        "text": "<p><span style=\"font-size:14.0pt;\">3, 4</span></p>"
      },
      {
        "id": 372522,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
      },
      {
        "id": 372523,
        "text": "<p><span style=\"font-size:14.0pt;\">4 only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman, 10 weeks pregnant, presents with fever, chills, and altered sensorium, diagnosed with severe falciparum malaria confirmed by peripheral smear. Which of the following drugs cannot be used for her treatment?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Quinine</span></li><li><span style=\"font-size:14.0pt;\">Doxycycline</span></li><li><span style=\"font-size:14.0pt;\">Artesunate</span></li><li><span style=\"font-size:14.0pt;\">Primaquine</span></li></ol>",
    "unique_key": "Q9042332",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 2, 4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient, at 10 weeks gestation (first trimester), has <strong>severe falciparum malaria</strong>, a life-threatening condition requiring urgent treatment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Severe malaria in pregnancy necessitates parenteral antimalarials initially, followed by oral therapy, with careful consideration of drug safety due to fetal risks.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Treatment approach</strong>: Severe falciparum malaria in the first trimester is treated with <strong>parenteral artesunate</strong> (first-line) or <strong>quinine</strong> (alternative if artesunate is unavailable), followed by oral artemisinin-based combination therapy (ACT) or quinine plus clindamycin.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Local measures (e.g., supportive care, monitoring) are critical, but drug safety is paramount.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Doxycycline</strong>: Contraindicated in pregnancy, especially in the first trimester, due to risks of fetal bone and dental developmental abnormalities (e.g., tooth discoloration, impaired bone growth). It is a tetracycline antibiotic not recommended for malaria treatment in pregnant women.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Primaquine</strong>: Contraindicated in pregnancy due to the risk of hemolytic anemia in the fetus, particularly if G6PD status is unknown. It is used for radical cure of Plasmodium vivax or ovale, not falciparum malaria, and is avoided in pregnancy across all trimesters.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Parenteral artesunate is the first-line treatment for severe malaria in all trimesters of pregnancy.</span></li><li><span style=\"font-size:14.0pt;\">Quinine is a safe alternative for severe malaria in the first trimester when artesunate is unavailable.</span></li><li><span style=\"font-size:14.0pt;\">Doxycycline and primaquine are contraindicated in pregnancy due to fetal risks of developmental abnormalities and hemolysis, respectively.</span></li></ul>",
    "correct_choice_id": 372522,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93568/Neet_Pg_22_Sep_2025_Medicine_Question_51.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93568/Neet_Pg_22_Sep_2025_Medicine_Question_51.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93327,
    "choices": [
      {
        "id": 371576,
        "text": "<p><span style=\"font-size:14.0pt;\">Herald patch precedes eruptions by 1\u20132 weeks</span></p>"
      },
      {
        "id": 371577,
        "text": "<p><span style=\"font-size:14.0pt;\">Caused by HHV 7 &amp; 6</span></p>"
      },
      {
        "id": 371578,
        "text": "<p><span style=\"font-size:14.0pt;\">Can be drug induced</span></p>"
      },
      {
        "id": 371579,
        "text": "<p><span style=\"font-size:14.0pt;\">Has a very chronic course</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 22-year-old woman presents with multiple oval, scaly plaques on her trunk, distributed along the lines of cleavage in a classic \u201cChristmas tree\u201d arrangement. Which of the following statements about pityriasis rosea is not true?&nbsp;</span></p>",
    "unique_key": "Q5201911",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Has a very chronic course</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pityriasis rosea does not have a very chronic course; rather, it is an <strong>acute and self-limiting</strong> dermatosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It usually resolves within 6\u201312 weeks without scarring. Thus, describing it as having a \u201cvery chronic course\u201d is not true, which makes this the correct Ans.&nbsp;to the question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Herald patch precedes eruptions by 1\u20132 weeks:&nbsp;</strong>This statement is true. In pityriasis rosea, a single larger lesion known as the herald patch typically appears before the eruption of generalized lesions. The interval is usually 1\u20132 weeks, and this feature is considered classical.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Caused by HHV 7 &amp; 6:&nbsp;</strong>This is also true. Although the exact cause of pityriasis rosea is not fully understood, human herpesvirus types 6 and 7 (HHV-6 and HHV-7) are most commonly implicated in its pathogenesis. Therefore, attributing it to these viruses is correct.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Can be drug induced:&nbsp;</strong>This is true as well. Pityriasis rosea\u2013like eruptions can occur secondary to certain medications. Drugs such as ACE inhibitors, metronidazole, gold, and others have been reported to trigger PR-like presentations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pityriasis rosea is an <strong>acute, self-limiting dermatosis</strong> characterized by a herald patch, \u201cChristmas tree\u201d distribution, possible drug-induced variants, and an association with HHV-6/7.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It resolves spontaneously in 6\u201312 weeks, and it does <strong>not</strong> have a chronic course.</span></li></ul>",
    "correct_choice_id": 371579,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93327/NEET_PG_22_Sep_2025_Derma_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      18
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93327/NEET_PG_22_Sep_2025_Derma_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93543,
    "choices": [
      {
        "id": 372424,
        "text": "<p><span style=\"font-size:14.0pt;\">Immediate induction of labor</span></p>"
      },
      {
        "id": 372425,
        "text": "<p><span style=\"font-size:14.0pt;\">Plan delivery at 37 weeks with maternal monitoring (including BP) and fetal surveillance</span></p>"
      },
      {
        "id": 372426,
        "text": "<p><span style=\"font-size:14.0pt;\">Emergency cesarean delivery</span></p>"
      },
      {
        "id": 372427,
        "text": "<p><span style=\"font-size:14.0pt;\">Weekly liver function tests with plan for delivery at 34 weeks</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old G2P1L1 at 33 weeks presents with nocturnal pruritus predominantly on the palms, a history of similar symptoms in her first pregnancy, mild icterus, and normal blood pressure (130/84 mmHg). On abdominal exam, the uterus measures about 32 weeks, and fetal heart rate is 140 bpm. Labs show SGOT 112 IU/L, SGPT 124 IU/L, and serum bilirubin 2 mg%. What is the next best step in management?</span></p>",
    "unique_key": "Q2582437",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Plan delivery at 37 weeks with maternal monitoring (including BP) and fetal surveillance</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This clinical picture\u2014<strong>27-year-old</strong>, <strong>G2P1L1</strong>, <strong>33 weeks</strong>, <strong>itching worse at night</strong> on the <strong>palms</strong>, <strong>mild icterus</strong>, <strong>elevated transaminases (SGOT 112 IU/L, SGPT 124 IU/L)</strong>, and <strong>serum bilirubin 2 mg%</strong>, with <strong>BP 130/84 mmHg</strong> and <strong>FHR 140 bpm</strong>\u2014is classic for <strong>intrahepatic cholestasis of pregnancy (ICP)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>next best step</strong> is <strong>expectant management with close maternal\u2013fetal monitoring and planned delivery at 37 weeks</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This balances the risk of <strong>stillbirth</strong> associated with ICP against prematurity; standard practice is to <strong>plan delivery at 36\u201337 weeks</strong>, commonly <strong>37 weeks</strong> when the patient is stable, as here.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Monitoring includes maternal status (including <strong>BP</strong>, even though it\u2019s normal at <strong>130/84 mmHg</strong>), <strong>serial LFTs</strong>, pruritus control (e.g., <strong>ursodeoxycholic acid</strong>), and <strong>fetal surveillance</strong> (e.g., NST/BPP).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The uterus measuring <strong>~32 weeks</strong> at <strong>33 weeks</strong> and <strong>FHR 140 bpm</strong> (normal baseline) support stability and allow planned timing.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Immediate induction of labor</strong>: Incorrect. At <strong>33 weeks</strong>, immediate delivery is not indicated in a <strong>stable</strong> ICP patient with <strong>FHR 140 bpm</strong>, <strong>BP 130/84 mm Hg</strong>, <strong>mild icterus</strong>, <strong>SGOT 112</strong>, <strong>SGPT 124</strong>, and <strong>bilirubin 2 mg%</strong>. Early induction would increase prematurity risk without urgent maternal/fetal compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Emergency cesarean delivery</strong>: Incorrect. There is no obstetric emergency. ICP with <strong>no fetal distress</strong> (FHR normal at <strong>140 bpm</strong>) and <strong>stable maternal vitals</strong> (<strong>130/84 mm Hg</strong>) is managed expectantly; <strong>mode of delivery</strong> is based on usual obstetric indications, not ICP alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Weekly liver function tests with plan for delivery at 34 weeks:</strong></span><br><span style=\"font-size:14.0pt;\">Weekly LFTs are part of monitoring, but <strong>delivery at 34 weeks</strong> is not routinely indicated unless <strong>LFTs worsen severely</strong> or other complications arise. <strong>Delivery at 37 weeks</strong> is standard.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>intrahepatic cholestasis of pregnancy</strong>\u2014characterized by <strong>pruritus (often nocturnal, palms/soles)</strong>, <strong>elevated LFTs</strong>, and possible <strong>mild jaundice</strong>\u2014the <strong>next best step</strong> in a <strong>stable</strong> patient at <strong>~33 weeks</strong> is <strong>expectant management with surveillance and planned delivery at 37 weeks</strong> to mitigate stillbirth risk while minimizing prematurity.</span></p>",
    "correct_choice_id": 372425,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93543/NEET_PG_22_Sep_2025_OBG_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93543/NEET_PG_22_Sep_2025_OBG_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93626,
    "choices": [
      {
        "id": 372744,
        "text": "<p><span style=\"font-size:14.0pt;\">It requires a mandatory test dose before administration</span></p>"
      },
      {
        "id": 372745,
        "text": "<p><span style=\"font-size:14.0pt;\">It is administered by intravenous route</span></p>"
      },
      {
        "id": 372746,
        "text": "<p><span style=\"font-size:14.0pt;\">It has a high risk of causing hypophosphatemia compared to ferric carboxymaltose</span></p>"
      },
      {
        "id": 372747,
        "text": "<p><span style=\"font-size:14.0pt;\">It is contraindicated in patients receiving erythropoietin therapy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old man with chronic kidney disease on erythropoietin therapy develops severe iron-deficiency anemia. His nephrologist decides to start intravenous iron therapy. Which of the following statements about&nbsp;iron isomaltoside&nbsp;is correct?</span></p>",
    "unique_key": "Q5624787",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) It is administered by intravenous route</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The drug is given&nbsp;<strong>intravenously</strong>&nbsp;(bolus or infusion).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its main advantage is that a&nbsp;<strong>large single dose (up to 1000 mg)</strong>&nbsp;can be given safely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It requires a mandatory test dose before administration:&nbsp;</strong>Incorrect.&nbsp;Iron isomaltoside has a low risk of hypersensitivity, unlike high-molecular weight iron dextran.&nbsp;<strong>No test dose is required.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It has a high risk of causing hypophosphatemia compared to ferric carboxymaltose:&nbsp;</strong>Incorrect.&nbsp;This is actually a feature of&nbsp;<strong>ferric carboxymaltose</strong>, not iron isomaltoside. Iron isomaltoside has&nbsp;<strong>much lower risk</strong>&nbsp;of causing hypophosphatemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is contraindicated in patients receiving erythropoietin therapy:&nbsp;</strong>Incorrect.&nbsp;In fact, IV iron (including isomaltoside) is often used&nbsp;<strong>together with ESAs</strong>&nbsp;in CKD to optimize hemoglobin response.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Iron isomaltoside is an intravenous iron formulation with lower immunogenicity than iron dextran, does not require a test dose, does not cause hypophosphatemia and can be co-administered with erythropoietin in anemia of chronic kidney disease.</span></p>",
    "correct_choice_id": 372745,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93626/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_8.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93626/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_8.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93650,
    "choices": [
      {
        "id": 372836,
        "text": "<p><span style=\"font-size:14.0pt;\">CK5/6+ and p63+</span></p>"
      },
      {
        "id": 372837,
        "text": "<p><span style=\"font-size:14.0pt;\">TTF-1 positive</span></p>"
      },
      {
        "id": 372838,
        "text": "<p><span style=\"font-size:14.0pt;\">CK7+ and CK20+</span></p>"
      },
      {
        "id": 372839,
        "text": "<p><span style=\"font-size:14.0pt;\">CK7\u2013 and CK20\u2013</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 59-year-old man presents with painless hematuria persisting for a month. He has a long history of smoking and exposure to industrial chemicals. Urinalysis shows red blood cells, and cystoscopy reveals a suspicious bladder lesion. Which of the following immunohistochemical profiles is most consistent with this condition?&nbsp;</span></p>",
    "unique_key": "Q6840920",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) CK7+ and CK20+</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 59-year-old man with painless hematuria, along with risk factors of smoking and industrial chemical exposure (e.g., benzidine, aniline dyes), has classic features of urothelial carcinoma (bladder cancer).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The suspicious lesion seen on cystoscopy supports this diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">On immunohistochemistry, urothelial carcinoma typically shows positivity for both CK7 and CK20 (i.e., CK7+ and CK20+).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Cytokeratins are structural proteins of epithelial cells, and this dual positivity helps identify primary bladder cancer and distinguish it from other malignancies.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the most likely immunohistochemical result is CK7+ and CK20+.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. CK5/6+ and p63+</strong>: This immunoprofile is associated with squamous cell carcinoma, particularly of the lung or cervix, not with urothelial carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. TTF-1 positive:&nbsp;</strong>Thyroid transcription factor-1 (TTF-1) positivity is characteristic of lung adenocarcinoma and thyroid neoplasms, not bladder carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CK7\u2013 and CK20\u2013:&nbsp;</strong>This negative profile can be seen in renal cell carcinoma or hepatocellular carcinoma, but not in urothelial carcinoma, which typically expresses both CK7 and CK20.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bladder urothelial carcinoma, strongly associated with smoking and aromatic amine exposure, presents with painless hematuria and shows CK7+ and CK20+ immunohistochemical expression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note: Approach to Cytokeratin in Adenocarcinoma of Unknown primary (CK7; CK20):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20170008.jpg\" width=\"918\" height=\"397\"></strong></span></p>",
    "correct_choice_id": 372838,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93650/NEET_PG_22_Sep_2025_Pathology_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      5
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93650/NEET_PG_22_Sep_2025_Pathology_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93263,
    "choices": [
      {
        "id": 371324,
        "text": "<p><span style=\"font-size:14.0pt;\">110\u2013130 mmHg</span></p>"
      },
      {
        "id": 371325,
        "text": "<p><span style=\"font-size:14.0pt;\">100\u2013140 mmHg</span></p>"
      },
      {
        "id": 371326,
        "text": "<p><span style=\"font-size:14.0pt;\">90\u2013150 mmHg</span></p>"
      },
      {
        "id": 371327,
        "text": "<p><span style=\"font-size:14.0pt;\">105\u2013135 mmHg</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">In a population, the mean systolic blood pressure is 120 mmHg with a standard deviation (SD) of 10 mmHg. What range of values would include approximately 95% of the population?</span></p>",
    "unique_key": "Q9732530",
    "difficulty_level": "beginner",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) 100\u2013140 mmHg</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is based on the <strong>Empirical Rule</strong> (also known as the <strong>68-95-99.7 rule</strong>) for <strong>normal (Gaussian) distribution</strong>:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>68%</strong> of data lie within <strong>\u00b11 SD</strong> from the mean</span></li><li><span style=\"font-size:14.0pt;\"><strong>95%</strong> lie within <strong>\u00b12 SD</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>99.7%</strong> lie within <strong>\u00b13 SD</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20130600.jpg\" width=\"865\" height=\"557\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Given:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mean = 120 mmHg</span></li><li><span style=\"font-size:14.0pt;\">SD = 10 mmHg</span></li><li><span style=\"font-size:14.0pt;\">\u00b12 SD = 120 \u00b1 (2 \u00d7 10) = <strong>100 to 140 mmHg</strong></span></li><li><span style=\"font-size:14.0pt;\">So, approximately 95% of the population would have systolic BP in the range <strong>100\u2013140 mmHg</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a normally distributed population, 95% of values lie within two standard deviations (\u00b12 SD) of the mean.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This principle is crucial for estimating confidence intervals and evaluating population variability in clinical and research settings.</span></li></ul>",
    "correct_choice_id": 371325,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93263/Neet_Pg_22_Sept_2025_Psm_Q_11.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      7
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93263/Neet_Pg_22_Sept_2025_Psm_Q_11.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93600,
    "choices": [
      {
        "id": 372640,
        "text": "<p><span style=\"font-size:14.0pt;\">White blood cell count &gt;25,000/mm\u00b3</span></p>"
      },
      {
        "id": 372641,
        "text": "<p><span style=\"font-size:14.0pt;\">Pleural fluid to serum glucose ratio of 0.2</span></p>"
      },
      {
        "id": 372642,
        "text": "<p><span style=\"font-size:14.0pt;\">Serum:pleural albumin gradient &lt;1.2 g/dL</span></p>"
      },
      {
        "id": 372643,
        "text": "<p><span style=\"font-size:14.0pt;\">Pleural fluid LDH:serum LDH &gt;0.6</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 48-year-old man with a 14-year history of rheumatoid arthritis treated with methotrexate presents with dyspnea and pleuritic chest pain for several weeks. Chest X-ray reveals a unilateral pleural effusion. Thoracentesis is performed to analyze the pleural fluid. Which of the following findings is not consistent with a rheumatoid pleural effusion?</span></p>",
    "unique_key": "Q9875607",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) White blood cell count &gt;25,000/mm\u00b3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s long-standing rheumatoid arthritis (RA), dyspnea, pleuritic chest pain, and unilateral pleural effusion on chest X-ray suggest a <strong>rheumatoid pleural effusion</strong>, a known extra-articular manifestation of RA, particularly in men with chronic disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Rheumatoid effusions are typically <strong>exudative</strong> and have specific pleural fluid characteristics: low pH (&lt;7.3), low glucose (&lt;50 mg/dL or pleural fluid:serum glucose ratio &lt;0.5), high lactate dehydrogenase (LDH, often &gt;700 IU/L or fluid:serum LDH &gt;0.6), and a serum:pleural albumin gradient &lt;1.2 g/dL (indicating exudate per Light\u2019s criteria).</span></li><li><span style=\"font-size:14.0pt;\">A <strong>white blood cell (WBC) count &gt;25,000/mm\u00b3</strong> in pleural fluid is suggestive of an <strong>empyema</strong> or parapneumonic effusion, <strong>not a rheumatoid effusion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Rheumatoid pleural effusions typically have a WBC count of 1,000 - 5,000/mm\u00b3, predominantly lymphocytes or monocytes, reflecting chronic inflammation rather than acute purulent infection.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A count &gt;25,000/mm\u00b3 would raise suspicion for infection, which is not typical for RA-related effusions unless complicated by secondary infection.</span></li><li><span style=\"font-size:14.0pt;\">Thoracentesis analysis is critical to differentiate rheumatoid effusions from other causes (e.g., infection, malignancy).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Management includes optimizing RA treatment (e.g., methotrexate continuation, possible steroids) and, in severe cases, drainage or pleurodesis, but infection must be ruled out.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pleural fluid to serum glucose ratio of 0.2</strong>: Consistent. Rheumatoid pleural effusions characteristically have very low glucose levels (&lt;50 mg/dL) and a pleural fluid:serum glucose ratio &lt;0.5 (e.g., 0.2), due to glucose consumption by inflamed pleura and impaired transport across the pleural membrane, a hallmark feature of RA effusions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Serum:pleural albumin gradient &lt;1.2 g/dL</strong>: Consistent. This indicates an exudative effusion per Light\u2019s criteria (serum albumin minus pleural fluid albumin &lt;1.2 g/dL). Rheumatoid effusions are exudative due to chronic inflammation, with high protein content, making this finding typical.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pleural fluid LDH:serum LDH &gt;0.6</strong>: Consistent. Rheumatoid effusions are exudative, with elevated LDH levels (often &gt;700 IU/L) and a pleural fluid:serum LDH ratio &gt;0.6, another Light\u2019s criterion for exudates, reflecting active pleural inflammation in RA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pleural fluid:serum glucose ratio &lt;0.5 is characteristic of rheumatoid pleural effusions.</span></li><li><span style=\"font-size:14.0pt;\">Serum:pleural albumin gradient &lt;1.2 g/dL and pleural fluid:serum LDH &gt;0.6 confirm exudative nature in RA effusions.</span></li><li><span style=\"font-size:14.0pt;\">WBC count &gt;25,000/mm\u00b3 suggests empyema, not typical rheumatoid effusion.</span></li></ul>",
    "correct_choice_id": 372640,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93600/NEET_PG_22_Sep_2025_MEDICINE_Question_13.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93600/NEET_PG_22_Sep_2025_MEDICINE_Question_13.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92950,
    "choices": [
      {
        "id": 370092,
        "text": "<p><span style=\"font-size:14.0pt;\">Argininosuccinate lyase</span></p>"
      },
      {
        "id": 370093,
        "text": "<p><span style=\"font-size:14.0pt;\">Ornithine-\u03b4-aminotransferase</span></p>"
      },
      {
        "id": 370094,
        "text": "<p><span style=\"font-size:14.0pt;\">Tyrosine hydroxylase</span></p>"
      },
      {
        "id": 370095,
        "text": "<p><span style=\"font-size:14.0pt;\">Phenylalanine hydroxylase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 13-year-old boy is evaluated for progressive vision loss, including night blindness and loss of peripheral vision. He also has myopia. Fundoscopic examination reveals gyrate atrophy of the choroid and retina. The patient has a family history of a similar disorder, and genetic testing confirms an autosomal recessive pattern of inheritance. This condition is most likely due to the deficiency of which of the following enzymes?</span></p>",
    "unique_key": "Q7087810",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Ornithine-\u03b4-aminotransferase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with symptoms of gyrate atrophy, an autosomal recessive condition caused by a deficiency of <strong>ornithine-\u03b4-aminotransferase</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This enzyme is responsible for converting ornithine into pyrroline-5-carboxylate in the mitochondria.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A deficiency in this enzyme leads to elevated levels of ornithine, which is toxic to the retina and choroid, resulting in the characteristic vision problems, including night blindness and loss of peripheral vision.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The condition also causes progressive degeneration of the retina, which is visible as gyrate atrophy on fundoscopic examination.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Argininosuccinate lyase:</strong> This enzyme is involved in the urea cycle, and its deficiency leads to argininosuccinic aciduria, a metabolic disorder that causes hyperammonemia. It is not associated with gyrate atrophy or the retinal findings described in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tyrosine hydroxylase:</strong> Deficiency of this enzyme can lead to tyrosine hydroxylase deficiency, which primarily affects dopamine synthesis, leading to movement disorders and developmental delays, but it does not cause gyrate atrophy or night blindness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Phenylalanine hydroxylase:</strong> Deficiency in this enzyme results in phenylketonuria (PKU), a condition marked by intellectual disability and musty body odor due to the inability to metabolize phenylalanine. It is not associated with vision problems or gyrate atrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Gyrate atrophy of the choroid and retina is an autosomal recessive condition caused by a deficiency of <strong>ornithine-\u03b4-aminotransferase</strong>, leading to progressive vision loss, including night blindness and peripheral vision deficits.</span></p>",
    "correct_choice_id": 370093,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92950/NEET_PG_22_Sep_2025_Biochemistry_Question_10.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      1
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92950/NEET_PG_22_Sep_2025_Biochemistry_Question_10.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93338,
    "choices": [
      {
        "id": 371616,
        "text": "<p><span style=\"font-size:14.0pt;\">Diastasis of pubis</span></p>"
      },
      {
        "id": 371617,
        "text": "<p><span style=\"font-size:14.0pt;\">Vesico-ureteric reflux</span></p>"
      },
      {
        "id": 371618,
        "text": "<p><span style=\"font-size:14.0pt;\">Inguinal hernia</span></p>"
      },
      {
        "id": 371619,
        "text": "<p><span style=\"font-size:14.0pt;\">Hypospadiasis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 1-year-old boy is brought to a tertiary care hospital because his parents noticed a red, exposed mass in the lower abdomen since birth. Which of the following is not typically associated with this condition?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gx5vH0m.png\" width=\"382\" height=\"388\"></strong></span></p>",
    "unique_key": "Q2619542",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Hypospadiasis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ectopia vesicae is usually associated with epispadiasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Diastasis of pubis: </strong>Children with bladder exstrophy have a wide separation of the pubic bones due to failure of midline closure during development. This results in an abnormal pelvic anatomy and contributes to genital malformations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Vesico-ureteric reflux:&nbsp;</strong>Because of abnormal anatomy of the bladder neck and vesicoureteric junction, vesico-ureteric reflux is a common association. This predisposes the child to recurrent urinary tract infections and potential renal damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Inguinal hernia:&nbsp;</strong>Up to 70-80% of patients with bladder exstrophy have inguinal hernias, often bilateral, due to weakness in the inguinal canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bladder exstrophy is associated with pubic diastasis, vesico-ureteric reflux, and genital malformations, but it predisposes to adenocarcinoma of the bladder\u2014not squamous cell carcinoma.</span></p>",
    "correct_choice_id": 371619,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93338/NEET_PG_22_Sep_2025_Surgery_Question_6.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      12
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93338/NEET_PG_22_Sep_2025_Surgery_Question_6.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93617,
    "choices": [
      {
        "id": 372708,
        "text": "<p><span style=\"font-size:14.0pt;\">Sertraline</span></p>"
      },
      {
        "id": 372709,
        "text": "<p><span style=\"font-size:14.0pt;\">Vilazodone</span></p>"
      },
      {
        "id": 372710,
        "text": "<p><span style=\"font-size:14.0pt;\">Cyproheptadine</span></p>"
      },
      {
        "id": 372711,
        "text": "<p><span style=\"font-size:14.0pt;\">Fluoxetine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man with a long-standing history of major depressive disorder has been stable on an SSRI for several months. Two weeks ago, he developed a complicated skin and soft tissue infection and was prescribed linezolid. He now presents with acute onset agitation, tremors, involuntary jerks of the extremities, diaphoresis, and hyperreflexia. On examination, he is restless, his temperature is mildly elevated, and he demonstrates myoclonus with inducible clonus at the ankle. Laboratory studies are unremarkable. Which of the following medications would be most appropriate for treating this patient\u2019s current condition?</span></p>",
    "unique_key": "Q3118206",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Cyproheptadine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient developed <strong>serotonin syndrome</strong> after starting <strong>linezolid</strong> while already on an SSRI for major depression.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Linezolid has <strong>monoamine oxidase inhibitor (MAOI) activity</strong>, and when combined with serotonergic drugs (SSRIs, SNRIs, TCAs, MAOIs, certain opioids), it can result in <strong>excess serotonergic activity</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clinical features</strong> of serotonin syndrome include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Neuromuscular hyperactivity</strong> \u2192 myoclonus, hyperreflexia, tremor, clonus</span></li><li><span style=\"font-size:14.0pt;\"><strong>Autonomic instability</strong> \u2192 diaphoresis, hyperthermia, hypertension, tachycardia</span></li><li><span style=\"font-size:14.0pt;\"><strong>Altered mental status</strong> \u2192 agitation, confusion</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Cyproheptadine</strong> is a <strong>serotonin receptor antagonist (5-HT2A blocker)</strong> and is the drug of choice for moderate to severe serotonin syndrome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sertraline:</strong> An SSRI; giving another serotonergic drug would worsen serotonin syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Vilazodone:</strong> An SSRI and partial 5-HT1A agonist; it also increases serotonergic activity, so it would exacerbate the syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fluoxetine:</strong> Another SSRI; like the others, it would further increase serotonin and worsen symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Serotonin syndrome results from excess serotonergic activity, often due to drug interactions such as SSRIs with linezolid.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clinical features include agitation, hyperreflexia, clonus, and myoclonus.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The specific antidote is cyproheptadine, a serotonin receptor antagonist.</span></li></ul>",
    "correct_choice_id": 372710,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93617/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93617/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93611,
    "choices": [
      {
        "id": 372684,
        "text": "<p><span style=\"font-size:14.0pt;\">I \u2013 g, II \u2013 b, III \u2013 e, IV \u2013 a</span></p>"
      },
      {
        "id": 372685,
        "text": "<p><span style=\"font-size:14.0pt;\">I \u2013 g, II \u2013 b, III \u2013 c, IV \u2013 f</span></p>"
      },
      {
        "id": 372686,
        "text": "<p><span style=\"font-size:14.0pt;\">I \u2013 a, II \u2013 b, III \u2013 c, IV \u2013 f</span></p>"
      },
      {
        "id": 372687,
        "text": "<p><span style=\"font-size:14.0pt;\">I \u2013 a, II \u2013 g, III \u2013 e, IV \u2013 f</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following systemic conditions to the ocular findings they are most commonly associated with:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-20%20165408.jpg\" width=\"986\" height=\"359\"></p>",
    "unique_key": "Q7046205",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) I \u2013 a, II \u2013 b, III \u2013 c, IV \u2013 f</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>I. Hypertensive retinopathy \u2192 a. Systemic lupus erythematosus (SLE): </strong>SLE can cause secondary hypertension, and hypertensive retinopathy can occur due to renal involvement and systemic vascular inflammation. Retinal changes in SLE often resemble hypertensive or vasculitic retinopathy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>II. Granulomatous uveitis \u2192 b. Sarcoidosis: </strong>Sarcoidosis is a granulomatous disease that commonly presents with <strong>granulomatous uveitis</strong>, characterized by mutton-fat keratic precipitates and iris nodules.</span></li><li><span style=\"font-size:14.0pt;\"><strong>III. Necrotizing chorioretinitis \u2192 c. CMV retinitis: </strong>CMV retinitis in immunocompromised patients (e.g., HIV/AIDS) presents with <strong>necrotizing chorioretinitis</strong>, typically described as \"pizza-pie\" or \"cottage cheese and ketchup\" appearance on fundus.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IV. Nuclear pearly cataract \u2192 f. Congenital rubella: </strong>Congenital rubella syndrome classically includes <strong>nuclear cataracts</strong>, sensorineural hearing loss, and cardiac defects. The cataract may have a pearly appearance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Systemic diseases often present with specific ocular findings</strong> that aid diagnosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Examples include:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>SLE</strong> with hypertensive-like retinopathy</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sarcoidosis</strong> with granulomatous uveitis</span></li><li><span style=\"font-size:14.0pt;\"><strong>CMV infection</strong> with necrotizing chorioretinitis</span></li><li><span style=\"font-size:14.0pt;\"><strong>Congenital rubella</strong> with nuclear cataract</span></li></ul></li></ul>",
    "correct_choice_id": 372686,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93611/NEET_PG_22_Sep_2025_Opthalmology_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      8
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93611/NEET_PG_22_Sep_2025_Opthalmology_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93637,
    "choices": [
      {
        "id": 372784,
        "text": "<p><span style=\"font-size:14.0pt;\">Protamine sulfate</span></p>"
      },
      {
        "id": 372785,
        "text": "<p><span style=\"font-size:14.0pt;\">Idarucizumab</span></p>"
      },
      {
        "id": 372786,
        "text": "<p><span style=\"font-size:14.0pt;\">Epsilon aminocaproic acid</span></p>"
      },
      {
        "id": 372787,
        "text": "<p><span style=\"font-size:14.0pt;\">Andexanet alfa</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old man with a history of ischemic stroke receives intravenous alteplase (tPA) for acute thrombolysis. Two hours later, he develops severe oropharyngeal bleeding and a rapidly expanding neck hematoma. The infusion is immediately stopped. Which of the following agents is the most appropriate antidote for reversing the effect of fibrinolytic therapy?</span></p>",
    "unique_key": "Q1349760",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Epsilon aminocaproic acid</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fibrinolytics (e.g., alteplase, reteplase, streptokinase, tenecteplase) work by converting <strong>plasminogen \u2192 plasmin</strong>, leading to degradation of fibrin clots.</span></li><li><span style=\"font-size:14.0pt;\">A dangerous adverse effect of fibrinolytics is <strong>severe bleeding</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Epsilon aminocaproic acid</strong> is a synthetic <strong>lysine analogue</strong> that <strong>inhibits plasminogen activation</strong>, thereby <strong>blocking fibrinolysis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is the specific <strong>antidote</strong> used to reverse fibrinolytic-induced bleeding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Protamine sulfate:&nbsp;</strong>Antidote for <strong>heparin toxicity</strong>, not for fibrinolytics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Idarucizumab:</strong> It is an antidote of dabigatran and not an anti-fibrinolytic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Andexanet alfa:</strong> A recombinant modified factor Xa decoy protein used as an antidote for <strong>direct factor Xa inhibitors</strong> (e.g., rivaroxaban, apixaban). It does not work for fibrinolytics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The antidote for fibrinolytic-induced bleeding is epsilon aminocaproic acid, which inhibits plasminogen activation and prevents fibrin degradation.</span></p>",
    "correct_choice_id": 372786,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93637/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_15.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93637/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_15.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93316,
    "choices": [
      {
        "id": 371532,
        "text": "<p><span style=\"font-size:14.0pt;\">Osteoid osteoma</span></p>"
      },
      {
        "id": 371533,
        "text": "<p><span style=\"font-size:14.0pt;\">Ewing's sarcoma</span></p>"
      },
      {
        "id": 371534,
        "text": "<p><span style=\"font-size:14.0pt;\">Osteosarcoma</span></p>"
      },
      {
        "id": 371535,
        "text": "<p><span style=\"font-size:14.0pt;\">Osteochondroma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A young male presents with pain in his thigh. The pain is worse at night and is partially relieved by salicylates. What is the most likely diagnosis?</span><span style=\"color:black;font-size:14.0pt;\"><strong>&nbsp;</strong></span></p>",
    "unique_key": "Q2809901",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Osteoid osteoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">It's a benign bone tumor that typically affects young males.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The pain is caused by the high concentration of prostaglandins produced by the tumor's nidus (the core).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This makes the pain highly responsive to NSAIDs, which inhibit prostaglandin synthesis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The radiographic image would typically show a small, lucent nidus surrounded by a dense, reactive bone sclerosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ewing's sarcoma:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ewing's sarcoma is a highly malignant bone tumor that usually presents with pain, swelling, and systemic symptoms like fever and an elevated white blood cell count.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Radiographically, it often appears as an \"onion skin\" periosteal reaction and a large destructive mass.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The pain is generally not reliably relieved by NSAIDs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Osteosarcoma:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Osteosarcoma is the most common primary malignant bone tumor in children and young adults.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It presents with progressive, localized pain and swelling.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The pain is typically severe and constant, not specifically worse at night or relieved by NSAIDs in the classic manner of osteoid osteoma.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Radiographs show a destructive lesion with characteristic \"sunburst\" or \"Codman's triangle\" patterns.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Osteochondroma:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Osteochondroma is the most common benign bone tumor.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It presents as a painless, bony projection near a joint, covered by a cartilage cap.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While it can cause pain due to mass effect on a nerve or tendon, the pain is not typically worse at night or relieved by NSAIDs in the classic fashion seen with osteoid osteoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient's clinical presentation\u2014a painful bone mass with pain that is <strong>worse at night</strong> and is <strong>classically relieved by NSAIDs</strong>\u2014is a hallmark feature of this benign bone tumor.</span></p>",
    "correct_choice_id": 371532,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93316/NEET_PG_22_Sep_2025_Orthopedics_Question_5.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      15
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93316/NEET_PG_22_Sep_2025_Orthopedics_Question_5.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93520,
    "choices": [
      {
        "id": 372332,
        "text": "<p><span style=\"font-size:14.0pt;\">Peritubular capillaries</span></p>"
      },
      {
        "id": 372333,
        "text": "<p><span style=\"font-size:14.0pt;\">Loop of Henle</span></p>"
      },
      {
        "id": 372334,
        "text": "<p><span style=\"font-size:14.0pt;\">Vasa recta</span></p>"
      },
      {
        "id": 372335,
        "text": "<p><span style=\"font-size:14.0pt;\">Juxtaglomerular apparatus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following structures in the kidney functions as the countercurrent exchanger, helping maintain the osmotic gradient necessary for urine concentration?</span></p>",
    "unique_key": "Q4450611",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Vasa recta</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The vasa recta are straight capillaries in the renal medulla that run parallel to the loop of Henle.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They act as <strong>countercurrent exchangers</strong>, allowing slow blood flow in opposite direction to tubular filtrate, which preserves the medullary osmotic gradient.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This mechanism is crucial for water reabsorption and concentration of urine.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Peritubular capillaries:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>These surround proximal and distal tubules and participate in solute and water reabsorption, but they are <strong>not countercurrent exchangers</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Loop of Henle:&nbsp;</strong>Incorrect.The loop of Henle acts as the <strong>countercurrent multiplier</strong>, generating the osmotic gradient. It does not function as the exchanger.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Juxtaglomerular apparatus:&nbsp;</strong>Incorrect. This regulates blood pressure and glomerular filtration via renin release. It does not contribute to the countercurrent mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The vasa recta serve as the kidney\u2019s countercurrent exchangers, maintaining the medullary osmotic gradient required for water reabsorption and concentrated urine formation.</span></p>",
    "correct_choice_id": 372334,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93520/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_7.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      2
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93520/NEET_PG_22_Sep_2025_PHYSIOLOGY_Question_7.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93634,
    "choices": [
      {
        "id": 372772,
        "text": "<p><span style=\"font-size:14.0pt;\">Isosorbide mononitrate</span></p>"
      },
      {
        "id": 372773,
        "text": "<p><span style=\"font-size:14.0pt;\">Diltiazem</span></p>"
      },
      {
        "id": 372774,
        "text": "<p><span style=\"font-size:14.0pt;\">Metoprolol</span></p>"
      },
      {
        "id": 372775,
        "text": "<p><span style=\"font-size:14.0pt;\">Ranolazine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man presents with recurrent episodes of substernal chest pain that occur at rest, particularly in the early morning hours. The pain is occasionally associated with mild diaphoresis but not exertion. An ECG obtained during one of these episodes reveals transient ST-segment elevation in the anterior leads, which resolves spontaneously within minutes. Which of the following medications would most likely exacerbate his condition?</span></p>",
    "unique_key": "Q8011550",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Metoprolol</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Prinzmetal (variant) angina is caused by <strong>transient coronary artery vasospasm</strong>, producing rest pain with <strong>temporary ST-segment elevation</strong> that resolves after vasodilation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>First-line therapy</strong>: Calcium channel blockers (e.g., diltiazem) and nitrates (e.g., isosorbide mononitrate) because they reduce vasospasm by promoting smooth muscle relaxation and vasodilation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Beta-blockers (e.g., metoprolol)</strong> are contraindicated because they block <strong>\u03b2\u2082-mediated vasodilation</strong>, leaving <strong>unopposed \u03b1-adrenergic vasoconstriction</strong>, which can <strong>worsen coronary vasospasm</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Thus, the drug most likely to exacerbate the condition is <strong>Metoprolol</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Isosorbide mononitrate:</strong> Long-acting nitrate; causes vasodilation and relieves coronary vasospasm. Helpful, not harmful.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Diltiazem:</strong> Calcium channel blocker; prevents coronary vasospasm and improves symptoms. Beneficial.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ranolazine:</strong> A late sodium current inhibitor used in refractory <strong>chronic stable angina</strong>; while not first-line for Prinzmetal angina, it does not exacerbate vasospasm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In vasospastic (Prinzmetal) angina, beta-blockers such as metoprolol are contraindicated because they worsen vasospasm via unopposed alpha-adrenergic vasoconstriction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Calcium channel blockers and nitrates are preferred therapies.</span></li></ul>",
    "correct_choice_id": 372774,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93634/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_12.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93634/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_12.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92943,
    "choices": [
      {
        "id": 370064,
        "text": "<p><span style=\"font-size:14.0pt;\">ATP is required for the reaction in which argininosuccinate is cleaved to form arginine</span></p>"
      },
      {
        "id": 370065,
        "text": "<p><span style=\"font-size:14.0pt;\">Urea is produced directly by the hydrolysis of ornithine</span></p>"
      },
      {
        "id": 370066,
        "text": "<p><span style=\"font-size:14.0pt;\">The two nitrogen atoms incorporated into urea enter the cycle as ammonia and alanine</span></p>"
      },
      {
        "id": 370067,
        "text": "<p><span style=\"font-size:14.0pt;\">Urinary urea is increased by a diet rich in protein</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Regarding the urea cycle, which statement is most accurate?<strong>&nbsp;</strong></span></p>",
    "unique_key": "Q9687895",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Urinary urea is increased by a diet rich in protein</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>diet rich in protein</strong> increases amino acid catabolism, generating more <strong>ammonia (NH\u2083/NH\u2084\u207a)</strong> that must be detoxified via the <strong>urea cycle</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The liver converts nitrogen to <strong>urea</strong>, which is then eliminated as <strong>urinary urea</strong>; therefore, protein loading raises both blood urea nitrogen and urinary excretion\u2014making the statement <strong>\u201cUrinary urea is increased by a diet rich in protein\u201d</strong> correct and the <strong>best</strong> description of a <strong>correct aspect of the urea cycle</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key mechanistic context to cover all original phrases:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>\u201cTwo nitrogen atoms that are incorporated into urea\u201d</strong>: One nitrogen enters the cycle as <strong>free ammonia</strong> (via <strong>carbamoyl phosphate synthetase I</strong>, mitochondrial), and the second enters as <strong>aspartate</strong>, not <strong>alanine</strong>. Thus, \u201c<strong>ammonia and alanine</strong>\u201d is incorrect; alanine transports nitrogen to the liver (via the glucose\u2013alanine cycle), but the actual urea nitrogen donors are <strong>ammonia and aspartate</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>\u201cUrea is produced directly by the hydrolysis of ornithine\u201d</strong> is incorrect because <strong>arginase</strong> hydrolyzes <strong>arginine</strong> to <strong>urea and ornithine</strong>; <strong>ornithine</strong> is not hydrolyzed to form urea. Ornithine re-enters the cycle by accepting <strong>carbamoyl phosphate</strong> to form <strong>citrulline</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>\u201cATP is required for the reaction in which argininosuccinate is cleaved to form arginine\u201d</strong> is incorrect. <strong>Argininosuccinate lyase</strong> cleaves <strong>argininosuccinate \u2192 arginine + fumarate</strong> <strong>without ATP</strong>. ATP is consumed earlier: <strong>carbamoyl phosphate synthetase I</strong> uses <strong>2 ATP</strong>, and <strong>argininosuccinate synthetase</strong> uses <strong>ATP \u2192 AMP + PPi</strong> (equivalent to two high-energy bonds).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Because protein intake increases nitrogen disposal through the urea cycle, <strong>urinary urea</strong> appropriately rises\u2014exactly matching choice <strong>D</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. ATP is required for the reaction in which argininosuccinate is cleaved to form arginine</strong>: Incorrect. The <strong>reaction in which argininosuccinate is cleaved to form arginine</strong> is catalyzed by <strong>argininosuccinate lyase</strong> and <strong>does not require ATP</strong>. Although the <strong>urea cycle</strong> does use ATP (e.g., CPS I; <strong>argininosuccinate synthetase</strong>), ATP is <strong>not</strong> used at the lyase step. Therefore, this statement does <strong>not</strong> describe a <strong>correct aspect</strong> of the cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Urea is produced directly by the hydrolysis of ornithine:</strong> Incorrect. <strong>Urea is produced</strong> by <strong>hydrolysis of arginine</strong>, not ornithine. <strong>Arginase</strong> converts <strong>arginine \u2192 urea + ornithine</strong>. The produced <strong>ornithine</strong> re-enters the <strong>urea cycle</strong> (accepts carbamoyl phosphate to form citrulline) but is <strong>not</strong> directly hydrolyzed to generate urea. Hence, this statement is <strong>not</strong> correct.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The two nitrogen atoms that are incorporated into urea enter the cycle as ammonia and alanine:</strong> Incorrect. While <strong>ammonia</strong> is indeed one nitrogen source, the other nitrogen comes from <strong>aspartate</strong>, not <strong>alanine</strong>. <strong>Alanine</strong> carries nitrogen from muscle to liver but does <strong>not</strong> directly serve as the second nitrogen donor <strong>incorporated into urea</strong>. Thus, the phrase \u201c<strong>ammonia and alanine</strong>\u201d is <strong>not</strong> a correct description of nitrogen entry into the <strong>urea cycle</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>diet rich in protein</strong> increases nitrogen disposal via the <strong>urea cycle</strong>, leading to <strong>increased urinary urea</strong>.</span></p>",
    "correct_choice_id": 370067,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92943/NEET_PG_22_Sep_2025_Biochemistry_Question_3.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      1
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92943/NEET_PG_22_Sep_2025_Biochemistry_Question_3.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93643,
    "choices": [
      {
        "id": 372808,
        "text": "<p><span style=\"font-size:14.0pt;\">Omalizumab</span></p>"
      },
      {
        "id": 372809,
        "text": "<p><span style=\"font-size:14.0pt;\">Dupilumab</span></p>"
      },
      {
        "id": 372810,
        "text": "<p><span style=\"font-size:14.0pt;\">Benralizumab</span></p>"
      },
      {
        "id": 372811,
        "text": "<p><span style=\"font-size:14.0pt;\">Trastuzumab</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 46-year-old woman with a history of poorly controlled asthma despite maximal inhaled corticosteroid and long-acting \u03b2\u2082-agonist therapy presents with recurrent hospitalizations for exacerbations. Peripheral blood studies show an eosinophil count of 1,200/\u00b5L (normal &lt;500/\u00b5L). Pulmonary function testing demonstrates a reduced FEV\u2081 with partial reversibility after bronchodilator use. Given her severe eosinophilic asthma, she is started on a monoclonal antibody that binds to the IL-5 receptor \u03b1 chain. Which of the following biologic agents best fits this mechanism?</span></p>",
    "unique_key": "Q3240101",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Benralizumab</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Benralizumab</strong> is a <strong>monoclonal antibody against the IL-5 receptor \u03b1 chain</strong> on eosinophils and basophils.</span></li><li><span style=\"font-size:14.0pt;\">It triggers <strong>antibody-dependent cell-mediated cytotoxicity (ADCC)</strong>, leading to rapid and nearly complete <strong>eosinophil depletion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is FDA-approved as an add-on therapy for <strong>severe eosinophilic asthma</strong>, especially in patients who remain symptomatic despite high-dose inhaled corticosteroids and long-acting \u03b2\u2082-agonists.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Omalizumab:</strong> Anti-IgE monoclonal antibody used in <strong>moderate to severe allergic asthma</strong> with elevated serum IgE. It does not target IL-5.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Dupilumab:</strong> Anti-IL-4 receptor \u03b1 monoclonal antibody that blocks IL-4 and IL-13 signaling. It is used for <strong>moderate-to-severe asthma</strong>, atopic dermatitis, and chronic rhinosinusitis with nasal polyps.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Trastuzumab:</strong> Anti-her-2/neu monoclonal antibody that is used for treatment of breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Benralizumab is an IL-5 receptor \u03b1 monoclonal antibody that induces eosinophil apoptosis via antibody-dependent cell-mediated cytotoxicity, and is used as add-on therapy for severe eosinophilic asthma.</span></p>",
    "correct_choice_id": 372810,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93643/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_20.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      4
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93643/NEET_PG_22_Sep_2025_PHARMACOLOGY_Question_20.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93315,
    "choices": [
      {
        "id": 371528,
        "text": "<p><span style=\"font-size:14.0pt;\">Hemiarthroplasty</span></p>"
      },
      {
        "id": 371529,
        "text": "<p><span style=\"font-size:14.0pt;\">Closed Reduction Internal Fixation</span></p>"
      },
      {
        "id": 371530,
        "text": "<p><span style=\"font-size:14.0pt;\">Closed Reduction</span></p>"
      },
      {
        "id": 371531,
        "text": "<p><span style=\"font-size:14.0pt;\">Open + Closed Reduction</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman was taken to a trauma centre after suffering an accident. An X-ray of her pelvis was taken, and the image below demonstrates an intracapsular fracture NOF. In this instance, what is the management?&nbsp; &nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_WqDjp5p.png\" width=\"265\" height=\"346\"></span></p>",
    "unique_key": "Q5919024",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Closed Reduction Internal Fixation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This procedure involves realigning the bone fragments without an open incision (closed reduction) and then stabilizing them with screws or pins (internal fixation).</span></li><li><span style=\"font-size:14.0pt;\">This is the preferred treatment for an intracapsular NOF fracture in a young adult because it aims to preserve the native hip joint.</span></li><li><span style=\"font-size:14.0pt;\">A successful reduction and fixation provides the best chance for the fracture to heal, restoring the original anatomy and function of the hip.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hemiarthroplasty:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While hemiarthroplasty (replacement of only the femoral head component of the hip joint) is a common treatment option for older patients with displaced femoral neck fractures, it might not be the best choice for a younger patient with the potential for long-term joint function.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hemiarthroplasty is considered a salvage procedure for joints with severe degenerative arthritis or avascular necrosis.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Closed Reduction:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This procedure involves manipulating the bone fragments back into position without surgery.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, it is less likely to be successful with a displaced intracapsular fracture, especially in a younger patient.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Closed reduction may be considered for nondisplaced fractures or as an initial attempt before resorting to ORIF.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Open + Closed Reduction:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This option combines open surgical exposure with closed manipulation of the fracture fragments.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While technically possible, it is generally not preferred over a standard ORIF due to the increased complexity and potential for complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">At age 45, preserving the natural hip joint is the priority. CRIF allows for this, while a hemiarthroplasty would require subsequent revision surgeries due to the patient's greater life expectancy and activity level.</span></p>",
    "correct_choice_id": 371529,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93315/NEET_PG_22_Sep_2025_Orthopedics_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      15
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93315/NEET_PG_22_Sep_2025_Orthopedics_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92916,
    "choices": [
      {
        "id": 369960,
        "text": "<p><span style=\"font-size:14.0pt;\">Secretory otitis media</span></p>"
      },
      {
        "id": 369961,
        "text": "<p><span style=\"font-size:14.0pt;\">Otosclerosis</span></p>"
      },
      {
        "id": 369962,
        "text": "<p><span style=\"font-size:14.0pt;\">Acute otitis media</span></p>"
      },
      {
        "id": 369963,
        "text": "<p><span style=\"font-size:14.0pt;\">Eustachian tube dysfunction</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman presents with a 6-month history of progressive hearing difficulty in her right ear. She denies vertigo but reports occasional tinnitus. On otoscopic examination, the tympanic membrane appears normal. Pure tone audiometry shows an air-bone gap of 25 dB at low frequencies with normal bone conduction thresholds. Tympanometry demonstrates a Type As curve with reduced compliance but normal middle ear pressure. Acoustic reflex is absent on the affected side. Which of the following is the most likely diagnosis?</span></p>",
    "unique_key": "Q7965862",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Otosclerosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Otosclerosis is a hereditary disorder characterized by abnormal bony remodeling at the stapes footplate, leading to conductive hearing loss.</span></li><li><span style=\"font-size:14.0pt;\">Audiometry shows an <strong>air-bone gap</strong> (conductive pattern), tympanometry shows a <strong>Type As curve</strong> (stiff system with reduced compliance), and absent acoustic reflexes further confirm stapes fixation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The normal tympanic membrane rules out middle ear effusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Secretory otitis media:&nbsp;</strong>This condition produces a conductive hearing loss, but tympanometry usually shows a <strong>Type B curve</strong> (flat, indicating fluid in the middle ear). Additionally, the tympanic membrane often appears dull or retracted, which was not observed in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Acute otitis media:&nbsp;</strong>Acute infection of the middle ear typically presents with fever, ear pain, and a bulging, erythematous tympanic membrane. Audiometry would show conductive loss, but tympanometry would more likely show a <strong>Type C curve</strong> if negative pressure is present or <strong>Type B</strong> if effusion has developed. The chronic, painless course in this patient does not fit.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Eustachian tube dysfunction:&nbsp;</strong>This often produces a <strong>Type C tympanogram</strong> (negative middle ear pressure) due to poor aeration of the middle ear. Patients usually report ear fullness or popping sensations, not progressive conductive hearing loss with normal tympanic membrane and absent stapedial reflex.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In audiology, <strong>otosclerosis</strong> is characterized by a conductive hearing loss with an <strong>air-bone gap, Type As tympanogram, and absent acoustic reflexes</strong>, distinguishing it from otitis media and eustachian tube dysfunction.</span></p>",
    "correct_choice_id": 369961,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92916/Neet_Pg_22_Sep_2025_Ent_Question_4.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      9
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92916/Neet_Pg_22_Sep_2025_Ent_Question_4.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92913,
    "choices": [
      {
        "id": 369948,
        "text": "<p><span style=\"font-size:14.0pt;\">Wait and watch for 4\u20135 days to allow spontaneous healing</span></p>"
      },
      {
        "id": 369949,
        "text": "<p><span style=\"font-size:14.0pt;\">Do an MRI to localize the leak and repair endoscopically</span></p>"
      },
      {
        "id": 369950,
        "text": "<p><span style=\"font-size:14.0pt;\">Insert a lumbar (dural) catheter to control CSF leak</span></p>"
      },
      {
        "id": 369951,
        "text": "<p><span style=\"font-size:14.0pt;\">Perform transcranial repair of the frontobasal defect</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old male presents to the emergency department after a road traffic accident. He is conscious and oriented but complains of watery discharge from his right nostril. NCCT head reveals a inoperable frontobasal skull fracture. What is the most appropriate initial management?</span></p>",
    "unique_key": "Q3062164",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Wait and watch for 4\u20135 days to allow spontaneous healing</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The majority of cases of post-traumatic CSF rhinorrhea close spontaneously within a few days.</span></li><li><span style=\"font-size:14.0pt;\">Conservative management includes bed rest, head elevation, avoidance of coughing/sneezing, and prophylactic antibiotics to prevent meningitis.</span></li><li><span style=\"font-size:14.0pt;\">Immediate surgical intervention is not required unless the leak persists beyond 7\u201310 days or complications (like meningitis) arise.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Do an MRI to localize the leak and repair endoscopically:&nbsp;</strong>Endoscopic repair is considered for <strong>persistent or recurrent leaks</strong> that do not close with conservative management. It is not the first-line approach in an acute setting where healing can occur spontaneously.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Insert a lumbar (dural) catheter to control CSF leak:&nbsp;</strong>Lumbar drains may be used as a supportive measure in <strong>persistent leaks</strong> to reduce intracranial pressure and facilitate healing, but they are not indicated in the initial conservative phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Perform transcranial repair of the frontobasal defect:&nbsp;</strong>This is reserved for complex, persistent, or recurrent leaks that cannot be managed endoscopically. It carries higher morbidity and is not appropriate for an initial non-surgical case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Most cases of <strong>post-traumatic CSF rhinorrhea</strong> resolve spontaneously; hence, the initial management is <strong>conservative observation for 4\u20135 days</strong>, reserving surgical repair for persistent or complicated leaks.</span></p>",
    "correct_choice_id": 369948,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92913/Neet_Pg_22_Sep_2025_Ent_Question_1.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      9
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92913/Neet_Pg_22_Sep_2025_Ent_Question_1.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92888,
    "choices": [
      {
        "id": 369848,
        "text": "<p><span style=\"font-size:14.0pt;\">Larvae migrate and encyst in skeletal muscles</span></p>"
      },
      {
        "id": 369849,
        "text": "<p><span style=\"font-size:14.0pt;\">Coproantigen ELISA can confirm active intestinal infection</span></p>"
      },
      {
        "id": 369850,
        "text": "<p><span style=\"font-size:14.0pt;\">Adult worms are isolated from CSF during early infection</span></p>"
      },
      {
        "id": 369851,
        "text": "<p><span style=\"font-size:14.0pt;\">Muscle biopsy near tendon is a reliable diagnostic method</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following are true regarding Trichinella spiralis except:</span></p>",
    "unique_key": "Q9547155",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Adult worms are isolated from CSF during early infection</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Adult worms are isolated from CSF during early infection is incorrect, because Trichinella spiralis adult worms are <strong>not found in the CSF</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">After ingestion of <strong>first-stage larvae (L1)</strong> from undercooked pork, the parasite matures into adults in the <strong>intestinal mucosa</strong>, not in the central nervous system.</span></li><li><span style=\"font-size:14.0pt;\">The larvae migrate via the bloodstream to <strong>striated muscle</strong>, not the CSF, where they encyst.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20121107.jpg\" width=\"774\" height=\"764\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Larvae migrate and encyst in skeletal muscles:</strong> True. This is a classic feature of T. spiralis. Preferred sites include <strong>extraocular muscles</strong>, <strong>jaw</strong>, <strong>neck</strong>, <strong>diaphragm</strong>, and <strong>deltoid</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Coproantigen ELISA can confirm active intestinal infection:</strong> True. The <strong>double sandwich ELISA</strong> targeting larval somatic antigens in stool helps confirm <strong>intestinal phase</strong> of the infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Muscle biopsy near tendon is a reliable diagnostic method:</strong> True. Muscle biopsy from <strong>areas near tendons</strong> (e.g., deltoid insertion) is diagnostic and can reveal <strong>encysted larvae</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Trichinella spiralis is transmitted via ingestion of <strong>L1 larvae</strong> in undercooked pork. Larvae <strong>encyst in skeletal muscle</strong>, not CSF.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Diagnosis can include <strong>muscle biopsy</strong>, <strong>coproantigen detection</strong>, and <strong>serology</strong>, but <strong>adult worms are confined to the intestinal mucosa</strong>.</span></li></ul>",
    "correct_choice_id": 369850,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92888/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_15.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      6
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92888/NEET_PG_22_Sep_2025_MICROBIOLOGY_Question_15.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93554,
    "choices": [
      {
        "id": 372468,
        "text": "<p><span style=\"font-size:14.0pt;\">Hysterosalpingography</span></p>"
      },
      {
        "id": 372469,
        "text": "<p><span style=\"font-size:14.0pt;\">Serum prolactin level</span></p>"
      },
      {
        "id": 372470,
        "text": "<p><span style=\"font-size:14.0pt;\">Hysteroscopy</span></p>"
      },
      {
        "id": 372471,
        "text": "<p><span style=\"font-size:14.0pt;\">Progesterone challenge test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman presents to the clinic concerned about the absence of her menstrual periods for the past 9 months. Her symptoms began after she underwent a dilation and curettage procedure following a missed abortion. Laboratory results show serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels are within normal limits. What is the most appropriate next diagnostic investigation?</span></p>",
    "unique_key": "Q5551479",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Hysteroscopy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 28-year-old woman presents with secondary amenorrhea lasting 9 months following a dilation and curettage (D&amp;C) procedure after a missed abortion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The normal serum FSH and LH levels indicate intact hypothalamic-pituitary-ovarian axis function, ruling out central causes of amenorrhea.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Given the temporal relationship between the D&amp;C procedure and the onset of amenorrhea, the most likely diagnosis is Asherman's syndrome (intrauterine adhesions or synechiae).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hysteroscopy is the gold standard diagnostic tool for directly visualizing the uterine cavity and identifying intrauterine adhesions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It allows for both diagnosis and potential therapeutic intervention during the same procedure, making it the most appropriate next investigation in this clinical scenario.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A</strong>. <strong>Hysterosalpingography:&nbsp;</strong>Although this imaging study can identify uterine cavity abnormalities and tubal patency, it is less sensitive than hysteroscopy for detecting intrauterine adhesions. It also involves radiation exposure and cannot provide therapeutic intervention if adhesions are found.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B</strong>. <strong>Serum prolactin level:</strong> While elevated prolactin can cause amenorrhea, the normal FSH and LH levels make a prolactin-related cause less likely. Additionally, the clear temporal relationship with the D&amp;C procedure points toward a structural uterine cause rather than a hormonal one.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D</strong>. <strong>Progesterone challenge test:</strong> This test evaluates estrogen levels and endometrial responsiveness but would not be the next best step when structural uterine pathology is suspected. With normal FSH and LH levels, hormonal causes are less likely, and the progesterone challenge would not identify intrauterine adhesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Following dilation and curettage procedures, patients who develop secondary amenorrhea with normal FSH and LH levels should be evaluated for Asherman's syndrome using hysteroscopy as the diagnostic method of choice.</span></p>",
    "correct_choice_id": 372470,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93554/NEET_PG_22_Sep_2025_OBG_Question_15.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      14
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93554/NEET_PG_22_Sep_2025_OBG_Question_15.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92890,
    "choices": [
      {
        "id": 369856,
        "text": "<p><span style=\"font-size:14.0pt;\">1\u2013b, 2\u2013c, 3\u2013a, 4\u2013d</span></p>"
      },
      {
        "id": 369857,
        "text": "<p><span style=\"font-size:14.0pt;\">1\u2013c, 2\u2013b, 3\u2013d, 4\u2013a</span></p>"
      },
      {
        "id": 369858,
        "text": "<p><span style=\"font-size:14.0pt;\">1\u2013d, 2\u2013c, 3\u2013a, 4\u2013b</span></p>"
      },
      {
        "id": 369859,
        "text": "<p><span style=\"font-size:14.0pt;\">1\u2013b, 2\u2013d, 3\u2013c, 4\u2013a</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-09-10%20121218.jpg\" width=\"1105\" height=\"461\"></strong></span></p>",
    "unique_key": "Q9780678",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1\u2013b, 2\u2013c, 3\u2013a, 4\u2013d</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1. Amitriptyline \u2192 b. Acute angle-closure glaucoma:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Amitriptyline</strong> is a <strong>tricyclic antidepressant (TCA)</strong> with <strong>potent anticholinergic effects</strong>.</span></li><li><span style=\"font-size:14.0pt;\">These effects can lead to <strong>mydriasis (pupil dilation)</strong>, which may precipitate <strong>acute angle-closure glaucoma</strong>, especially in predisposed individuals with shallow anterior chambers.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>2. SSRIs (e.g., Fluoxetine) \u2192 c. Sexual dysfunction:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Selective serotonin reuptake inhibitors (SSRIs)</strong> commonly cause <strong>sexual side effects</strong>, including <strong>delayed ejaculation, decreased libido, and anorgasmia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is one of the <strong>most frequent causes</strong> of SSRI discontinuation.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>3. Trazodone \u2192 a. Priapism: Trazodone</strong>, an antidepressant with <strong>serotonergic and alpha-1 adrenergic blocking properties</strong>, is notorious for causing <strong>priapism</strong> (prolonged, painful erection) as a rare but serious side effect.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4. Bupropion \u2192 d. Seizure threshold lowering:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Bupropion</strong> is a <strong>norepinephrine-dopamine reuptake inhibitor (NDRI)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>contraindicated in patients with seizure disorders</strong>, as it <strong>lowers the seizure threshold</strong>, especially at <strong>high doses</strong> or in predisposed individuals (e.g., bulimia, anorexia nervosa).</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Side effects of commonly used antidepressants:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Amitriptyline (TCA) can trigger acute angle-closure glaucoma due to anticholinergic action.</span></li><li><span style=\"font-size:14.0pt;\">SSRIs often cause sexual dysfunction, the most common reason for discontinuation.</span></li><li><span style=\"font-size:14.0pt;\">Trazodone is uniquely associated with priapism, a rare urologic emergency.</span></li><li><span style=\"font-size:14.0pt;\">Bupropion lowers the seizure threshold and must be avoided in predisposed individuals</span></li></ul>",
    "correct_choice_id": 369856,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92890/NEET_PG_22_Sep_2025_PSYCHIATRY_Question_2.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      16
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92890/NEET_PG_22_Sep_2025_PSYCHIATRY_Question_2.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 93609,
    "choices": [
      {
        "id": 372676,
        "text": "<p><span style=\"font-size:14.0pt;\">Initiate antihypertensive medication immediately</span></p>"
      },
      {
        "id": 372677,
        "text": "<p><span style=\"font-size:14.0pt;\">Recommend lifestyle modifications and repeat BP in 3 months</span></p>"
      },
      {
        "id": 372678,
        "text": "<p><span style=\"font-size:14.0pt;\">Order an echocardiogram to assess for target organ damage</span></p>"
      },
      {
        "id": 372679,
        "text": "<p><span style=\"font-size:14.0pt;\">Refer to a cardiologist for further evaluation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old man with no cardiovascular risk factors presents for a routine check-up. His office BP readings over three visits in the past month are consistently 132/84 mmHg, 135/86 mmHg, and 134/85 mmHg. He is asymptomatic with a normal physical examination. What should be the next step in his management?</span></p>",
    "unique_key": "Q6702485",
    "difficulty_level": "intermediate",
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Recommend lifestyle modifications and repeat BP in 3 months</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient\u2019s office BP (130\u2013139/80\u201389 mmHg) falls into the <strong>elevated BP</strong> category per the ESC 2024 guidelines, which define this range as a continuum of cardiovascular risk without meeting the hypertension threshold (\u2265140/90 mmHg).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The absence of CV risk factors and symptoms suggests a low immediate risk, guiding a conservative approach.</span></li><li><span style=\"font-size:14.0pt;\">The ESC 2024 guidelines recommend <strong>lifestyle modifications</strong> (e.g., sodium reduction &lt;5 g/day, 150\u2013300 min/week moderate exercise, weight loss if BMI &gt;25 kg/m\u00b2) for elevated BP, especially in the absence of CV risk factors.</span></li><li><span style=\"font-size:14.0pt;\">Repeat BP measurement in <strong>3 months</strong> allows assessment of progression or stability, aligning with the guideline\u2019s emphasis on monitoring before initiating pharmacotherapy in low-risk cases.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Rationale</strong>: The patient\u2019s consistent readings and lack of risk factors indicate a need for non-pharmacologic intervention first, with follow-up to determine if hypertension develops (\u2265140/90 mmHg), as per the risk-based strategy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Initiate antihypertensive medication immediately</strong>: Incorrect. Immediate medication is not indicated for elevated BP (130\u2013139/80\u201389 mmHg) without CV risk factors or target organ damage, per ESC 2024. Pharmacotherapy is reserved for hypertension (\u2265140/90 mmHg) or high-risk patients, avoiding unnecessary treatment in this low-risk case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Order an echocardiogram to assess for target organ damage</strong>: Incorrect. Echocardiography is not routinely recommended for elevated BP without symptoms, signs of left ventricular hypertrophy, or other CV risk factors. The ESC 2024 guidelines suggest imaging only as an optional step to assess HMOD, not a mandate.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Refer to a cardiologist for further evaluation</strong>: Incorrect. Referral is unwarranted for elevated BP without risk factors or abnormal findings. The ESC guidelines advocate primary care management with lifestyle changes and follow-up, reserving specialist referral for resistant hypertension or secondary cause suspicion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Elevated BP (130\u2013139/80\u201389 mmHg) without CV risk factors warrants lifestyle modifications (e.g., sodium &lt;5 g/day, exercise) and BP recheck in 3 months.</span></li><li><span style=\"font-size:14.0pt;\">Immediate antihypertensive therapy is not indicated unless BP reaches \u2265140/90 mmHg or risk factors are present.</span></li><li><span style=\"font-size:14.0pt;\">Routine echocardiography or cardiology referral is unnecessary without evidence of target organ damage or complications.</span></li></ul>",
    "correct_choice_id": 372677,
    "question_audio": null,
    "question_video": null,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93609/Neet_Pg_22_Sep_2025_Medicine_Question_201.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [],
    "subjects_id": [
      11
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/93609/Neet_Pg_22_Sep_2025_Medicine_Question_201.mp4",
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Inicet Mock Test-3 - 22-09-2025';
        const quizFilename = 'inicet-mock-test-3-22-09-2025-002becb7.html';
        let hierarchy = ["Cerebellum", "Mock Test", "GT"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>